FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU da Silva, W
   Cardoso, DT
   Morais, MHF
   Carneiro, M
   Moraga, P
   Barbosa, DS
AF da Silva, Wellington Junior
   Cardoso, Diogo Tavares
   Franco Morais, Maria Helena
   Carneiro, Mariangela
   Moraga, Paula
   Barbosa, David Soeiro
TI Spatiotemporal patterns and integrated approach to prioritize areas for
   surveillance and control of visceral leishmaniasis in a large
   metropolitan area in Brazil
SO ACTA TROPICA
LA English
DT Article
DE Leishmaniasis visceral; Spatial analysis; Spatio-temporal analysis
ID BELO-HORIZONTE; SPATIAL-ANALYSIS; MINAS-GERAIS; STATE
AB Visceral leishmaniasis (VL) is a neglected disease with worldwide distribution. Brazil is the country with the largest number of cases in the Americas, and the state of Minas Gerais presents a high VL-related burden and a high case fatality rate. We aimed to analyse the spatial and spatiotemporal patterns of VL occurrence and to identify priority risk areas for surveillance and control in the metropolitan region of Belo Horizonte-MG, the third largest metropolitan area in Brazil. An ecological study was conducted considering all cases of VL in humans confirmed from 2006 to 2017. The crude and smoothed incidence rates were used to analyse the distribution patterns of the disease (dispersed, random, or clustered) based on global and local indicators of spatial association and space-time risk assessment. Positive spatial autocorrelation and spatial dependence were found between incidence rates. It was possible to observe a high concentration of VL cases in the metropolitan core area, with the identification of two high-risk clusters in strictly urban areas, showing an urban association with the disease. Ten municipalities were categorised as high risk for VL occurrence. Our results provide evidence for making decisions in surveillance programs, suggesting the prioritisation of the municipalities with more risk of transmission.
C1 [da Silva, Wellington Junior; Cardoso, Diogo Tavares; Carneiro, Mariangela; Barbosa, David Soeiro] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Franco Morais, Maria Helena] Belo Horizonte Hlth Dept, Ave Afonso Pena 2336, BR-30130012 Belo Horizonte, MG, Brazil.
   [Moraga, Paula] Univ Bath, Dept Math Sci, North Rd, Bath BA2 7AY, Avon, England.
   [Barbosa, David Soeiro] Univ London, London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
RP Barbosa, DS (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Barbosa, DS (corresponding author), Univ London, London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM davidsoeiro@gmail.com
OI /0000-0001-5266-0201
FU CNPq-Brazil (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [409901/2016-4]; CAPES/PRINT (Coordination for the
   Improvement of Higher Education Personnel) [88887.474426/2020-00];
   CNPq-BrazilNational Council for Scientific and Technological Development
   (CNPq); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)Minas
   Gerais State Research Foundation (FAPEMIG) [PPM00,591-16]
FX David Soeiro Barbosa is grateful for the research grants from
   CNPq-Brazil (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - Grant number 409901/2016-4) and CAPES/PRINT (Coordination
   for the Improvement of Higher Education Personnel - Grant number
   88887.474426/2020-00). M. Carneiro is grateful to CNPq-Brazil for the
   productivity research fellowships and FAPEMIG (Fundacao de Amparo a
   Pesquisa de Minas Gerais) for the Pesquisador Mineiro (PPM00,591-16).
   These funding sources had no role in the design, execution, analyses,
   interpretation of the data, or decision to submit results of this study.
CR Abrams AM, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-6
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Arizona State University/Center for Geospatial Analysis and Computation, 2000, GEODA SPAT DAT AN
   Barbosa DS, 2014, ACTA TROP, V131, P56, DOI 10.1016/j.actatropica.2013.12.002
   Bevilacqua PD, 2001, ARQ BRAS MED VET ZOO, V53, P1, DOI 10.1590/S0102-09352001000100001
   von Zuben APB, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00087415
   Caiaffa Waleska Teixeira, 2005, Cad. Saúde Pública, V21, P958, DOI 10.1590/S0102-311X2005000300032
   Coura-Vital W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208613
   Druck S, 2004, ANALISE ESPACIAL DAD
   Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125
   e Silva RA, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170377
   de Arruda RMF, 2019, ACTA TROP, V197, DOI 10.1016/j.actatropica.2019.105052
   Genaro O, 1990, Rev Soc Bras Med Trop, V23, P121, DOI 10.1590/S0037-86821990000200011
   IBGE, 2018, EST POP
   Kazimoto TA, 2018, VECTOR-BORNE ZOONOT, V18, P356, DOI 10.1089/vbz.2017.2166
   Melchior LAK, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0311-5
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   Kulldorff M, 2015, SATSCAN SOFTWARE SPA
   Luz ZMP, 2001, REV SOC BRAS MED TRO, V34, P249, DOI DOI 10.1590/S0037-86822001000300004
   Leite BMM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006496
   Margonari C, 2006, MEM I OSWALDO CRUZ, V101, P31, DOI 10.1590/S0074-02762006000100007
   Ministerio da Saude, 2019, SIST INF AGR NOT SIN
   Ministerio da Saude, 2006, MAN VIG CONTR LEISHM, DOI [10.4271/962014, DOI 10.4271/962014]
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   Oliveira C.D., 2001, ESC NAC SAUDE PUBLIC, V17, P1231, DOI [10.1590/S0102-311X2001000500023, DOI 10.1590/S0102-311X2001000500023]
   PAHO, 2019, LEISHM INF EP NAS AM
   Bruhn FRP, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2877-6
   QGIS project, 2019, QGIS US GUID REL 2 1
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   Silva T.A.M., 2017, PLOS NEGLECT TROP D, V11, P2002, DOI [10.1371/journal.pntd., DOI 10.1371/JOURNAL.PNTD]
   Maia-Elkhoury ANS, 2007, REV SAUDE PUBL, V41, P929
   WHO, 2019, FACT SHEETS LEISHM
NR 33
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2020
VL 211
AR 105615
DI 10.1016/j.actatropica.2020.105615
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA NS5UZ
UT WOS:000572327300025
PM 32621931
DA 2020-12-08
ER

PT J
AU Bezerra, JMT
   Barbosa, DS
   Martins-Melo, FR
   Werneck, GL
   Braga, EM
   Tauil, PL
   Carneiro, M
AF Trindade Bezerra, Juliana Maria
   Barbosa, David Soeiro
   Martins-Melo, Francisco Rogerlandio
   Werneck, Guilherme Loureiro
   Braga, Erika Martins
   Tauil, Pedro Luiz
   Carneiro, Mariangela
TI Changes in malaria patterns in Brazil over 28years (1990-2017): results
   from the Global Burden of Disease Study 2017
SO POPULATION HEALTH METRICS
LA English
DT Article
DE Malaria; Burden of disease; Disability-adjusted life year; Brazil
ID PLASMODIUM-VIVAX MALARIA; ENDEMIC AREA; STATE; AMAZON; EPIDEMIOLOGY;
   INFECTION
AB BackgroundThis study presents the malaria burden in Brazil from 1990 to 2017 using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017), by analyzing disease burden indicators in federated units of the Legal Amazon and Extra-Amazon regions, as well as describing malaria cases according to Plasmodium species occurring in the country.MethodsWe used estimates from the GBD 2017 to report years of life lost due to premature death (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) for malaria in Brazil, grouped by gender, age group, and Brazilian federated unit, from 1990 to 2017. Results are presented as absolute numbers and age-standardized rates (per 100,000 inhabitants) with 95% uncertainty intervals (UI).ResultsAt the national level, the age-standardized DALYs rate due to malaria decreased by 92.0%, from 42.5 DALYs per 100,000 inhabitants (95% UI 16.6-56.9) in 1990 to 3.4 DALYs per 100,000 inhabitants (95% UI 2.7-4.7) in 2017. The YLLs were the main component of the total DALYs rate for malaria in 1990 (67.3%), and the YLDs were the main component of the metric in 2017 (61.8%). In 2017, the highest sex-age DALYs rate was found among females in the "<1-year-old" age group, with a 6.4 DALYs per 100,000 inhabitants (95% UI 1.8-14.7) and among males in the age group of "20 to 24years old", with a 4.7 DALYs per 100,000 inhabitants (95% UI 3.3-9.9). Within the Brazilian Amazon region, the three federated units with the highest age-standardized DALYs rates in 2017 were Acre [28.4 (95% UI 14.2-39.1)], Roraima [28.3 (95% UI 13.5-40.2)], and Rondonia [24.7 (95% UI 11.4-34.8)]. Concerning the parasite species that caused malaria, 73.5% of the total of cases registered in the period had Plasmodium vivax as the etiological agent.ConclusionsThe results of the GBD 2017 show that despite the considerable reduction in the DALYs rates between 1990 and 2017, malaria remains a relevant and preventable disease, which in recent years has generated more years of life lost due to disability than deaths. The states endemic for malaria in the Amazon region require constant evaluation of preventive and control measures. The present study will contribute to the direction of current health policies aimed at reducing the burden of malaria in Brazil, as knowing the geographical and temporal distribution of the risk of death and disability of this disease can facilitate the planning, implementation, and improvement of control strategies aimed at eliminating the disease.
C1 [Trindade Bezerra, Juliana Maria; Barbosa, David Soeiro; Carneiro, Mariangela] Univ Fed Minas Gerais, Lab Epidemiol Infect & Parasit Dis, Dept Parasitol, Inst Biol Sci, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Martins-Melo, Francisco Rogerlandio] Fed Inst Educ Sci & Technol Ceara, Rua Francisco Rocha Martins S-N, BR-61609090 Caucaia, Ceara, Brazil.
   [Martins-Melo, Francisco Rogerlandio] Univ Estado Rio de Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524, BR-20550013 Maracana, RJ, Brazil.
   [Werneck, Guilherme Loureiro] Univ Fed Rio de Janeiro, Inst Publ Hlth Studies, Ave Horacio Macedo S-N,Cidade Univ, BR-21941598 Rio De Janeiro, Brazil.
   [Braga, Erika Martins] Univ Fed Minas Gerais, Inst Biol Sci, Lab Malaria, Dept Parasitol, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Tauil, Pedro Luiz] Univ Brasilia, Sch Med, Postgrad Program Trop Med, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Postgrad Program Hlth Sci Infectol & Trop Med, Ave Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Lab Epidemiol Infect & Parasit Dis, Dept Parasitol, Inst Biol Sci, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Carneiro, M (corresponding author), Univ Fed Minas Gerais, Postgrad Program Hlth Sci Infectol & Trop Med, Ave Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
EM mcarneiro@ufmg.br
OI Carneiro, Mariangela/0000-0002-9390-7714
FU Brazilian Ministry of Health through Secretariat of Health Surveillance;
   Universidade Federal de Minas Gerais (Health) [25000.479735/2017-40 TED
   125/2017]
FX Publication costs, the GBD 2017 Brazilian database, and methods were
   funded by the Brazilian Ministry of Health through the agreement of the
   Secretariat of Health Surveillance and the Universidade Federal de Minas
   Gerais (Health Process no. 25000.479735/2017-40 TED 125/2017).
CR Ajani O. I. Y., 2008, African Journal of Biomedical Research, V11, P259
   Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685
   do Nascimento JAA, 2016, REV SOC BRAS MED TRO, V49, P99, DOI 10.1590/0037-8682-0153-2015
   Badirzadeh A, 2016, ARCH IRAN MED, V19, P241, DOI 0161904/AIM.004
   Barata R C, 1995, Cad Saude Publica, V11, P128
   Raposo CCBS, 2013, REV SOC BRAS MED TRO, V46, P67, DOI 10.1590/0037-868212382013
   Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10
   Braz Rui Moreira, 2014, Rev. bras. epidemiol., V17, P615, DOI 10.1590/1809-4503201400030004
   Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477
   Lanca EFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035406
   Centers for Disease Control and Prevention, 2018, PAR MAL
   Cesario M, 2006, SCI AM BRASIL, V54, P54
   Chaves Sandra S., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P269, DOI 10.1590/S0036-46652000000500006
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055
   da Silva AR, 2009, REV SOC BRAS MED TRO, V42, P318, DOI 10.1590/S0037-86822009000300015
   da Silva R, 2015, HIST CIENC SAUDE-MAN, V22, P95, DOI 10.1590/S0104-59702015000100006
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   DEANE LM, 1988, AM J TROP MED HYG, V38, P223, DOI 10.4269/ajtmh.1988.38.223
   Duarte EC, 2014, REV SOC BRAS MED TRO, V47, P763, DOI 10.1590/0037-8682-0274-2014
   Ferreira MU, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1335-1
   Franca EB, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0156-y
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   Global Burden of Diseases, 2017, GLOB BURD DIS GBD CO
   Global Burden of Diseases, 2017, GLOBAL BURDEN DIS GB
   Goncalves LA, 2014, MEM I OSWALDO CRUZ, V109, P534, DOI 10.1590/0074-0276130579
   Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131
   Gunda R, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020244
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241
   Institute for Health Metrics and Evaluation, 2018, GLOB BURD DIS CRIT R
   Institute for Health Metrics and Evaluation, 2018, ICD COD
   Institute for Health Metrics and Evaluation, 2018, GLOB BURD DIS HIST
   Institute for Health Metrics and Evaluation, 2018, GBD COMP LIF EXP
   Instituto Brasileiro de Geografia e Estatistica, 2017, DIV REG BRAS
   Instituto Brasileiro de Geografia e Estatistica, 2018, PROJ POP BRAS UN FED
   Lorenz C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0934-6
   Malta DC, 2007, EPIDEMIOL SERV SAUDE, V16, P233
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P713, DOI [10.5123/S1679-49742016000400005, 10.5123/s1679-49742016000400005]
   Marques A C, 1982, Rev Bras Malariol Doencas Trop, V34, P1
   Martins-Melo FR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006559
   Ministerio da Saude, 2003, PROGR NAC PREV CONTR
   Ministerio da Saude, 1997, SER HIST CAS AGR DOE
   Ministerio da Saude, 2019, MAL SIT EP DAD REG A
   Ministerio da Saude, 2010, SIST VIG SAUD GUIA P
   Ministerio da Saude, 2019, SIST INF VIG EP NOT
   Ministerio da Saude, 2018, MAL DESCR DOENC
   Ministerio da Saude. FundacAo Nacional de Saude (FUNASA), 2002, PLAN INT AC CONTR MA
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
   Naing C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003071
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Pan American Health Organization, 2018, EP UPD INCR MAL AM
   Pan American Health Organization, 2017, SIT MAL REG AM 2000
   Purdy M, 2013, AM J TROP MED HYG, V89, P819, DOI 10.4269/ajtmh.12-0689
   Renault CS, 2007, REV PARAENSE MEDICIN, V21, P19
   REUBEN R, 1993, SOC SCI MED, V37, P473, DOI 10.1016/0277-9536(93)90282-9
   Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actatropica.2003.11.002
   Siqueira AM, 2016, AM J TROP MED HYG, V95, P87, DOI 10.4269/ajtmh.16-0204
   Souza Maria de Fatima Marinho de, 2017, Rev Bras Epidemiol, V20Suppl 01, P1, DOI 10.1590/1980-5497201700050001
   Tauil PL, 1985, CAD SAUDE PUBLICA, V1, P71
   Bezerra JMT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006697
   Val FF, 2014, MEM I OSWALDO CRUZ, V109, P522, DOI 10.1590/0074-0276140240
   van Hellemond JJ, 2009, EMERG INFECT DIS, V15, P1478, DOI 10.3201/eid1509.090358
   Vlassoff C, 1998, TROP MED INT HEALTH, V3, P1011
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2
   Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0
   White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889
   WHO, 2017, WORLD MAL REP 2017
   World Health Organization, 2018, MAL DEATHS
NR 70
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-7954
J9 POPUL HEALTH METR
JI Popul. Health Metr.
PD SEP 30
PY 2020
VL 18
SU 1
AR 5
DI 10.1186/s12963-020-00211-6
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA NZ2QE
UT WOS:000576940400002
PM 32993671
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Cunha, GMR
   Carneiro, M
   Pascoal-Xavier, MA
   da Rocha, ICM
   Magalhaes, FD
   Martins, OA
   Oliveira, E
   Peruhype-Magalhaes, V
AF da Cunha, Gisele Macedo Rodrigues
   Carneiro, Mariangela
   Pascoal-Xavier, Marcelo Antonio
   da Rocha, Iara Caixeta Marques
   Magalhaes, Fernanda do Carmo
   Martins-Filho, Olindo Assis
   Oliveira, Edward
   Peruhype-Magalhaes, Vanessa
TI Prospection of immunological biomarkers for characterization and
   monitoring of asymptomaticLeishmania(Leishmania)infantuminfection
SO PARASITOLOGY
LA English
DT Article
DE AsymptomaticL; infantuminfection; immunological biomarkers; visceral
   leishmaniasis
ID AMERICAN VISCERAL LEISHMANIASIS; CHAGASI; DIAGNOSIS; ANTIBODY; ANTIGEN;
   INFECTION; CYTOKINES; PROFILES; CARRIERS; AVIDITY
AB In areas endemic forLeishmania infantum, an asymptomatic infection may be an indicator of the extent of transmission. The main goal of this study was to evaluate the applicability of measuring circulating immunological biomarkers as an alternative strategy to characterize and monitorL. infantumasymptomatic infections in combination with serological methods. To this end, 179 children from a region endemic for visceral leishmaniasis (VL), aged 1-10 years old, selected from a cross-sectional study, were identified as asymptomatic (n= 81) or uninfected (n= 98) by qPCR and/or serological tests (ELISA usingL. infantumsoluble antigen and rK39), and, together with serum samples of children diagnosed with VL (n= 43), were subjected to avidity tests and cytokine levels measurement. Avidity rates (AR) ranging from 41 to 70% were found in 29 children (66%) from the asymptomatic group. On the other hand, high AR (above 70%) were observed in 27 children (64%) from the VL group. Logistic Regression and Classification and Regression Tree (CART) analyses demonstrated that lower AR and IFN-gamma production associated with higher IL-17A levels were hallmarks in asymptomaticL. infantuminfections. Therefore, this study proposes an association of immunological biomarkers that can be used as a complementary strategy for the characterization and monitoring of asymptomatic VL infections in children living in endemic areas.
C1 [da Cunha, Gisele Macedo Rodrigues; Carneiro, Mariangela; da Rocha, Iara Caixeta Marques; Magalhaes, Fernanda do Carmo] Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Posgrad Ciencias Saude Infectol & Med Trop, Fac Med, Belo Horizonte, MG, Brazil.
   [Pascoal-Xavier, Marcelo Antonio] Fundacao Oswaldo Cruz FIOCRUZ, Grp Imunol Doencas Virais, Inst Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   [Pascoal-Xavier, Marcelo Antonio] Univ Fed Minas Gerais, Lab Patol Mol, Dept Anat Patol, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [Martins-Filho, Olindo Assis; Peruhype-Magalhaes, Vanessa] Fundacao Oswaldo Cruz FIOCRUZ, Grp Integrado Pesquisas Biomarcadores, Inst Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   [Oliveira, Edward] Fundacao Oswaldo Cruz FIOCRUZ, Pesquisa Clin & Polit Publ Doencas Infecciosas &, Inst Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.; Carneiro, M (corresponding author), Univ Fed Minas Gerais, Posgrad Ciencias Saude Infectol & Med Trop, Fac Med, Belo Horizonte, MG, Brazil.
EM mcarneiro@iufmg.br
OI Carneiro, Mariangela/0000-0002-9390-7714
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico),
   Brasilia, DF, BrazilNational Council for Scientific and Technological
   Development (CNPq) [448449/2014-5]; Brazilian Ministry of
   Health/National Leishmaniasis Control Program/Fundo Nacional de Saude
   [25000_ 204799/2013-65]; Fundacao de Amparo a Pesquisa de Minas Gerais -
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG) [PPM-00591-16];
   Capes-Brazil (Coordenacao de Aperfeicoamento de Nivel Superior);
   CNPq-Brazil (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [301159/2016-5]
FX CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico),
   Brasilia, DF, Brazil (no. 448449/2014-5), Brazilian Ministry of
   Health/National Leishmaniasis Control Program/Fundo Nacional de Saude
   (no. 25000_ 204799/2013-65), and Fundacao de Amparo a Pesquisa de Minas
   Gerais - FAPEMIG, financial support Pesquisador Mineiro (PPM-00591-16).
   G.M.R. Cunha is grateful to Capes-Brazil (Coordenacao de Aperfeicoamento
   de Nivel Superior) for a master fellowship. M. Carneiro is grateful to
   CNPq-Brazil (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico) for the productivity research fellowships. E. Oliveira is
   supported by CNPq-Brazil (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Proc. 301159/2016-5).
CR Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Costa ASA, 2012, MEM I OSWALDO CRUZ, V107, P735, DOI 10.1590/S0074-02762012000600005
   [Anonymous], 2012, DRUG SAFETY UPDATE, V6, pA1
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Caldas AJM, 2001, REV SOC BRASILEIRA M, V34, P15
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   Costa CHN, 1999, T ROY SOC TROP MED H, V93, P464, DOI 10.1016/S0035-9203(99)90340-1
   Costa DL, 2013, PATHOG GLOB HEALTH, V107, P78, DOI 10.1179/2047773213Y.0000000078
   de Souza MA, 2005, REV SOC BRAS MED TRO, V38, P137, DOI 10.1590/S0037-86822005000200002
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Filisetti Denis, 2004, Ann Ist Super Sanita, V40, P71
   GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58
   HO M, 1983, AM J TROP MED HYG, V32, P943, DOI 10.4269/ajtmh.1983.32.943
   Ibarra-Meneses AV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01208
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Khoshdel A, 2009, BRAZ J INFECT DIS, V13, P44, DOI 10.1590/S1413-86702009000100010
   da Rocha ICM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3166-0
   Moreno EC, 2006, REV SOC BRAS MED TRO, V39, P421, DOI 10.1590/S0037-86822006000500001
   Moreno EC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000536
   Musso O, 1996, J VIROL METHODS, V56, P125, DOI 10.1016/0166-0934(95)01892-1
   OP026, 2016, J CROHNS COLITIS, V10, pS21
   Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x
   Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x
   Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813
   Redhu NS, 2006, CLIN VACCINE IMMUNOL, V13, P969, DOI 10.1128/CVI.00149-06
   Neto JFR, 2018, AM J TROP MED HYG, V98, P875, DOI 10.4269/ajtmh.16-0747
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Tiburcio MGS, 2013, CLIN VACCINE IMMUNOL, V20, P1697, DOI 10.1128/CVI.00367-13
   Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002
   VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   WHO, 2019, LEISHM GEN WHO
   Wortmann G, 2001, AM J TROP MED HYG, V65, P583, DOI 10.4269/ajtmh.2001.65.583
   2019, J CROHNS COLITIS S1, V13
NR 38
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD SEP
PY 2020
VL 147
IS 10
BP 1124
EP 1132
AR PII S0031182020000852
DI 10.1017/S0031182020000852
PG 9
WC Parasitology
SC Parasitology
GA MS1EX
UT WOS:000554029000008
PM 32460936
DA 2020-12-08
ER

PT J
AU Magalhaes, FD
   Resende, SD
   Senra, C
   Graeff-Teixeira, C
   Enk, MJ
   Coelho, PMZ
   Oliveira, E
   Negrao-Correa, DA
   Geiger, SM
   Carneiro, M
AF Magalhaes, Fernanda do Carmo
   Resende, Samira Diniz
   Senra, Carolina
   Graeff-Teixeira, Carlos
   Enk, Martin Johannes
   Coelho, Paulo Marcos Zech
   Oliveira, Edward
   Negrao-Correa, Deborah Aparecida
   Geiger, Stefan Michael
   Carneiro, Mariangela
TI Accuracy of real-time polymerase chain reaction to detectSchistosoma
   mansoni -infected individuals from an endemic area with low parasite
   loads
SO PARASITOLOGY
LA English
DT Article
DE Diagnosis; low parasite load; RT-PCR; Schistosomiasis mansoni
ID KATO-KATZ TECHNIQUE; FECAL EGG COUNTS; DAY-TO-DAY; SCHISTOSOMA-MANSONI;
   STOOL SAMPLES; PCR ASSAY; DIAGNOSIS; DNA; JAPONICUM; INTENSITY
AB Due to the efforts to control schistosomiasis transmission in tropical countries, a large proportion of individuals from endemic areas present low parasite loads, which hinders diagnosis of intestinal schistosomiasis by the Kato-Katz (KK) method. Therefore, the development of more sensitive diagnostic methods is essential for efficient control measures. The aim was to evaluate the accuracy of a real-time polymerase chain reaction (RT-PCR) to detectSchistosoma mansoniDNA in fecal samples of individuals with low parasite loads. A cross-sectional population-based study was conducted in a rural community (n= 257) in Brazil. POC-CCA(R)was performed in urine and feces were used for RT-PCR. In addition, fecal exams were completed by 18 KK slides, saline gradient and Helmintex techniques. The combined results of the three parasitological tests detected schistosome eggs in 118 participants (45.9%) and composed the consolidated reference standard (CRS). By RT-PCR, 117 out of 215 tested samples were positive, showing 91.4% sensitivity, 80.2% specificity and good concordance with the CRS (kappa = 0.71). RT-PCR identified 86.9% of the individuals eliminating less than 12 eggs/g of feces, demonstrating much better performance than POC-CCA(R)(50.8%). Our results showed that RT-PCR is a valuable alternative for the diagnosis of intestinal schistosomiasis in individuals with very low parasite loads.
C1 [Magalhaes, Fernanda do Carmo; Resende, Samira Diniz; Negrao-Correa, Deborah Aparecida; Geiger, Stefan Michael; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Senra, Carolina; Oliveira, Edward] Fundacao Oswaldo Cruz FIOCRUZ, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infecciosas &, BR-30190002 Belo Horizonte, MG, Brazil.
   [Graeff-Teixeira, Carlos] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Enk, Martin Johannes] Minist Saude, Secretaria Vigilancia Saude, Inst Evandro Chagas, Belem, Para, Brazil.
   [Coelho, Paulo Marcos Zech] Fundacao Oswaldo Cruz FIOCRUZ, Inst Rene Rachou, Diagnost & Terapia Doencas Infecciosas & Oncol, BR-30190002 Belo Horizonte, MG, Brazil.
RP Magalhaes, FD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
EM nandademagalhaes@yahoo.com.br
OI Negrao-Correa, Deborah/0000-0001-7670-5216
FU National Brazilian Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [404405/2012-6];
   Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)Minas Gerais
   State Research Foundation (FAPEMIG) [APQ 01637-17]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPESBrazil), Programa de
   Pos-Graduacao em Parasitologia; Fundacao de Amparo a Pesquisa de Minas
   Gerais (FAPEMIG - Brazil) within the Pesquisador Mineiro program
   (PPM-2016); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX The authors received financial support from the National Brazilian
   Research Council (CNPq) for research in neglected tropical diseases,
   DECIT program 2012 #404405/2012-6. DN-C received financial support from
   Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), within the
   Edital of PP-SUS and grant #APQ 01637-17. FCM thanks the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPESBrazil), Programa de
   Pos-Graduacao em Parasitologia, for PhD-scholarship. MC would like to
   thank the Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG -
   Brazil) for the grant within the Pesquisador Mineiro program (PPM-2016)
   and CNPq for her research fellowship.
CR Oliveira LMA, 2010, DIAGN MICR INFEC DIS, V68, P416, DOI 10.1016/j.diagmicrobio.2010.07.016
   Allam AF, 2009, TROP MED INT HEALTH, V14, P316, DOI 10.1111/j.1365-3156.2009.02225.x
   [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15
   [Anonymous], 2012, REGEN MED S3, V7, pS14
   Bergquist R, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0370-7
   Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004
   Berhe N, 2004, ACTA TROP, V92, P205, DOI 10.1016/j.actatropica.2004.06.011
   Carneiro TR, 2013, MEM I OSWALDO CRUZ, V108, P1037, DOI 10.1590/0074-0276130202
   Espirito-Santo MCC, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0558-4
   Cnops L, 2012, TROP MED INT HEALTH, V17, P1208, DOI 10.1111/j.1365-3156.2012.03060.x
   Coelho PMZ, 2009, MEM I OSWALDO CRUZ, V104, P720, DOI 10.1590/S0074-02762009000500010
   Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2
   Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639
   de Carvalho GC, 2012, MEM I OSWALDO CRUZ, V107, P899, DOI 10.1590/S0074-02762012000700010
   Dean AG, 2013, OPENEPI OPEN SOURCE
   do Amaral RS, 2006, MEM I OSWALDO CRUZ, V101, P79, DOI 10.1590/S0074-02762006000900012
   Gomes ALD, 2006, MEM I OSWALDO CRUZ, V101, P133, DOI 10.1590/S0074-02762006000900021
   Engels D, 1996, AM J TROP MED HYG, V54, P319, DOI 10.4269/ajtmh.1996.54.319
   Enk MJ, 2008, ACTA TROP, V108, P222, DOI 10.1016/j.actatropica.2008.09.016
   Ferrari MLA, 2003, B WORLD HEALTH ORGAN, V81, P190
   Gomes LI, 2009, MEM I OSWALDO CRUZ, V104, P1194, DOI 10.1590/S0074-02762009000800021
   Gomes LI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000664
   Gordon CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003483
   Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3
   Hamburger J, 1998, AM J TROP MED HYG, V59, P872, DOI 10.4269/ajtmh.1998.59.872
   Hamburger J, 1998, AM J TROP MED HYG, V59, P468, DOI 10.4269/ajtmh.1998.59.468
   HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R
   He P, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0390-y
   Katz I, 2018, ROUT RES HIGH EDUC, P22
   Kongs A, 2001, TROP MED INT HEALTH, V6, P163, DOI 10.1046/j.1365-3156.2001.00687.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lier T., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P257
   Lier T, 2009, AM J TROP MED HYG, V81, P428, DOI 10.4269/ajtmh.2009.81.428
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
   Oliveira WJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006232
   Pontes LA, 2003, AM J TROP MED HYG, V68, P652, DOI 10.4269/ajtmh.2003.68.652
   Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157
   Rabello A, 2002, MEMORIAS I O CRUZ S1, V97, P71
   Sandoval N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898
   Senra Carolina, 2018, BMC Res Notes, V11, P455, DOI 10.1186/s13104-018-3571-7
   STANDLEY CJ, 2010, PARASITE VECTOR, V3, DOI DOI 10.1186/1756-3305-3-7.
   Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7
   Stothard JR, 2009, ACTA TROP, V111, P64, DOI 10.1016/j.actatropica.2009.02.009
   ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011
   Utzinger J, 2001, PARASITOLOGY, V122, P537, DOI 10.1017/S0031182001007752
   Utzinger J, 2000, TROP MED INT HEALTH, V5, P771, DOI 10.1046/j.1365-3156.2000.00646.x
   Van Dorssen CF, 2017, PARASITOLOGY, V144, P1633, DOI [10.1017/S0031182017000907, 10.1017/s0031182017000907]
   VANDAM GJ, 1994, EUR J BIOCHEM, V225, P467, DOI 10.1111/j.1432-1033.1994.00467.x
   Siqueira LMV, 2016, REV SOC BRAS MED TRO, V49, P341, DOI 10.1590/0037-8682-0070-2016
   Siqueira LMV, 2015, MEM I OSWALDO CRUZ, V110, P209, DOI 10.1590/0074-02760140375
   Weerakoon KG, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3030081
   Weerakoon KG, 2017, J INFECT DIS, V216, P1611, DOI 10.1093/infdis/jix521
   Weerakoon KG, 2016, J MICROBIOL METH, V125, P19, DOI 10.1016/j.mimet.2016.03.012
   WHO, 2016, WORLD HLTH STAT 2016
   Wichmann D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000422
   World Health Organization, 1993, WHO TECHN REP SER, V830
   World Health Organization, 2002, WHO TECHN REP SER, V912
   Coelho PMZ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004778
NR 58
TC 0
Z9 0
U1 2
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD SEP
PY 2020
VL 147
IS 10
BP 1140
EP 1148
AR PII S003118202000089X
DI 10.1017/S003118202000089X
PG 9
WC Parasitology
SC Parasitology
GA MS1EX
UT WOS:000554029000010
PM 32484122
DA 2020-12-08
ER

PT J
AU da Silva, TAM
   Morais, MHF
   Lopes, HMDR
   Goncalves, SA
   Magalhaes, FD
   Amancio, FF
   Antunes, CMF
   Carneiro, M
AF Marques da Silva, Thais Almeida
   Franco Morais, Maria Helena
   de Oliveira Ramos Lopes, Helen Maria
   Goncalves, Stefanne Aparecida
   Magalhaes, Fernanda do Carmo
   Amancio, Frederico Figueiredo
   Figueiredo Antunes, Carlos Mauricio
   Carneiro, Mariangela
TI Prognostic factors associated with death from visceral leishmaniasis: a
   case-control study in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE case control; death; prognostic factors; visceral leishmaniasis
ID INFLAMMATORY RESPONSE; KALA-AZAR; STATE; MORTALITY; GRANDE
AB Background: The aim of this study was to identify the prognostic factors associated with death from visceral leishmaniasis (VL) considering the clinical evolution of patients through a case-control study.
   Methods: We randomly selected 180 cases (death caused by VL) and 180 controls (cured) from Belo Horizonte's hospitals in Brazil, according to data found in the patients' medical records. Five models of multivariate logistic regression were performed following the chronological order of the variables between the onset of the symptoms and evolution of the VL cases.
   Results: Considering the multivariate models and the stages of clinical evolution of VL, the prognostic factors associated with death are: age >60 y, minor hemorrhagic phenomena, increased abdominal volume, jaundice, dyspnea, malnutrition, TB, billirubin >2 mg/dL, Aspartate Aminotransferase (AST) or Alanine Aminotransferase (ALT) >100 U/L, leukocytes >7000/mm(3), hemoglobin <7 g/dL, platelets <50000/mm(3) and infection without defined focus and bleeding.
   Conclusions: Knowledge regarding the prognostic factors associated with death from VL in different stages of the disease in large Brazilian urban centers such as Belo Horizonte may help optimize patient management strategies and contribute to reduce the high fatality rates in these cities.
C1 [Marques da Silva, Thais Almeida; Goncalves, Stefanne Aparecida; Magalhaes, Fernanda do Carmo; Amancio, Frederico Figueiredo; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [Marques da Silva, Thais Almeida; Figueiredo Antunes, Carlos Mauricio] Inst Ensino & Pesquisa Santa Casa BH, Lab Epidemiol & Bioestat, Programa Posgrad Stricto Sensu Med & Biomed, Belo Horizonte, MG, Brazil.
   [Franco Morais, Maria Helena; de Oliveira Ramos Lopes, Helen Maria] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
RP da Silva, TAM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.; da Silva, TAM (corresponding author), Inst Ensino & Pesquisa Santa Casa BH, Lab Epidemiol & Bioestat, Programa Posgrad Stricto Sensu Med & Biomed, Belo Horizonte, MG, Brazil.
EM thaisalmeidamarques@yahoo.com.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPQ/Universal)National Council for Scientific and Technological
   Development (CNPq) [448449/2014-5]; Brazilian Ministry of
   Health/National - Leishmaniasis Control Programme/Fundo Nacional de
   Saude [25000.204799/2013-65]; Fundacao de Amparo a Pesquisa de Minas
   Gerais - FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [PPM/2016]
FX This study was supported by the following grants: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPQ/Universal 448449/2014-5),
   Brazilian Ministry of Health/National - Leishmaniasis Control
   Programme/Fundo Nacional de Saude (no. 25000.204799/2013-65) and
   Fundacao de Amparo a Pesquisa de Minas Gerais - FAPEMIG through the
   financial support Pesquisador Mineiro (PPM/2016).
CR Abdelmoula Mohamed Slim, 2003, Tunis Med, V81, P535
   Botelho ACA, 2009, REV SOC BRAS MED TRO, V42, P503, DOI 10.1590/S0037-86822009000500006
   Sampaio MJAD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000877
   ANDRADE TM, 1990, J INFECT DIS, V162, P1354, DOI 10.1093/infdis/162.6.1354
   Belo VS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002982
   Brasil Ministerio da Saude . Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2006, MAN VIG CONTR LEISHM
   Brasil Ministerio da Saude . Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, LEISHM VISC REC CLIN
   Brasil Ministerio da Saude . Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica. Sistema de InformacAo de Agravos de NotificacAo (SINAN), 2016, LET LEISHM VISC
   Brasil Ministerio da Saude . Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica. Sistema de InformacAo de Agravos de NotificacAo (SINAN), 2016, CAS CONF LEISHM VISC
   Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2
   Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203
   Costa DL, 2016, REV SOC BRAS MED TRO, V49, P728, DOI 10.1590/0037-8682-0258-2016
   Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195
   Coura-Vital W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003374
   de Alvarenga DG, 2010, REV SOC BRAS MED TRO, V43, P194, DOI 10.1590/S0037-86822010000200017
   de Oliveira JM, 2010, REV SOC BRAS MED TRO, V43, P188, DOI 10.1590/S0037-86822010000200016
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   Esmon CT, 2004, THROMB RES, V114, P321, DOI 10.1016/j.thromres.2004.06.028
   Leite Alexandro Iris, 2013, Revista de Patologia Tropical, V42, P301, DOI 10.5216/rpt.v42i3.26928
   Lomtadze M L, 2005, Georgian Med News, P47
   Martins-Melo FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093770
   de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511
   Mueller Y, 2009, TROP MED INT HEALTH, V14, P910, DOI 10.1111/j.1365-3156.2009.02305.x
   Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010
   PBH. Prefeitura de Belo Horizonte (PBH), LEISHM VISC MUN BEL
   Seaman J, 1996, ANN INTERN MED, V124, P664, DOI 10.7326/0003-4819-124-7-199604010-00007
   Teles EBT, 2013, MANIFESTACOES HEMORR
   Tourinho BD, 2017, T ROY SOC TROP MED H, V111, P163, DOI 10.1093/trstmh/trx029
   Bezerra JMT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006697
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9
NR 30
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY
PY 2020
VL 114
IS 5
BP 346
EP 354
DI 10.1093/trstmh/traa010
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA NO5LW
UT WOS:000569532200004
PM 32118274
DA 2020-12-08
ER

PT J
AU Rabelo, ACL
   Amancio, FF
   Oiko, CSF
   Ferraz, ML
   Carneiro, M
AF Lemos Rabelo, Ana Carolina
   Amancio, Frederico Figueiredo
   Fogaca Oiko, Carla Sayuri
   Ferraz, Marcela Lencine
   Carneiro, Mariangela
TI Characterization of dengue cases confirmed using the database linkage
   technique: assessment of virus circulation in Belo Horizonte, Brazil,
   2009-2014
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Article
DE Dengue; Dengue Virus; Epidemiological Monitoring; Database
ID RECORD; QUALITY
AB Objective: to describe dengue virus circulation in Belo Horizonte, Brazil, from 2009 to 2014. Methods: this is a series study of cases of dengue infected by different virus serotypes, identified by virus isolation or RT-PCR; database linkage was performed between the Notifiable Health Conditions Information System (SINAN), the Brazilian National Health System Hospital Information System (SIH/SUS) and the Laboratory Environment Manager (GAL). Results: 91.1% of the records were linked (n= 775); among the cases (n=851), 60.4% (n= 514) were confirmed as DENY-1, 22.1% (n=188) DENY-4, 9.8% (n= 83) as DENY-2, and 7.7% (n= 66) as DENY-3; DENY-2 accounted for a higher percentage of severe cases (4.5%). Conclusion: DENY-1 prevailed and circulated in all evaluated years.
C1 [Lemos Rabelo, Ana Carolina] Univ Fed Minas Gerais, Programa Posgrad Ciencias Saude, Belo Horizonte, MG, Brazil.
   [Amancio, Frederico Figueiredo] Hosp Joao XXIII, Fundacao Hosp Estado Minas Gerais, Belo Horizonte, MG, Brazil.
   [Fogaca Oiko, Carla Sayuri] Secretaria Municipal Saude Belo Horizonte, Gerencia Zoonoses Norte, Belo Horizonte, MG, Brazil.
   [Ferraz, Marcela Lencine] Secretaria Estado Saude Minas Gerais, Superintendencia Vigilancia Epidemiol, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Rabelo, ACL (corresponding author), Inst Rene Rachou, Inst Oswaldo Cruz, World Mosquito Program, Av Augusto de Lima 1715,Anexo 31, BR-30190002 Belo Horizonte, MG, Brazil.
EM aclrabelo@gmail.com
CR Barbosa JR, 2015, EPIDEMIOL SERV SAUDE, V24, P49, DOI 10.5123/S1679-49742015000100006
   Bartholomay P, 2014, CAD SAUDE PUBLICA, V30, P2459, DOI 10.1590/0102-311X00116313
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Burattini MN, 2016, CLINICS, V71, P455, DOI 10.6061/clinics/2016(08)08
   Camargo Junior KR, 2006, CAD SAUDE COLET RIO, V14, DOI [DOI 10.1590/S0102-311X2000000200014, 10.1590/S0102-311X2000000200014]
   Campos KB, 2012, BELO HORIZONTE
   Capuani L, 2014, CAD SAUDE PUBLICA, V30, P1623, DOI 10.1590/0102-311X00024914
   Coeli CM, 2015, EPIDEMIOL SERV SAUDE, V24, P795, DOI 10.5123/S1679-49742015000400023
   de Oliveira GP, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S1518-8787.2016050006327
   Soeiro CMD, 2014, CAD SAUDE PUBLICA, V30, P715, DOI 10.1590/0102-311X00156312
   Duarte HHP, 2006, REV SAUDE PUBL, V40, P134, DOI 10.1590/S0034-89102006000100021
   Escosteguy CC, 2013, EPIDEMIOL SERV SAUDE, V22, P67, DOI 10.5123/S1679-49742013000100007
   Fundacao Ezequiel Dias-FUNED, 2018, MAN COL AC TRANSP MA
   Governo do Mato Grosso. Secretaria de Estado de Saude, 2015, DIAGN LAB PEC NOV CL
   Instituto Brasileiro de Geografia e Estatistica-IBGE, 2017, SINT BEL HOR
   Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003
   Martins MMF, 2015, REV ESPACO SAUDE, V16, P64
   McBride WJH, 2009, DIAGN MICR INFEC DIS, V64, P31, DOI 10.1016/j.diagmicrobio.2009.01.002
   Ministerio da Saude (BR), 2016, SECR VIG SAUD COORD
   Ministerio da Saude (BR), 2014, B EPIDEMIOL, V45, P1
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Nascimento LB, 2015, EPIDEMIOL SERV SAUDE, V24, P475
   Plataforma Devmedia, 2014, SQL JOIN ENTENDA COM
   Rossetto EV, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00014115
   Sayers A, 2016, INT J EPIDEMIOL, V45, P954, DOI 10.1093/ije/dyv322
   Secretaria Municipal de Saude (Belo Horizonte), 2018, BAL DENG
   Tauil P. L., 2015, MODELAGEM SISTEMAS C, P11
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
NR 28
TC 0
Z9 0
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2020
VL 29
IS 3
AR e2019354
DI 10.5123/S1679-49742020000300016
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA MO8ZH
UT WOS:000551806000008
PM 32556043
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Martins-Melo, FR
   Carneiro, M
   Ribeiro, ALP
   Bezerra, JMT
   Werneck, GL
AF Martins-Melo, Francisco Rogerlandio
   Carneiro, Mariangela
   Pinho Ribeiro, Antonio Luiz
   Trindade Bezerra, Juliana Maria
   Werneck, Guilherme Loureiro
TI Burden of Chagas disease in Brazil, 1990-2016: findings from the Global
   Burden of Disease Study 2016
SO INTERNATIONAL JOURNAL FOR PARASITOLOGY
LA English
DT Article
DE Chagas disease; Burden of disease; Disability-adjusted life year;
   Mortality; Morbidity; Brazil
ID ADJUSTED LIFE-YEARS; SYSTEMATIC ANALYSIS; MULTIPLE CAUSES; MORTALITY;
   CHALLENGES; DISABILITY; SEROPREVALENCE; INFECTION; FUTURE; STATE
AB Chagas disease continues to be an important cause of morbidity, mortality and disability in several Latin American countries, including Brazil. Using findings from the Global Burden of Disease Study 2016 (GBD, 2016), we present years of life lost, years lived with disability, and disability-adjusted life years due to Chagas disease in Brazil, by sex, age group, and Brazilian states, from 1990 to 2016. Results are reported in absolute numbers and age-standardized rates (per 100,000 population) with 95% uncertainty intervals. In 2016, 141,640 disability-adjusted life years (95% uncertainty intervals: 129,065-155,941) due to Chagas disease were estimated in Brazil, with a relative reduction of 36.7% compared with 1990 (223,879 disability-adjusted life years (95% uncertainty intervals: 209,372-238,591)). Age-standardized disability-adjusted life year rates declined at the national level (-69.7%) and in all Brazilian states between 1990 and 2016, but with different regional patterns. The decrease in the disability-adjusted life year rates was driven primarily by a consistent reduction in the years of life lost rates, the main component of total disability-adjusted life years for Chagas disease. The highest fatal and non-fatal burden due to Chagas disease was observed among males, the elderly, and in those Brazilian states encompassing important endemic areas for vector transmission in the past. Despite the consistent reduction in its burden during the period, Chagas disease is still an important and neglected cause of health lost due to premature mortality and disability in Brazil. Efforts should be made to maintain the political interest and sustainability of surveillance and control actions for Chagas disease, prevent the risk of re-emergence of vector transmission in endemic areas, and provide health care to chronically infected individuals, including early diagnosis and treatment interventions. (C) 2019 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.
C1 [Martins-Melo, Francisco Rogerlandio] Fed Inst Educ Sci & Technol Ceara, Rua Francisco da Rocha Martins S-N, BR-61609090 Caucaia, CE, Brazil.
   [Martins-Melo, Francisco Rogerlandio; Werneck, Guilherme Loureiro] Univ Fed Rio de Janeiro, Inst Studies Publ Hlth, Ave Horacio Macedo S-N, BR-21941598 Rio De Janeiro, RJ, Brazil.
   [Carneiro, Mariangela; Trindade Bezerra, Juliana Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pinho Ribeiro, Antonio Luiz] Univ Fed Minas Gerais, Hosp Clin, Ave Prof Alfredo Balena 110, BR-30130100 Belo Horizonte, MG, Brazil.
   [Pinho Ribeiro, Antonio Luiz] Univ Fed Minas Gerais, Fac Med, Ave Prof Alfredo Balena 110, BR-30130100 Belo Horizonte, MG, Brazil.
   [Werneck, Guilherme Loureiro] Univ Estado Rio De Janeiro, Social Med Inst, Dept Epidemiol, Rua Sao Francisco Xavier 524, BR-20550013 Rio De Janeiro, RJ, Brazil.
RP Martins-Melo, FR (corresponding author), Fed Inst Educ Sci & Technol Ceara, Rua Francisco da Rocha Martins S-N, BR-61609090 Caucaia, CE, Brazil.
EM rogerlandio@bol.com.br
RI Werneck, Guilherme/A-2841-2013; Martins-Melo, Francisco
   Rogerlandio/I-4868-2012
OI Werneck, Guilherme/0000-0003-1169-1436; Martins-Melo, Francisco
   Rogerlandio/0000-0003-3690-5023
FU Bill & Melinda Gates Foundation, USABill & Melinda Gates Foundation;
   Brazilian Ministry of Health [25000.479735/2017-40]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)CAPES;
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq) [465518/2014-1, 310679/2016-8]; Fundacao de Amparo a Pesquisa de
   Minas Gerais (FAPEMIG, Brazil)Minas Gerais State Research Foundation
   (FAPEMIG) [PPM-00428-17]; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ/Brazil)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX We thank the Institute for Health Metrics and Evaluation (IHME) at the
   University of Washington, USA, for providing the Global Burden of
   Disease Study 2016 (GBD 2016) estimates. The GBD study is funded by Bill
   & Melinda Gates Foundation, USA, and GBD Brazil-states is funded by the
   Brazilian Ministry of Health (grant number 25000.479735/2017-40). FRM
   and JMTB were funded by a postdoctoral fellowship from the Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil). ALPR
   was supported in part by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Brazil; grants 465518/2014-1 and
   310679/2016-8) and by the Fundacao de Amparo a Pesquisa de Minas Gerais
   (FAPEMIG, Brazil; PPM-00428-17). MC would like to thank the CNPq for the
   research productivity fellowship and FAPEMIG for the grant of the
   Programa Pesquisador Mineiro (PPM-2016). GLW would like to thank the
   CNPq for the research productivity fellowship and Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil) for the grant of
   the Programa Cientistas do Nosso Estado (CNE-2015).
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   Brant Luisa Campos Caldeira, 2017, Rev. bras. epidemiol., V20, P116, DOI 10.1590/1980-5497201700050010
   Capuani L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005542
   Corassa RB, 2017, PERSPECT PUBLIC HEAL, V137, P289, DOI 10.1177/1757913916671160
   Corrêa Ricardo de Amorim, 2017, Rev. bras. epidemiol., V20, P171, DOI 10.1590/1980-5497201700050014
   Costa MFFLE, 2001, INT J EPIDEMIOL, V30, P887, DOI 10.1093/ije/30.4.887
   Coura JR, 2015, MEM I OSWALDO CRUZ, V110, P277, DOI 10.1590/0074-0276140362
   Cucunuba ZM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1315-x
   da Nobrega AA, 2014, AM J TROP MED HYG, V91, P528, DOI 10.4269/ajtmh.13-0574
   Alves RMD, 2009, REV SOC BRAS MED TRO, V42, P622, DOI 10.1590/S0037-86822009000600002
   Braz SCD, 2011, REV SOC BRAS MED TRO, V44, P318, DOI [10.1590/S0037-86822011005000038, 10.1590/s0037-86822011005000038]
   Drumond João Augusto Guimarães, 2006, Cad. Saúde Pública, V22, P2131, DOI 10.1590/S0102-311X2006001000019
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688
   Franca EB, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0156-y
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Herricks JR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005424
   Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X
   Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1
   Lima-Costa MF, 2010, INT J CARDIOL, V145, P362, DOI 10.1016/j.ijcard.2010.02.036
   Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P713, DOI [10.5123/S1679-49742016000400005, 10.5123/s1679-49742016000400005]
   Martins-Melo FR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006559
   Martins-Melo FR, 2016, B WORLD HEALTH ORGAN, V94, P103, DOI 10.2471/BLT.15.152363
   Martins-Melo FR, 2014, ACTA TROP, V130, P167, DOI 10.1016/j.actatropica.2013.10.002
   Martins-Melo FR, 2012, J INFECT DEV COUNTR, V6, P817, DOI 10.3855/jidc.2459
   Martins-Melo FR, 2012, REV SOC BRAS MED TRO, V45, P591, DOI 10.1590/S0037-86822012000500010
   Martins-Melo FR, 2012, TROP MED INT HEALTH, V17, P1066, DOI 10.1111/j.1365-3156.2012.03043.x
   Martins-Melo FR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001508
   Murray CJL, 2018, LANCET INFECT DIS, V18, P261, DOI 10.1016/S1473-3099(17)30703-X
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
   Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9
   Ostermayer AL, 2011, REV SOC BRAS MED TRO, V44, P108, DOI 10.1590/S0037-86822011000800015
   Pereira M G, 1984, Bull Pan Am Health Organ, V18, P1
   Dias JCP, 2016, REV SOC BRAS MED TRO, V49, P3, DOI 10.1590/0037-8682-0505-2016
   Dias JCP, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/789758
   Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Santo AH, 2009, REV PANAM SALUD PUBL, V26, P299
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P122, DOI 10.1590/S0037-86822011000800016
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P52, DOI 10.1590/S0037-86822011000800009
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P33, DOI 10.1590/S0037-86822011000800006
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P26, DOI 10.1590/S0037-86822011000800005
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2
NR 44
TC 5
Z9 6
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-7519
EI 1879-0135
J9 INT J PARASITOL
JI Int. J. Parasit.
PD MAR
PY 2019
VL 49
IS 3-4
BP 301
EP 310
DI 10.1016/j.ijpara.2018.11.008
PG 10
WC Parasitology
SC Parasitology
GA HU3DY
UT WOS:000465153200010
PM 30738925
DA 2020-12-08
ER

PT J
AU Resende, SD
   Magalhaes, FC
   Rodrigues-Oliveira, JL
   Castro, VN
   Souza, CSA
   Oliveira, EJ
   Carneiro, M
   Geiger, SM
   Negrao-Correa, DA
AF Resende, Samira D.
   Magalhaes, Fernanda C.
   Rodrigues-Oliveira, Jailza L.
   Castro, Vanessa N.
   Souza, Carolina S. A.
   Oliveira, Edward J.
   Carneiro, Mariangela
   Geiger, Stefan M.
   Negrao-Correa, Deborah A.
TI Modulation of Allergic Reactivity in Humans Is Dependent on Schistosoma
   mansoni Parasite Burden, Low Levels of IL-33 or TNF-alpha and High
   Levels of IL-10 in Serum
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Schistosoma mansoni; low parasite burden; humans; IgE-reactivity;
   household dust allergen; immunoregulation; IL-10; IL-33
ID BARRIER EPITHELIAL-CELLS; REGULATORY T-CELLS; HELMINTH INFECTIONS;
   ANTIGENS MODULATE; IMMUNE-RESPONSES; MURINE MODEL; RURAL AREA; ASTHMA;
   ATOPY; CHILDREN
AB Helminth infections and allergies are characterized by a predominant type-2 immune response. In schistosomiasis, the Th-2 response is usually accompanied by induction of immunoregulatory mechanisms that contribute to worm survival and less severe schistosomiasis. Although helminth-induced immunomodulatory mechanisms seem to affect atopy, epidemiological studies on the relationship between helminths and allergy have been inconsistent, and data suggest that the modulatory effects may be influenced by helminth species, chronicity of infection, and parasite burden. Here we performed a cross-sectional study to investigate the effects of Schistosoma mansoni parasite burden and immune response on allergic reactivity of individuals living in a schistosomiasis endemic area in Brazil. Fecal samples from the participants were collected for extensive parasitological examinations by spontaneous sedimentation, Kato-Katz, Helmintex and Saline Gradient tests and molecular detection of S. mansoni by qPCR. Additionally, the concentrations of cytokines and chemokines, total IgE and IgE-reactivity to common house dust allergens were quantified from serum samples. IgE reactivity to dust allergens was detected in 47 individuals (23.8%), and 140 individuals (54.4%) were diagnosed with S. mansoni infection. Most of the infected population (108 individuals) presented very low parasite burden (<= 12 eggs/g of feces). The frequency and intensity (p <= 0.03) of allergic reactivity were lower in S. mansoni-infected compared with noninfected individuals. Multivariable logistic regression models adjusted by age revealed that allergic reactivity was positively associated with low IL-10 response (OR, 4.55, 95% CI, 0.56-7.36) and high concentration of the inflammatory mediators IL-33 (OR, 2.70, 95% CI, 1.02-7.15) or TNF-alpha (OR, 6.88, 95% CI, 0.32-143.39) in serum, and inversely associated with S. mansoni infection (OR, 0.38, 95% CI, 0.16-0.87). Most importantly, the logistic regression demonstrated that the modulatory effects of Schistosoma infection depend on parasite burden, with individuals infected with <= 12 eggs/g of feces showing allergic IgE-reactivity similar to non-infected individuals Altogether, our data show that immunomodulation of allergic reactivity depends on S. mansoni burden, low type-2 inflammatory response, and high level of IL-10.
C1 [Resende, Samira D.; Magalhaes, Fernanda C.; Rodrigues-Oliveira, Jailza L.; Castro, Vanessa N.; Carneiro, Mariangela; Geiger, Stefan M.; Negrao-Correa, Deborah A.] Fed Univ Minas Gerais UFMG, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Souza, Carolina S. A.; Oliveira, Edward J.] Fundacao Oswaldo Cruz, Rene Rachou Res Ctr, Schistosomiasis Lab, Belo Horizonte, MG, Brazil.
RP Negrao-Correa, DA (corresponding author), Fed Univ Minas Gerais UFMG, Dept Parasitol, Belo Horizonte, MG, Brazil.
EM denegrao@icb.ufmg.br
FU National Brazilian Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [404405/2012-6];
   Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) from the State
   of Minas Gerais, Brazil [APQ 01637-17]; Pro-Reitoria de Pesquisa e
   Programa de Pos-Graduacao em Parasitologia - UFMG
FX The authors would like to thank the people from the communities Pe da
   Serra, Tocantins, and Santana for their collaboration and the warm
   reception during the field activities. We are also thankful to the
   municipal government of Januaria for the logistic support during the
   field studies and to Mr. Adailton Viana Bitencourt and the technicians
   from the Schistosomiasis Control Program for their valuable help. This
   manuscript was reviewed by a professional science editor to improve
   readability. The authors received financial support from the National
   Brazilian Research Council (CNPq) for research in neglected tropical
   diseases, DECIT program 2012 #404405/2012-6. DN-C received financial
   support from Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG),
   within the program to support research from the State of Minas Gerais,
   Brazil (APQ 01637-17). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. Publication fee was partly financed by Pro-Reitoria de
   Pesquisa e Programa de Pos-Graduacao em Parasitologia - UFMG.
CR Alcantara-Neves NM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-114
   Alcantara-Neves Neuza Maria, 2014, BMC Res Notes, V7, P817, DOI 10.1186/1756-0500-7-817
   Alcantara-Neves NM, 2012, J ALLERGY CLIN IMMUN, V129, P359, DOI 10.1016/j.jaci.2011.09.015
   Araujo ML, 2004, MEM I OSWALDO CRUZ, V99, P27, DOI 10.1590/S0074-02762004000900005
   Bager P, 2010, J ALLERGY CLIN IMMUN, V125, P123, DOI 10.1016/j.jaci.2009.08.006
   Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012
   Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488
   Burbank AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1, DOI 10.1016/j.jaci.2017.05.010
   Cardoso LS, 2010, CLIN EXP IMMUNOL, V160, P266, DOI 10.1111/j.1365-2249.2009.04084.x
   Espirito-Santo MCC, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0558-4
   Choi JP, 2016, ALLERGY ASTHMA IMMUN, V8, P362, DOI 10.4168/aair.2016.8.4.362
   Cooper PJ, 2008, CLIN EXP ALLERGY, V38, P551, DOI 10.1111/j.1365-2222.2008.02934.x
   Cooper Philip J, 2006, BMC Pulm Med, V6, P24, DOI 10.1186/1471-2466-6-24
   Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348
   Costa RD, 2017, ANN ALLERG ASTHMA IM, V118, P483, DOI 10.1016/j.anai.2017.01.028
   Cruz AA, 2017, J ALLERGY CLIN IMMUN, V140, P1217, DOI 10.1016/j.jaci.2017.09.005
   Dagoye D, 2003, AM J RESP CRIT CARE, V167, P1369, DOI 10.1164/rccm.200210-1204OC
   de Kouchkovsky DA, 2017, TRENDS IMMUNOL, V38, P154, DOI 10.1016/j.it.2016.12.002
   Deckers J, 2017, IMMUNOL REV, V278, P131, DOI 10.1111/imr.12542
   Endara P, 2015, CLIN EXP ALLERGY, V45, P438, DOI 10.1111/cea.12399
   Evans H, 2015, J ALLERGY CLIN IMMUN, V135, P343, DOI 10.1016/j.jaci.2014.07.007
   Feary J, 2011, ALLERGY, V66, P569, DOI 10.1111/j.1398-9995.2010.02512.x
   Figueiredo CA, 2013, J ALLERGY CLIN IMMUN, V131, P1683, DOI 10.1016/j.jaci.2012.10.043
   Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2
   Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007
   Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476
   Gazzinelli A, 2006, ACTA TROP, V99, P260, DOI 10.1016/j.actatropica.2006.09.001
   HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R
   Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007
   Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC
   Heinrich J, 1998, AM J PUBLIC HEALTH, V88, P1319, DOI 10.2105/AJPH.88.9.1319
   Hoffman W. A., 1934, Puerto Rico Journal of Public Health & Tropical Medicine, V9, P283
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   HOSMER DW, 1989, BIOMETRICS, V45, P1265, DOI 10.2307/2531779
   Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V119, P654, DOI 10.1016/j.jaci.2006.12.609
   Igetei JE, 2017, IMMUNOLOGY, V150, P506, DOI 10.1111/imm.12711
   Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13
   JARRETT E, 1980, NATURE, V283, P302, DOI 10.1038/283302a0
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Katz N, 2003, CIENC CULT, V55, P38
   KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775
   Khan AR, 2013, INT J PARASITOL, V43, P293, DOI 10.1016/j.ijpara.2012.12.002
   Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829
   Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC
   Lynch SV, 2016, CURR OPIN ALLERGY CL, V16, P165, DOI 10.1097/ACI.0000000000000255
   Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007
   Marinho FV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160118
   McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123
   McSorley HJ, 2015, EXP PARASITOL, V158, P8, DOI 10.1016/j.exppara.2015.02.009
   McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11
   Medeiros M, 2003, J ALLERGY CLIN IMMUN, V111, P947, DOI 10.1067/mai.2003.1381
   Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312
   Negrao-Correa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088042
   Noya O, 2015, NEGLECT TROP DIS, P11, DOI 10.1007/978-3-7091-1422-3_2
   Oliveira WJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006232
   Pacifico LGG, 2009, INFECT IMMUN, V77, P98, DOI 10.1128/IAI.00783-07
   Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047
   Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387
   Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064
   Grenfell RFQ, 2013, MEM I OSWALDO CRUZ, V108, P328, DOI 10.1590/S0074-02762013000300011
   Robinson D, 2017, CLIN EXP ALLERGY, V47, P161, DOI 10.1111/cea.12880
   Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Ruas MDB, 2013, ESQUISTOSSOMOSE MANS, P18
   Rujeni N, 2012, INT ARCH ALLERGY IMM, V158, P288, DOI 10.1159/000332949
   Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x
   Sanya RE, 2017, T ROY SOC TROP MED H, V111, P3, DOI 10.1093/trstmh/trx010
   Sawant DV, 2014, J IMMUNOL, V192, P2904, DOI 10.4049/jimmunol.1202502
   Schmiedel Y, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003995
   Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015
   Schroder PC, 2017, ALLERGY, V72, P604, DOI 10.1111/all.13069
   Smits HH, 2007, ANN MED, V39, P428, DOI 10.1080/07853890701436765
   Smits HH, 2010, CURR ALLERGY ASTHM R, V10, P3, DOI 10.1007/s11882-009-0085-3
   Stein M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004208
   STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259
   Suchiva P, 2017, J DERMATOL SCI, V86, pe14, DOI [10.1016/j.jdermsci.2017.02.039, DOI 10.1016/J.JDERMSCI.2017.02.039]
   Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005
   Teixeira CF, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000073
   Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888
   van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2
   von Mutius E, 2002, J ALLERGY CLIN IMMUN, V109, pS525, DOI 10.1067/mai.2002.124565
   Webb EL, 2016, ALLERGY, V71, P1156, DOI 10.1111/all.12867
   Weitnauer M, 2016, MUCOSAL IMMUNOL, V9, P287, DOI 10.1038/mi.2015.126
   WHO, 2014, SCHISTOSOMIASIS
   Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062
   Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490
   Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012
   Coelho PMZ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004778
NR 88
TC 3
Z9 3
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JAN 18
PY 2019
VL 9
AR 3158
DI 10.3389/fimmu.2018.03158
PG 14
WC Immunology
SC Immunology
GA HH8NT
UT WOS:000455989600001
PM 30713536
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Vega, FLR
   Bezerra, JMT
   Said, RFD
   Neto, AND
   Cotrim, EC
   Mendez, D
   Amancio, FF
   Carneiro, M
AF Romero Vega, Farley Liliana
   Trindade Bezerra, Juliana Maria
   de Carmo Said, Rodrigo Fabiano
   da Gama Neto, Aloysio Nogueira
   Cotrim, Emanuela Cardoso
   Mendez, Dora
   Amancio, Frederico Figueiredo
   Carneiro, Mariangela
TI Emergence of chikungunya and Zika in a municipality endemic to dengue,
   Santa Luzia, MG, Brazil, 2015-2017
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Dengue; Diagnosis; Chikungunya; Outbreak; Symptoms; Zika
ID CO-CIRCULATION; VIRUSES; BURDEN
AB Introduction: The recent circulation of arboviruses transmitted by vectors, such as dengue, chikungunya, and Zika, is concerning due to the high morbidity rates, clinical complications, and increased demand on health services. The objective of this study was to analyze the clinical and epidemiological aspects of an epidemic caused by arboviruses in the municipality of Santa Luzia, Minas Gerais, Brazil. Methods: Longitudinal study of patients with acute febrile disease and suspected arbovirus infection reported to Brazilian Notifiable Disease Information System (Sistema de Informacao de Agravos de Notificacao) from the epidemiological week 44 of 2015 to epidemiological week 52 of 2016. Patients with confirmed chikungunya were followed-up for 18 months and those with Zika for 15 months. Additionally, we analyzed and described the temporal distribution of confirmed cases of these arboviruses in this municipality. Results: Overall 3,531 arboviruses cases, including 3,481 (98.7%) cases of dengue, 38 (1.0%) cases of chikungunya, and 12 (0.3%) cases of Zika were confirmed. The highest incidence of arbovirus infection occurred in the first quarter of 2016 (epidemiological week 7 to 14). The most frequent symptoms were for dengue, which included fever. headache, retro-orbital pain, and exanthema. Chikungunya infection was associated with fever, myalgia, arthralgia, and rash while Zika infection with pruritus and rash. Conclusions: Given the similarities in the initial clinical profiles of these arboviruses, it is important to perform a detailed clinical analysis, laboratory diagnosis, and patient follow-up.
C1 [Romero Vega, Farley Liliana; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
   [Trindade Bezerra, Juliana Maria; Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [de Carmo Said, Rodrigo Fabiano] Secretaria Saude Estadual Minas Gerais, Subsecretaria Vigilancia & Protecao Saude, Programa Estadual Controle Doencas Transmitidas A, Belo Horizonte, MG, Brazil.
   [da Gama Neto, Aloysio Nogueira; Cotrim, Emanuela Cardoso] Secretaria Municipal Saude Santa Luzia, Santa Luzia, MG, Brazil.
   [Mendez, Dora] Nucleo Acoes & Pesquisa Apoio Diagnost, Lab Genet & Biol Mol, Belo Horizonte, MG, Brazil.
   [Amancio, Frederico Figueiredo] Fundacao Hosp Estado Minas Gerais, Hosp Joao XXIII, Belo Horizonte, MG, Brazil.
RP Vega, FLR (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
EM lilianaromerovega@gmail.com
FU Ministry of Health of Brazil, Fundo Nacional de Saude
   [25000.214371/2012-4]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES-Brazil), Post-Graduate Program of Infectology and
   Tropical Medicine, Universidade Federal de Minas Gerais; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (PNPD/CAPES-Brazil),
   Post-Graduation Program in Parasitology, Universidade Federal de Minas
   Gerais; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG -
   Brazil)Minas Gerais State Research Foundation (FAPEMIG); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq)
FX This study was supported by the Ministry of Health of Brazil, Fundo
   Nacional de Saude. (Grant No. 25000.214371/2012-4). FLRV thanks
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES-Brazil), Post-Graduate Program of Infectology and Tropical
   Medicine, Universidade Federal de Minas Gerais for the Doctoral
   schoralship. JMTB thanks to the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (PNPD/CAPES-Brazil), Post-Graduation Program
   in Parasitology, Universidade Federal de Minas Gerais for the
   Postdoctoral fellowship. MC would like to thank to the Fundacao de
   Amparo a Pesquisa de Minas Gerais (FAPEMIG - Brazil) for the grant of
   the Programa Pesquisador Mineiro (PPM-2016) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil) for the research
   fellowship.
CR Aguiar S, 2018, INT J INFECT DIS, P342
   [Anonymous], 2014, PREFEITURA MUNICIPAL
   Araujo Valdelaine Etelvina Miranda de, 2017, Rev Bras Epidemiol, V20Suppl 01, P205, DOI 10.1590/1980-5497201700050017
   Bautista-Reyes E, 2017, REV INVEST CLIN, V69, P299, DOI 10.24875/RIC.17002029
   Baylis M, 2017, ENVIRON HEALTH-GLOB, V16, P45, DOI 10.1186/s12940-017-0326-1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carlson C, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004968
   Center for Disease Control and Prevention, DIV VECT BORN DIS
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P578, DOI 10.1002/art.40384
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   Cordel N, 2017, JAMA DERMATOL, V153, P326, DOI 10.1001/jamadermatol.2016.5442
   de Souza LJ, 2013, BRAZ J INFECT DIS, V17, P27, DOI 10.1016/j.bjid.2012.08.020
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gerardin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4137
   Gerardin P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-5
   Instituto brasileiro de geografia e estatistica, 2017, SANT LUZ MG
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Korman AM, 2017, J AM ACAD DERMATOL, V76, P538, DOI 10.1016/j.jaad.2016.08.034
   Magalhaes T, 2017, PLOS NEGLECT TROP D, P11
   Matta L, 2016, BIOMEDICA, V36, P133, DOI 10.7705/biomedica.v36i1.2627
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Ministerio de Saude (MS) Brasil, 2017, B EPIDEMIOLOGICO, V35
   Mogami Roberto, 2017, Radiol Bras, V50, P71, DOI 10.1590/0100-3984.2016.0221
   Montibeler EE, 2018, ACTA TROP, V178, P318, DOI 10.1016/j.actatropica.2017.11.016
   PAHO-Pan American Health Organization, 2017, DENG DAT MAPS STAT
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pan American Health Organization, 2017, CHIK DAT MAPS STAT
   Pan American Health Organization, 2016, DENG GUID PAT CAR RE, P10
   Pereira AM, 2018, J TURK-GER GYNECOL A, V19, P39, DOI 10.4274/jtgga.2017.0072
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282X20160138, 10.1590/0004-282x20160138]
   Proenca-Modena JL, 2018, MICROBES INFECT, P30052
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Schawartz O, 2010, NAT MICROBIOL, P497
   Secretaria de Saude Minas Gerais, 2017, B EP MON CAS DENG CH
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sutaria RB, 2018, CURR OPIN RHEUMATOL, V30, P256, DOI 10.1097/BOR.0000000000000486
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004
   Wold Health Organization (WHO), 2012, GLOB STRAT DENG PREV, P22
   Wold Health Organization (WHO), 2016, ZIK CAS CONG SYNDR A
NR 44
TC 1
Z9 1
U1 1
U2 5
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e-20180347
DI 10.1590/0037-8682-0347-2018
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HI0VR
UT WOS:000456163000001
PM 30652797
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Coura-Vital, W
   Leal, GGD
   Marques, LA
   Pinheiro, AD
   Carneiro, M
   Reis, AB
AF Coura-Vital, Wendel
   de Almeida Leal, Gleisiane Gomes
   Marques, Luana Araujo
   Pinheiro, Aimara da Costa
   Carneiro, Mariangela
   Reis, Alexandre Barbosa
TI Effectiveness of deltamethrin-impregnated dog collars on the incidence
   of canine infection by Leishmania infantum: A large scale intervention
   study in an endemic area in Brazil
SO PLOS ONE
LA English
DT Article
ID ZOONOTIC VISCERAL LEISHMANIASIS; PROTECT DOGS; TRANSMISSION; COHORT
AB To reduce morbidity and mortality caused by visceral leishmaniasis (VL), the Brazilian Visceral Leishmaniasis Control and Surveillance Program promotes the diagnosis and treatment of cases, vector control, euthanasia of seropositive dogs, and health education. Nevertheless, the effectiveness of these measures is questionable as they lead to little reduction in the transmission of the disease. Thus, the effectiveness of strategies such as insecticide-impregnated collars, spot-on insecticides, and immunization of dogs should be assessed. Herein, we evaluated the effectiveness of deltamethrin-impregnated collars on reducing the incidence of Leishmania infantum infection in dogs living in an endemic area of VL. An intervention study was conducted and a total 5,850 dogs were analyzed in baseline. Of these 3,742 seronegative dogs were divided into two groups: collared and uncollared (control). Dogs were followed for 12 months and three interventions were performed. The Cox regression model was used to evaluate the effectiveness of the collar. All analyzes were performed by Intention-to-treat and per-protocol. By intention-to-treat, the incidence rates of L. infantum infection were 7.5 and 7.9 in the collar group, and 6.5 and 13.2 per 1,000 dogs-months in the control group after 6 and 12 months, respectively. In the per-protocol analysis, the incidence rates in the control group were similar to those observed in the intention-to-treat analysis. In the collar group, the incidence rate was 5.1/1,000 dogs-months after 6 and 12 months. The effectiveness by intention-to-treat after adjustment by the multivariate Cox model was 48%. In the analysis per-protocol, the effectiveness increased to 63%. Although collar use was effective when it was evaluated by intention-to-treat, higher effectiveness was found in the per-protocol analysis after one year of follow-up. The data emphasize the importance of the uninterrupted use of deltamethrin-impregnated collars to increase protection against canine VL.
C1 [Coura-Vital, Wendel] Univ Fed Ouro Preto, Dept Anal Clin, Escola Farm, Programa Posgrad Ciencias Farmaceut, Ouro Preto, MG, Brazil.
   [Coura-Vital, Wendel; de Almeida Leal, Gleisiane Gomes; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Programa Posgrad Ciencias Biol, Nucleo Pesquisa Ciencias Biol, Ouro Preto, MG, Brazil.
   [Marques, Luana Araujo; Pinheiro, Aimara da Costa] Secretaria Municipal Saude, Ctr Controle Zoonoses, Governador Valadares, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitaries, Belo Horizonte, MG, Brazil.
   [Reis, Alexandre Barbosa] INCT DT, Salvador, BA, Brazil.
RP Coura-Vital, W (corresponding author), Univ Fed Ouro Preto, Dept Anal Clin, Escola Farm, Programa Posgrad Ciencias Farmaceut, Ouro Preto, MG, Brazil.; Coura-Vital, W (corresponding author), Univ Fed Ouro Preto, Lab Imunopatol, Programa Posgrad Ciencias Biol, Nucleo Pesquisa Ciencias Biol, Ouro Preto, MG, Brazil.
EM wendelcoura@ufop.edu.br
OI Reis, AlessanRSS/0000-0001-8486-7469
FU Brazilian Ministry of Health/Fundo Nacional de Saude/National
   Leishmaniasis Control Program [25000.204799/2013-65]; Conselho Nacional
   de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [409869/2016-3];
   Universidade Federal de Ouro Preto; CNPqNational Council for Scientific
   and Technological Development (CNPq); CAPESCAPES; FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG)
FX This study was supported by grants from the Brazilian Ministry of
   Health/Fundo Nacional de Saude/National Leishmaniasis Control Program
   (no. 25000.204799/2013-65) (MC), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (BR) grant 409869/2016-3 (WCV), and by the
   research assistance grant from the Universidade Federal de Ouro Preto
   (WCV). ABR and MC are grateful to CNPq for the researcher fellowships,
   GGAL is grateful to CAPES for the fellowship, and MC is grateful to
   FAPEMIG for PPM/2016. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   [Anonymous], 2006, MAN VIG CONTR LEISHM
   Barata RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/405083
   Brianti E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004987
   von Zuben APB, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00087415
   Coura-Vital W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003374
   Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312
   Courtenay O, 2009, MED VET ENTOMOL, V23, P245, DOI 10.1111/j.1365-2915.2009.00815.x
   Davoust B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-323
   Ferroglio E, 2008, ZOONOSES PUBLIC HLTH, V55, P145, DOI 10.1111/j.1863-2378.2007.01092.x
   Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5
   Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005
   Guarga JL, 2000, ACTA TROP, V77, P203, DOI 10.1016/S0001-706X(00)00141-8
   Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221
   IBGE, 2017, CENS DEM 2010
   KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x
   Manzillo VF, 2006, VET PARASITOL, V142, P142, DOI 10.1016/j.vetpar.2006.06.029
   Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x
   Ministerio da Saude, 2011, 01201CGDTCGLABDEVITS
   Ministerio da Saude, 2014, PORT SAUD SVS LEISHM
   Ministerio da Saude Ministerio da Agricultura Pecuaria e Abastecimento, 2016, 0012016 MAPAMS
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   Molina R, 2001, Vet Ther, V2, P261
   Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4
   Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI [10.1590/S0037-86822011005000014, 10.1590/s0037-86822011005000014]
   Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005
   Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006
   PAHO. Pan-American Health Organization (PAHO), 2017, INF EP AM INF LEISHM
   Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156
   Ranganathan Priya, 2016, Perspect Clin Res, V7, P144, DOI 10.4103/2229-3485.184823
   Regina-Silva S, 2016, VACCINE, V34, P2233, DOI 10.1016/j.vaccine.2016.03.019
   Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006
   Reithinger R, 2001, EMERG INFECT DIS, V7, P872
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Rossi PG, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-28
   Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251
   Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h681
   Werneck GL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00ED010616
   Werneck GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003172
NR 40
TC 8
Z9 8
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 10
PY 2018
VL 13
IS 12
AR e0208613
DI 10.1371/journal.pone.0208613
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HD6JR
UT WOS:000452644700037
PM 30532255
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Rocha, ICM
   dos Santos, LHM
   Coura-Vital, W
   da Cunha, GMR
   Magalhaes, FD
   da Silva, TAM
   Morais, MHF
   Oliveira, E
   Reis, IA
   Carneiro, M
AF Marques da Rocha, Iara Caixeta
   Marques dos Santos, Leticia Helena
   Coura-Vital, Wendel
   Rodrigues da Cunha, Gisele Macedo
   Magalhaes, Fernanda do Carmo
   Marques da Silva, Thais Almeida
   Franco Morais, Maria Helena
   Oliveira, Edward
   Reis, Ilka Afonso
   Carneiro, Mariangela
TI Effectiveness of the Brazilian Visceral Leishmaniasis Surveillance and
   Control Programme in reducing the prevalence and incidence of Leishmania
   infantum infection
SO PARASITES & VECTORS
LA English
DT Article
DE Control programme; Visceral leishmaniasis; Effectiveness; Leishmania
   infantum infection; Quasi-experimental study
ID MINAS-GERAIS; TRANSMISSION; EPIDEMIOLOGY; DIAGNOSIS; CARRIERS; AREA
AB Background: Control strategies adopted by the Brazilian Visceral Leishmaniasis Surveillance and Control Programme (VLSCP) include identifying and culling seropositive infected dogs, early diagnosis and treatment of human cases, chemical control of the vector and population awareness. This study evaluated the effectiveness of the VLSCP on the prevalence and incidence rates of Leishmania infantum in children residing in areas under different VLSCP intervention times.
   Methods: A quasi-experimental epidemiological study with a panel (two cross-sectional) and a concurrent cohort was performed in three areas of Belo Horizonte, southeast Brazil. The first cross-sectional study (I) was carried out with 1875 children, 478 of which were enrolled in the cohort study. In the second cross-sectional study (II), 413 additional children were included, totalizing 891 children. Laboratory diagnosis was performed by ELISA-rK39. Analyses included multilevel logistic and Poisson regression models.
   Results: The incidence rates of L. infantum infection were: 14.4% in the area where VLSCP intervention was initiated in 2006 (AI2006); 21.1% in the area where intervention was initiated in 2008 (AI2008); and 11.6% in the area where intervention was initiated in 2010 (AI2010 - control area). A follow-up period of 24 months showed that the persons-time incidence rates in AI2006, AI2008, and AI2010 were: 6.2/100, 10/100, and 5.6/100 persons/24 months, respectively. The final prevalence rates of infection (cross-sectional II - in 2012), compared to the initial rates (cross-sectional I - in 2010), increased 83.7% in AI2006, 74.1% in AI2008, and decreased 5% in AI2010. Analysis of the effectiveness revealed that children residing in AI2008 are more likely to be infected (OR = 1.84; 95% CI: 1.06-3.23) and present a higher risk of infection (IRR = 1.76; 95% CI: 1.05-2.95) compared to those in AI2010. No statistically significant differences were observed in asymptomatic infection (OR and IRR) in AI2006 compared to AI2010.
   Conclusions: The VLSCP was not effective at controlling L. infantum infection in areas where interventions had respectively been carried out for six and four years. However, it is unclear what the consequences in terms of human infection and diseases would be in the absence of the VLSCP. Efforts to improve the effectiveness of control measures remain a necessary priority.
C1 [Marques da Rocha, Iara Caixeta; Marques dos Santos, Leticia Helena; Rodrigues da Cunha, Gisele Macedo; Magalhaes, Fernanda do Carmo; Marques da Silva, Thais Almeida; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [Marques da Rocha, Iara Caixeta; Franco Morais, Maria Helena] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel] Univ Fed Ouro Preto, Escola Farm, Posgrad Ciencias Farmaceut, Dept Anal Clin, Ouro Preto, MG, Brazil.
   [Coura-Vital, Wendel] Univ Fed Ouro Preto, Posgrad Ciencias Biol, Nucl Pesquisa Ciencias Biol, Ouro Preto, MG, Brazil.
   [Marques da Silva, Thais Almeida] Inst Ensino & Pesquisa Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Oliveira, Edward] Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Pesquisas Clin, Belo Horizonte, MG, Brazil.
   [Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.; Carneiro, M (corresponding author), Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
EM mcarneiro@ufmg.br
RI Reis, Ilka Afonso/AAG-8007-2019
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [CNPQ/Universal 78528/2012-4, CNPQ/Universal 448449/2014-5]; Brazilian
   Ministry of Health/National Leishmaniasis Control Programme/Fundo
   Nacional de Saude [25000.204799/2013-65]; Fundacao de Amparo a Pesquisa
   de Minas Gerais - FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX This study was supported by the following grants: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPQ/Universal 78528/2012-4,
   CNPQ/Universal 448449/2014-5), Brazilian Ministry of Health/National
   Leishmaniasis Control Programme/Fundo Nacional de Saude (no.
   25000.204799/2013-65), and Fundacao de Amparo a Pesquisa de Minas Gerais
   - FAPEMIG through the financial support Pesquisador Mineiro (PPM/2016).
CR Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   AssociacAo Brasileira de Empresas de Pesquisa, 2012, CRIT CLASS EC BRAS
   Brasil Ministerio da Saude . Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2006, MAN VIG CONTR LEISHM
   von Zuben APB, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00087415
   Caldas A J, 2001, Rev Soc Bras Med Trop, V34, P445, DOI 10.1590/S0037-86822001000500007
   Carneiro M, 2011, DRUG DEVELOP RES, V72, P442, DOI 10.1002/ddr.20451
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   Dantas-Torres Filipe, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P151, DOI 10.1590/S0036-46652006000300007
   Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096
   Marques LHD, 2017, PARASITOLOGY, V144, P546, DOI 10.1017/S0031182016002134
   Marques LHD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001955
   Morais MHF, 2015, EPIDEMIOL SERV SAUDE, V24, P485, DOI 10.5123/S1679-49742015000300014
   Genaro O, 1990, Rev Soc Bras Med Trop, V23, P121, DOI 10.1590/S0037-86821990000200011
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   IBGE, 2010, CENS DEM SET SENS
   INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA (IBGE), CENS DEM 2010
   Katz MH, 2010, EVALUATING CLIN PUBL
   LAINSON R, 1978, NATURE, V273, P595, DOI 10.1038/273595a0
   Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484
   de Souza VMM, 2008, EPIDEMIOL SERV SAUDE, V17, P97
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   Morais MHF, 2012, VIGILANCIA CONTROLE
   Moreno EC, 2006, REV SOC BRAS MED TRO, V39, P421, DOI 10.1590/S0037-86822006000500001
   Moreno EC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000536
   Nascimento Maria do Desterro Soares Brandão, 2005, Cad. Saúde Pública, V21, P1801, DOI 10.1590/S0102-311X2005000600028
   Costa CHN, 2007, REV SOC BRAS MED TRO, V40, P415, DOI 10.1590/S0037-86822007000400009
   Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI [10.1590/S0037-86822011005000014, 10.1590/s0037-86822011005000014]
   Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005
   Pedras MJ, 2008, T ROY SOC TROP MED H, V102, P172, DOI 10.1016/j.trstmh.2007.11.004
   Fiuza VDP, 2008, REV SOC BRAS MED TRO, V41, P82
   Prefeitura Municipal de Belo Horizonte, 2017, VIG EP LEISHM VISC B
   Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Romero HD, 2009, AM J TROP MED HYG, V81, P27
   SINAN, 2016, DATASUS LEISHM VISC
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   Werneck GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003172
   Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023
   WHO, 2017, LEISHMANIASIS
NR 39
TC 6
Z9 6
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD NOV 12
PY 2018
VL 11
AR 586
DI 10.1186/s13071-018-3166-0
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HB2FI
UT WOS:000450852100003
PM 30419944
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ferreira, AC
   Teixeira, AL
   Silveira, MF
   Carneiro, M
AF Ferreira, Antonio Carlos
   Teixeira, Antonio Lucio
   Silveira, Marise Fagundes
   Carneiro, Mariangela
TI Quality of life predictors for people living with HIV/AIDS n an
   impoverished region of Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE quality of life; HIV; Acquired immune deficiency syndrome; Depression;
   WHOQOL-HIV Bref
ID ANTIRETROVIRAL THERAPY; HIV; VALIDATION; HEALTH
AB Introduction: Quality of life (QoL) is important for people living with HIV/AIDS, particularly as the disease progresses. This study evaluated the QoL of people living with HIV/AIDS (PLWHA), as well as its predictors, in one of the most impoverished regions of Brazil. Methods: This cross-sectional study was conducted with patients older than 18 years with HIV/AIDS from two specialized HIV/AIDS care centers in the city of Montes Clams between 2013 and 2014. Sample size was calculated considering the estimates of mean scores for various dimensions of the European Portuguese version of the World Health's Organization Quality of Life Instrument in HIV Infection (WHOQOL-HIV Bref). The following parameters were adopted: CI of 95%, estimated mean scores for QoL equal to 15, estimated variance for QoL scores equal to 16, and 5% relative margin of error. An increase of 20% was established to compensate for possible non-responses or losses, and correcting any design effect, adopting a deff equal to 2.0. Calculations revealed the need to interview at least 221 patients. Therefore, 226 patients living with HIV/AIDS were randomly selected. Results: A total of 226 patients with mean age 43.7 years were evaluated: 51.8% men, 51.8% unemployed, 51.8% with low schooling level, 89.8% used antiretrovirals, and 43.3% experienced depression. Despite this, data indicated that 65% self-assessed their QoL as good and very good. Low QoL was associated with sociodemographic variables and some clinical variables. Conclusions: Depression was the main predictor of low QoL in all domains evaluated.
C1 [Ferreira, Antonio Carlos; Teixeira, Antonio Lucio; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
   [Ferreira, Antonio Carlos] Univ Estadual Montes Claros, Dept Saude Mental & Saude Colet, Montes Claros, MG, Brazil.
   [Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, Brazil.
   [Silveira, Marise Fagundes] Univ Estadual Montes Claros, Dept Ciencias Exatas, Montes Claros, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Ferreira, AC (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.; Ferreira, AC (corresponding author), Univ Estadual Montes Claros, Dept Saude Mental & Saude Colet, Montes Claros, MG, Brazil.
EM acf452000@yahoo.com.br
RI Teixeira, Antonio L/N-3315-2014
OI Teixeira, Antonio L/0000-0002-9621-5422
CR ABEP-AssociacAo Brasileira de Empresas de Pesquisa, 2011, CRIT CLASS EC BRAS
   ARANGO HG, 2005, BIOESTATISTICA TEORI
   de Souza PRB, 2011, CAD SAUDE PUBLICA, V27, pS56, DOI 10.1590/S0102-311X2011001300007
   Brasil Ministry of Health, 2010, B EP AIDS DST
   Brazil Ministry of Health, 2014, B EP AIDS DST
   Calvetti Prisla Ücker, 2008, Psicol. Estud., V13, P523
   Ferreira Brunno Elias, 2012, Rev. bras. epidemiol., V15, P75, DOI 10.1590/S1415-790X2012000100007
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Gaspar J, 2011, REV ESC ENFERM USP, V45, P225
   Gir Elucir, 2005, Rev. Latino-Am. Enfermagem, V13, P634, DOI 10.1590/S0104-11692005000500005
   Gomes-Oliveira MH, 2012, REV BRAS PSIQUIATR, V34, P389, DOI 10.1016/j.rbp.2012.03.005
   Karkashadze E, 2017, INT J STD AIDS, V28, P672, DOI 10.1177/0956462416662379
   Passos SMK, 2015, CAD SAUDE PUBLICA, V31, P800, DOI 10.1590/0102-311X00000514
   Malbergier Andre, 2001, Revista Brasileira de Psiquiatria, V23, P160, DOI 10.1590/S1516-44462001000300009
   Medeiros Bruno, 2012, Estud. psicol. (Campinas), V29, P53, DOI 10.1590/S0103-166X2012000100006
   Paz Filho G J, 2001, Rev Assoc Med Bras (1992), V47, P65
   Pereira M, 2011, AIDS BEHAV, V15, P1857, DOI 10.1007/s10461-011-9928-8
   PNUD BRAZIL, HUM DEV HDI
   Razera F, 2008, INT J STD AIDS, V19, P519, DOI 10.1258/ijsa.2008.007289
   Reis RK, 2011, TEXTO CONTEXTO ENFER, V20, P365
   Remor Eduardo Augusto, 2002, Psic.: Teor. e Pesq., V18, P283, DOI 10.1590/S0102-37722002000300007
   Santos Elisabete Cristina Morandi dos, 2007, Rev. Saúde Pública, V41, P64, DOI 10.1590/s0034-89102007000900011
   Silva PE, 2014, REV BAIANA ENFERM, V28, P61
   Souza PRB, 2007, CLINICS, V62, P579, DOI 10.1590/S1807-59322007000500008
   Tancredi MV, 2014, T ROY SOC TROP MED H, V108, P408, DOI 10.1093/trstmh/tru078
   Silveira MPT, 2012, REV BRAS PSIQUIATR, V34, P162, DOI 10.1590/S1516-44462012000200008
   UNAIDS, 2014, AMB TREATM TAG WRIT
   World Health Organization, 2002, WHOQOL HIV INSTR US, P22
   Zimpel RR, 2007, AIDS CARE, V19, P923, DOI 10.1080/09540120701213765
NR 29
TC 4
Z9 5
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2018
VL 51
IS 6
BP 743
EP 751
DI 10.1590/0037-8682-0442-2017
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HC6QJ
UT WOS:000451926100004
PM 30517527
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Bezerra, JMT
   de Araujo, VEM
   Barbosa, DS
   Martins-Melo, FR
   Werneck, GL
   Carneiro, M
AF Trindade Bezerra, Juliana Maria
   Miranda de Araujo, Valdelaine Etelvina
   Barbosa, David Soeiro
   Martins-Melo, Francisco Rogerlandio
   Werneck, Guilherme Loureiro
   Carneiro, Mariangela
TI Burden of leishmaniasis in Brazil and federated units, 1990-2016:
   Findings from Global Burden of Disease Study 2016
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; TEGUMENTARY
   LEISHMANIASIS; STATE; EPIDEMIOLOGY; CHALLENGES; DEATH
AB Background
   The study presents estimates for the burden of visceral leishmaniasis (VL) and cutaneous and mucocutaneous leishmaniasis (CML) in Brazil and its 27 federated units using data from the Global Burden of Disease Study (GBD) 2016.
   Methodology
   We report the incidence, years of life lost (YLL), years lived with disability (YLD), and disability-adjusted life years (DALY) for leishmaniasis in Brazil from 1990 to 2016. The metrics are presented as age-standardized rates per 100,000 inhabitants with their respective uncertainty intervals (95%UI) and relative percentages of change.
   Principal findings
   The age-standardized incidence rate of leishmaniasis decreased 48.5% from 1990 (71.0, 95%U124.3-150.7) to 2016 (36.5, 95%U124.7-50.9), whereas the age-standardized DALY increased 83.6% over the studied period from 12.2 (95%U17.9-18.8) to 22.4 (95%U113.336.2). The age-standardized incidence rate and YLL for VL increased by 52.9% and 108% from 1990 to 2016, respectively. Considering CML, the age-standardized incidence rate and YLD decreased by 51% and 31.8% respectively for the same period. For VL, similar profiles for male and female were observed, with YLL and DALY increasing over time; with males presenting slightly higher values. The highest YLL rates were among "under 1-year old" children, which increased 131.2% from 1990 to 2016. Regarding CML, the highest values of YLD and DALY were verified among males, and YLD values showed a similar profile, with rates increasing with age. The VL burden increased in some states in the Northeast and Southeast regions and decreased for CML in some Northern states.
   Conclusion
   The increase of VL burden over the study period might be associated with the difficulties in controlling the disease spread. Information regarding the weight of VL and CML, including the death and disability tolls that they cause, highlights the impact of these neglected diseases on public health and the importance of effective prevention and treatment.
C1 [Trindade Bezerra, Juliana Maria; Barbosa, David Soeiro; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Epidemiol Infect & Parasit Dis Lab, Belo Horizonte, MG, Brazil.
   [Miranda de Araujo, Valdelaine Etelvina] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Martins-Melo, Francisco Rogerlandio] Fed Inst Educ Sci & Technol Ceara, Caucaia, Ceara, Brazil.
   [Martins-Melo, Francisco Rogerlandio; Werneck, Guilherme Loureiro] Univ Fed Rio de Janeiro, Inst Publ Hlth Studies, Rio De Janeiro, RJ, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Postgrad Program Hlth Sci Infectol & Trop Med, Belo Horizonte, MG, Brazil.
RP Bezerra, JMT (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Epidemiol Infect & Parasit Dis Lab, Belo Horizonte, MG, Brazil.
EM jmt_bezerra@hotmail.com
RI Werneck, Guilherme/A-2841-2013; Martins-Melo, Francisco
   Rogerlandio/I-4868-2012
OI Werneck, Guilherme/0000-0003-1169-1436; Martins-Melo, Francisco
   Rogerlandio/0000-0003-3690-5023; Trindade Bezerra, Juliana
   Maria/0000-0001-9840-6217
FU Bill & Melinda Gates FoundationBill & Melinda Gates Foundation;
   Brazilian Ministry of Health [25000.479735/2017-40 TED 125/2017];
   PNPD/Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior)/Post-Graduation Program in Parasitology/Universidade Federal
   de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/Brazil)CAPES; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-Brazil)National Council for Scientific
   and Technological Development (CNPq); Fundacao de Amparo a Pesquisa de
   Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG);
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ/Brazil)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX The GBD 2016 Brazilian database and methods are funded by Bill & Melinda
   Gates Foundation and by the Brazilian Ministry of Health through the
   agreement of the Secretariat of Health Surveillance and the Federal
   University of Minas Gerais - Health Process no. 25000.479735/2017-40 TED
   125/2017. JMTB is grateful for PNPD/Capes (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior)/Post-Graduation Program in
   Parasitology/Universidade Federal de Minas Gerais for the Postdoctoral
   fellowship. FRM was funded by a postdoctoral fellowship from the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/Brazil). MC is grateful to Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-Brazil) for the research fellowships and
   Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) for Programa
   Pesquisador Mineiro (PPM/2016). GLW is grateful to Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil) and the Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil) for the
   grant of the Programa Cientistas do Nosso Estado (CNE-2015). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213
   Bailey F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005739
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Basano Sergio de Almeida, 2004, Rev. bras. epidemiol., V7, P328
   Bedoya-Pacheco SJ, 2011, AM J TROP MED HYG, V84, P901, DOI 10.4269/ajtmh.2011.10-0595
   Belo VS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002982
   Belo VS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002182
   Brahim LR, 2017, MEM I OSWALDO CRUZ, V112, P838, DOI 10.1590/0074-02760160478
   Brasil. Ministerio da Saude (MS), 2000, MAN CONTR LEISHM TEG
   Comissao  Nacional De Incorporacao de Tecnologias do SUS (CONATEC), 2017, PROP EL PROT CLIN DI
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Costa J M, 1995, Cad Saude Publica, V11, P321, DOI 10.1590/S0102-311X1995000200016
   Coura-Vital W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003374
   DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198
   dos Reis LL, 2017, REV SOC BRAS MED TRO, V50, P638, DOI 10.1590/0037-8682-0243-2017
   Franca EB, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0156-y
   Furtado AS, 2015, CIENC SAUDE COLETIVA, V20, P3935, DOI 10.1590/1413-812320152012.01672015
   GBD, 2017, GBD COMPARE
   Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Herricks JR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005424
   Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102
   Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865
   IHME, 2016, GLOB BURD DIS
   IHME, 2013, EST CARG DOENC GLOB
   Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7
   LAINSON R, 1987, T ROY SOC TROP MED H, V81, P517, DOI 10.1016/0035-9203(87)90187-8
   LAINSON R, 1978, NATURE, V273, P595, DOI 10.1038/273595a0
   Leite ID, 2015, CAD SAUDE PUBLICA, V31, P1551, DOI 10.1590/0102-311X00111614
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P713, DOI [10.5123/S1679-49742016000400005, 10.5123/s1679-49742016000400005]
   da Silva TAM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005950
   Martins-Melo FR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006559
   Martins-Melo FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093770
   Marzochi M C, 1994, Cad Saude Publica, V10 Suppl 2, P359, DOI 10.1590/S0102-311X1994000800014
   Morais AN, 2013, REV BRAS PARASITOL V, V22, P225, DOI 10.1590/S1984-29612013005000024
   MS, 2016, LET LEISHM VISC
   MS, 2016, GRAND DAD FED 1990 2
   MS, 2016, PROP EL PROT CLIN DI
   MS/SVS/DVE-Ministerio da Saude/Secretaria de Vigilancia em Saude/Departamento de Vigilancia Epidemiologica, 2014, MAN VIG CONTR LEISHM
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Murray CJL, 1996, GLOBAL BURDEN DIS CO
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
   NCCID, 2017, DIS MOR JUST NUMB EX
   Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007
   PAHO, 2017, REL OMS INF PROGR SE
   PAHO. Pan-American Health Organization (PAHO), 2017, INF EP AM INF LEISHM
   PAHO WHO, 2017, PLAN ACT STRENGTH SU
   Pelissari DM, 2011, EPIDEMIOL SERV SAUDE, V20, P107, DOI 10.5123/S1679-49742011000100012
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Souza Maria de Fatima Marinho de, 2017, Rev Bras Epidemiol, V20Suppl 01, P1, DOI 10.1590/1980-5497201700050001
   Tourinho BD, 2017, T ROY SOC TROP MED H, V111, P163, DOI 10.1093/trstmh/trx029
   UN, 2017, UN TRANSF OUR WORLD
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   Werneck GL, 2010, CAD SAUDE PUBLICA, V26, P645
   WHO, 2017, NUMB CAS CUT LEISHM
   WHO, 2017, LEISHM FACT SHEET UP
NR 61
TC 17
Z9 17
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2018
VL 12
IS 9
AR e0006697
DI 10.1371/journal.pntd.0006697
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GV4FY
UT WOS:000446054600011
PM 30188898
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-08
ER

PT J
AU Martins-Melo, FR
   Carneiro, M
   Ramos, AN
   Heukelbach, J
   Ribeiro, ALP
   Werneck, GL
AF Martins-Melo, Francisco Rogerlandio
   Carneiro, Mariangela
   Ramos, Alberto Novaes, Jr.
   Heukelbach, Jorg
   Pinho Ribeiro, Antonio Luiz
   Werneck, Guilherme Loureiro
TI The burden of Neglected Tropical Diseases in Brazil, 1990-2016: A
   subnational analysis from the Global Burden of Disease Study 2016
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHAGAS-DISEASE; MULTIPLE CAUSES; SAO-PAULO; MORTALITY; TRENDS;
   PREVALENCE; NEUROCYSTICERCOSIS; LEISHMANIASIS; EPIDEMIOLOGY; CHALLENGES
AB Background
   Neglected Tropical Diseases (NTDs) are important causes of morbidity, disability, and mortality among poor and vulnerable populations in several countries worldwide, including Brazil. We present the burden of NTDs in Brazil from 1990 to 2016 based on findings from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016).
   Methodology
   We extracted data from GBD 2016 to assess years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) for NTDs by sex, age group, causes, and Brazilian states, from 1990 to 2016. We included all NTDs that were part of the priority list of the World Health Organization (WHO) in 2016 and that are endemic/autochthonous in Brazil. YLDs were calculated by multiplying the prevalence of sequelae multiplied by its disability weight. YLLs were estimated by multiplying each death by the reference life expectancy at each age. DALYs were computed as the sum of YLDs and YLLs.
   Principal findings
   In 2016, there were 475,410 DALYs (95% uncertainty interval [UI]: 337,334-679,482; age-standardized rate of 232.0 DALYs/100,000 population) from the 12 selected NTDs, accounting for 0.8% of national all-cause DALYs. Chagas disease was the leading cause of DALYs among all NTDs, followed by schistosomiasis and dengue. The sex-age-specific NTD burden was higher among males and in the youngest and eldest (children <1 year and those aged >= 70 years). The highest age-standardized DALY rates due to all NTDs combined at the state level were observed in Goias (614.4 DALYs/100,000), Minas Gerais (433.7 DALYs/100,000), and Distrito Federal (430.0 DALYs/100,000). Between 1990 and 2016, the national age-standardized DALY rates from all NTDs decreased by 45.7%, with different patterns among NTD causes and Brazilian states. Most NTDs decreased in the period, with more pronounced reduction in DALY rates for onchocerciasis, lymphatic filariasis, and rabies. By contrast, age-standardized DALY rates due to dengue, visceral leishmaniasis, and trichuriasis increased substantially. Age-standardized DALY rates decreased for most Brazilian states, increasing only in the states of Amapa A, Ceara A, Rio Grande do Norte, and Sergipe.
   Conclusions/Significance
   GBD 2016 findings show that, despite the reduction in disease burden, NTDs are still important and preventable causes of disability and premature death in Brazil. The data call for renewed and comprehensive efforts to control and prevent the NTD burden in Brazil through evidence-informed and efficient and affordable interventions. Multi-sectoral and integrated control and surveillance measures should be prioritized, considering the population groups and geographic areas with the greatest morbidity, disability, and most premature deaths due to NTDs in the country.
C1 [Martins-Melo, Francisco Rogerlandio] Fed Inst Educ Sci & Technol Ceara, Caucaia, Ceara, Brazil.
   [Martins-Melo, Francisco Rogerlandio; Werneck, Guilherme Loureiro] Univ Fed Rio de Janeiro, Inst Studies Publ Hlth, Rio De Janeiro, RJ, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Ramos, Alberto Novaes, Jr.; Heukelbach, Jorg] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.
   [Pinho Ribeiro, Antonio Luiz] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Pinho Ribeiro, Antonio Luiz] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil.
   [Werneck, Guilherme Loureiro] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
RP Martins-Melo, FR (corresponding author), Fed Inst Educ Sci & Technol Ceara, Caucaia, Ceara, Brazil.; Martins-Melo, FR (corresponding author), Univ Fed Rio de Janeiro, Inst Studies Publ Hlth, Rio De Janeiro, RJ, Brazil.
EM rogerlandio@bol.com.br
RI Ribeiro, Antonio L/C-2707-2009; Junior, Alberto Novaes
   Ramos/A-4276-2013; Martins-Melo, Francisco Rogerlandio/I-4868-2012;
   Werneck, Guilherme/A-2841-2013
OI Ribeiro, Antonio L/0000-0002-2740-0042; Junior, Alberto Novaes
   Ramos/0000-0001-7982-1757; Martins-Melo, Francisco
   Rogerlandio/0000-0003-3690-5023; Werneck, Guilherme/0000-0003-1169-1436;
   Heukelbach, Jorg/0000-0002-7845-5510
FU Bill & Melinda Gates FoundationBill & Melinda Gates Foundation;
   Brazilian Ministry of Health (GBD Brazil) [25000.479735/2017-40];
   Coordenacao de Aperfeicoamento de Pessoal de Novel Superior
   (CAPES/Brazil)CAPES; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ/Brazil)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [CNE-2015]; Instituto de
   Avaliacao de Tecnologia em SauAde (IATS/CNPq); Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research
   Foundation (FAPEMIG); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX Bill & Melinda Gates Foundation (GBD Global) and Brazilian Ministry of
   Health (GBD Brazil; Grant No. 25000.479735/2017-40). FRM was funded by a
   postdoctoral fellowship from the Coordenacao de Aperfeicoamento de
   Pessoal de Novel Superior (CAPES/Brazil). GLW, MC, JH, and ALPR are
   research fellows (Bolsista de Produtividade em Pesquisa-PQ) from the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil). GLW would like to thank the Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ/Brazil) for the grant of the
   Programa Cientistas do Nosso Estado (CNE-2015). ALPR also receives
   unrestricted grants from the Instituto de Avaliacao de Tecnologia em
   SauAde (IATS/CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG). MC would like to thank to the FAPEMIG for the grant of
   the Programa Pesquisador Mineiro (PPM-2016). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agapejev S, 2003, ARQ NEURO-PSIQUIAT, V61, P822, DOI 10.1590/S0004-282X2003000500022
   [Anonymous], 2012, INT PLAN STRAT ACT E
   Araujo Valdelaine Etelvina Miranda de, 2017, Rev Bras Epidemiol, V20Suppl 01, P205, DOI 10.1590/1980-5497201700050017
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Bennema SC, 2014, REV INST MED TROP SP, V56, P35, DOI 10.1590/S0036-46652014000100005
   Brazilian Ministry of Health, 2018, NEGL TROP DIS BRAZ V
   Brazilian Ministry of Health, 2017, INF TECN OP CAMP NAC
   de Albuquerque MAC, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0232-8
   Passos ADC, 2011, REV SOC BRAS MED TRO, V44, P47, DOI 10.1590/S0037-86822011000800008
   Coura JR, 2015, MEM I OSWALDO CRUZ, V110, P277, DOI 10.1590/0074-0276140362
   da Nobrega AA, 2014, AM J TROP MED HYG, V91, P528, DOI 10.4269/ajtmh.13-0574
   Luna EJD, 2016, OPHTHAL EPIDEMIOL, V23, P360, DOI 10.1080/09286586.2016.1244274
   Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5
   Deribew A, 2017, Ethiop Med J, V55, P3
   do Amaral RS, 2006, MEM I OSWALDO CRUZ, V101, P79, DOI 10.1590/S0074-02762006000900012
   Duncan BB, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0216-2
   Favoretto SR, 2013, EPIDEMIOL INFECT, V141, P1552, DOI 10.1017/S0950268813000198
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688
   Franca EB, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0156-y
   Furst T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005759
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   GBD, 2015, INT J PUBLIC HLTH
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Herricks JR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005424
   Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0003895
   Hotez PJ, 2014, MICROBES INFECT, V16, P601, DOI 10.1016/j.micinf.2014.07.006
   Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865
   IBGE I. B. de G. e E, 2017, PROJ POP BRAS UN FED
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2017, SINT IND SOC AN COND
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2017, PESQ NAC AM DOM CONT
   Karimkhani C, 2017, JAMA DERMATOL, V153, P406, DOI 10.1001/jamadermatol.2016.5538
   Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7
   Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X
   Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003
   Fonseca EOL, 2010, CAD SAUDE PUBLICA, V26, P143, DOI 10.1590/S0102-311X2010000100015
   Lotufo Paulo Andrade, 2017, Rev. bras. epidemiol., V20, P129, DOI 10.1590/1980-5497201700050011
   Luz JE, 1999, BRAZ J INFECT DIS, V3, P220
   Mackey TK, 2014, CLIN MICROBIOL REV, V27, P949, DOI 10.1128/CMR.00045-14
   Madalosso G, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/281572
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P713, DOI [10.5123/S1679-49742016000400005, 10.5123/s1679-49742016000400005]
   Martins-Melo FR, 2017, PARASITOLOGY, V144, P669, DOI 10.1017/S0031182016002341
   Martins-Melo Francisco Rogerlandio, 2016, Parasite Epidemiol Control, V1, P56, DOI 10.1016/j.parepi.2016.03.002
   Martins-Melo FR, 2016, B WORLD HEALTH ORGAN, V94, P103, DOI 10.2471/BLT.15.152363
   Martins-Melo FR, 2016, ACTA TROP, V153, P128, DOI 10.1016/j.actatropica.2015.10.011
   Martins-Melo FR, 2015, T ROY SOC TROP MED H, V109, P643, DOI 10.1093/trstmh/trv069
   Martins-Melo FR, 2014, INT J PARASITOL, V44, P1055, DOI 10.1016/j.ijpara.2014.07.009
   Martins-Melo FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093770
   Martins-Melo FR, 2014, ACTA TROP, V130, P167, DOI 10.1016/j.actatropica.2013.10.002
   Martins-Melo FR, 2012, REV SOC BRAS MED TRO, V45, P591, DOI 10.1590/S0037-86822012000500010
   Martins-Melo FR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001508
   Melo Ana Paula Souto, 2017, Rev. bras. epidemiol., V20, P61, DOI 10.1590/1980-5497201700050006
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
   Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9
   Nascimento GL, 2014, T ROY SOC TROP MED H, V108, P29, DOI 10.1093/trstmh/trt109
   Nery JS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003357
   Noblick J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001022
   Ostermayer AL, 2011, REV SOC BRAS MED TRO, V44, P108, DOI 10.1590/S0037-86822011000800015
   Paixao ES, 2015, REV SOC BRAS MED TRO, V48, P399, DOI 10.1590/0037-8682-0145-2015
   Dias JCP, 2016, REV SOC BRAS MED TRO, V49, P3, DOI 10.1590/0037-8682-0505-2016
   Ramos AN, 2010, REV SOC BRAS MED TRO, V43, P12
   Rocha SM, 2017, TRANSBOUND EMERG DIS, V64, P624, DOI 10.1111/tbed.12428
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Santo AH, 2007, CAD SAUDE PUBLICA, V23, P2917, DOI 10.1590/S0102-311X2007001200013
   Santo AH, 2009, REV PANAM SALUD PUBL, V26, P299
   Stolk WA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004560
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Toledo J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004284
   United Nations, 2017, SUST DEV GOALS
   Uniting to Combat Neglected Tropical Diseases, 2012, LOND DECL NEGL TROP
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2
   Wada MY, 2011, EPIDEMIOL SERV SAUDE, V20, P509, DOI 10.5123/S1679-49742011000400010
   Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0
   Werneck GL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00ED010616
   WHO, 2012, ACC WORK OV GLOB IMP
   WHO, 2017, INT NEGL TROP DIS GL
   World Bank; World Development Indicators, 2016, GROSS DOM PROD D
   World Health Organization, 2015, INV OV GLOB IMP NEGL
NR 80
TC 36
Z9 35
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006559
DI 10.1371/journal.pntd.0006559
PG 24
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000035
PM 29864133
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Leal, JA
   Fausto, MA
   Carneiro, M
   Tubinambas, U
AF Leal, Jose Adalberto
   Fausto, Maria Arlene
   Carneiro, Mariangela
   Tubinambas, Unai
TI Prevalence of hypoalbuminemia in outpatients with HIV/AIDS
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE HIV; Albumin; Antiretroviral therapy
ID SERUM-ALBUMIN; DISEASE; PREDICTOR; SURVIVAL; THERAPY
AB Introduction: Hypoalbuminemia may predict progression of disease and mortality in patients with human immunodeficiency virus (HIV) infection/acquired immune deficiency syndrome (AIDS). This study was conducted to investigate the risk factors associated with hypoalbuminemia in outpatients with HIV/AIDS. Methods: A cross-sectional study was performed in 196 outpatients with HIV/AIDS. Results: The prevalence of hypoalbuminemia was 11.7%. The only risk factor associated with hypoalbuminemia was current antiretroviral therapy (no exposure: odds ratio=3.46, 95% confidence interval=1.20-10.02). Conclusions: The monitoring of plasma albumin is key to determine when antiretroviral therapy should be initiated in individuals not exposed to antiretroviral medicines.
C1 [Leal, Jose Adalberto; Carneiro, Mariangela; Tubinambas, Unai] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Doencas Infecciosas & Med Trop, Belo Horizonte, MG, Brazil.
   [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, Ouro Preto, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Tubinambas, Unai] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, Brazil.
RP Leal, JA (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Doencas Infecciosas & Med Trop, Belo Horizonte, MG, Brazil.
EM jal.leal@hotmail.com
CR Feldman JG, 2003, JAIDS-J ACQ IMM DEF, V33, P66, DOI 10.1097/00126334-200305010-00010
   Feldman JG, 2000, AIDS, V14, P863, DOI 10.1097/00002030-200005050-00013
   FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
   FLECK A, 1989, P NUTR SOC, V48, P347, DOI 10.1079/PNS19890050
   FLECK A, 1985, LANCET, V1, P781
   Graham SM, 2007, AIDS RES HUM RETROV, V23, P1197, DOI 10.1089/aid.2007.0065
   Mehta SH, 2006, AIDS RES HUM RETROV, V22, P14, DOI 10.1089/aid.2006.22.14
   Mendez Christian M, 2005, Nutr Clin Pract, V20, P314, DOI 10.1177/0115426505020003314
   Olawumi HO, 2006, HIV MED, V7, P351, DOI 10.1111/j.1468-1293.2006.00391.x
   Shah S, 2007, HIV MED, V8, P38, DOI 10.1111/j.1468-1293.2007.00434.x
   Sudfeld CR, 2013, J INFECT DIS, V207, P1370, DOI 10.1093/infdis/jit027
NR 11
TC 1
Z9 1
U1 2
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAR-APR
PY 2018
VL 51
IS 2
BP 203
EP 206
DI 10.1590/0037-8682-0093-2017
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GG0TA
UT WOS:000432390600013
PM 29768554
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Oliveira, JLR
   Teixeira, MM
   Lambertucci, JR
   Antunes, CMF
   Carneiro, M
   Negrao-Correa, D
AF Rodrigues Oliveira, J. L.
   Teixeira, M. M.
   Lambertucci, J. R.
   Antunes, C. M. F.
   Carneiro, M.
   Negrao-Correa, D.
TI Plasma levels of innate immune mediators are associated with liver
   fibrosis in low parasite burden Schistosoma mansoni-infected individuals
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE blood; chemokines; human; infections; inflammation; molecules;
   parasitic; processes; subject; tissues
ID TUMOR-NECROSIS-FACTOR; MIGRATION INHIBITORY FACTOR; MACROPHAGE
   INFLAMMATORY PROTEIN-1-ALPHA; PERIPORTAL FIBROSIS; TNF-ALPHA; IFN-GAMMA;
   MYCOBACTERIAL TYPE-1; CHEMOKINE RECEPTORS; GRANULOMA-FORMATION; CYTOKINE
   PRODUCTION
AB In the murine model, it was demonstrated that pro-inflammatory cytokines and chemokines are essential to the formation and modulation of Schistosoma-induced granulomatous inflammation. However, the relationship of these immune mediators and disease severity is hard to be established in naturally infected individuals. The current study evaluates the association between plasma concentrations of MIF, sTNF-R1, CCL3, CCL7 and CCL24 and schistosomiasis morbidity in Schistosoma mansoni-infected patients with a low parasite burden. For this propose, 97 S.mansoni-infected individuals were subjected to abdominal ultrasound analysis and clinical examination. Among them, 88 had plasma concentration of immune mediators estimated by ELISA assay. Multivariate linear regression models were used to evaluate the relationship between the plasma concentration of immune mediators and the variables investigated. Although most individuals presented low parasite burden, over 30% of them showed signs of fibrosis defined by ultrasound measurements and 2 patients had a severe form of schistosomiasis. No association between parasite burden and the plasma levels of chemokine/cytokines or disease severity was observed. There was a positive association between plasma concentration of CCL4, sTNF-R1, CCL3 and MIF with gall bladder thickness and/or with portal vein thickness that are liver fibrosis markers. In contrast, no association was found between CCL7 plasma concentrations with any of the schistosomiasis morbidity parameters evaluated. The data showed that CCL24, sTNFR1, MIF and CCL3 can be detected in plasma of S.mansoni-infected individuals and their concentration would be used as prognostic makers of Schistosoma-induced liver fibrosis, even in individuals with low parasite burden.
C1 [Rodrigues Oliveira, J. L.; Carneiro, M.; Negrao-Correa, D.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Teixeira, M. M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Lambertucci, J. R.; Carneiro, M.] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude, Belo Horizonte, MG, Brazil.
   [Antunes, C. M. F.] Santa Casa Belo Horizonte, Inst Ensino & Pesquisa, Belo Horizonte, MG, Brazil.
RP Negrao-Correa, D (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
EM denegrao@icb.ufmg.br
RI Teixeira, Mauro M/A-4587-2008
OI Teixeira, Mauro M/0000-0002-6944-3008; Negrao-Correa,
   Deborah/0000-0001-7670-5216
FU Fundacao de Amparo a Pesquisa de Minas Gerais - FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG) [APQ 03184-10, PPM0060111]
FX Fundacao de Amparo a Pesquisa de Minas Gerais - FAPEMIG, Grant/Award
   Number: APQ 03184-10, PPM0060111
CR Abath FGC, 2006, TRENDS PARASITOL, V22, P85, DOI 10.1016/j.pt.2005.12.004
   Adewusi OI, 1996, EXP PARASITOL, V84, P115, DOI 10.1006/expr.1996.0097
   Akuthota P, 2008, CLIN EXP ALLERGY, V38, P1254, DOI 10.1111/j.1365-2222.2008.03037.x
   Alessandri AL, 2006, INFLAMM RES, V55, P528, DOI 10.1007/s00011-006-5136-9
   AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0
   Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x
   Barnes MA, 2015, J LEUKOCYTE BIOL, V97, P161, DOI 10.1189/jlb.3A0614-280R
   Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869
   Booth M, 2004, J IMMUNOL, V172, P1295, DOI 10.4049/jimmunol.172.2.1295
   BOROS DL, 1975, J IMMUNOL, V114, P1437
   Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x
   Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598
   Bustinduy AL, 2015, AM J TROP MED HYG, V92, P945, DOI 10.4269/ajtmh.14-0444
   Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723
   Cheever AW, 2000, IMMUNOL TODAY, V21, P465, DOI 10.1016/S0167-5699(00)01626-1
   Chen XD, 2010, CYTOKINE, V50, P84, DOI 10.1016/j.cyto.2009.12.008
   Chensue SW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00043
   Chensue SW, 1999, J IMMUNOL, V163, P165
   Chiu BC, 2003, AM J RESP CELL MOL, V29, P106, DOI 10.1165/rcmb.2002-0241OC
   Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009
   Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2
   Correa-Oliveira R, 1998, BRAZ J MED BIOL RES, V31, P171, DOI 10.1590/S0100-879X1998000100024
   de Jesus AR, 2004, INFECT IMMUN, V72, P3391, DOI 10.1128/IAI.72.6.3391-3397.2004
   de Souza HS, 2015, MUCOSAL IMMUNOL, V8, P1154, DOI 10.1038/mi.2015.6
   De Souza Robson Da Paixao, 2012, J Parasitol Res, V2012, P394981, DOI 10.1155/2012/394981
   DIEZRUIZ A, 1995, EUR J HAEMATOL, V54, P1, DOI 10.1111/j.1600-0609.1995.tb01618.x
   Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x
   Fairfax KC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002490
   Falcao PL, 2002, J INFECT DIS, V186, P1696, DOI 10.1086/345370
   Fallon PG, 2000, IMMUNOL TODAY, V21, P29, DOI 10.1016/S0167-5699(99)01551-0
   FINKELMAN FD, 1993, J IMMUNOL, V151, P1235
   Finkelman FD, 1999, INT IMMUNOL, V11, P1811, DOI 10.1093/intimm/11.11.1811
   Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959
   Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004
   Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089
   Henri S, 2002, J IMMUNOL, V169, P929, DOI 10.4049/jimmunol.169.2.929
   Herbert DR, 2008, J IMMUNOL, V180, P4948, DOI 10.4049/jimmunol.180.7.4948
   Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157
   HOMEIDA M, 1988, AM J TROP MED HYG, V39, P196, DOI 10.4269/ajtmh.1988.39.196
   Isgro M, 2013, MUCOSAL IMMUNOL, V6, P718, DOI 10.1038/mi.2012.109
   Ishida Y, 2007, AM J PATHOL, V170, P843, DOI 10.2353/ajpath.2007.051213
   Jeng JE, 2007, NEOPLASIA, V9, P987, DOI 10.1593/neo.07781
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Kohan M, 2010, ANN ALLERG ASTHMA IM, V104, P66, DOI 10.1016/j.anai.2009.11.003
   Lambertucci JR, 2001, MEM I OSWALDO CRUZ, V96, P147, DOI 10.1590/S0074-02762001000900022
   Lambertucci JR, 2000, ACTA TROP, V77, P101, DOI 10.1016/S0001-706X(00)00124-8
   LANTZ M, 1990, J CLIN INVEST, V86, P1396, DOI 10.1172/JCI114853
   Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5
   LUKACS NW, 1993, J EXP MED, V177, P1551, DOI 10.1084/jem.177.6.1551
   LUKACS NW, 1994, J IMMUNOL, V152, P5883
   Lundy SK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00039
   Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248
   Mentink-Kane MM, 2004, IMMUNOL REV, V202, P191, DOI 10.1111/j.0105-2896.2004.00210.x
   Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102
   Moukoko CE, 2003, INFECT IMMUN, V71, P5456, DOI 10.1128/IAI.71.10.5456-5460.2003
   Munitz A, 2004, ALLERGY, V59, P268, DOI 10.1111/j.1398-9995.2003.00442.x
   Mwatha JK, 1998, J IMMUNOL, V160, P1992
   Nakajima H, 2006, LIVER INT, V26, P346, DOI 10.1111/j.1478-3231.2005.01216.x
   Negrao-Correa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088042
   Oliveira DM, 2000, PARASITOLOGY, V120, P391, DOI 10.1017/S0031182099005636
   Oliveira LFA, 2006, INFECT IMMUN, V74, P1215, DOI 10.1128/IAI.74.2.1215-1221.2006
   Qidwai T, 2016, IMMUNOL LETT, V176, P128, DOI 10.1016/j.imlet.2016.05.018
   Grenfell RFQ, 2013, MEM I OSWALDO CRUZ, V108, P328, DOI 10.1590/S0074-02762013000300011
   Richter J, 2001, MEM I OSWALDO CRUZ, V96, P151, DOI 10.1590/S0074-02762001000900023
   Richter J, WHOTDRSTRSCH001
   Russo RC, 2011, AM J RESP CELL MOL, V45, P72, DOI 10.1165/rcmb.2009-0406OC
   Ruth JH, 1998, J IMMUNOL, V161, P4276
   Shang XZ, 2002, AM J PATHOL, V161, P257, DOI 10.1016/S0002-9440(10)64177-6
   Silveira-Lemos D, 2010, MEM I OSWALDO CRUZ, V105, P380, DOI 10.1590/S0074-02762010000400006
   Sousa-Pereira SR, 2006, PARASITE IMMUNOL, V28, P473, DOI 10.1111/j.1365-3024.2006.00896.x
   Souza ALS, 2011, INFECT IMMUN, V79, P1741, DOI 10.1128/IAI.00502-10
   Souza ALS, 2005, INFECT IMMUN, V73, P2515, DOI 10.1128/IAI.73.4.2515-2523.2005
   Souza PRS, 2008, ACTA TROP, V108, P135, DOI 10.1016/j.actatropica.2008.04.016
   Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388
   Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3
   WHO, 2014, SCHIST FACT SHEET 11
   Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418
   Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139
NR 78
TC 4
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-9475
EI 1365-3083
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD MAR
PY 2018
VL 87
IS 3
AR e12642
DI 10.1111/sji.12642
PG 13
WC Immunology
SC Immunology
GA FX7UL
UT WOS:000426296600004
PM 29363152
OA Bronze
DA 2020-12-08
ER

PT J
AU Oliveira, WJ
   Magalhaes, FD
   Elias, AMS
   de Castro, VN
   Favero, V
   Lindholz, CG
   Oliveira, AA
   Barbosa, FS
   Gil, F
   Gomes, MA
   Graeff-Teixeira, C
   Enk, MJ
   Coelho, PMZ
   Carneiro, M
   Negrao-Correa, DA
   Geiger, SM
AF Oliveira, Warllem Junio
   Magalhaes, Fernanda do Carmo
   Saldanha Elias, Andressa Mariana
   de Castro, Vanessa Normandio
   Favero, Vivian
   Lindholz, Catieli Gobetti
   Oliveira, Aureo Almeida
   Barbosa, Fernando Sergio
   Gil, Frederico
   Gomes, Maria Aparecida
   Graeff-Teixeira, Carlos
   Enk, Martin Johannes
   Zech Coelho, Paulo Marcos
   Carneiro, Mariangela
   Negrao-Correa, Deborah Aparecida
   Geiger, Stefan Michael
TI Evaluation of diagnostic methods for the detection of intestinal
   schistosomiasis in endemic areas with low parasite loads: Saline
   gradient, Helmintex, Kato-Katz and rapid urine test
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CIRCULATING CATHODIC ANTIGEN; LATERAL FLOW ASSAY; MINAS-GERAIS; MANSONI
   INFECTIONS; ANODIC ANTIGEN; LEWIS-X; PREVALENCE; INTENSITY; STATE;
   FLUCTUATION
AB Background
   In some tropical countries, such as Brazil, schistosomiasis control programs have led to a significant reduction in the prevalence and parasite burden of endemic populations. In this setting, the Kato-Katz technique, as the standard diagnostic method for the diagnosis of Schistosoma mansoni infections, which involves the analysis of two slides from one fecal sample, loses its sensitivity. As a result, a significant number of infected individuals are not detected. The objective of this study was to perform extensive parasitological testing of up to three fecal samples and include a rapid urine test (POC-CCA) in a moderate prevalence area in Northern Minas Gerais, Brazil, and evaluate the performance of each test separately and in combination.
   Methods and findings
   A total of 254 individuals were examined with variants of the standard Kato-Katz technique (up to 18 Kato-Katz slides prepared from three fecal samples), a modified Helmintex (30 g of feces), the saline gradient (500 mg of feces), and the POC-CCA methods. We established a reference standard taking into consideration all the positive results in any of the parasitological exams. Evaluation of the parasite burden by two Kato-Katz slides confirmed that most of the individuals harbored a light infection. When additional slides and different parasitological methods were included, the estimated prevalence rose 2.3 times, from 20.4% to 45.9%. The best sensitivity was obtained with the Helmintex method (84%). All parasitological methods readily detected a high or moderate intensity of infection; however, all lost their high sensitivity in the case of low or very low intensity infections. The overall sensitivity of POC-CCA (64.9%) was similar to the six Kato-Katz slides from three fecal samples. However, POC-CCA showed low concordance (K = 0.34) when compared with the reference standard.
   Conclusions
   The recommended Kato-Katz method largely underestimated the prevalence of S. mansoni infection. Because the best performance was achieved with a modified Helmintex method, this technique might serve as a more precise reference standard. An extended number of Kato-Katz slides in combination with other parasitological methods or with POC-CCA was able to detect more than 80% of egg-positive individuals; however, the rapid urine test (POC-CCA) produced a considerable percentage of false positive results.
C1 [Oliveira, Warllem Junio; Magalhaes, Fernanda do Carmo; Saldanha Elias, Andressa Mariana; de Castro, Vanessa Normandio; Barbosa, Fernando Sergio; Gil, Frederico; Gomes, Maria Aparecida; Carneiro, Mariangela; Negrao-Correa, Deborah Aparecida; Geiger, Stefan Michael] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Favero, Vivian; Lindholz, Catieli Gobetti; Graeff-Teixeira, Carlos] Pontificia Univ Catolica Rio Grande do Sul, Grp Parasitol Med, Porto Alegre, RS, Brazil.
   [Oliveira, Aureo Almeida; Zech Coelho, Paulo Marcos] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Esquistossomose, Belo Horizonte, MG, Brazil.
   [Enk, Martin Johannes] Minist Saude, Inst Evandro Chagas, Secretaria Vigilancia Saude, Belem, Para, Brazil.
RP Geiger, SM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
EM stefan.geiger76@gmail.com
RI Geiger, Stefan/E-6748-2016; Saldanha-Elias, A.M./AAE-2729-2020; Enk,
   Martin Johannes/J-6400-2012
OI Saldanha-Elias, A.M./0000-0003-3443-2904; Enk, Martin
   Johannes/0000-0002-3209-1758; Geiger, Stefan/0000-0002-9741-2727
FU National Brazilian Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [404405/2012-6];
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); World Health Organization,
   TDR Program (Small Grants Scheme) [A-869/2015]
FX The authors received financial support from the National Brazilian
   Research Council (CNPq) for research in neglected tropical diseases,
   DECIT program 2012 #404405/2012-6. MC is grateful to CNPq for research
   fellowships. MC and DANC received financial support from Fundacao de
   Amparo a Pesquisa de Minas Gerais (FAPEMIG), within the program to
   support researchers from the State of Minas Gerais, Brazil (PPM
   program). SMG received additional financial support from the World
   Health Organization, TDR Program (Small Grants Scheme, #A-869/2015). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Amaral RS, 2006, MEMORIAS I O CRUZ S1, V101, pS79
   [Anonymous], 2012, Wkly Epidemiol Rec, V87, P37
   [Anonymous], 2014, VIG ESQ MANS DIR TEC, P146
   BARRETO ML, 1990, T ROY SOC TROP MED H, V84, P554, DOI 10.1016/0035-9203(90)90037-F
   Berhe N, 2004, ACTA TROP, V92, P205, DOI 10.1016/j.actatropica.2004.06.011
   Cai YC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-138
   Espirito-Santo MCC, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0558-4
   Cavalcanti MG, 2013, TRENDS PARASITOL, V29, P75, DOI 10.1016/j.pt.2012.11.003
   Coelho PMZ, 2009, MEM I OSWALDO CRUZ, V104, P720, DOI 10.1590/S0074-02762009000500010
   Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2
   Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639
   Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07
   Corstjens PLAM, 2014, PARASITOLOGY, V141, P1841, DOI 10.1017/S0031182014000626
   Coulibaly JT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-29
   Coura JR, 2004, MEM I OSWALDO CRUZ S, V99, pS13
   Coura-Filho P, 1995, Cad Saude Publica, V11, P254, DOI 10.1590/S0102-311X1995000200009
   Pinheiro MCC, 2012, MEM I OSWALDO CRUZ, V107, P873, DOI 10.1590/S0074-02762012000700006
   de Noya BA, 2007, ACTA TROP, V103, P41, DOI 10.1016/j.actatropica.2007.04.018
   DeClercq D, 1997, TROP MED INT HEALTH, V2, P680, DOI 10.1046/j.1365-3156.1997.d01-354.x
   DEVLAS SJ, 1992, PARASITOL TODAY, V8, P274, DOI 10.1016/0169-4758(92)90144-Q
   DeVlas SJ, 1997, PARASITOLOGY, V114, P113, DOI 10.1017/S0031182096008207
   Disch J, 1997, T ROY SOC TROP MED H, V91, P222, DOI 10.1016/S0035-9203(97)90233-9
   Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019
   Engels D, 1996, AM J TROP MED HYG, V54, P319, DOI 10.4269/ajtmh.1996.54.319
   Enk MJ, 2008, ACTA TROP, V108, P222, DOI 10.1016/j.actatropica.2008.09.016
   Favero V, 2017, EXP PARASITOL, V177, P28, DOI 10.1016/j.exppara.2017.04.001
   Fleming FM, 2006, TROP MED INT HEALTH, V11, P56, DOI 10.1111/j.1365-3156.2005.01541.x
   Goncalves MML, 2006, ACTA TROP, V100, P24, DOI 10.1016/j.actatropica.2006.09.004
   Grenfell R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002054
   Gryseels B, 1996, AM J TROP MED HYG, V55, P103, DOI 10.4269/ajtmh.1996.55.103
   Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3
   Guimaraes RJPS, 2008, ACTA TROP, V108, P234, DOI 10.1016/j.actatropica.2008.07.001
   Hawkins KR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004985
   Hoffman W. A., 1934, Puerto Rico Journal of Public Health & Tropical Medicine, V9, P283
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Jin YM, 2010, CLIN VACCINE IMMUNOL, V17, P476, DOI 10.1128/CVI.00418-09
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Katz N, 2000, Rev Soc Bras Med Trop, V33, P303, DOI 10.1590/S0037-86822000000300009
   Kittur N, 2016, AM J TROP MED HYG, V94, P605, DOI 10.4269/ajtmh.15-0725
   Lamberton PHL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003139
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lin DD, 2008, PARASITOL INT, V57, P281, DOI 10.1016/j.parint.2008.04.005
   Lo NC, 2016, LANCET INFECT DIS, V16, P1065, DOI 10.1016/S1473-3099(16)30073-1
   Midzi N, 2009, T ROY SOC TROP MED H, V103, P45, DOI 10.1016/j.trstmh.2008.08.018
   Noya O, 2015, NEGLECT TROP DIS, P11, DOI 10.1007/978-3-7091-1422-3_2
   Passos ADC, 1998, REV SOC BRAS MED T S, V31, pS61
   Polman K, 1998, AM J TROP MED HYG, V59, P150, DOI 10.4269/ajtmh.1998.59.150
   Rabello A, 2008, SCHISTOSOMA MANSONI, P895
   Rabelo ALT, 1994, REV SOC BRAS MED T S, V27, P177
   Sarvel AK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000990
   Scholte RGC, 2014, ACTA TROP, V132, P57, DOI 10.1016/j.actatropica.2013.12.007
   Silveira AMS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004357
   Sousa-Figueiredo JC, PLOS NEGL TROP DIS, V7, pe2008
   Guimaraes RJDS, 2010, MEM I OSWALDO CRUZ, V105, P524, DOI 10.1590/S0074-02762010000400030
   Speich B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-71
   Standley CJ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-7
   Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7
   Stothard JR, 2014, PARASITOLOGY, V141, P1947, DOI 10.1017/S0031182014001152
   Stothard JR, 2006, ACTA TROP, V97, P219, DOI 10.1016/j.actatropica.2005.11.004
   Stothard JR, 2009, PARASITOLOGY, V136, P1
   Tchuente LAT, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0256-8
   Tchuente LAT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001758
   Teixeira CF, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000073
   Teles Horacio Manuel Santana, 2003, Rev. Soc. Bras. Med. Trop., V36, P503, DOI 10.1590/S0037-86822003000400012
   Turner HC, 2017, TRENDS PARASITOL, V33, P435, DOI 10.1016/j.pt.2017.01.007
   Utzinger J, 2000, TROP MED INT HEALTH, V5, P771, DOI 10.1046/j.1365-3156.2000.00646.x
   van Dam GJ, 2004, J CLIN MICROBIOL, V42, P5458, DOI 10.1128/JCM.42.12.5458-5461.2004
   van Dam GJ, 2015, ACTA TROP, V141, P190, DOI 10.1016/j.actatropica.2014.08.004
   van Dam GJ, 2013, EXP PARASITOL, V135, P274, DOI 10.1016/j.exppara.2013.06.017
   van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9
   vanDam GJ, 1996, BLOOD, V88, P4246, DOI 10.1182/blood.V88.11.4246.bloodjournal88114246
   VANDAM GJ, 1994, EUR J BIOCHEM, V225, P467, DOI 10.1111/j.1432-1033.1994.00467.x
   Siqueira LMV, 2015, MEM I OSWALDO CRUZ, V110, P209, DOI 10.1590/0074-02760140375
   Siqueira LMV, 2011, MEM I OSWALDO CRUZ, V106, P844, DOI 10.1590/S0074-02762011000700010
   WHO (World Health Organization), 2002, 912 WHO, V912
   Coelho PMZ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004778
NR 76
TC 21
Z9 21
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006232
DI 10.1371/journal.pntd.0006232
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700025
PM 29470516
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Leal, GGD
   Carneiro, M
   Pinheiro, AD
   Marques, LA
   Ker, HG
   Reis, AB
   Coura-Vital, W
AF de Almeida Leal, Gleisiane Gomes
   Carneiro, Mariangela
   Pinheiro, Aimara da Costa
   Marques, Luana Araujo
   Ker, Henrique Gama
   Reis, Alexandre Barbosa
   Coura-Vital, Wendel
TI Risk profile for Leishmania infection in dogs coming from an area of
   visceral leishmaniasis reemergence
SO PREVENTIVE VETERINARY MEDICINE
LA English
DT Article
DE Risk factors; Seroprevalence; Leishmania; Canine visceral leishmaniasis;
   Prophylaxis; Serology; Brazil
ID SANDFLIES DIPTERA PSYCHODIDAE; CANINE LEISHMANIASIS; MINAS-GERAIS;
   GOVERNADOR-VALADARES; ENDEMIC AREA; RAPID TEST; RIO-DOCE; STATE;
   EPIDEMIOLOGY; TESTS
AB Until the 1980s, visceral leishmaniasis was concentrated in poor rural areas of Brazil. The Vale do Rio Doce, located in the Southeastern Brazilian state of Minas Gerais, was an endemic area with high numbers of human and canine cases. Prophylactic measures adopted since the 1960s reduced the number of cases and the region became a 'controlled endemic' area. In the early 1990s, however, the program was interrupted, and the human disease reemerged in 2008. This cross-sectional study evaluated the prevalence and the risk profile of infection of dogs with Leishmania spp in this reemergence area of visceral leishmaniasis. Among a population of approximately 280,000 people, a total of 3835 dog owners were interviewed about socioeconomic conditions, housing, peridomicile features, and their dogs' characteristics and behavior. Blood samples were collected from 5822 dogs of an estimated canine population of 20,000 and anti-Leishmaniasis antibodies were identified using Dual-Path Platform and ELISA. We observed that 1282 of the 5822 dogs were seropositive for the protozoan indicating a seroprevalence of 22%. The risk factors associated with Leishmania infection in dogs were: non-paved backyard (OR 1.4; 95%CI 1.2-1.7); the presence of dry leaves and decaying fruit in the backyard (OR 1.3; 95%CI 1.1-1.5); medium-sized (OR 1.3; 95% 1.1-1.5) or big-sized dogs (OR 1.8; 95%CI 1.5-2.3); short-haired dogs (OR 1.8; 95%CI 1.5-2.1); dogs that slept in the backyard (OR 2.6; 95%CI 1.8-3.6) or in the balcony (OR 1.6; 95%CI 1.1-2.3); and history of canine visceral leishmaniasis in the household (OR 1.3; 95%CI 1.1-1.5). Our results suggest a strong reemergence of canine visceral leishmaniasis after the discontinuation of the control programs. Also, the observed risk factors reinforce the role of health education and environmental management measures to the effective control of the disease.
C1 [de Almeida Leal, Gleisiane Gomes; Ker, Henrique Gama; Reis, Alexandre Barbosa; Coura-Vital, Wendel] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisa Ciencias Biol, Ouro Preto, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Pinheiro, Aimara da Costa; Marques, Luana Araujo] Secretaria Municipal Saude, Ctr Controle Zoonoses, Governador Valadares, MG, Brazil.
   [Coura-Vital, Wendel] Univ Fed Ouro Preto, Lab Pesquisa Epidemiol, Dept Anal Clin, Ouro Preto, MG, Brazil.
RP Coura-Vital, W (corresponding author), Univ Fed Ouro Preto, Lab Pesquisa Epidemiol, Dept Anal Clin, Ouro Preto, MG, Brazil.
EM wendelcoura@gmail.com
OI Reis, AlessanRSS/0000-0001-8486-7469; /0000-0002-1434-7676
FU Brazilian Ministry of Health/Fundo Nacional de Saude/National
   Leishmaniasis Control Program [25000.204799/2013-65]; CNPq/BR/grant
   [409869/2016-3]; Universidade Federal de Ouro Preto; CNPqNational
   Council for Scientific and Technological Development (CNPq); CAPESCAPES
FX This study was supported by grants from the Brazilian Ministry of
   Health/Fundo Nacional de Saude/National Leishmaniasis Control Program
   (no. 25000.204799/2013-65), CNPq/BR/grant 409869/2016-3, and the
   research assistance grant from the Universidade Federal de Ouro Preto.
   The funders had no participation in the study design, data collection or
   analysis, the decision to publish, or the preparation of the manuscript.
   ABR and MC are grateful to CNPq and GGAL is grateful to CAPES for their
   research fellowships. MC is grateful to FAPEMIG for PPM/2016. We also
   thank the staff of the Secretaria Municipal de Saude of Governador
   Valadares for the logistical support and their commitment to the
   fulfillment of this project.
CR [Anonymous], 2006, MAN VIG CONTR LEISHM
   Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213
   Barata RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/405083
   Barata RA, 2011, REV SOC BRAS MED TRO, V44, P136, DOI [10.1590/S0037-86822011005000003, 10.1590/s0037-86822011005000003]
   Belo VS, 2017, PREV VET MED, V146, P10, DOI 10.1016/j.prevetmed.2017.07.011
   Belo VS, 2013, VET PARASITOL, V195, P1, DOI 10.1016/j.vetpar.2013.03.010
   COELHO MARCELLO de VASCONCELLOS, 1966, J BRASIL MED, V10, P259
   Malaquias LCC, 2007, PARASITOL RES, V100, P233, DOI 10.1007/s00436-006-0259-z
   Coura-Vital W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091009
   Coura-Vital W, 2013, VET PARASITOL, V197, P411, DOI 10.1016/j.vetpar.2013.07.031
   Coura-Vital W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071833
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   DATASUS, 2017, LEISHM VISC CAS CONF
   de Arruda MM, 2016, MEM I OSWALDO CRUZ, V111, P168, DOI 10.1590/0074-02760150364
   de Mendonca IL, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759039, 10.1590/s1678-9946201759039]
   Deane M. P., 1954, ENC LEISHM NAS VISC, P419
   DESANTIS B, 2013, BRAZ J VET RES ANIM, V50, P198
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8
   do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015
   Fraga DBM, 2012, VET PARASITOL, V190, P591, DOI 10.1016/j.vetpar.2012.06.025
   Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5
   Galvez R, 2010, VET PARASITOL, V169, P327, DOI 10.1016/j.vetpar.2009.11.025
   Genaro O, 1990, Rev Soc Bras Med Trop, V23, P121, DOI 10.1590/S0037-86821990000200011
   Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001
   IBGE, 2017, CENS DEM 2010
   Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2
   MAGALHAES P A, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P197
   Sanchez JM, 2009, EMERG INFECT DIS, V15, P795, DOI 10.3201/eid1505.080969
   MAYRINK W, 1979, ANN TROP MED PARASIT, V73, P123, DOI 10.1080/00034983.1979.11687239
   Ministerio da Saude, 2011, ESCL SUBS PROT DIAGN
   Miranda TM, 2011, REV PAN AMAZ SAUDE, V2, P27
   Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393
   Nunes CM, 2010, VET PARASITOL, V170, P131, DOI 10.1016/j.vetpar.2010.01.044
   Rivas GBS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-278
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Silva DA, 2011, VET PARASITOL, V179, P257, DOI 10.1016/j.vetpar.2011.01.048
   SINAN, 2016, DATASUS LEISHM VISC
   Tanure A, 2015, REV INST MED TROP SP, V57, P321, DOI 10.1590/S0036-46652015000400008
   Werneck GL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00ED010616
   Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023
   WHO, 2017, LEISHMANIASIS
NR 42
TC 10
Z9 10
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5877
EI 1873-1716
J9 PREV VET MED
JI Prev. Vet. Med.
PD FEB 1
PY 2018
VL 150
BP 1
EP 7
DI 10.1016/j.prevetmed.2017.11.022
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA FX4FE
UT WOS:000426027300001
PM 29406075
DA 2020-12-08
ER

PT J
AU Franca, EB
   Passos, VMD
   Malta, DC
   Duncan, BB
   Ribeiro, ALP
   Guimaraes, MDC
   Abreu, DMX
   Vasconcelos, AMN
   Carneiro, M
   Teixeira, R
   Camargos, P
   Melo, APS
   Queiroz, BL
   Schmidt, MI
   Ishitani, L
   Ladeira, RM
   Morais-Neto, OL
   Bustamante-Teixeira, MT
   Guerra, MR
   Bensenor, I
   Lotufo, P
   Mooney, M
   Naghavi, M
AF Franca, Elisabeth B.
   de Azeredo Passos, Valeria Maria
   Malta, Deborah Carvalho
   Duncan, Bruce B.
   Ribeiro, Antonio Luiz P.
   Guimaraes, Mark D. C.
   Abreu, Daisy M. X.
   Vasconcelos, Ana Maria N.
   Carneiro, Mariangela
   Teixeira, Renato
   Camargos, Paulo
   Melo, Ana Paula S.
   Queiroz, Bernardo L.
   Schmidt, Maria Ines
   Ishitani, Lenice
   Ladeira, Roberto Marini
   Morais-Neto, Otaliba L.
   Bustamante-Teixeira, Maria Tereza
   Guerra, Maximiliano R.
   Bensenor, Isabela
   Lotufo, Paulo
   Mooney, Meghan
   Naghavi, Mohsen
TI Cause-specific mortality for 249 causes in Brazil and states during
   1990-2015: a systematic analysis for the global burden of disease study
   2015
SO POPULATION HEALTH METRICS
LA English
DT Article
DE Mortality; Causes of death; Global burden of disease; Brazil
ID CHILDHOOD MORTALITY; PROJECT-ICSAP; HEALTH; DEATH; DIARRHEA; PROGRAM;
   TRENDS; COUNTRIES; RATES
AB Background: Reliable data on cause of death (COD) are fundamental for planning and resource allocation priorities. We used GBD 2015 estimates to examine levels and trends for the leading causes of death in Brazil from 1990 to 2015.
   Methods: We describe the main analytical approaches focused on both overall and specific causes of death for Brazil and Brazilian states.
   Results: There was an overall improvement in life expectancy at birth from 1990 to 2015, but with important heterogeneity among states. Reduced mortality due to diarrhea, lower respiratory infections, and other infectious diseases contributed the most for increasing life expectancy in most states from the North and Northeast regions. Reduced mortality due to cardiovascular diseases was the highest contributor in the South, Southeast, and Center West regions. However, among men, intentional injuries reduced life expectancy in 17 out of 27 states. Although age-standardized rates due to ischemic heart disease (IHD) and cerebrovascular disease declined over time, these remained the leading CODs in the country and states. In contrast, leading causes of premature mortality changed substantially - e.g., diarrheal diseases moved from 1st to 13th and then the 36th position in 1990, 2005, and 2015, respectively, while violence moved from 7th to 1st and to 2nd. Overall, the total age-standardized years of life lost (YLL) rate was reduced from 1990 to 2015, bringing the burden of premature deaths closer to expected rates given the country's Socio-demographic Index (SDI). In 1990, IHD, stroke, diarrhea, neonatal preterm birth complications, road injury, and violence had ratios higher than the expected, while in 2015 only violence was higher, overall and in all states, according to the SDI.
   Conclusions: A widespread reduction of mortality levels occurred in Brazil from 1990 to 2015, particularly among children under 5 years old. Major shifts in mortality rates took place among communicable, maternal, neonatal, and nutritional disorders. The mortality profile has shifted to older ages with increases in non-communicable diseases as well as premature deaths due to violence. Policymakers should address health interventions accordingly.
C1 [Franca, Elisabeth B.; Guimaraes, Mark D. C.; Teixeira, Renato] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Saude Publ, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
   [de Azeredo Passos, Valeria Maria; Ribeiro, Antonio Luiz P.] Univ Fed Minas Gerais, Sch Med, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
   [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Escola Enfermagem, Dept Enfermagem Materno Infantil, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
   [Duncan, Bruce B.; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Programa Posgrad Epidemiol, R Ramiro Barcelos 2600-414, BR-90035003 Porto Alegre, RS, Brazil.
   [Abreu, Daisy M. X.] Univ Fed Minas Gerais, Fac Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
   [Vasconcelos, Ana Maria N.] Univ Brasilia, Programa Posgrad Desenvolvimento Soc & Cooperacao, BR-70910900 Brasilia, DF, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Ave Antonio Carlos 6670, BR-31270901 Belo Horizonte, MG, Brazil.
   [Camargos, Paulo; Melo, Ana Paula S.] Univ Fed Sao Joao Del Rei, Fac Med, Praca Frei Orlando 170, BR-36307352 Centro, Sao Joao Del Re, Brazil.
   [Queiroz, Bernardo L.] Univ Fed Minas Gerais, Fac Ciencias Econ, Dept Demog, Av Antonio Carlos 6670, BR-31270901 Belo Horizonte, MG, Brazil.
   [Ishitani, Lenice] Univ Fed Minas Gerais, GPEAS, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
   [Ladeira, Roberto Marini] Fundacao Hosp Estado Minas Gerais, Alameda Alvaro Celso 100-231, BR-30150260 Belo Horizonte, MG, Brazil.
   [Morais-Neto, Otaliba L.] Univ Fed Goias, Dept Saude Colet, Inst Patol Trop & Saude Publ, Rua 235 S-N, BR-74605050 Goiania, Go, Brazil.
   [Bustamante-Teixeira, Maria Tereza; Guerra, Maximiliano R.] Univ Fed Juiz de Fora, Programa Posgrad Saude Colet, Campus Univ UFJF,Rua Jose Lourenco Kelmer S-N, BR-36036330 Martelos, Juiz De Fora, Brazil.
   [Bensenor, Isabela; Lotufo, Paulo] Univ Sao Paulo, Ctr Pesquisa Clin & Epidemiol, Hosp Univ, Av Lineu Prestes 256,3 Andar, BR-05508000 Sao Paulo, Brazil.
   [Mooney, Meghan; Naghavi, Mohsen] Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600,Box 358210, Seattle, WA 98121 USA.
RP Franca, EB (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Saude Publ, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
EM efranca@medicina.ufmg.br
RI Passos, Valeria/B-5345-2014; Vasconcelos, Ana Maria
   Nogales/AAL-9776-2020; Schmidt, Maria/V-3196-2019; Ribeiro, Antonio
   L/C-2707-2009; Malta, Deborah Carvalho/L-2491-2019; Vasconcelos,
   Ana/AAK-4526-2020; Queiroz, Bernardo/U-7783-2017
OI Passos, Valeria/0000-0003-2829-5798; Vasconcelos, Ana Maria
   Nogales/0000-0001-7589-107X; Ribeiro, Antonio L/0000-0002-2740-0042;
   Malta, Deborah Carvalho/0000-0002-8214-5734; Queiroz,
   Bernardo/0000-0002-2890-1025
FU Ministry of Health of Brazil [25000192049/2014-14]
FX The Ministry of Health of Brazil was responsible for funding the GBD
   2015 Brazil Study (Fundo Nacional de Saude, grant number
   25000192049/2014-14).
CR Alfradique ME, 2009, CAD SAUDE PUBLICA, V25, P1337, DOI 10.1590/S0102-311X2009000600016
   Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9
   Barreto ML, 2006, T ROY SOC TROP MED H, V100, P234, DOI 10.1016/j.trstmh.2005.03.010
   Beato CCFilho, 2007, HOMICIDIOS BRASIL, P177
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2015, VIG BRAZ 2014 PROT R
   de Lima EEC, 2014, CAD SAUDE PUBLICA, V30, P1721, DOI 10.1590/0102-311X00131113
   CANO I, 2007, HOMICIDIOS NO BRASIL, P51
   Canudas-Romo V, 2017, J EPIDEMIOL COMMUN H, V71, P188, DOI 10.1136/jech-2015-207015
   Carmos GMI, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001024
   Chalmers JD, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0242-0
   COHEN RL, 2014, GLOB HLTH, V10
   De Boni RB, 2014, REV BRAS PSIQUIATR, V36, P11, DOI 10.1590/1516-4446-2013-1131
   Jose BPD, 2014, REV ASSOC MED BRAS, V60, P599, DOI 10.1590/1806-9282.60.06.021
   de Vasconcellos EA, 2013, INT J INJ CONTROL SA, V20, P144, DOI 10.1080/17457300.2012.696663
   Dourado I, 2011, MED CARE, V49, P577, DOI 10.1097/MLR.0b013e31820fc39f
   Duncan Bruce Bartholow, 2017, Rev. bras. epidemiol., V20, P90, DOI 10.1590/1980-5497201700050008
   Ferrer SR, 2008, INT J EPIDEMIOL, V37, P805, DOI 10.1093/ije/dyn093
   Fonseca JE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002943
   Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1
   Franca E, 2008, INT J EPIDEMIOL, V37, P891, DOI 10.1093/ije/dyn121
   Franca E, 2014, REV SAUDE PUBL, V48, P671, DOI 10.1590/S0034-8910.2014048005146
   Franca E, 2012, REV PANAM SALUD PUBL, V31, P275, DOI 10.1590/S1020-49892012000400002
   Gamarra CJ, 2010, REV SAUDE PUBL, V44, P629, DOI 10.1590/S0034-89102010000400006
   Garcia LP, 2015, IMPACTO INTERVENCOES, P397
   Graudenz GS, 2014, REV ASSOC MED BRAS, V60, P255, DOI 10.1590/1806-9282.60.03.015
   Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025
   Heller L, 2003, REV SOC BRAS MED TRO, V36, P45
   Hyder AA, 2014, B WORLD HEALTH ORGAN, V92, P423, DOI 10.2471/BLT.13.132613
   Iser BPM, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0185-x
   Jaime PC, 2013, OBES REV, V14, P88, DOI 10.1111/obr.12101
   Jensen HH, 2006, EUR RESPIR J, V28, P781, DOI 10.1183/09031936.06.00152205
   Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2
   Levy D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001336
   Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2
   Lopez-Campos JL, 2016, RESPIROLOGY, V21, P14, DOI 10.1111/resp.12660
   Machado CV, 2011, REV SAUDE PUBL, V45, P519, DOI 10.1590/s0034-89102011005000022
   Macinko J, 2006, J EPIDEMIOL COMMUN H, V60, P13, DOI 10.1136/jech.2005.038323
   Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140
   Malta DC, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S1518-8787.2016050006209
   Malta DC, 2016, CIENC SAUDE COLETIVA, V21, P327, DOI 10.1590/1413-81232015212.23602015
   Malta DC, 2013, CAD SAUDE PUBLICA, V29, P812, DOI [10.1590/S0102-311X2013000800018, 10.1590/S0102-311X2013000400018]
   de Souza MDM, 2007, HEALTH AFFAIR, V26, P575, DOI 10.1377/hlthaff.26.2.575
   Martins ET, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004227
   Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534
   Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262
   Murray CJL, 1996, GLOBAL BURDEN DIS CO
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Neri MC, 2008, NOVA CLASSE MEDIA MO
   Nielsen A., 2009, CRIMINALIDADE AVANCA
   Paes NA, 2005, REV SAUDE PUBL, V39, P882, DOI 10.1590/S0034-89102005000600003
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Rasella D., 2014, BMJ-BRIT MED J, V349, P4014, DOI DOI 10.1136/BMJ.G4014
   Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1
   Rasella D, 2010, PEDIATRICS, V126, pE534, DOI 10.1542/peds.2009-3197
   Reichenheim ME, 2011, VIOLENCE INJURIES BR, P377
   Ribeiro ALP, 2016, CIRCULATION, V133, P422, DOI 10.1161/CIRCULATIONAHA.114.008727
   Santosa A, 2014, GLOBAL HEALTH ACTION, V7, P56, DOI 10.3402/gha.v7.23574
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Simoes EJ, 2009, AM J PUBLIC HEALTH, V99, P68, DOI 10.2105/AJPH.2008.141978
   Szwarcwald CL, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-16
   Ulinski SL, 2016, REV BRAS PSIQUIATR, V38, P106, DOI 10.1590/1516-4446-2014-1574
   Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   Wareham NJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002097
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
NR 66
TC 40
Z9 44
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-7954
J9 POPUL HEALTH METR
JI Popul. Health Metr.
PD NOV 22
PY 2017
VL 15
AR 39
DI 10.1186/s12963-017-0156-y
PG 17
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FN5QN
UT WOS:000416062800001
PM 29166948
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, TAM
   Coura-Vital, W
   Barbosa, DS
   Oiko, CSF
   Morais, MHF
   Tourinho, BD
   de Melo, DPO
   Reis, IA
   Carneiro, M
AF Marques da Silva, Thais Almeida
   Coura-Vital, Wendel
   Barbosa, David Soeiro
   Fogaca Oiko, Carla Sayuri
   Franco Morais, Maria Helena
   Tourinho, Bruna Dias
   Ornelas de Melo, Diogo Portella
   Reis, Ilka Afonso
   Carneiro, Mariangela
TI Spatial and temporal trends of visceral leishmaniasis by mesoregion in a
   southeastern state of Brazil, 2002-2013
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PHLEBOTOMINE SAND FLIES; MINAS-GERAIS; BELO-HORIZONTE; ENDEMIC AREA;
   LUTZOMYIA-LONGIPALPIS; MONTES-CLAROS; TRANSMISSION; PORTEIRINHA; HUMANS;
   URBAN
AB Background
   Visceral leishmaniasis (VL) is expanding in Brazil and in other South American countries, a process that has been associated with the urbanization of the disease. This study analyzes the spatial and temporal distribution of VL in the Brazilian state of Minas Gerais and identifies the areas with higher risks of transmission.
   Methodology
   An ecological study with spatial and time series analyzes of new confirmed cases of VL notified to the Brazilian Notifiable Disease Information System between 2002 and 2013, considering the 12 mesoregions of Minas Gerais. Two complementary methodologies were used: thematic maps of incidence and Poisson (log-linear) generalized linear model. Thematic maps using crude and smoothed cumulative incidences were generated for four trienniums. Poisson Regression measured the variation of the average number of cases from one year to the following, for each mesoregion.
   Principal findings
   The 5,778 cases analyzed revealed a heterogeneous spatial and temporal distribution of VL in Minas Gerais. Six mesoregions (Central Mineira, Jequitinhonha, Metropolitan area of Belo Horizonte, Northwest of Minas, North of Minas, and Vale do Rio Doce) were responsible for the expansion and maintenance of VL, with incidence rates as high as 26/100,000 inhabitants. The Vale do Rio Doce and Jequitinhonha mesoregions showed a considerable increase in the incidence rates in the last period studied. The other six mesoregions reported only sporadic cases and presented low and unsteady incidence rates, reaching a maximum of 1.2/100,000 inhabitants.
   Conclusions/Significance
   The results contribute to further the current understanding about the expansion of VL in Minas Gerais and may help guide actions for disease control.
C1 [Marques da Silva, Thais Almeida; Barbosa, David Soeiro; Fogaca Oiko, Carla Sayuri; Carneiro, Mariangela] Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Marques da Silva, Thais Almeida] Inst Ensino & Pesquisa Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel] Univ Fed Ouro Preto, Lab Epidemiol & Citol, Escola Farm, Ouro Preto, MG, Brazil.
   [Franco Morais, Maria Helena; Ornelas de Melo, Diogo Portella] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Tourinho, Bruna Dias] Secretaria Estadual Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Posgrad Ciencias Saude Infectol & Med Trop, Fac Med, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.; Carneiro, M (corresponding author), Univ Fed Minas Gerais, Posgrad Ciencias Saude Infectol & Med Trop, Fac Med, Belo Horizonte, MG, Brazil.
EM mcarneiro@ufmg.br
RI Reis, Ilka Afonso/AAG-8007-2019
OI Tourinho, Bruna/0000-0001-7597-1387; Carneiro,
   Mariangela/0000-0002-9390-7714; /0000-0002-1434-7676
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPQNational Council for Scientific and Technological Development (CNPq)
   [448449/2014-5]; Brazilian Ministry of Health/National Leishmaniasis
   Control Program/Fundo Nacional de Saude [25000.204799/2013-65];
   CNPq-BrazilNational Council for Scientific and Technological Development
   (CNPq)
FX This study was supported by the following grants: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPQ (www.cnpg.br) (grant no.
   Universal 448449/2014-5), Brazilian Ministry of Health/National
   Leishmaniasis Control Program/Fundo Nacional de Saude (no.
   25000.204799/2013-65). TAMS is grateful to CNPq-Brazil for a doctoral
   Research Fellowship. MC is grateful to CNPq-Brazil for the research
   fellowships and Fundacao de Amaparo a Pesquisa de Minas Gerais - FAPEMIG
   (www.fapemig.br) for Programa Pesquisador Mineiro (PPM/2016). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barata RA, 2005, REV SOC BRAS MED TRO, V38, P421, DOI 10.1590/S0037-86822005000500012
   Barata RA, 2004, MEM I OSWALDO CRUZ, V99, P481, DOI 10.1590/S0074-02762004000500004
   Barata RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/405083
   Barata RA, 2011, REV SOC BRAS MED TRO, V44, P386, DOI 10.1590/S0037-86822011000300025
   Barbosa DS, 2014, ACTA TROP, V131, P56, DOI 10.1016/j.actatropica.2013.12.002
   Barrio A, 2012, EMERG INFECT DIS, V18, P354, DOI [10.3201/eid1802.110924, 10.3291/eid1802.110924]
   Bevilacqua PD, 2001, ARQ BRAS MED VET ZOO, V53, P1, DOI 10.1590/S0102-09352001000100001
   Bhunia GS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-64
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2006, MAN VIG CONTR LEISHM, P120
   Caiaffa Waleska Teixeira, 2005, Cad. Saúde Pública, V21, P958, DOI 10.1590/S0102-311X2005000300032
   Canese A, 2003, REV PARAG MICROBIOL, V23, P1
   Canese J, 2010, PEDIATRIA-ASUNCION, V37, P167
   Cardim MFM, 2013, REV SAUDE PUBL, V47, P1
   COELHO MARCELLO de VASCONCELLOS, 1966, J BRASIL MED, V10, P259
   Antonialli SAC, 2007, J INFECTION, V54, P509, DOI 10.1016/j.jinf.2006.08.004
   Malaquias LCC, 2007, PARASITOL RES, V100, P233, DOI 10.1007/s00436-006-0259-z
   Salomon OD, 2016, REV PANAM SALUD PUBL, V40, P29
   Dantas-Torres F, 2006, REV SOC BRAS MED TRO, V39, P352, DOI 10.1590/S0037-86822006000400007
   de Almeida AS, 2011, AM J TROP MED HYG, V84, P681, DOI 10.4269/ajtmh.2011.10-0325
   de Castro JM, 2016, ENS CIENC, V20, P93
   Dias ES, 2011, VET PARASITOL, V176, P101, DOI 10.1016/j.vetpar.2010.11.014
   Druck S, 2004, ANAL ESPACIAL DADOS
   de Souza VAF, 2012, CAD SAUDE PUBLICA, V28, P1949, DOI 10.1590/S0102-311X2012001000013
   Fraga LAO, 2013, GERAIS REV SAUDE PUB, V1, P105
   Franca-Silva JC, 2005, VET PARASITOL, V131, P213, DOI 10.1016/j.vetpar.2005.05.006
   Morais MHF, 2015, EPIDEMIOL SERV SAUDE, V24, P485, DOI 10.5123/S1679-49742015000300014
   Furtado AS, 2015, CIENC SAUDE COLETIVA, V20, P3935, DOI 10.1590/1413-812320152012.01672015
   Genaro O, 1990, Rev Soc Bras Med Trop, V23, P121, DOI 10.1590/S0037-86821990000200011
   Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   IBGE, 2016, EST POP
   IBGE, 2016, IND DES HUM IDH
   IBGE, 2016, ESTADO MINAS GERAIS
   Karagiannis-Voules D, 2013, PLOS NEGLECT TROP D, V7, P2213
   Laughton BA, 2015, ANALISE LEISHMANIOSE
   Lopes EGP, 2010, ARQ BRAS MED VET ZOO, V62, P1062, DOI 10.1590/S0102-09352010000500007
   Luz ZMP, 2001, REV SOC BRAS MED TRO, V34, P249, DOI DOI 10.1590/S0037-86822001000300004
   MAGALHAES P A, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P197
   Marques L, 2016, PARASITOLOGY, V144, P1
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   Monteiro EM, 2005, REV SOC BRAS MED TRO, V38, P147, DOI 10.1590/S0037-86822005000200004
   Cardim MFM, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050005965, 10.1590/s1518-8787.2016050005965]
   Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023
   OPS/ OMS, 2016, LEISHM INF EP AM
   Reithinger R, 2002, TRENDS PARASITOL, V19, P299
   Ryan JR, 2006, AM J TROP MED HYG, V74, P308
   Saraiva L, 2011, ACTA TROP, V117, P137, DOI 10.1016/j.actatropica.2010.11.007
   Sherlock IA, 1996, MEM I OSWALDO CRUZ, V91, P671, DOI 10.1590/S0074-02761996000600003
   Santini MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003951
   Sousa RG, 2008, ACTA SCI-HEALTH SCI, V30, P155, DOI 10.4025/actascihealthsci.v30i2.671
   Teixeira-Neto RG, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0485-7
   Ursine RL, 2016, MEM I OSWALDO CRUZ, V111, P505, DOI 10.1590/0074-02760160133
   Vianna EN, 2016, MEM I OSWALDO CRUZ, V111, P302, DOI 10.1590/0074-02760150366
   Vieira CP, 2014, REV SOC BRAS MED TRO, V47, P350, DOI 10.1590/0037-8682-0047-2014
   Werneck GL, 2008, INTRO CAD SAUDE PUBL, V24, P937
   Werneck Guilherme L., 2010, Cad. Saúde Pública, V26, P644, DOI 10.1590/S0102-311X2010000400001
NR 56
TC 7
Z9 7
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2017
VL 11
IS 10
AR e0005950
DI 10.1371/journal.pntd.0005950
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FL5JJ
UT WOS:000414271400026
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Tourinho, BD
   Amancio, FF
   Ferraz, ML
   Carneiro, M
AF Tourinho, Bruna Dias
   Amancio, Frederico Figueiredo
   Ferraz, Marcela Lencine
   Carneiro, Mariangela
TI Prognostic factors for death from visceral leishmaniasis in patients
   treated with liposomal amphotericin B in an endemic state in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Brazil; Case-fatality rates; Liposomal amphotericin B; Minas Gerais;
   Prognostic factors; Visceral leishmaniasis
ID HIV-INFECTED PATIENTS; EFFICACY
AB Objective: To characterize the clinical and epidemiological profiles of patients with visceral leishmaniasis (VL) treated with liposomal amphotericin B (LAmB) and to identify prognostic factors for death from VL in 2008-2012 in the state of Minas Gerais, Brazil.
   Methods: A historical cohort study was conducted using data obtained from treatment requests forms, Brazilian Notifiable Disease Information System and the Mortality Information System. Case-fatality rates of patients with VL treated with LAmB were compared with patients treated with other therapies. Logistic regression analysis was used to identify prognostic factors for death.
   Results: The overall case-fatality rate of the 577 patients treated with LAmB was 19.4%. Prognostic factors for death from VL were age between 35 and 49 years (OR 2.7; 95% CI 1.3-5.4) and above 50 years (OR 2.6; 95% CI 1.3-4.9), jaundice (OR 2.2; 95% CI 1.2-3.7), kidney disease (OR 2.8; 95% CI 1.6-4.9), presence of other infections (OR 2.4; 95% CI 1.5-4.1), edema ( OR 2.0; 95% CI 1.1-3.4), platelet count below 50.000/mm3 (OR 3.6; 95% CI 2.1-6.0), AST higher than 100 U/L (OR 2.2; 95% CI 1.3-3.8), and assistance in non-specialized institutions (OR 1.9; 95% CI 1.0-3.5).
   Conclusions: Case-fatality rates were higher than that observed among patients with VL treated with other therapies. Identification of prognostic factors of death from VL may allow early diagnosis of patients prone to such outcome and prompt an expeditious and appropriate management of VL to reduce fatality rates.
C1 [Tourinho, Bruna Dias; Carneiro, Mariangela] Univ Fed Minas Gerais, Programa Pos Grad Ciencias Saude Infectol & Med T, Fac Med, BR-30130 Belo Horizonte, MG, Brazil.
   [Tourinho, Bruna Dias; Ferraz, Marcela Lencine] Secretaria Estado Saude Minas Gerais, Diretoria Vigilancia Ambiental Superintendencia V, Subsecretaria Vigilancia Saude, BR-30130 Belo Horizonte, MG, Brazil.
   [Tourinho, Bruna Dias; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, BR-30130 Belo Horizonte, MG, Brazil.
   [Amancio, Frederico Figueiredo] Fundacao Hosp Estado Minas Gerais, BR-30130 Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Programa Pos Grad Ciencias Saude Infectol & Med T, Fac Med, BR-30130 Belo Horizonte, MG, Brazil.; Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, BR-30130 Belo Horizonte, MG, Brazil.; Carneiro, M (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneiro@ufmg.br
OI Tourinho, Bruna/0000-0001-7597-1387
FU Brazilian Ministry of Health/Visceral Leishmaniasis Control Program
   [25000.204799/201465]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [448449/2014-5]
FX The project was funded by the Brazilian Ministry of Health/Visceral
   Leishmaniasis Control Program [Grant No 25000.204799/201465] and CNPq
   [Grant No. 448449/2014-5].
CR Alencar J.E., 1983, CEARA MED, V5, P86
   Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, P31511
   Barreto ML, 2011, LANCET, V6736, P47
   Belo VS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002182
   Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25
   Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530
   Braga ASC, 2010, REV SOC BRAS MED TRO, V46, P55
   Brazilian Institute of Geography and Statistics (IBGE), 2015, CENS DEM 2010
   Costa DL, 2013, PATHOG GLOB HEALTH, V107, P78, DOI 10.1179/2047773213Y.0000000078
   Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195
   Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153
   Coura-Vital W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003374
   de Oliveira JM, 2010, REV SOC BRAS MED TRO, V43, P188, DOI 10.1590/S0037-86822010000200016
   Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003
   Madalosso G, 2012, J TROPICAL MED, V2012, P1
   Melo EC, 2013, J TROP MED, V2013, P1
   Ministry of Health of Brazil, 2016, LEISHM VISC
   Ministry of Health of Brazil, 2016, GUIA VIG SAUD
   Ministry of Health of Brazil, 2011, LEISHM VISC REC CLIN
   Ministry of Health of Brazil, 2006, MAN VIG CONTR LEISHM
   Muniaraj M, 2012, T ROY SOC TROP MED H, V106, P770, DOI 10.1016/j.trstmh.2012.08.010
   Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010
   Paredes R, 2003, J Postgrad Med, V49, P39
   Queiroz MJL, 2003, REV BRAS SAUDE MATER, V34, P491
   Santos Mácia A., 2002, Rev. Soc. Bras. Med. Trop., V35, P629, DOI 10.1590/S0037-86822002000600014
   Sinha PK, 2011, CLIN INFECT DIS, V53, pE91, DOI 10.1093/cid/cir521
   Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971
   Sundar S, 2010, INT J ENV RES PUB HE, V7, P4267, DOI 10.3390/ijerph7124267
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9
   WHO, 2016, LEISH FACT SHEET
NR 30
TC 4
Z9 4
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD APR
PY 2017
VL 111
IS 4
BP 163
EP 171
DI 10.1093/trstmh/trx029
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FA3NF
UT WOS:000405349900004
PM 28673017
DA 2020-12-08
ER

PT J
AU Marques, LHD
   Da Rocha, ICM
   Reis, IA
   Da Cunha, GMR
   Oliveira, E
   Pfeilsticker, TR
   De Araujo, VEM
   Morais, MHF
   Rabello, A
   Carneiro, M
AF Dos Santos Marques, Leticia Helena
   Marques Da Rocha, Iara Caixeta
   Reis, Ilka Afonso
   Rodrigues Da Cunha, Gisele Macedo
   Oliveira, Edward
   Pfeilsticker, Thais Ribeiro
   Miranda De Araujo, Valdelaine Etelvina
   Franco Morais, Maria Helena
   Rabello, Ana
   Carneiro, Mariangela
TI Leishmania infantum: illness, transmission profile and risk factors for
   asymptomatic infection in an endemic metropolis in Brazil
SO PARASITOLOGY
LA English
DT Article
DE visceral leishmaniasis; asymptomatic infection; infection; relative
   risk; Brazil
ID HUMAN VISCERAL LEISHMANIASIS; URBAN AREA; SPATIAL-ANALYSIS;
   MINAS-GERAIS; PIAUI STATE; KALA-AZAR; CHAGASI; ASSAY; MANIFESTATIONS;
   MUNICIPALITY
AB To evaluate the distribution of asymptomatic infection by Leishmania infantum in ametropolis in Brazil with different relative risks (RRs) for disease and risk factors associated with the infection, an ecological study was conducted using a Bayesian approach to estimate the RR of human visceral leishmaniasis (HVL) based on cases between 2008 and 2011. The areas were categorized and selected according to disease incidence: low (area-1), medium (area-2) and high (area-3). Cross-sectional study enrolling 935 children was used to estimate the prevalence of infection by L. infantum. Volunteers from these three areas were tested for L. infantum infection by ELISA (rK39 and soluble antigens). Infection prevalence rates were estimated and compared with the RR of disease. Multilevel logistic regression model evaluated the relationship between infection and the analysed variables. The RR of HVL was distributed heterogeneously in the municipality. The infection prevalence rates were: 34.9% in area-1; 29.3% in area-2; and 33.6% in area-3, with no significant differences between these areas. The variables 'Presence of backyards in the neighbourhood' and 'Younger children' were associated with L. infantuminfection. We conclude that infection by L. infantum affects a significant proportion of the infant population regardless of the RR of disease.
C1 [Dos Santos Marques, Leticia Helena; Marques Da Rocha, Iara Caixeta; Rodrigues Da Cunha, Gisele Macedo; Pfeilsticker, Thais Ribeiro; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, BR-31270901 Belo Horizonte, MG, Brazil.
   [Marques Da Rocha, Iara Caixeta; Franco Morais, Maria Helena] Secretaria Municipal Saude, Prefeitura Belo Horizonte, BR-30710040 Belo Horizonte, MG, Brazil.
   [Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil.
   [Oliveira, Edward; Rabello, Ana] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Pesquisas Clin, BR-30190002 Belo Horizonte, MG, Brazil.
   [Miranda De Araujo, Valdelaine Etelvina] Minist Saude, BR-70058900 Esplanada De Ministerios, DF, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecciosas & Parasitarias, Inst Ciencias Biol, Campus Pampulha,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Reis, Ilka Afonso/AAG-8007-2019; Pfeilsticker, Thais
   Ribeiro/AAE-4070-2019
OI Pfeilsticker, Thais Ribeiro/0000-0003-4690-4593
FU CNPq-Brazil for a doctoral Research Fellowship; FAPEMIG/PPM;
   CNPQ/UniversalNational Council for Scientific and Technological
   Development (CNPq) [478528/2012-4, 448449/20145]; Ministry of
   Health/Brazilian National Leishmaniasis Control Program
   [25000.204799/2013-65]
FX L.H.S.M. is grateful to CNPq-Brazil for a doctoral Research Fellowship.
   M.C. is grateful to CNPq-Brazil for the research fellowships and
   FAPEMIG/PPM. The authors are also grateful to the Pro-Reitoria de
   Pesquisa of Universidade Federal de Minas Gerais for supporting this
   publication. This study was supported by the following grants:
   CNPQ/Universal 478528/2012-4, CNPQ/Universal 448449/20145, Ministry of
   Health/Brazilian National Leishmaniasis Control Program (no. 25000.
   204799/2013-65).
CR Alonso DP, 2007, J INFECT DIS, V195, P1212, DOI 10.1086/512683
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Assuncao R M, 1998, Cad Saude Publica, V14, P713, DOI 10.1590/S0102-311X1998000400013
   Assuncao RM, 2001, STAT MED, V20, P2319, DOI 10.1002/sim.844
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Caldas AJM, 2002, T ROY SOC TROP MED H, V96, P21, DOI 10.1016/S0035-9203(02)90227-0
   Carneiro M, 2011, DRUG DEVELOP RES, V72, P442, DOI 10.1002/ddr.20451
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   Custodio E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001813
   de Almeida AS, 2011, AM J TROP MED HYG, V84, P681, DOI 10.4269/ajtmh.2011.10-0325
   Marques LHD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001955
   Elnaiem DEA, 2003, AM J TROP MED HYG, V68, P10, DOI 10.4269/ajtmh.2003.68.1.0680010
   Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5
   Goldstein H., 1995, MULTILEVEL STAT MODE
   Gouvea MV, 2007, ACTA TROP, V104, P99, DOI 10.1016/j.actatropica.2007.07.010
   HO M, 1983, AM J TROP MED HYG, V32, P943, DOI 10.4269/ajtmh.1983.32.943
   Hosmer Jr D. W., 1989, APPL LOGISITIC REGRE
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591
   Maia Z, 2016, VECTOR-BORNE ZOONOT, V16, P368, DOI 10.1089/vbz.2015.1880
   Margonari C, 2006, MEM I OSWALDO CRUZ, V101, P31, DOI 10.1590/S0074-02762006000100007
   MARZOCHI MCA, 1994, PARASITOL TODAY, V10, P37, DOI 10.1016/0169-4758(94)90358-1
   de Souza VMM, 2008, EPIDEMIOL SERV SAUDE, V17, P97
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511
   Moreno EC, 2006, REV SOC BRAS MED TRO, V39, P421, DOI 10.1590/S0037-86822006000500001
   Moreno EC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000536
   Nascimento Maria do Desterro Soares Brandão, 2005, Cad. Saúde Pública, V21, P1801, DOI 10.1590/S0102-311X2005000600028
   Oliveira CD, 2006, REV PANAM SALUD PUBL, V20, P369, DOI 10.1590/S1020-49892006001100002
   PBH, 2014, PREF MUN BEL HOR INF
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Romero HD, 2009, AM J TROP MED HYG, V81, P27
   Saraiva L, 2011, ACTA TROP, V117, P137, DOI 10.1016/j.actatropica.2010.11.007
   Silva LA, 2011, AM J TROP MED HYG, V84, P261, DOI 10.4269/ajtmh.2011.10-0092
   Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
NR 38
TC 6
Z9 6
U1 1
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD APR
PY 2017
VL 144
IS 4
BP 546
EP 556
DI 10.1017/S0031182016002134
PG 11
WC Parasitology
SC Parasitology
GA ER4ST
UT WOS:000398792200020
PM 27894365
DA 2020-12-08
ER

PT J
AU Medeiros, FAC
   Gomes, LI
   Oliveira, E
   de Souza, CSA
   Mourao, MV
   Cota, GF
   Marques, LHD
   Carneiro, M
   Rabello, A
AF Cardoso Medeiros, Fernanda Alvarenga
   Gomes, Luciana Inacia
   Oliveira, Edward
   Alves de Souza, Carolina Senra
   Mourao, Maria Vitoria
   Cota, Glaucia Fernandes
   dos Santos Marques, Leticia Helena
   Carneiro, Mariangela
   Rabello, Ana
TI Development and Validation of a PCR-ELISA for the Diagnosis of
   Symptomatic and Asymptomatic Infection by Leishmania (Leishmania)
   infantum
SO JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
ID LINKED-IMMUNOSORBENT-ASSAY; POLYMERASE-CHAIN-REACTION; VISCERAL
   LEISHMANIASIS; KINETOPLAST DNA; BLOOD-SAMPLES; WHOLE-BLOOD;
   QUANTIFICATION; METAANALYSIS; SENSITIVITY; PERFORMANCE
AB A kDNA PCR enzyme-linked immunosorbent assay (kDNA PCR-ELISA) for the diagnosis of human visceral leishmaniasis (HVL) was developed. The detection limit of the reaction, precision measurements, and cut-off of the kDNA PCR-ELISA were defined in a proof-of-concept phase. A reference strain of Leishmania (Leishmania) infantum and a bank of 14 peripheral blood samples from immunocompetent patients with VL were characterized using techniques considered gold standards, and 11 blood samples obtained from healthy individuals of an endemic area were also assessed. Phase II evaluation determined the performance of the assay in peripheral blood samples from 105 patients with VL (adults and children), 25 patients with Leishmania/HIV coinfection, 40 healthy individuals, and 33 asymptomatic individuals living in endemic areas. The kDNA PCR-ELISA exhibited satisfactory precision, with a detection limit of 0.07 fg of DNA from L. (L.) infantum and 1 parasite/mL blood. The overall sensitivity of the assay for all groups studied was 100% (95% confidence interval [CI]: 97.1-100%), and the specificity was 95% (95% CI: 83.5-98.6%). The kDNA PCR-ELISA was shown to be a useful tool for VL symptomatic and asymptomatic individuals diagnosis and its use in endemic countries may help monitor control interventions.
C1 [Cardoso Medeiros, Fernanda Alvarenga; Gomes, Luciana Inacia; Oliveira, Edward; Alves de Souza, Carolina Senra; Mourao, Maria Vitoria; Cota, Glaucia Fernandes; Rabello, Ana] Oswaldo Cruz Fdn Fiocruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [dos Santos Marques, Leticia Helena; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Oliveira, E (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
EM edwardjo@cpqrr.fiocruz.br
RI Cota, Glaucia/ABC-5378-2020
OI Cota, Glaucia/0000-0003-0538-7403; Oliveira, Edward/0000-0002-0042-5178
CR Abass E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116408
   Alborzi A, 2008, AM J TROP MED HYG, V79, P839, DOI 10.4269/ajtmh.2008.79.839
   Andreadou M, 2012, EXP PARASITOL, V131, P419, DOI 10.1016/j.exppara.2012.05.012
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P287
   Antinori S, 2012, EUR J CLIN MICROBIOL, V31, P109, DOI 10.1007/s10096-011-1276-0
   Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
   Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Carvalho SFG, 2003, AM J TROP MED HYG, V68, P321
   Chappuis F, 2006, BMJ-BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C
   Costa JM, 1996, J CLIN MICROBIOL, V34, P1831, DOI 10.1128/JCM.34.7.1831-1833.1996
   Cota GF, 2013, AM J TROP MED HYG, V89, P570, DOI 10.4269/ajtmh.13-0239
   Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665
   De Doncker S, 2005, T ROY SOC TROP MED H, V99, P25, DOI 10.1016/j.trstmh.2004.01.015
   de Ruiter CM, 2014, J CLIN MICROBIOL, V52, P3147, DOI 10.1128/JCM.00372-14
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   Disch J, 2003, T ROY SOC TROP MED H, V97, P391, DOI 10.1016/S0035-9203(03)90066-6
   Marques LHD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001955
   Fissore C, 2004, J CLIN MICROBIOL, V42, P5332, DOI 10.1128/JCM.42.11.5332-5333.2004
   Gomes LI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000664
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   Kobets T, 2010, NAT PROTOC, V5, P1074, DOI 10.1038/nprot.2010.68
   Koltas IS, 2016, EXP PARASITOL, V164, P43, DOI 10.1016/j.exppara.2016.02.007
   Lachaud L, 2000, J CLIN MICROBIOL, V38, P236
   Lachaud L, 2002, J CLIN MICROBIOL, V40, P210, DOI 10.1128/JCM.40.1.210-215.2002
   LUNEBERG E, 1993, J CLIN MICROBIOL, V31, P1088
   Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484
   Martin-Sanchez J, 2002, ANN TROP MED PARASIT, V96, P669, DOI 10.1179/000349802125001906
   Martin-Sanchez J, 2001, PARASITOLOGY, V122, P607, DOI 10.1017/S0031182001007909
   Martin-Sanchez J., 2003, MARTINSANCHEZ J, Patent No. CI-C12Q 1/68
   Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   Montalvo AM, 2012, EUR J CLIN MICROBIOL, V31, P1453, DOI 10.1007/s10096-011-1463-z
   Morata P, 2003, J CLIN MICROBIOL, V41, P144, DOI 10.1128/JCM.41.1.144-148.2003
   Moreno EC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000536
   Musiani M, 2007, NAT PROTOC, V2, P2511, DOI 10.1038/nprot.2007.312
   Musso O, 1996, J VIROL METHODS, V56, P125, DOI 10.1016/0166-0934(95)01892-1
   PIARROUX R, 1994, J CLIN MICROBIOL, V32, P746, DOI 10.1128/JCM.32.3.746-749.1994
   Queipo-Ortuno MI, 2004, MOL CELL PROBE, V18, P243, DOI 10.1016/j.mcp.2003.12.005
   Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76
   RODGERS MR, 1990, EXP PARASITOL, V71, P267, DOI 10.1016/0014-4894(90)90031-7
   Rolao N, 2004, J PARASITOL, V90, P1150, DOI 10.1645/GE-264R1
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1
   Sue MJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/653014
   ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008
   Wu Z, 1997, Southeast Asian J Trop Med Public Health, V28, P169
NR 49
TC 7
Z9 7
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9686
EI 1687-9694
J9 J TROP MED-US
JI J. Trop. Med.
PY 2017
VL 2017
AR 7364854
DI 10.1155/2017/7364854
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EH8UX
UT WOS:000392049300001
PM 28163725
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Silva, AP
   Greco, M
   Fausto, MA
   Carneiro, M
AF Silva, Ana Paula
   Greco, Marilia
   Fausto, Maria Arlene
   Carneiro, Mariangela
TI Loss to follow-up in a cohort of HIV-negative men who have sex with men:
   Project Horizonte
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Men; HIV Long-Term Survivors; Homosexuality, Male; Bisexuality; Lost to
   Follow-Up; Cohort Studies
ID INTERVENTION TRIALS; PREVENTION PROGRAM; BELO-HORIZONTE; BISEXUAL MEN;
   RETENTION; PREVALENCE; STRATEGIES; ATTRITION; BEHAVIOR; BRAZIL
AB OBJECTIVE: The objective of this study is to estimate the attrition rates and evaluate factors associated with loss to follow-up between 1994 and 2011 in an open cohort of HIV-negative men who have sex with men.
   METHODS: The Project Horizonte is an open cohort study that aimed to assess the incidence of HIV infection, evaluate the impact of educational interventions, and identify potential volunteers for HIV vaccine trials. The rates of losses to follow-up were estimated for three periods (1994-1999, 2000-2005, and 2006-2011). The variables analyzed were collected in a psychosocial questionnaire. Volunteers who dropped out were compared with the ones who remained in the study using a Cox regression model.
   RESULTS: A total of 1,197 volunteers were recruited. The median follow-up time in the study (n = 626) was 4.2 years. The median follow-up time for the volunteers who dropped out of the study (n = 571) was 1.46 years. The overall rate of loss to follow-up was 11.6/100 person-years. Attrition rates by period were: 12.60 (1994-1999), 11.80 (2000-2005), and 9.00 (2006-2011) per 100 person-years. Factors associated with losses to follow-up were: age group of 21-30 years old, monthly per capita income of more than six or less than one Brazilian minimum wage, having more than two dependents, report of bisexual practice, and inconsistent use of condoms for receptive anal sex.
   CONCLUSIONS: A slight decrease of the loss to follow-up was observed over time. Higher attrition rates happened in the first three years of follow-up. It is possible that the link of the volunteers were not yet well established. Those who reported inconsistent condom use in receptive anal sex were more likely to leave the study, suggesting an underestimation of the incidence of HIV infection in a cohort population. For greater effectiveness, retention strategies must be reassessed considering the connection between the characteristics of homosexual and bisexual behavior and the motivations to engage in health research.
C1 [Silva, Ana Paula; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
   [Silva, Ana Paula; Greco, Marilia; Carneiro, Mariangela] Univ Fed Minas Gerais, Projeto Horizonte, Belo Horizonte, MG, Brazil.
   [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, Ouro Preto, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Av Antonio Carlos,6627 Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Av Antonio Carlos,6627 Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneiro@ufmg.br
OI Silva, Ana Paula/0000-0003-1839-272X
FU Brazilian Ministry of Health, Department of STI, AIDS, and Viral
   Hepatitis [23633]; CNPq-BrazilNational Council for Scientific and
   Technological Development (CNPq)
FX Brazilian Ministry of Health, Department of STI, AIDS, and Viral
   Hepatitis (Grant 23633). MC is grateful to CNPq-Brazil for the research
   fellowships and FAPEMIG for the PPM (Programa Pesquisador Mineiro).
CR Benoit Ellen, 2012, J Ethn Subst Abuse, V11, P294, DOI 10.1080/15332640.2012.735165
   Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249
   Boys A, 2003, J ADOLESCENCE, V26, P363, DOI 10.1016/S0140-1971(03)00011-3
   Brown DM, 2006, AIDS CARE, V18, P821, DOI 10.1080/09540120500466747
   Carneiro M, 2000, J ACQ IMMUN DEF SYND, V25, P182, DOI 10.1097/00126334-200010010-00013
   Carneiro M, 2003, MEM I OSWALDO CRUZ, V98, P325, DOI 10.1590/S0074-02762003000300006
   Coday M, 2005, ANN BEHAV MED, V29, P55, DOI 10.1207/s15324796abm2902s_9
   DiFranceisco W, 1998, AM J PUBLIC HEALTH, V88, P1068, DOI 10.2105/AJPH.88.7.1068
   DUDLEY J, 1995, AM J EPIDEMIOL, V142, P323, DOI 10.1093/oxfordjournals.aje.a117638
   Greco Marília, 2007, Rev. Saúde Pública, V41, P109, DOI 10.1590/s0034-89102007000900017
   Guo Y, 2012, AIDS CARE, V24, P451, DOI 10.1080/09540121.2011.613914
   Harrison LH, 1999, J ACQ IMMUN DEF SYND, V21, P408
   Hosmer Jr DW, 2011, WILEY SERIES PROBABI, V618
   Hunt JR, 1998, EPIDEMIOL REV, V20, P57, DOI 10.1093/oxfordjournals.epirev.a017972
   Khosropour CM, 2011, J MED INTERNET RES, V13, DOI [10.2196/jmir.1717, 10.2196/jmir.1797]
   Kuhns LM, 2008, HEALTH EDUC RES, V23, P814, DOI 10.1093/her/cym066
   Ministerio da Saude (BR), 2010, B EP AIDS DST, V8
   Miskolci Richard, 2015, Cad. Pagu, V0, P61, DOI 10.1590/1809-4449201500440061
   MORSE EV, 1995, APPL NURS RES, V8, P8, DOI 10.1016/S0897-1897(95)80240-1
   Orellana ER, 2006, AIDS EDUC PREV, V18, P348, DOI 10.1521/aeap.2006.18.4.348
   Roffman R. A., 1997, AIDS BEHAV, V1, P125, DOI [DOI 10.1023/B:AIBE.0000002973.21222.BC, 10.1023/B:AIBE.0000002973.21222.bc]
   Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9
   Rutledge S. E., 2002, AIDS BEHAV, V6, P69, DOI DOI 10.1023/A:1014580629524
   Szklo M, 2000, EPIDEMIOLOGY BASICS, P3
   Tansey CM, 2007, INTENS CARE MED, V33, P2051, DOI 10.1007/s00134-007-0817-6
NR 25
TC 2
Z9 2
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2017
VL 51
AR 60
DI 10.1590/S1518-8787.2017051006681
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FG7OJ
UT WOS:000410607300010
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Vianna, EN
   Morais, MHF
   de Almeida, AS
   Sabroza, PC
   Reis, IA
   Dias, ES
   Carneiro, M
AF Vianna, Elisa Neves
   Franco Morais, Maria Helena
   de Almeida, Andrea Sobral
   Sabroza, Paulo Chagastelles
   Reis, Ilka Afonso
   Dias, Edelberto Santos
   Carneiro, Mariangela
TI Abundance of Lutzomyia longipalpis in urban households as risk factor of
   transmission of visceral leishmaniasis
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Lutzomyia longipalpis; household characteristics; visceral leishmaniasis
ID PHLEBOTOMINE SAND FLIES; MINAS-GERAIS; DIPTERA PSYCHODIDAE;
   BELO-HORIZONTE; CUTANEOUS LEISHMANIASIS; METROPOLITAN REGION; ENDEMIC
   AREA; EPIDEMIOLOGIC ASPECTS; SPATIAL-ANALYSIS; MATO-GROSSO
AB Urban occurrence of human and canine visceral leishmaniasis (VL) is linked to households with characteristics conducive to the presence of sand flies. This study proposes an ad hoc classification of households according to the environmental characteristics of receptivity to phlebotominae and an entomological study to validate the proposal. Here we describe the phlebotominae population found in intra-and peridomiciliary environments and analyse the spatiotemporal distribution of the VL vector Lutzomyia longipalpis of households receptive to VL. In the region, 153 households were classified into levels of receptivity to VL followed by entomological surveys in 40 of those properties. Kruskal-Wallis verified the relationship between the households' classification and sand fly abundance and Kernel analysis evaluated L. longipalpis spatial distribution: of the 740 sand flies were captured, 91% were L. longipalpis; 82% were found peridomiciliary whilst the remaining 18% were found intradomiciliary. No statistically significant association was found between sandflies and households levels. L. longipalpis counts were concentrated in areas of high vulnerability and some specific households were responsible for the persistence of the infestation. L. longipalpis prevails over other sand fly species for urban VL transmission. The entomological study may help target the surveillance and vector control strategies to domiciles initiating and/or maintaining VL outbreaks.
C1 [Vianna, Elisa Neves; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
   [Franco Morais, Maria Helena] Secretaria Municipal Saude, Prefeitura Belo Horizonte, Belo Horizonte, MG, Brazil.
   [de Almeida, Andrea Sobral; Sabroza, Paulo Chagastelles] Fundacao Oswaldo Cruz, Escola Saude Publ, Dept Doencas Endem, Rio De Janeiro, RJ, Brazil.
   [Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil.
   [Dias, Edelberto Santos] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Leishmanioses, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Vianna, EN (corresponding author), Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
EM ramarrina@gmail.com
RI Reis, Ilka Afonso/AAG-8007-2019; Sobral, Andrea/K-2319-2016
OI Sobral, Andrea/0000-0003-0552-771X
FU CAPES/PNPD/Institutional/ , Programa Nacional de Vigilancia em Controle
   da Leishmaniose Visceral (MS) [23038.007183/2011-23]
FX CAPES/PNPD/Institutional/2011 (process no 23038.007183/2011-23),
   Programa Nacional de Vigilancia em Controle da Leishmaniose Visceral
   (MS).
CR Andrade FJ, 1997, CAD SAUDE PUBLICA, V13, P767
   Bailey T., 1995, INTERACTIVE SPATIAL
   Barata RA, 2005, REV SOC BRAS MED TRO, V38, P421, DOI 10.1590/S0037-86822005000500012
   Barata RA, 2004, MEM I OSWALDO CRUZ, V99, P481, DOI 10.1590/S0074-02762004000500004
   Camargo-Neves V L, 2001, Cad Saude Publica, V17, P1263
   Carvalho GML, 2010, J MED ENTOMOL, V47, P972, DOI 10.1603/ME09127
   Coura-Vital W, 2013, VET PARASITOL, V197, P411, DOI 10.1016/j.vetpar.2013.07.031
   de Almeida AS, 2011, AM J TROP MED HYG, V84, P681, DOI 10.4269/ajtmh.2011.10-0325
   de Almeida PS, 2010, REV SOC BRAS MED TRO, V43, P723, DOI 10.1590/S0037-86822010000600025
   de Oliveira AG, 2006, MEM I OSWALDO CRUZ, V101, P869, DOI 10.1590/S0074-02762006000800008
   de Oliveira EF, 2012, MEM I OSWALDO CRUZ, V107, P396, DOI 10.1590/S0074-02762012000300015
   de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015
   de Resende MC, 2006, REV SOC BRAS MED TRO, V39, P51, DOI 10.1590/S0037-86822006000100010
   de Souza CM, 2004, MEM I OSWALDO CRUZ, V99, P795, DOI 10.1590/S0074-02762004000800003
   de Souza CF, 2014, ACTA TROP, V134, P72, DOI 10.1016/j.actatropica.2014.02.019
   DEANE L M, 1955, Rev Bras Malariol Doencas Trop, V7, P131
   Dias ES, 2007, REV SOC BRAS MED TRO, V40, P49, DOI 10.1590/S0037-86822007000100009
   Dias ES, 2011, VET PARASITOL, V176, P101, DOI 10.1016/j.vetpar.2010.11.014
   Santos Soraya Oliveira dos, 2003, Rev. Soc. Bras. Med. Trop., V36, P633, DOI 10.1590/S0037-86822003000500017
   Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x
   GALATI E A B, 1989, Revista Brasileira de Entomologia, V33, P465
   Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936
   Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338
   Holcman MM, 2013, REV SOC BRAS MED TRO, V46, P704, DOI 10.1590/0037-8682-0188-2013
   HVI - Health Vulnerability Index, SECR MUN SAUD PREF B
   IBGE - Instituto Brasileiro de Geografia e Estatistica, EST POP MUN BRAS
   JARVIS EK, 1992, J MED ENTOMOL, V29, P171, DOI 10.1093/jmedent/29.2.171
   KOPPEN W., 1928, KLIMATE DER ERDE
   Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001
   Lana RS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/385493
   Langeron M, 1949, PRECIS MICROSCOPIE
   Lara-Silva FD, 2015, ACTA TROP, V148, P128, DOI 10.1016/j.actatropica.2015.04.002
   Margonari C, 2006, MEM I OSWALDO CRUZ, V101, P31, DOI 10.1590/S0074-02762006000100007
   Martins AV, 1978, AM SAND FLIES DIPTER
   MAYRINK W, 1979, ANN TROP MED PARASIT, V73, P123, DOI 10.1080/00034983.1979.11687239
   Michalsky EM, 2009, MEM I OSWALDO CRUZ, V104, P56, DOI 10.1590/S0074-02762009000100009
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   Monteiro EM, 2005, REV SOC BRAS MED TRO, V38, P147, DOI 10.1590/S0037-86822005000200004
   Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393
   Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002
   *MS, 2006, MAN VIG CONTR LEISHM
   Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023
   Oliveira CD, 2006, REV PANAM SALUD PUBL, V20, P369, DOI 10.1590/S1020-49892006001100002
   Pan American Health Organization (PAHO), 2015, LEISHM EP REP AM
   PASSOS VMA, 1993, MEM I OSWALDO CRUZ, V88, P103, DOI 10.1590/S0074-02761993000100016
   PBH - Prefeitura Municipal de Belo Horizonte, DAD LEISHM VISC MUN
   Pessoa SB., 1948, LEISHMANIASIS TEGUME
   Pinto Israel de Souza, 2008, Biota Neotrop., V8, P221, DOI 10.1590/S1676-06032008000100024
   Pinto IS, 2010, J VECTOR ECOL, V35, P325, DOI 10.1111/j.1948-7134.2010.00090.x
   Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017
   QUINNELL RJ, 1994, MED VET ENTOMOL, V8, P219, DOI 10.1111/j.1365-2915.1994.tb00502.x
   Quintana MG, 2012, J TROP MED, V2012
   Rangel EF, 2003, FLEBOTOMINEOS BRASIL, P291
   Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025
   Rosa J, 2012, ACTA TROP, V123, P128, DOI 10.1016/j.actatropica.2012.04.008
   Salomon OD, 2004, J MED ENTOMOL, V41, P33, DOI 10.1603/0022-2585-41.1.33
   Sangiorgi B, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/124068
   Santos Soraya Oliveira Dos, 1998, Medical and Veterinary Entomology, V12, P315
   Saraiva L, 2011, ACTA TROP, V117, P137, DOI 10.1016/j.actatropica.2010.11.007
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   Smith R., 1941, Indian Journal of Medical Research, V29, P799
   Nasciment MDSB, 2013, REV SOC BRAS MED TRO, V46, P555, DOI 10.1590/0037-8682-0150-2013
   Fernandez MS, 2013, MEM I OSWALDO CRUZ, V108, P817, DOI 10.1590/0074-0276130047
   Fernandez MS, 2010, ACTA TROP, V114, P81, DOI 10.1016/j.actatropica.2010.01.008
   Santini MS, 2012, MEM I OSWALDO CRUZ, V107, P767, DOI 10.1590/S0074-02762012000600010
   TRAVI BL, 1990, T ROY SOC TROP MED H, V84, P676, DOI 10.1016/0035-9203(90)90142-2
   WHO, 2015, LEISHMANIASIS
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
   Young DG, 1994, MEMOIRS AM ENTOMOLOG, V54
NR 69
TC 8
Z9 8
U1 0
U2 8
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2016
VL 111
IS 5
BP 302
EP 310
DI 10.1590/0074-02760150366
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DN2EI
UT WOS:000376876500004
PM 27223866
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Zanin, FHC
   da Silva, CAM
   Bonomo, E
   Teixeira, RA
   Pereira, CAD
   dos Santos, KB
   Fausto, MA
   Negrao-Correa, DA
   Lamounier, JA
   Carneiro, M
AF Calheiros Zanin, Francisca Helena
   Mariano da Silva, Camilo Adalton
   Bonomo, Elido
   Teixeira, Romero Alves
   de Jesus Pereira, Cintia Aparecida
   dos Santos, Karina Benatti
   Fausto, Maria Arlene
   Negrao-Correa, Deborah Aparecida
   Lamounier, Joel Alves
   Carneiro, Mariangela
TI Determinants of Iron Deficiency Anemia in a Cohort of Children Aged 6-71
   Months Living in the Northeast of Minas Gerais, Brazil
SO PLOS ONE
LA English
DT Article
ID NUTRITIONAL-STATUS; SCHOOL-CHILDREN; INFECTIONS; HEALTH; STATE;
   COMMUNITY; DIAGNOSIS; INFANTS
AB Iron deficiency anemia is one of the most common nutritional disorders worldwide. The aim was to identify the prevalence and incidence of anemia in children and to identify predictors of this condition, including intestinal parasites, social, nutritional and environmental factors, and comorbidities. A population-based cohort study was conducted in a sample of 414 children aged 6-71 months living in Novo Cruzeiro in the Minas Gerais State. Data were collected in 2008 and 2009 by interview and included socio-economic and demographic information about the children and their families. Blood samples were collected for testing of hemoglobin, ferritin and C-reactive protein. Anthropometric measurements and parasitological analyses of fecal samples were performed. To identify risk factors associated with anemia multivariate analyses were performed using the generalized estimating equations (GEE). In 2008 and 2009, respectively, the prevalence rates of anemia were 35.9% (95% CI 31.2-40.8) and 9.8% (95% CI 7.2-12.9), the prevalence rates of iron deficiency were 18.4% (95% CI 14.7-22.6) and 21.8%(95% CI 17.8-26.2), and the incidence rates of anemia and iron deficiency were 3.2% and 21.8%. The following risk factors associated with anemia were: iron deficiency (OR = 3.2; 95% CI 2.0-. 5.3), parasitic infections (OR = 1.9; 95% CI 1.2-2.8), being of risk of or being a low length/height-for-age (OR = 2.1; 95% CI 1.4-3.2), and lower retinol intake (OR = 1.7; 95% CI 1.1-2.7), adjusted over time. Nutritional factors, parasitic infections and chronic malnutrition were identified as risk factors for anemia. These factors can be verified in a chronic process and have been classically described as risk factors for these conditions.
C1 [Calheiros Zanin, Francisca Helena; de Jesus Pereira, Cintia Aparecida; dos Santos, Karina Benatti; Negrao-Correa, Deborah Aparecida; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Mariano da Silva, Camilo Adalton; Bonomo, Elido] Univ Fed Ouro Preto, Dept Nutr Clin & Social, Escola Nutr, BR-35400000 Ouro Preto, MG, Brazil.
   [Teixeira, Romero Alves] Univ Fed Vales Jequitinhonha & Mucuri, Fac Ciencias Biol & Saude, BR-39100000 Diamantina, MG, Brazil.
   [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, BR-35400000 Ouro Preto, MG, Brazil.
   [Lamounier, Joel Alves] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste, BR-36307352 Divinopolis, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Infectol & Med Trop, BR-31270901 Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Teixeira, Romero A/B-1582-2017
OI Teixeira, Romero A/0000-0001-6623-8239; Silva, Camilo Adalton
   Mariano/0000-0002-5683-9556
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIGMinas
   Gerais State Research Foundation (FAPEMIG) [CDS-1897/2006];
   FAPEMIG/Pesquisador Mineiro
FX This study was supported by the Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais - FAPEMIG - Grant Number CDS-1897/2006 and
   FAPEMIG/Pesquisador Mineiro, 2008, MC. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALBUQUERQUE Maria de Fátima Machado de, 2002, Rev. Nutr., V15, P291, DOI 10.1590/S1415-52732002000300005
   ASSUNCAO MCF, 2007, REV SAUDE PUBL, V41, P1
   Azeredo CM, 2010, REV SAUDE PUBL, V44, P1
   Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576
   Bates I, 2007, PLOS MED, V4, P1285, DOI 10.1371/journal.pmed.0040231
   Boeke CE, 2010, J TROP PEDIATRICS, V56, P299, DOI 10.1093/tropej/fmp136
   Brasil Ministerio da Saude, 2009, PESQ NAC DEM SAUD CR
   Brasil Ministerio da Saude/SAS/Departamento de Atencao Basica, 2008, TET CRED IMPL ESTR A
   Brasil. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Atencao Basica, 2013, MAN COND GER PROGR N
   Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1
   de Oliveira TDC, 2014, CIENC SAUDE COLETIVA, V19, P59, DOI 10.1590/1413-81232014191.1927
   Carvalho AGC, 2010, REV SAUDE PUBL, V44, P513, DOI 10.1590/S0034-89102010000300015
   Silla LMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068805
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15
   Diggle P, 1994, ANAL LONGITUDINAL DA, Vxi
   ENDEF, 1999, I BRAS GEOGR EST IBG
   Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006
   GALEAZZI MAM, 1997, ESTUDO MULTICENTRICO
   Grotto Helena Z. W., 2010, Rev. Bras. Hematol. Hemoter., V32, P22
   Hoffman W. A., 1934, Puerto Rico Journal of Public Health & Tropical Medicine, V9, P283
   Instituto Brasileiro de Geografia e Estatistica, CENS DEM 2010 RES GE
   Janus J, 2010, AM FAM PHYSICIAN, V81, P1462
   JOHNS WL, 1989, B WORLD HEALTH ORGAN, V67, P627
   Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1
   Katz N, 1972, REV INST MED TROP SP, V14, P394
   Macedo MD, 2012, CAD SAUDE PUBLICA, V28, P346, DOI 10.1590/S0102-311X2012000200013
   McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401
   Cotta RMM, 2011, CAD SAUDE PUBLICA, V27, pS309, DOI 10.1590/S0102-311X2011001400017
   Morris LD, 2007, VOX SANG, V93, P64, DOI 10.1111/j.1423-0410.2007.00919.x
   Muniz PT, 2007, CAD SAUDE PUBLICA, V23, P1283, DOI 10.1590/S0102-311X2007000600004
   Mwanri L, 2000, J NUTR, V130, P2691
   Nguyen CK, 2010, PUBLIC HEALTH NUTR, V13, P1863, DOI 10.1017/S1368980010000571
   Rocha Daniela da Silva, 2012, Rev. bras. epidemiol., V15, P675, DOI 10.1590/S1415-790X2012000300020
   Gondim SSR, 2012, REV SAUDE PUBL, V46, P649, DOI [10.1590/S0034-89102012005000055, 10.1590/s0034-89102012005000055]
   Sari M, 2001, B WORLD HEALTH ORGAN, V79, P511
   Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320
   Sigulem DM, 2000, J PEDIAT, V76, P275, DOI DOI 10.1590/S0103-05822009000200004
   Silva RR, 2009, T ROY SOC TROP MED H, V103, P512, DOI 10.1016/j.trstmh.2008.10.019
   Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491
   TACO, 2006, NUCL EST PESQ AL U E
   Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44
   United Nations Development Program, 2009, REL DES HUM ULTR BAR
   Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704
   WHO/UNICEF/UNU, 2001, IR DEF AN ASS PREV C
   World Health Organisation, 1995, PHYS STAT US INT ANT
   World Health Organization, 2001, IR DEF AN ASS PREV C
   ZABOTTO CB, 1996, REGISTRO FOTOGRAFICO
NR 47
TC 9
Z9 9
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 7
PY 2015
VL 10
IS 10
AR e0139555
DI 10.1371/journal.pone.0139555
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT0TS
UT WOS:000362510600063
PM 26445270
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Morais, MHF
   Fiuza, VDP
   de Araujo, VEM
   de Menezes, FC
   Carneiro, M
AF Franco Morais, Maria Helena
   Pires Fiuza, Vanessa de Oliveira
   Miranda de Araujo, Valdelaine Etelvina
   de Menezes, Fernanda Carvalho
   Carneiro, Mariangela
TI Evaluation of visceral leishmaniasis control activities in Belo
   Horizonte, Minas Gerais, Brazil, 2006-2011
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA Portuguese
DT Article
DE Leishmaniasis; Visceral; Epidemiology; Descriptive; Program Evaluation;
   Epidemiological Surveillance
AB Objective: to evaluate visceral leishmaniasis (VL) control activities in Belo Horizonte-MG, Brazil. Methods: this was a descriptive study to evaluate VL control compliance with the objectives of the Brazilian Health Ministry's VL Control Program; data were collected from the Belo Horizonte Zoonosis Control and Notifiable Disease Information Systems. Results: between 2007-2011 the VL reservoir control strategy was adjusted to increase coverage of prioritized areas (23.4%) and coverage of the examined canine population (43.3%); more than 85.0% of seropositive dogs were put down; 47.8% reduction in canine seroprevalence. Between 2008-2011, human case incidence decreased from 7.2 to 3.9/100,000 inhabitants. There was no expansion of coverage in areas prioritized for vector control. Conclusion: program objectives were achieved, although adjustments differed between control strategies. However, the intervention's complexity indicates the need to review the proposed measures.
C1 [Franco Morais, Maria Helena; Pires Fiuza, Vanessa de Oliveira; Miranda de Araujo, Valdelaine Etelvina] Secretaria Municipal Saude, Prefeitura Municipal Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Franco Morais, Maria Helena; Miranda de Araujo, Valdelaine Etelvina; Carneiro, Mariangela] Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [de Menezes, Fernanda Carvalho] Minist Saude, Coordenacao Geral Informacao & Monitoramento Rede, Brasilia, DF, Brazil.
RP Morais, MHF (corresponding author), Secretaria Municipal Saude Belo Horizonte, Gerencia Controle Zoonoses, Ave Afonso Pena 2336,4 Andar, BR-30130007 Belo Horizonte, MG, Brazil.
EM mhfmorais@yahoo.com.br
CR Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53
   Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001
   Camargo-Neves V., 2004, ASPECTOS EPIDEMIOLOG
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Oliveira Simone Souza de, 2003, Cad. Saúde Pública, V19, P1681, DOI 10.1590/S0102-311X2003000600012
   Deane L. d. M., 1956, THESIS
   Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096
   Donabedian A., 1988, EXPLORATIONS QUALITY, V1
   Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Morais MHF, 2008, REV SOC BRAS MED TRO, V41, P77
   Hartz ZMA, 2005, AVALIACAO SAUDE MODE
   Instituto Brasileiro de Geografia e Estatistica, 2010, SIN CENS DEM 2010
   MAGALHAES P A, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P197
   de Souza VMM, 2008, EPIDEMIOL SERV SAUDE, V17, P97
   Ministerio da Saude (BR). Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 1 MIN SAUD BR
   Ministerio da Saude (BR). Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2006, MAN VIG CONTR LEISHM
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511
   Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004
   Costa CHN, 2007, REV SOC BRAS MED TRO, V40, P415, DOI 10.1590/S0037-86822007000400009
   Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023
   Organizacion Panamericana de la Salud, 2006, INF FIN REUN EXP OPS
   Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510
   Paranhos-Silva M, 1998, ACTA TROP
   Fiuza VDP, 2008, REV SOC BRAS MED TRO, V41, P82
   Santana FC, 2012, ARQ BRAS MED VET ZOO, V64, P899, DOI 10.1590/S0102-09352012000400017
   Secretaria de Saude (Belo Horizonte), 2011, INF LEISHM VISC 2011
   Werneck Guilherme L., 2002, Cad. Saúde Pública, V18, P633, DOI [10.1590/S0102-311X2002000300012, 10.1590/S0102-311X2002000300007]
NR 29
TC 9
Z9 9
U1 0
U2 3
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PD JUL-SEP
PY 2015
VL 24
IS 3
BP 485
EP 496
DI 10.5123/S1679-49742015000300014
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA VE5VE
UT WOS:000439660000015
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Amancio, FF
   Heringer, TP
   de Oliveira, CDHB
   Fassy, LB
   de Carvalho, FB
   Oliveira, DP
   de Oliveira, CD
   Botoni, FO
   Magalhaes, FD
   Lambertucci, JR
   Carneiro, M
AF Amancio, Frederico Figueiredo
   Heringer, Tiago Pires
   Hueb Barata de Oliveira, Cristina da Cunha
   Fassy, Liliane Boaventura
   de Carvalho, Frederico Bruzzi
   Oliveira, Daniela Pagliari
   de Oliveira, Claudio Dornas
   Botoni, Fernando Otoni
   Magalhaes, Fernanda do Carmo
   Lambertucci, Jose Roberto
   Carneiro, Mariangela
TI Clinical Profiles and Factors Associated with Death in Adults with
   Dengue Admitted to Intensive Care Units, Minas Gerais, Brazil
SO PLOS ONE
LA English
DT Article
ID HEMORRHAGIC-FEVER; RISK-FACTORS; SHOCK SYNDROME; SEPSIS; DETERMINANTS;
   MORTALITY; INFECTION; SYSTEM; HEALTH; INDIA
AB The purpose of our study was to describe the clinical profile of dengue-infected patients admitted to Brazilian intensive care units (ICU) and evaluate factors associated with death. A longitudinal, multicenter case series study was conducted with laboratory-confirmed dengue patients admitted to nine Brazilian ICUs situated in Minas Gerais state, southeastern Brazil from January 1, 2008, to December 31, 2013. Demographic, clinical and laboratory data; disease severity scores; and mortality were evaluated. A total of 97 patients were studied. The in-ICU and in-hospital mortality rates were 18.6% and 19.6%, respectively. Patients classified as having severe dengue according to current World Health Organization classifications showed an increased risk of death in a univariate analysis. Nonsurvivors were older, exhibited lower serum albumin concentrations and higher total leukocyte counts and serum creatinine levels. Other risk factors (vomiting, lethargy/restlessness, dyspnea/respiratory distress) were also associated with death in a univariate analysis. Multivariate analysis indicated that in-hospital mortality was significantly associated with Acute Physiology and Chronic Health Evaluation II and the Sequential Organ Failure Assessment score. The ICU and in-hospital mortality observed in this study were higher than values reported in similar studies. An increased frequency of ICU admission due to severe organ dysfunction, higher severity indices and scarcity of ICU beds may partially explain the higher mortality.
C1 [Amancio, Frederico Figueiredo; Lambertucci, Jose Roberto; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med, Belo Horizonte, MG, Brazil.
   [Amancio, Frederico Figueiredo; Oliveira, Daniela Pagliari] Fundacao Hosp Estado Minas Gerais, Hosp Joao 23, Belo Horizonte, MG, Brazil.
   [Heringer, Tiago Pires] Hosp Cesar Leite, Manhuacu, MG, Brazil.
   [Hueb Barata de Oliveira, Cristina da Cunha] Univ Fed Triangulo Mineiro, Fac Med, Uberaba, MG, Brazil.
   [Fassy, Liliane Boaventura] Hosp Dr Moises Magalhaes Freire, Pirapora, MG, Brazil.
   [de Carvalho, Frederico Bruzzi] Fundacao Hosp Estado Minas Gerais, Hosp Eduardo Menezes, Belo Horizonte, MG, Brazil.
   [de Carvalho, Frederico Bruzzi] Hosp Odilon Behrens, Belo Horizonte, MG, Brazil.
   [de Oliveira, Claudio Dornas] Hosp Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Botoni, Fernando Otoni] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [Botoni, Fernando Otoni] Hosp Risoleta Tolentino Neves, Belo Horizonte, MG, Brazil.
   [Magalhaes, Fernanda do Carmo; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Amancio, FF (corresponding author), Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med, Belo Horizonte, MG, Brazil.
EM manzoff@gmail.com
RI Carvalho, Frederico B/J-4879-2012; de Carvalho, Frederico
   Bruzzi/ABB-3911-2020
OI Carvalho, Frederico B/0000-0002-9752-5625; de Carvalho, Frederico
   Bruzzi/0000-0002-9752-5625
FU Brazilian Dengue Control Program, Ministry of Health of Brazil
   [258/2012]
FX The entire project was financially supported by the Brazilian Dengue
   Control Program, Ministry of Health of Brazil (grant number 258/2012).
CR Amancio FF, 2014, J INFECT PUBLIC HLTH
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Brasil, 2013, DENG DIAGN MAN CLIN
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Brito CAA, 2007, REV SOC BRAS MED TRO, V40, P220, DOI 10.1590/S0037-86822007000200015
   Campos KB, 2015, TROP MED INT HEALTH, V20, P211, DOI 10.1111/tmi.12425
   Chandralekha, 2008, T ROY SOC TROP MED H, V102, P143, DOI 10.1016/j.trstmh.2007.11.002
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009
   Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
   Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Hosmer DW, 1989, APPL LOGISTIC REGRES
   INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2010, CENS DEM BRAS
   Juneja D, 2011, J CRIT CARE, V26, P449, DOI 10.1016/j.jcrc.2011.05.007
   Karunakaran A, 2014, J INFECT PUBLIC HEAL, V7, P114, DOI 10.1016/j.jiph.2013.09.006
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee IK, 2005, AM J TROP MED HYG, V72, P221, DOI 10.4269/ajtmh.2005.72.221
   Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149
   Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532
   Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B
   McCluskey A, 1996, ANAESTHESIA, V51, P724, DOI 10.1111/j.1365-2044.1996.tb07883.x
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Pang JX, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0649-2
   Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641
   Schmitz L, 2011, J CRIT CARE, V26, P441, DOI 10.1016/j.jcrc.2011.05.008
   See KC, 2013, AM J TROP MED HYG, V89, P804, DOI 10.4269/ajtmh.13-0197
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060
   Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370
   Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156
   World Health Organization, 2012, GLOB STRAT DENG PREV
   World Health Organization, 1997, DENG HEM FEV DIAGN T
   World Health Organization & Special Programme for Research and Training in Tropical Diseases, 2012, HDB CLIN MAN DENG
NR 40
TC 18
Z9 18
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 19
PY 2015
VL 10
IS 6
AR e0129046
DI 10.1371/journal.pone.0129046
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL3FE
UT WOS:000356835000035
PM 26090676
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, TAM
   Gomes, LI
   Oliveira, E
   Coura-Vital, W
   Silva, LD
   Pais, FSM
   Ker, HG
   Reis, AB
   Rabello, A
   Carneiro, M
AF Marques da Silva, Thais Almeida
   Gomes, Luciana Inacia
   Oliveira, Edward
   Coura-Vital, Wendel
   Silva, Leticia de Azevedo
   Pais, Fabiano Sviatopolk-Mirsky
   Ker, Henrique Gama
   Reis, Alexandre Barbosa
   Rabello, Ana
   Carneiro, Mariangela
TI Genetic homogeneity among Leishmania (Leishmania) infantum isolates from
   dog and human samples in Belo Horizonte Metropolitan Area (BHMA), Minas
   Gerais, Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE Leishmania (Leishmania) infantum; Intraspecific genetic variability;
   PCR-RFLP
ID VISCERAL LEISHMANIASIS; DONOVANI COMPLEX; CUTANEOUS LEISHMANIASIS;
   MOLECULAR EPIDEMIOLOGY; EVOLUTIONARY GENETICS; URBAN AREA; PCR-RFLP;
   DIVERSITY; POPULATIONS; POLYMORPHISM
AB Background: Certain municipalities in the Belo Horizonte Metropolitan Area (BHMA), Minas Gerais, Brazil, have the highest human visceral leishmaniasis (VL) mortality rates in the country and also demonstrate high canine seropositivity. In Brazil, the etiologic agent of VL is Leishmania (Leishmania) infantum. The aim of this study was to evaluate the intraspecific genetic variability of parasites from humans and from dogs with different clinical forms of VL in five municipalities of BHMA using PCR-RFLP and two target genes: kinetoplast DNA (kDNA) and gp63.
   Methods: In total, 45 samples of DNA extracted from clinical samples (n = 35) or Leishmania infantum culture (n = 10) were evaluated. These samples originated from three groups: adults (with or without Leishmania/HIV co-infection; n = 14), children (n = 18) and dogs (n = 13). The samples were amplified for the kDNA target using the MC1 and MC2 primers (447 bp), while the Sg1 and Sg2 (1330 bp) primers were used for the gp63 glycoprotein target gene.
   Results: The restriction enzyme patterns of all the samples tested were monomorphic.
   Conclusions: These findings reveal a high degree of genetic homogeneity for the evaluated gene targets among L. infantum samples isolated from different hosts and representing different clinical forms of VL in the municipalities of BHMA studied.
C1 [Marques da Silva, Thais Almeida; Gomes, Luciana Inacia; Oliveira, Edward; Rabello, Ana] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Pesquisas Clin, Belo Horizonte, MG, Brazil.
   [Marques da Silva, Thais Almeida; Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol das Doencas Infecciosas & Parasitar, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel; Ker, Henrique Gama; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Lab Pesquisas Clin, Ouro Preto, MG, Brazil.
   [Pais, Fabiano Sviatopolk-Mirsky] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Grp Genom & Biol Computac, Belo Horizonte, MG, Brazil.
   [Silva, Leticia de Azevedo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Toxoplasmose, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol das Doencas Infecciosas & Parasitar, Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Pais, Fabiano S/G-5178-2015
OI Pais, Fabiano S/0000-0001-5958-2867; /0000-0002-1434-7676
FU PNPD/Institutional; PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant
   [CBB-APQ-00356-10]; CNPQ/UniversalNational Council for Scientific and
   Technological Development (CNPq) [478528/2012-4]; FAPEMIG/PPM;
   CNPqNational Council for Scientific and Technological Development
   (CNPq); PNPD/CAPESCAPES; CAPESCAPES
FX This study was supported by the following grants:
   PNPD/Institutional/2011, PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant
   CBB-APQ-00356-10; CNPQ/Universal 478528/2012-4 and FAPEMIG/PPM. The
   funders had no role in study design, data collection or analysis,
   decision to publish, or preparation of the manuscript. MC, AR, ABR, LAS
   and EO are grateful for CNPq fellowships. WCV is grateful to the
   PNPD/CAPES fellowships. TAMS is grateful for CAPES fellowships during
   her master's degree.
CR Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464
   Alonso DP, 2010, AM J TROP MED HYG, V82, P819, DOI 10.4269/ajtmh.2010.09-0600
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Banuls AL, 1999, INT J PARASITOL, V29, P1137, DOI 10.1016/S0020-7519(99)00083-1
   Batista LFD, 2012, AM J TROP MED HYG, V86, P799, DOI 10.4269/ajtmh.2012.11-0300
   Botilde Y, 2006, INFECT GENET EVOL, V6, P440, DOI 10.1016/j.meegid.2006.02.003
   Alvarenga JSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043363
   Chicharro C, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS93, DOI 10.1016/S0035-9203(02)90058-1
   Cortes S, 2004, T ROY SOC TROP MED H, V98, P12, DOI 10.1016/S0035-9203(03)00002-6
   Cortes S, 2006, PARASITOL INT, V55, P277, DOI 10.1016/j.parint.2006.07.003
   CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296
   Marques LHD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001955
   DUJARDIN JC, 1995, ACTA TROP, V59, P293, DOI 10.1016/0001-706X(95)00094-U
   Elamin EM, 2008, T ROY SOC TROP MED H, V102, P54, DOI 10.1016/j.trstmh.2007.10.005
   Guerbouj S, 2001, PARASITOLOGY, V122, P25, DOI 10.1017/S0031182000007125
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68
   Kuhls K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000261
   Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009
   Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155
   Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001
   Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104
   Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710
   Mauricio IL, 2001, PARASITOLOGY, V122, P393, DOI 10.1017/S0031182001007466
   Ferreira GEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036242
   Moreno EC, 2006, REV SOC BRAS MED TRO, V39, P421, DOI 10.1590/S0037-86822006000500001
   Morrison DA, 2005, INT J PARASITOL, V35, P567, DOI 10.1016/j.ijpara.2005.02.007
   Motoie G, 2013, INFECT GENET EVOL, V18, P48, DOI 10.1016/j.meegid.2013.04.031
   Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006
   Oliveira RP, 1997, PARASITOL TODAY, V13, P196, DOI 10.1016/S0169-4758(97)01044-2
   PBH, 2014, IND VULN SAUD
   Coutinho CER, 2011, REV SOC BRAS MED TRO, V44, P572, DOI [10.1590/S0037-86822011005000049, 10.1590/s0037-86822011005000049]
   Schwenkenbecher JM, 2004, INFECT GENET EVOL, V4, P99, DOI 10.1016/j.meegid.2004.01.005
   Segatto M, 2012, MEM I OSWALDO CRUZ, V107, P39, DOI 10.1590/S0074-02762012000100006
   Seridi N, 2008, T ROY SOC TROP MED H, V102, P556, DOI 10.1016/j.trstmh.2008.03.004
   Sreenivas G, 2004, J CLIN MICROBIOL, V42, P1739, DOI 10.1128/JCM.42.4.1739-1741.2004
   Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005
   Tibayrenc M, 1999, MICROBES INFECT, V1, P465, DOI 10.1016/S1286-4579(99)80050-1
   Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049
   Toledo A, 2002, MOL BIOCHEM PARASIT, V119, P257, DOI 10.1016/S0166-6851(01)00424-8
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008
   WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   World Health Organization, SUST DRIV OV GLOB IM
NR 44
TC 5
Z9 5
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 15
PY 2015
VL 8
AR 226
DI 10.1186/s13071-015-0837-y
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CG5GY
UT WOS:000353320300002
PM 25889010
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Campos, KB
   Amancio, FF
   de Araujo, VEM
   Carneiro, M
AF Campos, Kauara Brito
   Amancio, Frederico Figueiredo
   Miranda de Araujo, Valdelaine Etelvina
   Carneiro, Mariangela
TI Factors associated with death from dengue in the state of Minas Gerais,
   Brazil: historical cohort study
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE dengue fever; dengue haemorrhagic fever; dengue shock syndrome; plasma
   leakage; factors associated with death; case-fatality rate; Brazil
ID HEMORRHAGIC-FEVER; SHOCK SYNDROME; RISK-FACTORS
AB ObjectivesTo analyse the clinical and epidemiological profiles of dengue haemorrhagic fever (DHF), dengue shock syndrome (DSS) and complicated dengue cases and deaths from 2008 to 2010 that occurred in the state of Minas Gerais, south-eastern Brazil, and to identify factors associated with death from dengue.
   MethodsHistorical cohort study using data from the Brazilian Information System for Notifiable Diseases. A descriptive analysis of the DHF, DSS and complicated dengue cases and deaths was performed; the incidence, mortality and case-fatality rates were estimated. Logistic regression analysis was used to identify factors associated with death from dengue. Comorbidities were not included in the analysis because the information system does not contain such data.
   ResultsDuring the study period, 2214 DHF, DSS and complicated dengue cases were reported, including 156 deaths. The annual case-fatality rates for DHF/DSS and complicated dengue cases in the period of 2008-2010 were 7.3%, 4.8% and 7.9%, respectively. The factors associated with death from dengue included residence in a municipality with a population of fewer than 100000 inhabitants [odds ratio (OR) 2.46; 95% confidence interval (CI) 1.71-3.55], age over 65years (OR 3.05; 95% CI 1.99-4.68) and plasma leakage (OR 1.69; 95% CI 1.16-2.46).
   ConclusionsThe results support the importance of plasma leakage as a warning sign associated with death from dengue as well as the signs and symptoms that allow the diagnosis of DHF. Moreover, our findings suggest that increased attention is necessary for individuals over 65years of age and in municipalities with populations under 100000 inhabitants to ensure a better quality of care during the management of severe patients of dengue in these locations. Differences in the interpretation of the DHF definition have hindered the comparison of data from different countries; it can improve from the WHO 2009 dengue classification.
C1 [Campos, Kauara Brito; Amancio, Frederico Figueiredo; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, BR-31270901 Belo Horizonte, MG, Brazil.
   [Campos, Kauara Brito] Minist Saude, Dept Vigilancia Doencas Transmissiveis, Secretaria Vigilancia Saude, Programa Nacl Controle Dengue, Brasilia, DF, Brazil.
   [Amancio, Frederico Figueiredo; Miranda de Araujo, Valdelaine Etelvina; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, BR-31270901 Belo Horizonte, MG, Brazil.
   [Miranda de Araujo, Valdelaine Etelvina] Prefeitura Belo Horizonte, Secretaria Municipal Saude, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Campus Pampulha,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
FU Brazilian Dengue Control Program, Ministry of Health of Brazil;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX We thank the entire team of the Department of Epidemiology of the Health
   Secretariat of State of Minas Gerais, Brazil, for their assistance with
   data collection and the State Public Health Laboratory (Fundacao
   Ezequiel Dias) for laboratory support. The entire project was funded by
   the Brazilian Dengue Control Program, Ministry of Health of Brazil. MC
   is grateful for CNPq research fellowship and FAPEMIG (PPM). The authors
   thank the Pro-Reitoria de Pesquisa of Universidade Federal de Minas
   Gerais for help with editing the manuscript.
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   [Anonymous], 2009, DIR NAC PREV CONTR E
   [Anonymous], 2011, BAL DENG SEM EP 1 39
   Arima Y, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2012.3.4.019, 10.5365/WPSAR.2012.3.4.019]
   Bin Ghouth AS, 2012, AM J TROP MED HYG, V86, P1072, DOI 10.4269/ajtmh.2012.11-0723
   Brazil, 2009, GUIA VIG EP A
   Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gupta V, 2011, J TROP PEDIATRICS, V57, P451, DOI 10.1093/tropej/fmr020
   Guzman M G, 1999, Int J Infect Dis, V3, P130, DOI 10.1016/S1201-9712(99)90033-4
   IBGE Instituto Brasileiro de Geografia e Estatistica, 2010, SIN CENS DEM 2010
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149
   Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532
   Machado MH, 1997, MEDICOS NO BRASIL RE
   Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003
   Mia MS, 2013, ASIAN PAC J TROP MED, V6, P462, DOI 10.1016/S1995-7645(13)60075-9
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   PAHO, 2008, NUMB REP CAS DENG DE
   *PAHO, 2007, NUMB REP CAS DENG DE
   Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777
   Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333
   SES-MG Secretaria de Estado de Saude de Minas Gerais Brazil, 2009, LINH GUIA ATENCAO SA
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Tee H P, 2009, Med J Malaysia, V64, P316
   Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060
   Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614
   WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   WHO, 2011, SEARO TECHN PUBL SER, V60
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 30
TC 13
Z9 16
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD FEB
PY 2015
VL 20
IS 2
BP 211
EP 218
DI 10.1111/tmi.12425
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AY9UK
UT WOS:000347895700012
PM 25345964
OA Bronze
DA 2020-12-08
ER

PT J
AU Carneiro, M
   Coura-Vital, W
   Araujo, VEM
   Reis, IA
   Amancio, FF
   Reis, AB
   Rabello, A
AF Carneiro, M.
   Coura-Vital, W.
   Araujo, V. E. M.
   Reis, I. A.
   Amancio, F. F.
   Reis, A. B.
   Rabello, A.
TI Prognostic Factors and Scoring System for Death from Visceral
   Leishmaniasis: A Historical Cohort Study in Brazil.
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Meeting Abstract
CT 20th IEA World Congress of Epidemiology (WCE)
CY AUG 17-21, 2014
CL Anchorage, AK
SP Int Epidemiol Assoc
C1 [Carneiro, M.; Coura-Vital, W.; Reis, I. A.; Amancio, F. F.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Araujo, V. E. M.] Municipal Hlth Serv, Belo Horizonte, MG, Brazil.
   [Reis, A. B.] Univ Fed Ouro Preto, Ouro Preto, Brazil.
   [Rabello, A.] Fundacao Oswaldo Cruz, Belo Horizonte, MG, Brazil.
RI Reis, Ilka Afonso/AAG-8007-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PY 2015
VL 44
SU 1
MA 2625
BP 166
EP 167
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM9BV
UT WOS:000376659900418
OA Bronze
DA 2020-12-08
ER

PT J
AU Coura-Vital, W
   de Araujo, VEM
   Reis, IA
   Amancio, FF
   Reis, AB
   Carneiro, M
AF Coura-Vital, Wendel
   Miranda de Araujo, Valdelaine Etelvina
   Reis, Ilka Afonso
   Amancio, Frederico Figueiredo
   Reis, Alexandre Barbosa
   Carneiro, Mariangela
TI Prognostic Factors and Scoring System for Death from Visceral
   Leishmaniasis: An Historical Cohort Study in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RISK-FACTORS; INFLAMMATORY RESPONSE; CHILDREN; MODELS; IMPACT
AB Background: In Brazil, case-fatality rates attributable to visceral leishmaniasis (VL) are high and knowledge of the risk factors associated with death may help reduce mortality. The aim of this study was to construct and validate a scoring system for prognosis of death from VL by using all cases reported in Brazil from 2007 to 2011.
   Methodology: In this historical cohort study, 18,501 VL cases were analyzed; of these, 17,345 cases were cured and 1,156 cases caused death. The database was divided into two series: primary (two-thirds of cases), to develop the model score, and secondary (one-third of cases), to validate the scoring system. Multivariate logistic regression models were performed to identify factors associated with death from VL, and these were included in the scoring system.
   Principal Findings: The factors associated with death from VL were: bleeding (score 3); splenomegaly (score 1); edema (score 1); weakness (score 1); jaundice (score 1); Leishmania-HIV co-infection (score 1); bacterial infection (score 1); and age (<= 0.5 years [score 5]; >0.5 and <= 1 [score 2]; >19 and <= 50 [score 2]; >50 and <65 [score 3]; >= 65 [score 5]). It was observed that patients with a score of 4 had a probability of death of approximately 4.5% and had a worse prognosis. The sensitivity, specificity, and accuracy of this score were 89.4, 51.2, and 53.5, respectively.
   Conclusions/Significance: The scoring system based on risk factors for death showed good performance in identifying patients with signs of severity at the time of clinical suspicion of VL and can contribute to improving the surveillance system for reducing case fatalities. The classification of patients according to their prognosis for death may assist decision-making regarding the transfer of the patients to hospitals more capable of handling their condition, admission to the intensive care unit, and adequate support and specific treatment.
C1 [Coura-Vital, Wendel; Amancio, Frederico Figueiredo; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.
   [Miranda de Araujo, Valdelaine Etelvina] Prefeitura Belo Horizonte, Secretaria Municipal Saude, Belo Horizonte, MG, Brazil.
   [Miranda de Araujo, Valdelaine Etelvina; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil.
   [Amancio, Frederico Figueiredo] Fundacao Hosp Estado Minas Gerais, Belo Horizonte, MG, Brazil.
RP Coura-Vital, W (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Reis, Ilka Afonso/AAG-8007-2019
OI /0000-0002-1434-7676
FU PNPD/Institutional; Brazilian National Leishmaniasis Control Program;
   PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant [CBB-APQ-00356-10];
   CNPQ/UniversalNational Council for Scientific and Technological
   Development (CNPq) [478528/2012-4]; FAPEMIG/PPM
FX This study was supported by the following grants:
   PNPD/Institutional/2011, Brazilian National Leishmaniasis Control
   Program, PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10,
   CNPQ/Universal 478528/2012-4, and FAPEMIG/PPM. MC and ABR are grateful
   for CNPq fellowships, and WCV is grateful for the PNPD/CAPES
   fellowships. The funders had no role in study design, data collection or
   analysis, decision to publish, or preparation of the manuscript.
CR Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605
   Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Sampaio MJAD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000877
   ANDRADE TM, 1990, J INFECT DIS, V162, P1354, DOI 10.1093/infdis/162.6.1354
   Barquet N, 1997, JAMA-J AM MED ASSOC, V278, P491, DOI 10.1001/jama.278.6.491
   Belo VS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002982
   Caldas AJM, 2006, ACTA TROP, V97, P252, DOI 10.1016/j.actatropica.2005.09.010
   Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   Braga ASD, 2013, REV SOC BRAS MED TRO, V46, P55, DOI 10.1590/0037-868216432013
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   Esmon CT, 2004, THROMB RES, V114, P321, DOI 10.1016/j.thromres.2004.06.028
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   IBGE, 2013, CENS DEM 2010
   Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2
   Lomtadze M L, 2005, Georgian Med News, P47
   Madalosso G, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/281572
   Ministerio da saude, 2013, SIST INF AGR NOT SIN
   Ministerio da Saude, 2006, MAN VIG CONTR LEISHM
   Ministerio da Saude, 2006, LEISHM VISC GRAV NOR
   Ministry of Health of Brazil, 2011, VISC LEISHM CLIN REC
   de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511
   Mueller Y, 2009, TROP MED INT HEALTH, V14, P910, DOI 10.1111/j.1365-3156.2009.02305.x
   Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5
   Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010
   Olivier M, 2003, ANN TROP MED PARASIT, V97, P79, DOI 10.1179/000349803225002561
   Pintado V, 2001, MEDICINE, V80, P54, DOI 10.1097/00005792-200101000-00006
   Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009
   Rocha NA, 2013, PEDIATR INFECT DIS J, V32, pE182, DOI 10.1097/INF.0b013e3182814eae
   Seaman J, 1996, ANN INTERN MED, V124, P664, DOI 10.7326/0003-4819-124-7-199604010-00007
   SNEE RD, 1977, TECHNOMETRICS, V19, P415, DOI 10.2307/1267881
   Szklo M., 2007, EPIDEMIOLOGY BASICS
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9
   WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539
NR 36
TC 25
Z9 25
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2014
VL 8
IS 12
AR e3374
DI 10.1371/journal.pntd.0003374
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AX1IM
UT WOS:000346701000047
PM 25503575
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Amancio, FF
   Ferraz, ML
   Almeida, MCD
   Pessanha, JEM
   Iani, FCM
   Fraga, GL
   Lambertucci, JR
   Carneiro, M
AF Amancio, Frederico F.
   Ferraz, Marcela L.
   Almeida, Maria Cristina de M.
   Pessanha, Jose Eduardo M.
   Iani, Felipe C. M.
   Fraga, Gabriela L.
   Lambertucci, Jose Roberto
   Carneiro, Mariangela
TI Dengue virus serotype 4 in a highly susceptible population in Southeast
   Brazil
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Dengue; Brazil; Outbreak; Dengue serotype 4; Epidemiology
ID HEMORRHAGIC-FEVER; INFECTION
AB In Minas Gerais, Brazil, almost 500,000 dengue fever cases were reported to the State Surveillance System between November 2012 and July 2013. An analysis of the laboratory-confirmed cases revealed a higher age-specific incidence in adults and a higher case fatality rate in people aged >= 50. Dengue virus serotypes 1 and 4 (the latter of which is an emerging serotype in Brazil) were responsible for the outbreak. (C) 2014 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.
C1 [Amancio, Frederico F.; Lambertucci, Jose Roberto; Carneiro, Mariangela] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Ferraz, Marcela L.; Fraga, Gabriela L.] State Minas Gerais Hlth Secretariat, Dept Epidemiol, Belo Horizonte, MG, Brazil.
   [Almeida, Maria Cristina de M.; Pessanha, Jose Eduardo M.] Municipal Hlth Secretariat Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Iani, Felipe C. M.] Ezequiel Dias Fdn, Belo Horizonte, MG, Brazil.
RP Amancio, FF (corresponding author), Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Belo Horizonte, MG, Brazil.
EM manzoff@gmail.com
FU Brazilian Dengue Control Program, Ministry of Health of Brazil
   [258/2012]
FX The entire project was financially supported by the Brazilian Dengue
   Control Program, Ministry of Health of Brazil (grant number 258/2012).
CR Badurdeen S, 2011, BMC PUBLIC HEALTH, V13, P607
   Brasil. Ministerio da Saude Secretaria de Vtgilancia em Saude, 2011, DENG DIAGN MAN CLIN
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Gubler DJ, 1984, AM J TROP MED HYG, V33, P1984
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   IBGE, 2010, CENS DEM
   Kongsomboon K., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P913
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Thai KTD, 2010, EPIDEMIOL INFECT, V138, P585, DOI 10.1017/S095026880999046X
NR 18
TC 5
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD NOV-DEC
PY 2014
VL 7
IS 6
BP 547
EP 552
DI 10.1016/j.jiph.2014.07.016
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CI7SF
UT WOS:000354964200012
PM 25179890
OA Bronze
DA 2020-12-08
ER

PT J
AU Leal, GGD
   Roatt, BM
   Aguiar-Soares, RDD
   Carneiro, CM
   Giunchetti, RC
   Teixeira-Carvalho, A
   Martins, OA
   Francisco, AF
   Cardoso, JM
   Mathias, FAS
   Correa-Oliveira, R
   Carneiro, M
   Coura-Vital, W
   Reis, AB
AF de Almeida Leal, Gleisiane Gomes
   Roatt, Bruno Mendes
   de Oliveira Aguiar-Soares, Rodrigo Dian
   Carneiro, Claudia Martins
   Giunchetti, Rodolfo Cordeiro
   Teixeira-Carvalho, Andrea
   Martins-Filho, Olindo Assis
   Francisco, Amanda Fortes
   Cardoso, Jamille Mirelle
   Siqueira Mathias, Fernando Augusto
   Correa-Oliveira, Rodrigo
   Carneiro, Mariangela
   Coura-Vital, Wendel
   Reis, Alexandre Barbosa
TI Immunological profile of resistance and susceptibility in naturally
   infected dogs by Leishmania infantum
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Canine visceral leishmaniasis; Leishmania infantum; Clinical forms;
   Immunophenotyping; Cytokines
ID CANINE VISCERAL LEISHMANIASIS; AMERICAN CUTANEOUS LEISHMANIASIS;
   POLYMERASE-CHAIN-REACTION; TISSUE PARASITE DENSITY; IMMUNE-RESPONSE;
   CLINICAL STATUS; CIRCULATING LEUKOCYTES; VIANNIA BRAZILIENSIS;
   EXPERIMENTAL-MODEL; ASYMPTOMATIC DOGS
AB Visceral leishmaniasis has a great impact on public health, and dogs are considered the main domestic reservoir of Leishmania infantum, the causal parasite. In this study, 159 animals naturally infected by L infantum from an endemic area of Brazil were evaluated through an analysis of cellular responses, using flow cytometry, and of the hematological parameters. The results confirmed that disease progression is associated with anemia and reductions in eosinophils, monocytes and lymphocytes. The investigation of the immune response, based on the immunophenotypic profile of peripheral blood, showed declines in the absolute numbers of T lymphocytes CD5(+) and their subsets (CD4(+) and CD8(+)) and a drop of B lymphocytes in asymptomatic seropositive (AD-II) and symptomatic seropositive (SD) dogs. Neutrophils, when stimulated with soluble antigen of L. infantum, showed higher synthesis of interferon (IFN)-gamma(+) in AD-II and SD groups, with decreased production of interleukin (IL)-4(+) in asymptomatic seronegative dogs positive for L. infantum infection based on polymerase chain reaction testing (AD-I group). In the AD-II and SD groups, subpopulations of stimulated lymphocytes (CD4(+) and CD8(+)) also exhibited greater synthesis of IFN-gamma(+) and IL-4(+) in culture. These results suggest that the animals of the AD-II and SD groups exhibited a mixed immune response (Type 1 and 2) and the AD-I group presenting an immune profile very similar to normal control animals. (C) 2014 Elsevier B.V. All rights reserved.
C1 [de Almeida Leal, Gleisiane Gomes; Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Francisco, Amanda Fortes; Cardoso, Jamille Mirelle; Siqueira Mathias, Fernando Augusto; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, NUPEB, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, BR-35400000 Ouro Preto, MG, Brazil.
   [Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Carneiro, Claudia Martins; Coura-Vital, Wendel; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Pesquisas Clin, Dept Anal Clin, Escola Farm, BR-35400000 Ouro Preto, MG, Brazil.
   [Giunchetti, Rodolfo Cordeiro] Univ Fed Minas Gerais, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil.
   [Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fundacdo Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil.
   [Correa-Oliveira, Rodrigo] Fundacao Oswaldo Cruz, Ctr Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil.
   [Roatt, Bruno Mendes; Correa-Oliveira, Rodrigo; Coura-Vital, Wendel; Reis, Alexandre Barbosa] Inst Nacl Ciencia & Tecnol Doencas Trop, Salvador, BA, Brazil.
   [Carneiro, Mariangela; Coura-Vital, Wendel] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
RP Reis, AB (corresponding author), Univ Fed Ouro Preto, ICEB 2, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, BR-35400000 Ouro Preto, MG, Brazil.
EM alexreisufop@gmail.com
RI Roatt, Bruno M/R-5502-2016; de Oliveira Aguiar-Soares, Rodrigo
   Dian/ABB-7973-2020; carneiro, claudia m/B-6205-2013; carneiro, Claudia
   Martins/AAP-4455-2020
OI Roatt, Bruno M/0000-0001-5281-3263; de Oliveira Aguiar-Soares, Rodrigo
   Dian/0000-0001-8705-7357; carneiro, Claudia Martins/0000-0002-6002-857X;
   Correa-Oliveira, Rodrigo/0000-0001-6419-9459; Cordeiro Giunchetti,
   Rodolfo/0000-0003-4181-7546; Martins-Filho, Olindo
   Assis/0000-0002-5494-4889; Fortes Francisco, Amanda/0000-0002-3475-8130;
   /0000-0002-1434-7676; Siqueira Mathias, Fernando
   Augusto/0000-0003-2071-0344; de Oliveira Aguiar Soares, Rodrigo
   Dian/0000-0002-3390-7990
FU Federal University of Ouro Preto; DECIT/MS/CNPq/BR/grant
   [576062/2008-1]; FAPEMIG/BR/grant [CBB-APQ-3073-4.01/07]; CNPq/BR/grant
   [472554/2007-7]; PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant [CBB-APQ-00356-10];
   FAPEMIG/PPM; PNPD/Institutional
FX This study was supported by the following grants: Federal University of
   Ouro Preto; DECIT/MS/CNPq/BR/grant: 576062/2008-1; FAPEMIG/BR/grant:
   CBB-APQ-3073-4.01/07, CNPq/BR/grant: 472554/2007-7;
   PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10; FAPEMIG/PPM and
   PNPD/Institutional/2011. The funders had no role in study design, data
   collection or analysis, the decision to publish, or the preparation of
   the manuscript. ABR, CMC, RCG, ATC, OAMF, and MC are grateful for CNPq
   fellowships, WCV is grateful to the PNPD/CAPES fellowships and Federal
   University of Ouro Preto. We also thank the staff of the Secretaria
   Municipal de Saude de Belo Horizonte, Minas Gerais, for cooperation,
   logistical support, and special dedication to this work.
CR Alexandre-Pires G, 2010, VET IMMUNOL IMMUNOP, V137, P275, DOI 10.1016/j.vetimm.2010.06.007
   Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020
   Bourdoiseau G, 1997, VET IMMUNOL IMMUNOP, V56, P345, DOI 10.1016/S0165-2427(96)05768-6
   de Freitas JCC, 2012, RES VET SCI, V93, P705, DOI 10.1016/j.rvsc.2011.12.009
   Carrillo E, 2007, VACCINE, V25, P1534, DOI 10.1016/j.vaccine.2006.10.036
   Carrillo E, 2009, VET IMMUNOL IMMUNOP, V128, P67, DOI 10.1016/j.vetimm.2008.10.310
   Carvalho LP, 2012, J IMMUNOL, V188, P1394, DOI 10.4049/jimmunol.1101018
   Chamizo C, 2005, VET IMMUNOL IMMUNOP, V103, P67, DOI 10.1016/j.vetimm.2004.08.010
   Costa DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060535
   Coura-Vital W, 2011, Vet J, V190, pe43, DOI 10.1016/j.tvjl.2011.04.005
   Coura-Vital W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071833
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   da Costa-Val AP, 2007, VET J, V174, P636, DOI 10.1016/j.tvjl.2006.11.006
   de Abreu RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018873
   De Luna R, 2000, J COMP PATHOL, V122, P213, DOI 10.1053/jcpa.1999.0357
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   Fraga DBM, 2012, VET PARASITOL, V190, P591, DOI 10.1016/j.vetpar.2012.06.025
   Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005
   Giunchetti RC, 2007, VACCINE, V25, P7674, DOI 10.1016/j.vaccine.2007.08.009
   Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040
   Guerra LL, 2009, PARASITOL RES, V104, P611, DOI 10.1007/s00436-008-1237-4
   Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001
   Correa APFL, 2007, VET PARASITOL, V143, P267, DOI 10.1016/j.vetpar.2006.08.023
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07
   Menezes-Souza D, 2011, VET PARASITOL, V177, P39, DOI 10.1016/j.vetpar.2010.11.025
   Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4
   Moreno J, 1999, VET IMMUNOL IMMUNOP, V71, P181, DOI 10.1016/S0165-2427(99)00096-3
   Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4
   Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x
   Peters NC, 2009, CELL MICROBIOL, V11, P1290, DOI 10.1111/j.1462-5822.2009.01348.x
   Pinelli E, 1999, VET IMMUNOL IMMUNOP, V69, P121, DOI 10.1016/S0165-2427(99)00048-3
   PINELLI E, 1995, EUR J IMMUNOL, V25, P1594, DOI 10.1002/eji.1830250619
   PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994
   Pinelli E, 1999, IMMUNOGENETICS, V49, P696, DOI 10.1007/s002510050667
   Quinnell RJ, 2001, J INFECT DIS, V183, P1421, DOI 10.1086/319869
   Reis AB, 2006, CLIN EXP IMMUNOL, V146, P303, DOI 10.1111/j.1365-2249.2006.03206.x
   Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001
   Reis AB, 2006, RES VET SCI, V81, P68, DOI 10.1016/j.rvsc.2005.09.011
   Reis AB, 2010, TRENDS PARASITOL, V26, P341, DOI 10.1016/j.pt.2010.04.005
   Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307
   Ritter U, 2009, TRENDS PARASITOL, V25, P505, DOI 10.1016/j.pt.2009.08.003
   Rodriguez-Cortes A, 2007, VET IMMUNOL IMMUNOP, V116, P190, DOI 10.1016/j.vetimm.2007.01.015
   Rousseau D, 2001, BMC Microbiol, V1, P17, DOI 10.1186/1471-2180-1-17
   Strauss-Ayali D, 2007, VET RES, V38, P547, DOI 10.1051/vetres:2007015
   Tsagozis P, 2003, PARASITE IMMUNOL, V25, P569, DOI 10.1111/j.0141-9838.2004.00672.x
   Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008
   WHO, 2010, 1 WHO
NR 48
TC 24
Z9 24
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD OCT 15
PY 2014
VL 205
IS 3-4
BP 472
EP 482
DI 10.1016/j.vetpar.2014.08.022
PG 11
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA AS7GN
UT WOS:000344425200008
PM 25234767
DA 2020-12-08
ER

PT J
AU Silva, AP
   Greco, M
   Fausto, MA
   Greco, DB
   Carneiro, M
AF Silva, Ana Paula
   Greco, Marilia
   Fausto, Maria Arlene
   Greco, Dirceu B.
   Carneiro, Mariangela
TI Risk Factors Associated with HIV Infection among Male Homosexuals and
   Bisexuals Followed in an Open Cohort Study: Project Horizonte, Brazil
   (1994-2010)
SO PLOS ONE
LA English
DT Article
ID UNPROTECTED ANAL INTERCOURSE; RIO-DE-JANEIRO; REDUCTION PRACTICES; MEN;
   SEX; GAY; TRANSMISSION; PARTNERS; SWITZERLAND; PREVENTION
AB Background: There has recently been an increase in HIV infection rates among men who have sex with men (MSM). This study aimed at investigating risk factors associated with incident HIV infection in a MSM cohort-Project Horizonte, Belo Horizonte, Minas Gerais, Brazil.
   Methodology: This is a nested case-control study in an ongoing open cohort of homosexual and bisexual men, carried out in 1994-2010, during which 1,085 volunteers were enrolled. Each HIV seroconverted volunteer (case) was compared with three randomly selected HIV negative controls, matched by admission date and age (+/- 3 years). During follow-up, 93 volunteers seroconverted and were compared with 279 controls.
   Principal Findings: The risk factors associated with HIV seroconversion were: contact with partner's blood during sexual relations (OR 3.7; 95% CI 1.2-11.6), attendance at gay saunas in search for sexual partners (OR 2.6; 95% CI 1.3-5.4), occasional intake of alcohol when flirting and engaging in sexual activity (OR 2.5; 95% CI 1.3-5.1), inconsistent use of condoms in receptive anal sex (OR 2.4; 95% CI 1.1-5.4), little interest to look up information about AIDS (OR 2.6; 95% CI 1.0-6.7) particularly in newspapers (OR 3.4; 95% CI 1.4-8.1).
   Conclusions: This study shows that MSM are still engaging in risk behavior, such as unprotected anal intercourse, despite taking part in a cohort study on various preventive measures. New preventive strategies in touch with the epidemic's development and the specificities of this particular population are needed.
C1 [Silva, Ana Paula; Greco, Dirceu B.; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
   [Silva, Ana Paula; Greco, Marilia; Carneiro, Mariangela] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, Ouro Preto, Brazil.
   [Greco, Dirceu B.] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Greco, Dirceu/AAR-4714-2020
OI Greco, Dirceu/0000-0002-4419-5634; Silva, Ana Paula/0000-0003-1839-272X
FU Brazilian Ministry of Health, Department of STD, AIDS and Viral
   Hepatitis [19288]; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIG/PPM research fellowship
FX Project Horizonte is supported by the Brazilian Ministry of Health,
   Department of STD, AIDS and Viral Hepatitis, grant number 19288. MC is
   grateful for the CNPq and the FAPEMIG/PPM research fellowship. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ackers ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034972
   Andrade LT, 2004, CAD METROPOLE, V11, P137
   Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057
   Balthasar H, 2010, JAIDS-J ACQ IMM DEF, V54, P542, DOI 10.1097/QAI.0b013e3181e19a6b
   Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481
   Binson D, 2001, AM J PUBLIC HEALTH, V91, P1482, DOI 10.2105/AJPH.91.9.1482
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de DST/AIDS e Hepatites Virais, 2011, B EP AIDS
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de DST/AIDS e Hepatites Virais, 2007, PLAN NAC ENFR EP AID
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de DST/AIDS e Hepatites Virais, 2000, BEL VIST HOR EST COM
   Brignol Sandra, 2011, Rev. bras. epidemiol., V14, P423, DOI 10.1590/S1415-790X2011000300007
   Burt RD, 2012, AIDS BEHAV, V16, P599, DOI 10.1007/s10461-011-9979-x
   Carneiro M, 2000, J ACQ IMMUN DEF SYND, V25, P182, DOI 10.1097/00126334-200010010-00013
   Chamratrithirong A, 2006, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0042009
   Cardoso LRD, 2008, REV PSIQ CLIN-BRAZIL, V35, P70, DOI 10.1590/S0101-60832008000700015
   Dubois-Arber F, 2012, ARCH SEX BEHAV, V41, P1263, DOI 10.1007/s10508-011-9868-4
   Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013
   Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185
   Gondim RC, 2000, REV BRAS EPIDEMIOL, V3, P38
   Holliday CS, 2006, THESIS GEORGIA STATE, P27
   Hosmer D.W., 2000, APPL LOGISTIC REGRES
   Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a
   Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y
   Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050493
   Mansergh G, 2006, AIDS BEHAV, V10, P743, DOI 10.1007/s10461-006-9108-4
   McDaid LM, 2010, CURR OPIN HIV AIDS, V5, P311, DOI 10.1097/COH.0b013e32833a0b86
   Mirandola M, 2009, EUROSURVEILLANCE, V14, P22
   Mitchell JW, 2012, AIDS BEHAV, V16, P404, DOI 10.1007/s10461-011-9976-0
   Perez Lilli Ann, 2010, Calif J Health Promot, V8, P63
   Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7
   Rocha GM, 2013, AIDS BEHAV, V17, P1288, DOI 10.1007/s10461-012-0398-4
   Rodrigues J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-39
   Rosenberg ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-189
   Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9
   Souza CT, 1999, AIDS CARE, V11, P567
   Stata Corp, 2009, STAT STAT SOFTW REL
   Strathdee SA, 2000, CAN MED ASSOC J, V162, P21
   Vallabhaneni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045718
   Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6
   Woolf SE, 2009, AIDS BEHAV, V13, P757, DOI 10.1007/s10461-007-9354-0
   World Health Organization, 2005, ALC US SEX RISK BEH
   Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59
NR 41
TC 3
Z9 3
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2014
VL 9
IS 10
AR e109390
DI 10.1371/journal.pone.0109390
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ3DZ
UT WOS:000342670800075
PM 25279670
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Amancio, FF
   Pereira, MA
   Iani, FCM
   D'Anunciacao, L
   Almeida, JLC
   Soares, JAS
   Ferraz, ML
   Vale, TC
   Lambertucci, JR
   Carneiro, M
AF Amancio, Frederico F.
   Pereira, Maira A.
   Iani, Felipe C. M.
   D'Anunciacao, Lorena
   Almeida, Jorge L. C.
   Soares, Janer A. S.
   Ferraz, Marcela L.
   Vale, Thiago C.
   Lambertucci, Jose R.
   Carneiro, Mariangela
TI THROMBOCYTOPENIC PURPURA AND DENGUE REPLY
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Letter
ID CORTICOSTEROID-THERAPY; SHOCK SYNDROME; INFECTION
C1 [Amancio, Frederico F.; Lambertucci, Jose R.; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Curso Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
   [Pereira, Maira A.; Iani, Felipe C. M.; D'Anunciacao, Lorena] Fundacao Ezequiel Dias, Belo Horizonte, MG, Brazil.
   [Almeida, Jorge L. C.] Hosp Univ Clemente Faria, Montes Claros, MG, Brazil.
   [Soares, Janer A. S.] Univ Est Montes Claros, Belo Horizonte, MG, Brazil.
   [Ferraz, Marcela L.] Secret Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [Vale, Thiago C.] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Amancio, FF (corresponding author), Univ Fed Minas Gerais, Fac Med, Curso Posgrad Ciencias Saude Infectol & Med Trop, Belo Horizonte, MG, Brazil.
EM manzoff@gmail.com
CR Amancio FF, 2014, REV INST MED TROP SP, V56, P267, DOI 10.1590/S0036-46652014000300014
   Panpanich R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003488.pub2
   Premaratna R, 2012, INT J INFECT DIS, V16, pE565, DOI 10.1016/j.ijid.2012.02.014
   RodriguezAngulo EM, 1997, REV INVEST CLIN, V49, P47
   Shashidhara KC, 2013, J CLIN DIAGN RES, V7, P1397, DOI 10.7860/JCDR/2013/6135.3143
   Srichaikul Tanomsri, 2011, Journal of the Medical Association of Thailand, V94, P1419
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
NR 7
TC 0
Z9 0
U1 0
U2 1
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD SEP-OCT
PY 2014
VL 56
IS 5
BP 459
EP 460
PG 2
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AS5TL
UT WOS:000344332300019
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Fonseca, JE
   Carneiro, M
   Pena, JL
   Colosimo, EA
   da Silva, NB
   da Costa, AGFC
   Moreira, LE
   Cairncross, S
   Heller, L
AF Fonseca, Jacqueline Evangelista
   Carneiro, Mariangela
   Pena, Joao Luiz
   Colosimo, Enrico A.
   da Silva, Nivea Bispo
   da Costa, Andre Gabriel F. C.
   Moreira, Luciano E.
   Cairncross, Sandy
   Heller, Leo
TI Reducing Occurrence of Giardia duodenalis in Children Living in Semiarid
   Regions: Impact of a Large Scale Rainwater Harvesting Initiative
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SOUTHEAST QUEENSLAND; RURAL-COMMUNITY; WATER; QUALITY; PREVALENCE;
   LAMBLIA; RISK; SCHOOLCHILDREN; TRANSMISSION; INFECTIONS
AB Background: In Brazil, about two million people living in rural semiarid regions were benefited with the construction of rainwater cement cisterns, as an initiative from the program "One Million Cisterns" (P1MC). Nevertheless, few epidemiological studies have been conducted to assess health risks or protection effects associated with consumption of this water source. The aim of this study was to evaluate whether access to rainwater harvesting cisterns is associated with the decrease in the occurrence of Giardia duodenalis infections in children, compared to other children living in households supplied by other water sources.
   Methodology/Principal Findings: A quasi-experimental study with two concurrent cohorts was developed in two rural municipalities of the semiarid region of Brazil. A sample of 664 children, aged between 4 months and 5 years old, was followed up, of which 332 had access to rainwater cisterns (cistern group) and 332 did not, having water supplied from alternative sources (comparison group). In a period of approximately one year (2010) intestinal parasites were investigated in feces three times. The prevalence of G. duodenalis in children from the cistern group ranged from 4.8 to 10.5%, while the prevalence in the comparison group ranged from 7.6 to 16.7%. Multivariate analysis (GEE) showed a higher risk of G. duodenalis infection in children who did not have access to rainwater cisterns, when compared to children who did (OR 1.72; 95% CI 1.14-2.59). The other variables associated with G. duodenalis infection were: number of rooms per house (OR 0.89; 95% CI 0.80-0.99); family income (OR0.48; 95% CI 0.26-0.88); birth order (OR 1.72; 95% CI 1.17-2.51); preterm children (OR 1.70; 95% CI 1.19-2.43); and improper hand hygiene prior to food preparation (OR 4.78; 95% CI 1.95-11.76).
   Conclusions/Significance: Ownership of a rainwater cistern is associated with a lower prevalence of G. duodenalis infection in children after adjustment for environmental and family-related factors. Nevertheless, the study suggests the necessity to complement physical interventions with actions related to personal and domestic hygiene to enable further reductions in parasite infections affecting mainly the underprivileged populations.
C1 [Fonseca, Jacqueline Evangelista; Pena, Joao Luiz; Heller, Leo] Univ Fed Minas Gerais, Dept Sanit & Environm Engn, Sch Engn, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Inst Biol Sci, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Grad Program Hlth Sci Infect Dis & Trop Med, Belo Horizonte, MG, Brazil.
   [Colosimo, Enrico A.; da Silva, Nivea Bispo; da Costa, Andre Gabriel F. C.] Univ Fed Minas Gerais, Inst Math Sci, Dept Stat, Belo Horizonte, MG, Brazil.
   [Moreira, Luciano E.] Univ Presidente Antonio Carlos, Parasitol Lab, Teofilo Otoni, MG, Brazil.
   [Cairncross, Sandy] London Sch Hyg & Trop Med, London WC1, England.
RP Fonseca, JE (corresponding author), Univ Fed Minas Gerais, Dept Sanit & Environm Engn, Sch Engn, Belo Horizonte, MG, Brazil.
EM heller@desa.ufmg.br
FU National Council for Scientific and Technological Development (CNPq
   Brazil)National Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq Brazil). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbott S, 2007, P 13 INT C RAINW CAT
   Adeniyi IF, 2005, CHEM ECOL, V21, P149, DOI 10.1080/02757540500117318
   Ahmed W, 2008, APPL ENVIRON MICROB, V74, P5490, DOI 10.1128/AEM.00331-08
   Ahmed W, 2010, APPL ENVIRON MICROB, V76, P7382, DOI 10.1128/AEM.00944-10
   Ahmed W, 2010, CAN J MICROBIOL, V56, P471, DOI [10.1139/W10-037, 10.1139/w10-037]
   Albrechtsen HJ, 2002, WATER SCI TECHNOL, V46, P311
   Andrade Neto CO, 2004, P 11 S LUS BRAS ENG
   [Anonymous], 2020, TITLE ERROR, V3
   BIRKHEAD G, 1989, AM J EPIDEMIOL, V129, P762, DOI 10.1093/oxfordjournals.aje.a115191
   BRASIL, 2010, BRASILIA, V368
   BRASIL. Ministerio do Desenvolvimento Social e Combate a Fome, 2012, CIST
   BRASIL. Ministerio do Desenvolvimento Social e Combate a Fome, SUG AL NUTR CIST
   Cairncross S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P771
   Basso RMC, 2008, REV SOC BRAS MED TRO, V41, P263, DOI 10.1590/S0037-86822008000300008
   Chang MT, 2004, J ENVIRON MANAGE, V73, P307, DOI 10.1016/j.jenvman.2004.06.014
   Crabtree KD, 1996, WATER RES, V30, P208, DOI 10.1016/0043-1354(95)00100-Y
   de Andrade EC, 2011, EPIDEMIOL SERV SAUDE, V20, P337, DOI 10.5123/S1679-49742011000300008
   de Souza EA, 2007, CAD SAUDE PUBLICA, V23, P427, DOI 10.1590/S0102-311X2007000200019
   Evans CA, 2006, WATER RES, V40, P37, DOI 10.1016/j.watres.2005.10.034
   Fan RG, 2013, CLINICS, V68, P915, DOI 10.6061/clinics/2013(07)05
   Ferreira Haroldo da Silva, 2002, Rev. Bras. Saude Mater. Infant., V2, P177, DOI 10.1590/S1519-38292002000200010
   FLANAGAN PA, 1992, EPIDEMIOL INFECT, V109, P1
   Fonseca JE, 2012, THESIS U FEDERAL MIN
   Fonseca JE, 2011, P 26 C BRAS ENG SAN
   Graeff J. A., 1993, COMMUNICATION HLTH B
   Heller L, 2004, EPIDEMIOL SERV SAUDE, V13, P79
   Hoque ME, 2003, EPIDEMIOL INFECT, V131, P655, DOI 10.1017/S0950268803008598
   IBGE - Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010
   KEYSTONE JS, 1978, CAN MED ASSOC J, V119, P241
   Lye DJ, 2009, SCI TOTAL ENVIRON, V407, P5429, DOI 10.1016/j.scitotenv.2009.07.011
   Machado R C, 1999, Rev Soc Bras Med Trop, V32, P697, DOI 10.1590/S0037-86821999000600013
   Melidis P, 2007, ENVIRON MONIT ASSESS, V127, P15, DOI 10.1007/s10661-006-9254-1
   OMAR MS, 1995, J COMMUN HEALTH, V20, P433, DOI 10.1007/BF02260439
   Plazinska A., 2001, P 10 INT C RAINW CAT
   PNUD. Programa das Nacoes Unidas para o Desenvolvimento Humano, 2003, ATL ENV HUM BRAS
   Prado MS, 2005, PARASITOLOGY, V131, P51, DOI 10.1017/S0031182005007353
   Prado MS, 2003, EPIDEMIOL INFECT, V131, P899, DOI 10.1017/S0950268803001018
   Ratanapo S, 2008, AM J TROP MED HYG, V78, P611, DOI 10.4269/ajtmh.2008.78.611
   Rodrigo S, 2009, 84 WAT QUAL RES AUST
   Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015
   Silva RR, 2009, T ROY SOC TROP MED H, V103, P512, DOI 10.1016/j.trstmh.2008.10.019
   Simmon G, 2001, WATER RES, V35, P1518, DOI 10.1016/S0043-1354(00)00420-6
   Teixeira JU, 2007, CAD SAUDE PUBLICA, V23, P1489, DOI 10.1590/S0102-311X2007000600024
   Tomaz P., 2003, APROVEITAMENTO AGUA
   WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992
   de Carvalho GLX, 2012, MEM I OSWALDO CRUZ, V107, P80, DOI 10.1590/S0074-02762012000100011
   Xavier RP, 2010, THESIS U FEDERAL CAM
   YAZIZ MI, 1989, WATER RES, V23, P761, DOI 10.1016/0043-1354(89)90211-X
NR 48
TC 8
Z9 9
U1 3
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2014
VL 8
IS 6
AR e2943
DI 10.1371/journal.pntd.0002943
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AL0VW
UT WOS:000338846100050
PM 24945928
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-08
ER

PT J
AU Amancio, FF
   Pereira, MA
   Iani, FCD
   D'Anunciacao, L
   de Almeida, JLC
   Soares, JAS
   Ferraz, ML
   Vale, TC
   Lambertucci, JR
   Carneiro, M
AF Amancio, Frederico Figueiredo
   Pereira, Maira Alves
   de Melo Iani, Felipe Campos
   D'Anunciacao, Lorena
   Carvalho de Almeida, Jorge Luis
   Silveira Soares, Janer Aparecida
   Ferraz, Marcela Lencine
   Vale, Thiago Cardoso
   Lambertucci, Jose Roberto
   Carneiro, Mariangela
TI FATAL OUTCOME OF INFECTION BY DENGUE 4 IN A PATIENT WITH
   THROMBOCYTOPENIC PURPURA AS A COMORBID CONDITION IN BRAZIL
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Dengue; Risk factors; Dengue serotype 4; Epidemiology; Minas Gerais
ID VIRUS SEROTYPE 4; RISK-FACTORS; HEMORRHAGIC-FEVER; RORAIMA STATE; ADULTS
AB Dengue is currently a major public-health problem. Dengue virus (DENV) is classified into four distinct serotypes, DENV 1-4. After 28 years of absence, DENV-4 was again detected in Brazil in 2010 in Roraima State, and one year later, the virus was identified in the northern Brazilian states of Amazonas and Para, followed by Rio de Janeiro and Sao Paulo. In Minas Gerais, the first confirmed case of DENV-4 occurred in the municipality of Frutal in 2011 and has now been isolated from a growing number of patients. Although DENV-2 is associated with the highest risk of severe forms of the disease and death due to the infection, DENV-4 has also been associated with severe forms of the disease and an increasing risk of hemorrhagic manifestations. Herein, the first fatal case of confirmed DENV-4 in Brazil is reported. The patient was an 11-year-old girl from the municipality of Montes Claros in northern Minas Gerais State, Brazil. She had idiopathic thrombocytopenic purpura as a comorbid condition and presented with a fulminant course of infection, leading to death due to hemorrhagic complications. Diagnosis was confirmed by detection of Dengue-specific antibodies using IgM capture enzyme-linked immunosorbent assay and semi-nested RT-PCR. Primary care physicians and other health-care providers should bear in mind that DENV-4 can also result in severe forms of the disease and lead to hemorrhagic complications and death, mainly when dengue infection is associated with coexisting conditions.
C1 [Amancio, Frederico Figueiredo; Lambertucci, Jose Roberto; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Curso Posgrad Ciencias Saude Infectol & Med Trop, BR-30130100 Belo Horizonte, MG, Brazil.
   [Pereira, Maira Alves; de Melo Iani, Felipe Campos; D'Anunciacao, Lorena] Fundacao Ezequiel Dias, Belo Horizonte, MG, Brazil.
   [Carvalho de Almeida, Jorge Luis] Hosp Univ Clemente Faria, Montes Claros, MG, Brazil.
   [Silveira Soares, Janer Aparecida] Univ Estadual Montes Claros, Montes Claros, MG, Brazil.
   [Ferraz, Marcela Lencine] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [Vale, Thiago Cardoso] Univ Fed Minas Gerais, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30130100 Belo Horizonte, MG, Brazil.
RP Amancio, FF (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Ave Alfredo Balena 190,Campus Saude, BR-30130100 Belo Horizonte, MG, Brazil.
EM manzoff@gmail.com
OI Vale, Thiago/0000-0001-6145-9868; SOARES, JANER/0000-0002-0500-0769
FU Brazilian National Dengue Control Program
FX We would like to thank the staff of the Ezequiel Dias Foundation for
   their laboratorial support and the Minas Gerais Department of Health for
   epidemiological data. This report was partially supported by the
   Brazilian National Dengue Control Program.
CR Acosta POA, 2011, EMERG INFECT DIS, V17, P1979, DOI 10.3201/eid1710.110776
   Brasil. Ministerio da Saude, 2011, DIR TECN GEST DENG D
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Cecilia D, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-46
   Cunha RV, 1999, T ROY SOC TROP MED H, V93, P247, DOI 10.1016/S0035-9203(99)90008-1
   Diaz A, 1988, Bull Pan Am Health Organ, V22, P133
   Dietz V, 1996, P R Health Sci J, V15, P201
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   Guzman M G, 1987, Bull Pan Am Health Organ, V21, P270
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Kumaria R, 2010, BRAZ J INFECT DIS, V14, P141, DOI 10.1590/S1413-86702010000200005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee IK, 2005, AM J TROP MED HYG, V72, P221, DOI 10.4269/ajtmh.2005.72.221
   Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532
   Lee M. S., 2006, J MICROBIOL IMMUNOL, V39, P121
   Lorono-Pino M.A., 1993, REV INST MED TROP SP, V35, P449, DOI [10.1590/S0036-46651993000500011, DOI 10.1590/S0036-46651993000500011]
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Ooi Eng Eong, 2003, Int J Infect Dis, V7, P231, DOI 10.1016/S1201-9712(03)90057-9
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Rocco IM, 2012, REV INST MED TROP SP, V54, P49, DOI 10.1590/S0036-46652012000100009
   Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503
   RodriguezAngulo EM, 1997, REV INVEST CLIN, V49, P47
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Vazquez S, 2007, J CLIN VIROL, V39, P194, DOI 10.1016/j.jcv.2007.04.003
   World Health Organization & Special Programme for Research and Training in Tropical Diseases, 2012, HDB CLIN MAN DENG
NR 30
TC 6
Z9 6
U1 0
U2 3
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD MAY-JUN
PY 2014
VL 56
IS 3
BP 267
EP 270
DI 10.1590/S0036-46652014000300014
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AL7LO
UT WOS:000339315500014
PM 24879007
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Coura-Vital, W
   Ker, HG
   Roatt, BM
   Aguiar-Soares, RDO
   Leal, GGD
   Moreira, ND
   Oliveira, LAM
   Machado, EMD
   Morais, MHF
   Correa-Oliveira, R
   Carneiro, M
   Reis, AB
AF Coura-Vital, Wendel
   Ker, Henrique Gama
   Roatt, Bruno Mendes
   Oliveira Aguiar-Soares, Rodrigo Dian
   de Almeida Leal, Gleisiane Gomes
   Moreira, Nadia das Dores
   Machado Oliveira, Laser Antonio
   de Menezes Machado, Evandro Marques
   Franco Morais, Maria Helena
   Correa-Oliveira, Rodrigo
   Carneiro, Mariangela
   Reis, Alexandre Barbosa
TI Evaluation of Change in Canine Diagnosis Protocol Adopted by the
   Visceral Leishmaniasis Control Program in Brazil and a New Proposal for
   Diagnosis
SO PLOS ONE
LA English
DT Article
ID ENDEMIC AREA; MINAS-GERAIS; DOGS; INFANTUM; TESTS; SERODIAGNOSIS;
   INFECTIONS; ANTIGENS; HEALTH; COHORT
AB The techniques used for diagnosis of canine visceral leishmaniasis (CVL) in Brazil ELISA and IFAT have been extensively questioned because of the accuracy of these tests. A recent change in the diagnosis protocol excluded IFAT and included the Dual-Path Platform (DPP). We evaluated the prevalence and incidence rates of Leishmania spp. before and after the change in the protocol. In addition, based on our results, we propose a new alternative that is less expensive for the screening and confirmation of CVL. Plasma samples were obtained from a serobank from dogs evaluated in a cross-sectional study (1,226 dogs) and in a cohort study of susceptible animals (n = 447), followed for 26 months. Serology testing was performed using ELISA, IFAT, and DPP. The incidence and prevalence of CVL were determined by using the protocol of the Visceral Leishmaniasis Control and Surveillance Program until 2012 (ELISA and IFAT using filter paper) and the protocol used after 2012 (DPP and ELISA using plasma). The prevalence was 6.2% and the incidence was 2.8 per 1,000 dog-months for the protocol used until 2012. For the new diagnosis protocol for CVL resulted in an incidence of 5.4 per 1,000 dog-months and a prevalence of 8.1%. Our results showed that the prevalence and incidence of infection were far greater than suggested by the previously used protocol and that the magnitude of infection in endemic areas has been underestimated. As tests are performed sequentially and euthanasia of dogs is carried out when the serological results are positive in both tests, the sequence does not affect the number of animals to be eliminated by the Control Program. Then we suggest to municipalities with a large demand of exams to use ELISA for screening and DPP for confirmation, since this allows easier performance and reduced cost.
C1 [Coura-Vital, Wendel; Ker, Henrique Gama; Roatt, Bruno Mendes; Oliveira Aguiar-Soares, Rodrigo Dian; de Almeida Leal, Gleisiane Gomes; Moreira, Nadia das Dores; Machado Oliveira, Laser Antonio; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Lab Pesquisas Clin, Ouro Preto, MG, Brazil.
   [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [Ker, Henrique Gama; Roatt, Bruno Mendes; Oliveira Aguiar-Soares, Rodrigo Dian; de Almeida Leal, Gleisiane Gomes; Moreira, Nadia das Dores; de Menezes Machado, Evandro Marques; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.
   [Franco Morais, Maria Helena] Secretaria Municipal Saude, Belo Horizonte, MG, Brazil.
   [Correa-Oliveira, Rodrigo] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [Correa-Oliveira, Rodrigo; Reis, Alexandre Barbosa] INCTDT, Salvador, BA, Brazil.
RP Reis, AB (corresponding author), Univ Fed Ouro Preto, Escola Farm, Lab Pesquisas Clin, Ouro Preto, MG, Brazil.
EM alexreis@nupeb.ufop.br
RI Roatt, Bruno M/R-5502-2016; de Oliveira Aguiar-Soares, Rodrigo
   Dian/ABB-7973-2020
OI Roatt, Bruno M/0000-0001-5281-3263; de Oliveira Aguiar-Soares, Rodrigo
   Dian/0000-0001-8705-7357; /0000-0002-1434-7676; Correa-Oliveira,
   Rodrigo/0000-0001-6419-9459
FU Federal University of Ouro Preto; Brazilian Ministry of Health;
   DECIT/MS/CNPq/BRNational Council for Scientific and Technological
   Development (CNPq) [576062/2008-1]; FAPEMIG/BRMinas Gerais State
   Research Foundation (FAPEMIG) [CBB-APQ-3073-4.01/07]; CNPq/BRNational
   Council for Scientific and Technological Development (CNPq)
   [472554/2007-7]; PPSUS/MS/CNPq/FAPEMIG/SES-MGNational Council for
   Scientific and Technological Development (CNPq)Minas Gerais State
   Research Foundation (FAPEMIG) [CBB-APQ-00356-10]; FAPEMIG/PPM; PNPD;
   CNPqNational Council for Scientific and Technological Development
   (CNPq); PNPD/CAPESCAPES
FX This study was supported by the following grants: Federal University of
   Ouro Preto; Brazilian Ministry of Health; DECIT/MS/CNPq/BR/grant:
   576062/2008-1; FAPEMIG/BR/grant: CBB-APQ-3073-4.01/07, CNPq/BR/grant:
   472554/2007-7; PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10;
   FAPEMIG/PPM and PNPD/Institutional/2011. The funders had no role in the
   study design, the data collection and analysis, the decision to publish
   the manuscript, or the preparation of the manuscript. ABR, MC, and RCO
   are grateful for CNPq fellowships. WCV is supported by a PNPD/CAPES
   postdoctoral fellowship.
CR Alves AS, 2012, RES VET SCI, V93, P1329, DOI 10.1016/j.rvsc.2012.07.006
   [Anonymous], 2006, MAN VIG CONTR LEISHM
   Barata RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/405083
   CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227
   Malaquias LCC, 2007, PARASITOL RES, V100, P233, DOI 10.1007/s00436-006-0259-z
   Coura-Vital W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071833
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312
   Da Costa RT, 2003, T ROY SOC TROP MED H, V97, P678
   da Silva DA, 2013, VET J, V195, P252, DOI 10.1016/j.tvjl.2012.06.010
   da Silva ES, 2006, VET RES COMMUN, V30, P637, DOI 10.1007/s11259-006-3324-2
   de Arruda MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069988
   do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015
   Falqueto A, 2009, AM J TROP MED HYG, V80, P559, DOI 10.4269/ajtmh.2009.80.559
   Ferreira ED, 2007, VET PARASITOL, V146, P235, DOI 10.1016/j.vetpar.2007.02.015
   Figueiredo FB, 2010, REV INST MED TROP SP, V52, P193, DOI 10.1590/S0036-46652010000400005
   Fraga DBM, 2012, VET PARASITOL, V190, P591, DOI 10.1016/j.vetpar.2012.06.025
   Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005
   Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040
   Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001
   Lira RA, 2006, VET PARASITOL, V137, P11, DOI 10.1016/j.vetpar.2005.12.020
   Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484
   Marcondes M, 2013, VET PARASITOL, V197, P649, DOI 10.1016/j.vetpar.2013.07.013
   Ministerio da Saude, 2011, 012011CGDTCGLABDEVIT
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004
   Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI [10.1590/S0037-86822011005000014, 10.1590/s0037-86822011005000014]
   Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005
   Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06
   Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363
   Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Romero HD, 2009, AM J TROP MED HYG, V81, P27
   Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4
   Silva DA, 2011, VET PARASITOL, V179, P257, DOI 10.1016/j.vetpar.2011.01.048
   WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
NR 36
TC 39
Z9 40
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2014
VL 9
IS 3
AR e91009
DI 10.1371/journal.pone.0091009
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC4IY
UT WOS:000332485800079
PM 24608904
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Negrao-Correa, D
   Fittipaldi, JF
   Lambertucci, JR
   Teixeira, MM
   Antunes, CMD
   Carneiro, M
AF Negrao-Correa, Deborah
   Fittipaldi, Juliana F.
   Lambertucci, Jose Roberto
   Teixeira, Mauro Martins
   de Figueiredo Antunes, Carlos Mauricio
   Carneiro, Mariangela
TI Association of Schistosoma mansoni-Specific IgG and IgE Antibody
   Production and Clinical Schistosomiasis Status in a Rural Area of Minas
   Gerais, Brazil
SO PLOS ONE
LA English
DT Article
ID MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; ADULT WORM ANTIGENS;
   HEPATIC-FIBROSIS; PERIPORTAL FIBROSIS; IMMUNOGLOBULIN-E; ENDEMIC AREA;
   GRANULOMATOUS INFLAMMATION; ISOTYPE RESPONSES; LIVER PATHOLOGY;
   DOWN-REGULATION
AB Background: Studies in murine models and human populations have indicated that the collagen-rich granulomatous response against parasite eggs trapped in the liver is associated with the development of severe hepatosplenic schistosomiasis, characterized by periportal fibrosis and portal hypertension. The role of the humoral response in parasite susceptibility has been well established, but its participation in disease severity remains poorly understood. In this work, we evaluated the relationship between parasite-reactive IgE and IgG levels and schistosomiasis morbidity in infected patients with similar parasite burdens.
   Methodology/Principal Findings: Ninety-seven Schistosoma mansoni-infected individuals were subjected to clinical examination and abdominal ultrasound analysis. IgG reactivity and IgE concentration against Schistosoma mansoni soluble egg antigens (SEA) and adult worm antigen preparation (SWAP) were evaluated by ELISA assay. Multivariable linear regression models were used to evaluate the relationship between parasite-reactive antibodies and the co-variables investigated. The study population showed low parasite burden (median 30 eggs/g feces), constant re-infection, and signs of fibrosis was detected in more than 30% of individuals. Most infected individuals showed IgG reactivity, and the median concentrations of IgE anti-SEA and anti-SWAP antibodies were 1,870 and 1,375 ng/mL, respectively. There was no association between parasite burden and antibody response or any parameter of disease severity. However, IgG anti-SWAP level was positively associated with morbidity parameters, such as spleen size and thickness of portal vein at the entrance and secondary branch. In contrast, the data also revealed independent inverse correlations between concentration of parasite-reactive IgE and gallbladder wall thickness, a marker of fibrosis in schistosomiasis.
   Conclusions/Significance: The data indicate that IgG anti-SWAP is positively associated with severe schistosomiasis, independently of parasite burden, while high production of parasite-specific IgE is associated with mild disease in the human population. Antibody profiles are good correlates for schistosomiasis severity and could be tested as biomarkers of disease severity.
C1 [Negrao-Correa, Deborah; Fittipaldi, Juliana F.; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Programa Posgrad Parasitol, Belo Horizonte, MG, Brazil.
   [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Lambertucci, Jose Roberto; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
   [de Figueiredo Antunes, Carlos Mauricio] Santa Casa Belo Horizonte, Inst Ensino & Pesquisa, Belo Horizonte, MG, Brazil.
RP Negrao-Correa, D (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Programa Posgrad Parasitol, Belo Horizonte, MG, Brazil.
EM denegrao@icb.ufmg.br
RI Teixeira, Mauro M/A-4587-2008
OI Teixeira, Mauro M/0000-0002-6944-3008
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG (Minas
   Gerais State Foundation for Scientifical Research); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for
   the Scientific and Technological Development
FX The experimental work was partially supported by Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais - FAPEMIG (Minas Gerais State
   Foundation for Scientifical Research) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for
   the Scientific and Technological Development. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x
   Abath FGC, 2006, TRENDS PARASITOL, V22, P85, DOI 10.1016/j.pt.2005.12.004
   Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x
   Andrade ZA, 2008, ACTA TROP, V108, P79, DOI 10.1016/j.actatropica.2008.04.003
   Bina José Carlos, 2003, Rev. Soc. Bras. Med. Trop., V36, P211, DOI 10.1590/S0037-86822003000200003
   Black CL, 2010, J INFECT DIS, V202, P399, DOI 10.1086/653828
   Bonnard P, 2004, AM J TROP MED HYG, V71, P202, DOI 10.4269/ajtmh.2004.71.202
   Booth M, 2004, J IMMUNOL, V172, P1295, DOI 10.4049/jimmunol.172.2.1295
   Caldas IR, 2000, AM J TROP MED HYG, V62, P57, DOI 10.4269/ajtmh.2000.62.57
   CHEEVER AW, 1967, T ROY SOC TROP MED H, V61, P626, DOI 10.1016/0035-9203(67)90125-3
   CHEEVER AW, 1992, MEM I OSWALDO CRUZ, V87, P337, DOI 10.1590/S0074-02761992000800054
   Cheever AW, 1998, MEM I OSWALDO CRUZ, V93, P25, DOI 10.1590/S0074-02761998000700004
   Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325
   Coutinho HM, 2007, J INFECT DIS, V195, P288, DOI 10.1086/510313
   de Jesus AR, 2004, INFECT IMMUN, V72, P3391, DOI 10.1128/IAI.72.6.3391-3397.2004
   DUNNE DW, 1992, EUR J IMMUNOL, V22, P1483, DOI 10.1002/eji.1830220622
   DUNNE DW, 1992, MEM I OSWALDO CRUZ, V87, P99, DOI 10.1590/S0074-02761992000800014
   Fairfax KC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002490
   Falcao PL, 2002, J INFECT DIS, V186, P1696, DOI 10.1086/345370
   Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585
   Figueiredo JP, 2012, PARASITE IMMUNOL, V34, P604, DOI 10.1111/pim.12001
   Grogan JL, 1996, J INFECT DIS, V173, P1242, DOI 10.1093/infdis/173.5.1242
   Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3
   Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004
   HAGAN P, 1991, NATURE, V349, P243, DOI 10.1038/349243a0
   Henri S, 2002, J IMMUNOL, V169, P929, DOI 10.4049/jimmunol.169.2.929
   Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214
   HOMEIDA M, 1988, AM J TROP MED HYG, V39, P196, DOI 10.4269/ajtmh.1988.39.196
   Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261
   Jankovic D, 1999, J IMMUNOL, V163, P337
   Jankovic D, 1997, J IMMUNOL, V159, P1868
   Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619
   Jiz M, 2009, INFECT IMMUN, V77, P2051, DOI 10.1128/IAI.00012-09
   Kabatereine NB, 1999, PARASITOLOGY, V118, P101, DOI 10.1017/S0031182098003576
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   King CL, 1997, J IMMUNOL, V158, P294
   Lambertucci JR, 2001, MEM I OSWALDO CRUZ, V96, P147, DOI 10.1590/S0074-02762001000900022
   MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0
   Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x
   Mohamed-Ali Q, 1999, J INFECT DIS, V180, P1298, DOI 10.1086/314999
   Mutapi F, 2011, PARASITE IMMUNOL, V33, P181, DOI 10.1111/j.1365-3024.2010.01270.x
   Naus CWA, 1999, INFECT IMMUN, V67, P3444, DOI 10.1128/IAI.67.7.3444-3451.1999
   Naus CWA, 2003, TROP MED INT HEALTH, V8, P561, DOI 10.1046/j.1365-3156.2003.01056.x
   Negrao-Correa D, 1999, PARASITE IMMUNOL, V21, P287, DOI 10.1046/j.1365-3024.1999.00219.x
   Oliveira LFA, 2006, INFECT IMMUN, V74, P1215, DOI 10.1128/IAI.74.2.1215-1221.2006
   Oliveira RR, 2012, AM J TROP MED HYG, V86, P296, DOI 10.4269/ajtmh.2012.11-0204
   Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843
   PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159
   Pellegrino J, 1956, REV BRAS MALARIOL DO, V8, P585
   Polman K, 2002, ANN TROP MED PARASIT, V96, P679, DOI 10.1179/000349802125001708
   Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544
   Rezende SA, 1997, MEM I OSWALDO CRUZ, V92, P683, DOI 10.1590/S0074-02761997000500023
   Richter J, 2001, MEM I OSWALDO CRUZ, V96, P151, DOI 10.1590/S0074-02762001000900023
   Richter J., 2000, WHOTDRSTRSCH001
   RIHET P, 1991, EUR J IMMUNOL, V21, P2679, DOI 10.1002/eji.1830211106
   RIHET P, 1992, EUR J IMMUNOL, V22, P2063, DOI 10.1002/eji.1830220816
   Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718
   Silveira AMS, 2002, AM J TROP MED HYG, V66, P542
   Souza ALS, 2005, INFECT IMMUN, V73, P2515, DOI 10.1128/IAI.73.4.2515-2523.2005
   Stavitsky AB, 2004, INFECT IMMUN, V72, P1, DOI 10.1128/IAI.72.1.1-12.2004
   Tawfeek Gihan M., 2003, Journal of the Egyptian Society of Parasitology, V33, P597
   Vennervald BJ, 2004, CURR OPIN INFECT DIS, V17, P439, DOI 10.1097/00001432-200410000-00009
   Walter K, 2006, J IMMUNOL, V177, P5490, DOI 10.4049/jimmunol.177.8.5490
   Webster M, 1997, PARASITE IMMUNOL, V19, P333, DOI 10.1046/j.1365-3024.1997.d01-211.x
   WEINSTOCK JV, 1983, J IMMUNOL, V130, P423
   Wilson MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002171
   Wynn TA, 1998, J IMMUNOL, V160, P4473
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
NR 68
TC 15
Z9 15
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 4
PY 2014
VL 9
IS 2
AR e88042
DI 10.1371/journal.pone.0088042
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6GY
UT WOS:000336971300043
PM 24505371
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Coura-Vital, W
   Reis, AB
   Reis, LES
   Braga, SL
   Roatt, BM
   Aguiar-Soares, RDDO
   Marques, MJ
   Veloso, VM
   Carneiro, M
AF Coura-Vital, Wendel
   Reis, Alexandre Barbosa
   Soares Reis, Levi Eduardo
   Braga, Samuel Leoncio
   Roatt, Bruno Mendes
   de Oliveira Aguiar-Soares, Rodrigo Dian
   Marques, Marcos Jose
   Veloso, Vanja Maria
   Carneiro, Mariangela
TI Canine visceral leishmaniasis: Incidence and risk factors for infection
   in a cohort study in Brazil
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Risk factors; Incidence; Canine visceral leishmaniasis; Leishmania
   infantum; Cohort study; PCR-RFLP
ID AMERICAN CUTANEOUS LEISHMANIASIS; INFANTUM INFECTION; VIANNIA
   BRAZILIENSIS; MINAS-GERAIS; ENDEMIC AREA; PCR METHODS; NESTED-PCR; DOGS;
   DIAGNOSIS; STATE
AB Zoonotic visceral leishmaniasis in Brazil is caused by Leishmania infantum parasites and is transmitted by sand flies of the Phlebotominae family. Dogs are the main urban reservoirs and represent the major source of contagion for the vectors. Studies have shown that most infected dogs are polymerase chain reaction-positive months before seroconversion. Herein, we describe a cohort study designed to identify the incidence of and risk factors for L. infantum infection as detected by polymerase chain reaction-restriction fragment length polymorphism. To determine the risk factors for infection, we conducted a baseline canine survey (n = 1443) from which dogs were selected for the cohort study (n = 282) involving three evaluations over the course of a 26-month follow-up period. Serology, molecular tests, and a structured questionnaire were used. The risk factors for infection were identified by means of the Cox regression model. The overall infection incidence was 5.8 per 100 dog-months (95% confidence interval 5.1-6.5). Increased risk of infection was associated with the presence of previous cases of canine visceral leishmaniasis in the domiciles (hazard ratio [HR] 1.4; 95% confidence interval [CI] 1.1-1.8) and unplastered house walls (HR 3.6; 95% CI 1.6-8.1). These risk factors suggest that insecticide spraying in cracks and crevices in unplastered walls can reduce biting rates within and around homes. Furthermore, our results demonstrate that the Visceral Leishmaniasis Control and Surveillance Program should adopt environmental management measures in homes with previous cases of canine visceral leishmaniasis, because these homes are more likely to maintain the transmission cycle. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Ciencias Saude Infectol & Med Trop, BR-30130100 Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel; Reis, Alexandre Barbosa; Soares Reis, Levi Eduardo; Braga, Samuel Leoncio; Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Veloso, Vanja Maria] Univ Fed Ouro Preto, Escola Farm, Lab Pesquisas Clin, BR-35400000 Ouro Preto, MG, Brazil.
   [Reis, Alexandre Barbosa; Soares Reis, Levi Eduardo; Braga, Samuel Leoncio; Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Nucleo Pesquisas Ciencias Biol, Lab Imunopatol, BR-35400000 Ouro Preto, MG, Brazil.
   [Marques, Marcos Jose] Univ Fed Alfenas, Dept Ciencias Biol, Lab Parasitol Basica, BR-37130000 Alfenas, MG, Brazil.
   [Coura-Vital, Wendel; Reis, Alexandre Barbosa; Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian] Inst Nacl Ciencia & Tecnol Doencas Tropicais, Salvador, BA, Brazil.
RP Coura-Vital, W (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Campus Pampulha,Ave Antonio Carlos,6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM wendelcoura@gmail.com
RI Marques, Marcos Jose/G-8384-2012; Roatt, Bruno M/R-5502-2016; de
   Oliveira Aguiar-Soares, Rodrigo Dian/ABB-7973-2020
OI Roatt, Bruno M/0000-0001-5281-3263; de Oliveira Aguiar-Soares, Rodrigo
   Dian/0000-0001-8705-7357; de Oliveira Aguiar Soares, Rodrigo
   Dian/0000-0002-3390-7990; /0000-0002-1434-7676
FU PNPD; DECIT/MS/CNPq/BRNational Council for Scientific and Technological
   Development (CNPq) [57 6062/2008-1]; FAPEMIG/BRMinas Gerais State
   Research Foundation (FAPEMIG) [CBB-APQ-3073-4.01/07]; CNPq/BRNational
   Council for Scientific and Technological Development (CNPq)
   [472554/2007-7]; PPSUS/MS/ CNPq/ FAPEMIG/ SES-MGNational Council for
   Scientific and Technological Development (CNPq)Minas Gerais State
   Research Foundation (FAPEMIG) [CBB-APQ-00356-10]; FAPEMIG/ PPM; Federal
   University of Ouro Preto; CNPqNational Council for Scientific and
   Technological Development (CNPq); PNPD/CAPESCAPES
FX This study was supported by the following grants:
   PNPD/Institutional/2011, DECIT/MS/CNPq/BR/grant: 57 6062/2008-1;
   FAPEMIG/BR/grant: CBB-APQ-3073-4.01/07, CNPq/BR/grant: 472554/2007-7;
   PPSUS/MS/ CNPq/ FAPEMIG/ SES-MG/grant CBB-APQ-00356-10; FAPEMIG/ PPM and
   Federal University of Ouro Preto. The funders had no role in study
   design, data collection or analysis, the decision to publish, or the
   preparation of the manuscript. ABR and MC are grateful for CNPq
   fellowships, and WCV is grateful to the PNPD/CAPES fellowships. We also
   thank the staff of the Secretaria Municipal de Safide de Belo Horizonte,
   Minas Gerais, for cooperation, logistical support, and special
   dedication to-this work.
CR Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001
   Belo VS, 2013, VET PARASITOL, V195, P1, DOI 10.1016/j.vetpar.2013.03.010
   Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184
   Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748
   Cortes S, 2012, VET PARASITOL, V189, P189, DOI 10.1016/j.vetpar.2012.04.028
   Costa CHN, 2005, ANN TROP MED PARASIT, V99, P229, DOI 10.1179/136485905X28018
   Coura-Vital W, 2011, Vet J, V190, pe43, DOI 10.1016/j.tvjl.2011.04.005
   Coura-Vital W., 2013, PLOS ONE IN PRESS, DOI DOI 10.1371/J0URNAL.P0NE.0071833
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   da Silva JP, 2012, REV SOC BRAS MED TRO, V45, P480, DOI 10.1590/s0037-86822012005000009
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P531, DOI 10.1016/j.pt.2012.08.007
   DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   Dereure J, 2009, VECTOR-BORNE ZOONOT, V9, P687, DOI 10.1089/vbz.2008.0126
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   Di Muccio T, 2012, J CLIN MICROBIOL, V50, P2651, DOI 10.1128/JCM.00558-12
   Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5
   Galvez R, 2010, VET PARASITOL, V169, P327, DOI 10.1016/j.vetpar.2009.11.025
   Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2
   Lachaud L, 2002, PARASITOLOGY, V125, P197, DOI 10.1017/S0031182002002081
   Lachaud L, 2002, J CLIN MICROBIOL, V40, P210, DOI 10.1128/JCM.40.1.210-215.2002
   Manna L, 2004, VET PARASITOL, V125, P251, DOI 10.1016/j.vetpar.2004.07.019
   Martinez V, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-57
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4
   Nunes CM, 2010, VET PARASITOL, V170, P131, DOI 10.1016/j.vetpar.2010.01.044
   Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006
   Oliveira CD, 2006, REV PANAM SALUD PUBL, V20, P369, DOI 10.1590/S1020-49892006001100002
   Oliveira CDL, 2008, CAD SAUDE PUBLICA, V24, P2953, DOI 10.1590/S0102-311X2008001200026
   Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510
   de Almeida ADPF, 2009, REV SOC BRAS MED TRO, V42, P156, DOI 10.1590/S0037-86822009000200012
   Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4
   PBH, 2007, INF LEISHM 2005 2007
   Petersen CA, 2009, TOP COMPANION ANIM M, V24, P182, DOI 10.1053/j.tcam.2009.06.006
   Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363
   Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022
   Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008
   Wang JY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-69
   Werneck GL, 2007, EPIDEMIOL INFECT, V135, P195, DOI 10.1017/S0950268806006881
NR 41
TC 19
Z9 19
U1 1
U2 17
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD NOV 8
PY 2013
VL 197
IS 3-4
BP 411
EP 417
DI 10.1016/j.vetpar.2013.07.031
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA 266GD
UT WOS:000328010500001
PM 23941965
OA Green Published
DA 2020-12-08
ER

PT J
AU Reis, LES
   Coura-Vital, W
   Roatt, BM
   Bouillet, LEM
   Ker, HG
   de Brito, RCF
   Resende, DD
   Carneiro, M
   Giunchetti, RC
   Marques, MJ
   Carneiro, CM
   Reis, AB
AF Soares Reis, Levi Eduardo
   Coura-Vital, Wendel
   Roatt, Bruno Mendes
   Maduro Bouillet, Leoneide Erica
   Ker, Henrique Gama
   Fortes de Brito, Rory Cristiane
   Resende, Daniela de Melo
   Carneiro, Mariangela
   Giunchetti, Rodolfo Cordeiro
   Marques, Marcos Jose
   Carneiro, Claudia Martins
   Reis, Alexandre Barbosa
TI Molecular diagnosis of canine visceral leishmaniasis: A. comparative
   study of three methods using skin and spleen from dogs with natural
   Leishmania infantum infection
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Leishmania infantum; Molecular diagnostic; PCR; qPCR; snPCR; Skin;
   Spleen; Canine visceral leishmaniasis
ID REAL-TIME PCR; IMMUNE-RESPONSE; CLINICAL SIGNS; RFLP; DNA
AB Polymerase chain reaction (PCR) and its variations represent highly sensitive and specific methods for Leishmania DNA detection and subsequent canine visceral leishmaniasis (CVL) diagnosis. The aim of this work was to compare three different molecular diagnosis techniques (conventional PCR [cPCR], seminested PCR [snPCR], and quantitative PCR [qPCR]) in samples of skin and spleen from 60 seropositive dogs by immunofluorescence antibody test and enzyme-linked immunosorbent assay. Parasitological analysis was conducted by culture of bone marrow aspirate and optical microscopic assessment of ear skin and spleen samples stained with Giemsa, the standard tests for CVL diagnosis. The primers L150/L152 and LINR4/LIN17/LIN19 were used to amplify the conserved region of the Leishmania kDNA minicircle in the cPCR, and snPCR and qPCR were performed using the DNA polymerase gene (DNA pol alpha) primers from Leishmania infantum. The parasitological analysis revealed parasites in 61.7% of the samples. Sensitivities were 89.2%, 86.5%, and 973% in the skin and 81.1%, 94.6%, and 100.0% in spleen samples used for cPCR, snPCR, and qPCR, respectively. We demonstrated that the qPCR method was the best technique to detect L infantum in both skin and spleen samples. However, we recommend the use of skin due to the high sensitivity and sampling being less invasive. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Soares Reis, Levi Eduardo; Coura-Vital, Wendel; Maduro Bouillet, Leoneide Erica; Ker, Henrique Gama; Fortes de Brito, Rory Cristiane; Resende, Daniela de Melo; Carneiro, Claudia Martins; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Programa Posgrad Ciencias Farmaceut CiPharma, Lab Pesquisas Clin, Ouro Preto, MG, Brazil.
   [Roatt, Bruno Mendes; Carneiro, Claudia Martins; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil.
   [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [Giunchetti, Rodolfo Cordeiro] Univ Fed Minas Gerais, Dept Biol Celular, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil.
   [Marques, Marcos Jose] Univ Fed Alfenas, Dept Ciencias Biol, Lab Parasitol Basica, Alfenas, MG, Brazil.
   [Soares Reis, Levi Eduardo; Coura-Vital, Wendel; Roatt, Bruno Mendes; Reis, Alexandre Barbosa] CNPq, INCT DT, Inst Nacl Ciencia & Tecnol Doencas Tropicais, Brasilia, DF, Brazil.
RP Reis, AB (corresponding author), Univ Fed Ouro Preto, Escola Farm, Programa Posgrad Ciencias Farmaceut CiPharma, Lab Pesquisas Clin, Ouro Preto, MG, Brazil.
EM alexreis@nupeb.ufop.br
RI Giunchetti, Rodolfo/O-9878-2014; Marques, Marcos Jose/G-8384-2012;
   carneiro, Claudia Martins/AAP-4455-2020; Resende, Daniela M/E-7476-2011;
   De Brito, Rory Cristiane Fortes/AAD-9950-2019; Roatt, Bruno
   M/R-5502-2016; De Brito, Rory C. F./N-3147-2018; carneiro, claudia
   m/B-6205-2013
OI carneiro, Claudia Martins/0000-0002-6002-857X; Resende, Daniela
   M/0000-0002-5139-3022; De Brito, Rory Cristiane
   Fortes/0000-0002-7591-5331; Roatt, Bruno M/0000-0001-5281-3263; De
   Brito, Rory C. F./0000-0002-7591-5331; Cordeiro Giunchetti,
   Rodolfo/0000-0003-4181-7546; /0000-0002-1434-7676
FU DECIT/MS/CNPq/BRNational Council for Scientific and Technological
   Development (CNPq) [576062/2008-1]; FAPEMIG/BRMinas Gerais State
   Research Foundation (FAPEMIG) [CBB - APQ-3073-4.01/07]; CNPq/BRNational
   Council for Scientific and Technological Development (CNPq)
   [472554/2007-7]; PPSUS/MS/CNPq/FAPEMIG/SES-MGNational Council for
   Scientific and Technological Development (CNPq)Minas Gerais State
   Research Foundation (FAPEMIG) [CBB-APQ-00356-10]; Federal University of
   Ouro Preto; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); CAPES/PNPDCAPES
FX This study was supported by the DECIT/MS/CNPq/BR/grant: 576062/2008-1,
   FAPEMIG/BR/grant: CBB - APQ-3073-4.01/07, CNPq/BR/grant: 472554/2007-7,
   PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10 and Federal
   University of Ouro Preto. A.B.R., M.C., C.M.C. and R.C.G. thank Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and W.C.V.,
   L.E.M.B and D.M.R. thank CAPES/PNPD for fellowships. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X
   Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020
   Aransay AM, 2000, APPL ENVIRON MICROB, V66, P1933, DOI 10.1128/AEM.66.5.1933-1938.2000
   Barrouin-Melo SM, 2004, MEM I OSWALDO CRUZ, V99, P195, DOI 10.1590/S0074-02762004000200014
   Belinchon-Lorenzo S, 2013, VET PARASITOL, V192, P43, DOI 10.1016/j.vetpar.2012.11.007
   Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   de Andrade HM, 2006, VET PARASITOL, V140, P231, DOI 10.1016/j.vetpar.2006.03.031
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   Demeke T, 2010, ANAL BIOANAL CHEM, V396, P1977, DOI 10.1007/s00216-009-3150-9
   Ferreira SD, 2008, VET PARASITOL, V152, P257, DOI 10.1016/j.vetpar.2007.12.022
   Ferreira SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001596
   Ferreira SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002150
   Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011
   Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005
   Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001
   KEENAN CM, 1984, VET PATHOL, V21, P80, DOI 10.1177/030098588402100114
   Lachaud L, 2002, PARASITOLOGY, V125, P197, DOI 10.1017/S0031182002002081
   LAINSON R, 1978, NATURE, V273, P595, DOI 10.1038/273595a0
   LEVEILLE R, 1993, J AM VET MED ASSOC, V203, P413
   Maia C, 2008, VET PARASITOL, V158, P274, DOI 10.1016/j.vetpar.2008.07.028
   Maia C, 2009, VET J, V179, P142, DOI 10.1016/j.tvjl.2007.08.009
   Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009
   Manzillo VF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002225
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004
   Mortarino M., 2004, Parassitologia (Rome), V46, P163
   Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002
   Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006
   Quaresma PF, 2009, ACTA TROP, V111, P289, DOI 10.1016/j.actatropica.2009.05.008
   Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307
   Rodriguez-Cortes A, 2007, INT J PARASITOL, V37, P683, DOI 10.1016/j.ijpara.2006.11.007
   Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022
   Solca MD, 2012, VET PARASITOL, V184, P133, DOI 10.1016/j.vetpar.2011.08.026
   Neto RGT, 2010, VET PARASITOL, V169, P248, DOI 10.1016/j.vetpar.2010.01.023
   TRYPHONAS L, 1977, CAN J COMP MED, V41, P1
   Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008
   Watson AT, 2011, VET RADIOL ULTRASOUN, V52, P317, DOI 10.1111/j.1740-8261.2010.01778.x
NR 38
TC 29
Z9 29
U1 1
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD NOV 8
PY 2013
VL 197
IS 3-4
BP 498
EP 503
DI 10.1016/j.vetpar.2013.07.006
PG 6
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA 266GD
UT WOS:000328010500011
PM 23953760
OA Green Published
DA 2020-12-08
ER

PT J
AU de Araujo, VEM
   Pinheiro, LC
   Almeida, MCD
   de Menezes, FC
   Morais, MHF
   Reis, IA
   Assuncao, RM
   Carneiro, M
AF Miranda de Araujo, Valdelaine Etelvina
   Pinheiro, Leticia Cavalari
   de Mattos Almeida, Maria Cristina
   de Menezes, Fernanda Carvalho
   Franco Morais, Maria Helena
   Reis, Ilka Afonso
   Assuncao, Renato Martins
   Carneiro, Mariangela
TI Relative Risk of Visceral Leishmaniasis in Brazil: A Spatial Analysis in
   Urban Area
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID KALA-AZAR; PIAUI STATE; TERESINA; IDENTIFICATION; TRANSMISSION;
   INFECTION; INFANTUM; DISEASE; DOGS
AB Background: Visceral leishmaniasis (VL) is a vector-borne disease whose factors involved in transmission are poorly understood, especially in more urban and densely populated counties. In Brazil, the VL urbanization is a challenge for the control program. The goals were to identify the greater risk areas for human VL and the risk factors involved in transmission.
   Methodology: This is an ecological study on the relative risk of human VL. Spatial units of analysis were the coverage areas of the Basic Health Units (146 small-areas) of Belo Horizonte, Minas Gerais State, Brazil. Human VL cases, from 2007 to 2009 (n = 412), were obtained in the Brazilian Reportable Disease Information System. Bayesian approach was used to model the relative risk of VL including potential risk factors involved in transmission (canine infection, socioeconomic and environmental features) and to identify the small-areas of greater risk to human VL.
   Principal Findings: The relative risk of VL was shown to be correlated with income, education, and the number of infected dogs per inhabitants. The estimates of relative risk of VL were higher than 1.0 in 54% of the areas (79/146). The spatial modeling highlighted 14 areas with the highest relative risk of VL and 12 of them are concentrated in the northern region of the city.
   Conclusions: The spatial analysis used in this study is useful for the identification of small-areas according to risk of human VL and presents operational applicability in control and surveillance program in an urban environment with an unequal spatial distribution of the disease. Thus the frequent monitoring of relative risk of human VL in small-areas is important to direct and prioritize the actions of the control program in urban environment, especially in big cities.
C1 [Miranda de Araujo, Valdelaine Etelvina; Franco Morais, Maria Helena; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [Miranda de Araujo, Valdelaine Etelvina; de Mattos Almeida, Maria Cristina; de Menezes, Fernanda Carvalho; Franco Morais, Maria Helena] Secretaria Municipal Saude, Prefeitura Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Pinheiro, Leticia Cavalari; Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil.
   [Pinheiro, Leticia Cavalari] Fundacao Oswaldo Cruz, Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil.
   [Assuncao, Renato Martins] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Ciencia Comp, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
RP de Araujo, VEM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Reis, Ilka Afonso/AAG-8007-2019
OI Reis, Ilka Afonso/0000-0001-7199-8590
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq); Brazilian Ministry of
   Health-Department of Science and Technology (Decit/MS) [576062/2008-1];
   Foundation for Research Support of the State of Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Brazilian
   Ministry of Health; State Department of Health of Minas Gerais (SES-MG);
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [CDS-APQ-00343-10]; Pro-Reitoria de Pesquisa da Universidade Federal de
   Minas Gerais
FX This work was supported by the Brazilian National Research Council
   (CNPq) and Brazilian Ministry of Health-Department of Science and
   Technology (Decit/MS) (576062/2008-1). Additional funding was provided
   by the Foundation for Research Support of the State of Minas Gerais
   (FAPEMIG), Brazilian Ministry of Health, State Department of Health of
   Minas Gerais (SES-MG) and CNPq (CDS-APQ-00343-10). This publication was
   supported by the Pro-Reitoria de Pesquisa da Universidade Federal de
   Minas Gerais. MC and RMA are Research Fellows from the CNPq and FAPEMIG.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213
   Assuncao R M, 1998, Cad Saude Publica, V14, P713, DOI 10.1590/S0102-311X1998000400013
   Assuncao RM, 2001, STAT MED, V20, P2319, DOI 10.1002/sim.844
   BERNARDINELLI L, 1992, STAT MED, V11, P983, DOI 10.1002/sim.4780110802
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Bhunia GS, 2010, ANN TROP MED PARASIT, V104, P35, DOI 10.1179/136485910X12607012373678
   Brazil, 2010, CENS DEM BRAS
   Caiaffa Waleska Teixeira, 2005, Cad. Saúde Pública, V21, P958, DOI 10.1590/S0102-311X2005000300032
   Camargo-Neves V L, 2001, Cad Saude Publica, V17, P1263
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312
   de Almeida AS, 2011, AM J TROP MED HYG, V84, P681, DOI 10.4269/ajtmh.2011.10-0325
   de Resende MC, 2006, REV SOC BRAS MED TRO, V39, P51, DOI 10.1590/S0037-86822006000100010
   Elnaiem DEA, 2003, AM J TROP MED HYG, V68, P10, DOI 10.4269/ajtmh.2003.68.1.0680010
   Gavgani ASM, 2002, AM J TROP MED HYG, V67, P511, DOI 10.4269/ajtmh.2002.67.511
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   Hay SI, 1996, ANN TROP MED PARASIT, V90, P1
   Khanal B, 2010, PARASITOLOGY, V137, P1597, DOI 10.1017/S0031182010000521
   Koopman JS, 2005, EPIDEMIOLOGY, V16, P621, DOI 10.1097/01.ede.0000172133.46385.18
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Margonari C, 2006, MEM I OSWALDO CRUZ, V101, P31, DOI 10.1590/S0074-02762006000100007
   Marshall RM, 1991, APPL STAT-J ROY ST C, V40, P283
   Neto JC, 2009, CAD SAUDE PUBLICA, V25, P1543, DOI 10.1590/S0102-311X2009000700012
   Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023
   Oliveira CD, 2006, REV PANAM SALUD PUBL, V20, P369, DOI 10.1590/S1020-49892006001100002
   Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Saraiva L, 2011, ACTA TROP, V117, P137, DOI 10.1016/j.actatropica.2010.11.007
   Szklo M., 2007, EPIDEMIOLOGY BASICS
   Werneck GL, 2007, EPIDEMIOL INFECT, V135, P195, DOI 10.1017/S0950268806006881
   Werneck GL, 2002, EPIDEMIOLOGY, V13, P364, DOI 10.1097/00001648-200205000-00020
   Werneck Guilherme L., 2002, Cad. Saúde Pública, V18, P633, DOI [10.1590/S0102-311X2002000300012, 10.1590/S0102-311X2002000300007]
   WHO, 2010, 1 WHO
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   Zimmermann S, 2009, PROTIST, V160, P151, DOI 10.1016/j.protis.2008.12.001
NR 35
TC 47
Z9 47
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2013
VL 7
IS 11
AR e2540
DI 10.1371/journal.pntd.0002540
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 299EM
UT WOS:000330378400025
PM 24244776
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Coura-Vital, W
   Reis, AB
   Fausto, MA
   Leal, GGD
   Marques, MJ
   Veloso, VM
   Carneiro, M
AF Coura-Vital, Wendel
   Reis, Alexandre Barbosa
   Fausto, Maria Arlene
   de Almeida Leal, Gleisiane Gomes
   Marques, Marcos Jose
   Veloso, Vanja Maria
   Carneiro, Mariangela
TI Risk Factors for Seroconversion by Leishmania infantum in a Cohort of
   Dogs from an Endemic Area of Brazil
SO PLOS ONE
LA English
DT Article
ID CANINE VISCERAL LEISHMANIASIS; PHLEBOTOMINE SAND FLIES; HIGH
   TRANSMISSION; PARASITE DENSITY; IMMUNE-RESPONSE; MINAS-GERAIS; VACCINE;
   INFECTION; STATE; PCR
AB Visceral leishmaniasis (VL) has recently emerged in various urban and peri-urban areas of Brazil and other countries. Understanding the urbanization of VL requires identification of risk factors associated with human and canine infection. To determine the predictors of risk for canine VL, a survey was conducted of 1,443 dogs, from which a cohort was selected (n = 455) and evaluated for approximately 26 months. Serology was conducted with two enzyme-linked immunosorbent assays (ELISA): one conducted in the Laboratory of Zoonosis of the Belo Horizonte Health Department (LZOON) and the other in the Laboratory of Immunopathology of the Federal University of Ouro Preto (LIMP). A molecular diagnostic method (PCR-restriction fragment length polymorphism) and a structured questionnaire were also used. To identify the factors associated with seroconversion, two time-dependent Cox regression models were performed with different sensitivities (model 1, seroconversion by ELISA/LZOON; model 2, seroconversion by ELISA/LIMP). The overall incidences of seroconversion were 6.5/1000 dogs-months and 11.2/1000 dogs-months for ELISA/LZOON and ELISA/LIMP, respectively. Increased risk of seroconversion was associated with short fur (model 1: hazard ratio [HR] 1.9), the presence of dry leaves (model 1: HR 2.8) or manure (model 1: HR 3.5) in the backyard, dogs sleeping predominantly in the backyard (model 2: HR 2.1), the presence of symptoms (model 2: HR 2.0), and positive molecular results during follow-up (model 2: HR 1.5). Decreased risk was associated with insecticide spraying in the house (model 2: HR 0.5). These results indicate that more-vulnerable domiciles, certain dog behaviors, lack of vector control measures, and positive molecular results were associated with the occurrence of canine VL. Furthermore, it is important to emphasize that PCR-positive dogs should be monitored, owing to the possibility of seroconversion. Identifying risk factors for seroconversion in dogs is crucial for developing adequate strategies for VL prevention and control.
C1 [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel; Reis, Alexandre Barbosa; de Almeida Leal, Gleisiane Gomes] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.
   [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, Ouro Preto, MG, Brazil.
   [Marques, Marcos Jose] Univ Fed Alfenas, Dept Ciencias Biol, Alfenas, MG, Brazil.
   [Veloso, Vanja Maria] Univ Fed Ouro Preto, Escola Farm, Dept Farm, Ouro Preto, MG, Brazil.
RP Coura-Vital, W (corresponding author), Univ Fed Minas Gerais, Fac Med, Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil.
EM wendelcoura@gmail.com
RI Marques, Marcos Jose/G-8384-2012
OI /0000-0002-1434-7676
FU CAPES/PNPD grant [23038.007183/2011-23]; DECIT/MS/CNPq/BR/grant
   [576062/2008-1]; FAPEMIG/BR/grant [CBB - APQ-3073-4.01/07];
   CNPq/BR/grant [472554/2007-7]; PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant
   [CBB-APQ-00356-10]; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPES/PNPDCAPES
FX This study was supported by the CAPES/PNPD grant 23038.007183/2011-23,
   DECIT/MS/CNPq/BR/grant 576062/2008-1, FAPEMIG/BR/grant CBB -
   APQ-3073-4.01/07, CNPq/BR/grant 472554/2007-7 and
   PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. ABR and MC are grateful by the CNPq
   fellowships and WCV by CNPq and CAPES/PNPD fellowships.
CR [Anonymous], 2006, MAN VIG CONTR LEISHM
   Barbosa-de-Deus R, 2002, CLIN DIAGN LAB IMMUN, V9, P1361, DOI 10.1128/CDLI.9.6.1361-1366.2002
   Borja-Cabrera GP, 2008, VACCINE, V26, P4991, DOI 10.1016/j.vaccine.2008.07.029
   Cardoso L, 2007, VET IMMUNOL IMMUNOP, V117, P35, DOI 10.1016/j.vetimm.2007.01.014
   Coura-Vital W, 2011, Vet J, V190, pe43, DOI 10.1016/j.tvjl.2011.04.005
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312
   Courtenay O, 2009, MED VET ENTOMOL, V23, P245, DOI 10.1111/j.1365-2915.2009.00815.x
   da Silva JP, 2012, REV SOC BRAS MED TRO, V45, P480, DOI 10.1590/s0037-86822012005000009
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P531, DOI 10.1016/j.pt.2012.08.007
   de Andrade HM, 2006, VET PARASITOL, V140, P231, DOI 10.1016/j.vetpar.2006.03.031
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015
   DYE C, 1993, EPIDEMIOL INFECT, V110, P647, DOI 10.1017/S0950268800051074
   Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x
   Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095
   Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5
   Fujiwara RT, 2005, VET RES, V36, P827, DOI 10.1051/vetres:2005033
   Galvez R, 2010, VET PARASITOL, V169, P327, DOI 10.1016/j.vetpar.2009.11.025
   Giunchetti RC, 2008, VACCINE, V26, P623, DOI 10.1016/j.vaccine.2007.11.057
   Gradoni L, 2001, VET PARASITOL, V100, P87, DOI 10.1016/S0304-4017(01)00486-1
   Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   *IBGE, 2000, CENS DEM 2000 AGR SE
   Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2
   Killick-Kendrick R., 1999, P INT CAN LEISHM FOR, P26
   KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x
   Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083
   Manzillo VF, 2006, VET PARASITOL, V142, P142, DOI 10.1016/j.vetpar.2006.06.029
   Ministerio da Saude, 2011, 012011CGDTCGLABDEVIT
   Ministry of Health of Brazil, 2012, CAS CONF LEISHM VISC
   de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004
   Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393
   Moreno J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001683
   Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI [10.1590/S0037-86822011005000014, 10.1590/s0037-86822011005000014]
   Costa CHN, 2008, CAD SAUDE PUBLICA, V24, P2959, DOI 10.1590/S0102-311X2008001200027
   Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006
   Otranto D, 2009, CLIN VACCINE IMMUNOL, V16, P337, DOI 10.1128/CVI.00268-08
   de Almeida ADPF, 2009, REV SOC BRAS MED TRO, V42, P156, DOI 10.1590/S0037-86822009000200012
   Passantino A, 2010, REV SCI TECH OIE, V29, P537
   Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4
   PBH, 2010, PERC POS LEISHM VISC
   Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156
   Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363
   Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992
   Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001
   Roatt BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049780
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Rondon FCM, 2008, VET PARASITOL, V155, P24, DOI 10.1016/j.vetpar.2008.04.014
   Silva DA, 2011, VET PARASITOL, V179, P257, DOI 10.1016/j.vetpar.2011.01.048
   Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86
   Neto RGT, 2010, VET PARASITOL, V169, P248, DOI 10.1016/j.vetpar.2010.01.023
   Vittinghoff E, 2012, REGRESSION METHODS B
   Werneck GL, 2008, EPIDEMIOL SERV SAUDE, V17, P87
NR 57
TC 31
Z9 31
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 22
PY 2013
VL 8
IS 8
AR e71833
DI 10.1371/journal.pone.0071833
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 218ZA
UT WOS:000324470700021
PM 23990996
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Andrade, MMC
   Carneiro, M
   Medeiros, AD
   Neto, VA
   Vitor, RWA
AF Clementino Andrade, Milena M.
   Carneiro, Mariangela
   Medeiros, Andrea D.
   Neto, Valter Andrade
   Vitor, Ricardo W. A.
TI Seroprevalence and risk factors associated with ovine toxoplasmosis in
   Northeast Brazil
SO PARASITE
LA English
DT Article
DE Toxoplasma gondii; sheep; ELISA; seroprevalence
ID NEOSPORA-CANINUM ANTIBODIES; GONDII INFECTION; SHEEP; STATE; PREVALENCE;
   ANIMALS; AVIDITY; GOATS; CATTLE; PIGS
AB Serum samples of 930 sheep were tested by ELISA to assess the prevalence of anti-Toxoplasma gondii antibodies and to identify risk factors associated with the presence of toxoplasmosis in two regions of Rio Grande do Norte (Northeast Brazil), with different climatic conditions. The overall estimated prevalence was 22.1%, with 26.3% and 17.8% positive sheep in Leste Potiguar and Central Potiguar regions, respectively. Among the positive sheep, 18.1% had low-avidity IgG antibodies, suggesting the occurrence of recent toxoplasmosis. The risk factors for toxoplasmosis in sheep were: presence of cats (odds ratio (OR) = 1.55; confidence interval (CI) 95% = 1.11-2.16), age of the animals, with adults presenting a greater chance of infection (OR = 2.44; CI 95% = 1.58-3.75), and the use of running water (OR = 1.61; CI 95% = 1.25-2.09), characterizing the existence of transmission by sporulated oocysts of T. gondii in the environment.
C1 [Clementino Andrade, Milena M.; Carneiro, Mariangela; Vitor, Ricardo W. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Clementino Andrade, Milena M.; Medeiros, Andrea D.; Neto, Valter Andrade] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Microbiol & Parasitol, Natal, RN, Brazil.
RP Vitor, RWA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
EM ricardovitor@icb.ufmg.br
RI Vitor, Ricardo/B-8924-2013
CR Abu-Dalbouh MAA, 2012, TROP ANIM HEALTH PRO, V44, P49, DOI 10.1007/s11250-011-9885-2
   Barbosa IR, 2009, T ROY SOC TROP MED H, V103, P377, DOI 10.1016/j.trstmh.2008.11.025
   de Moraes EPBX, 2011, VET PARASITOL, V183, P152, DOI 10.1016/j.vetpar.2011.06.023
   Bartova E, 2009, VET PARASITOL, V161, P131, DOI 10.1016/j.vetpar.2008.12.022
   Caballero-Ortega H, 2008, PARASITOLOGY, V135, P1385, DOI 10.1017/S0031182008004873
   Carneiro ACAV, 2009, REV MED VET-TOULOUSE, V160, P527
   Chikweto A, 2011, J PARASITOL, V97, P950, DOI 10.1645/GE-2811.1
   Clementino MM, 2007, VET PARASITOL, V146, P199, DOI 10.1016/j.vetpar.2007.02.036
   Cozon GJN, 1998, EUR J CLIN MICROBIOL, V17, P32, DOI 10.1007/BF01584360
   Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673
   FAYER R, 1981, CAN VET J, V22, P344
   Fusco G, 2007, VET PARASITOL, V149, P271, DOI 10.1016/j.vetpar.2007.07.020
   Gondim LFP, 1999, VET PARASITOL, V82, P273, DOI 10.1016/S0304-4017(99)00033-3
   Gorman T, 1999, PREV VET MED, V40, P143, DOI 10.1016/S0167-5877(99)00044-6
   Halos L, 2010, INT J PARASITOL, V40, P193, DOI 10.1016/j.ijpara.2009.06.009
   Idema Instituto de Desenvolvimento Sustentavel e Meio Ambiente do RN, AN EST 2010
   Jokelainen P, 2010, VET PARASITOL, V171, P331, DOI 10.1016/j.vetpar.2010.04.008
   Kamani J, 2010, TROP ANIM HEALTH PRO, V42, P793, DOI 10.1007/s11250-009-9488-3
   Liu QA, 2010, J PARASITOL, V96, P1222, DOI 10.1645/GE-2601.1
   Luciano DM, 2011, PESQUI VET BRASIL, V31, P569, DOI 10.1590/S0100-736X2011000700004
   Opsteegh M, 2010, PREV VET MED, V96, P232, DOI 10.1016/j.prevetmed.2010.06.009
   Panadero R, 2010, RES VET SCI, V88, P111, DOI 10.1016/j.rvsc.2009.05.010
   Pinheiro JW, 2009, PARASITOL RES, V105, P709, DOI 10.1007/s00436-009-1472-3
   Ragozo AMA, 2008, J PARASITOL, V94, P1259, DOI 10.1645/GE-1641.1
   Silva Aristeu Vieira da, 2003, Cienc. Rural, V33, P115, DOI 10.1590/S0103-84782003000100018
   Soares HS, 2009, VET PARASITOL, V160, P211, DOI 10.1016/j.vetpar.2008.10.102
   Suarez-Aranda F, 2000, VET PARASITOL, V91, P23, DOI 10.1016/S0304-4017(00)00249-1
   Sukthana Y, 2006, TRENDS PARASITOL, V22, P137, DOI 10.1016/j.pt.2006.01.007
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   van der Puije WNA, 2000, ACTA TROP, V76, P21, DOI 10.1016/S0001-706X(00)00084-X
   Lopes WDZ, 2010, RES VET SCI, V88, P104, DOI 10.1016/j.rvsc.2009.06.006
NR 31
TC 18
Z9 20
U1 0
U2 9
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 1252-607X
EI 1776-1042
J9 PARASITE
JI Parasite
PD MAY 28
PY 2013
VL 20
AR 20
DI 10.1051/parasite/2013019
PG 5
WC Parasitology
SC Parasitology
GA 154LV
UT WOS:000319677800001
PM 23707895
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Souza-e-Silva, CH
   Vasconcelos-Santos, DV
   de Andrade, GQ
   Carellos, EVM
   Romanelli, RMD
   de Resende, LM
   Januario, JN
   Carneiro, M
   Carneiro, ACDV
   Vitor, RWD
AF de Souza-e-Silva, Carlos Henryque
   Vasconcelos-Santos, Daniel Vitor
   de Andrade, Glaucia Queiroz
   Machado Carellos, Ericka Viana
   de Castro Romanelli, Roberta Maia
   de Resende, Luciana Macedo
   Januario, Jose Nelio
   Carneiro, Mariangela
   de Aguiar Vasconcelos Carneiro, Ana Carolina
   de Almeida Vitor, Ricardo Wagner
TI Association Between IgG Subclasses Against Toxoplasma gondii and
   Clinical Signs in Newborns With Congenital Toxoplasmosis
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE congenital toxoplasmosis; MIC3; IgG subclasses; retinochoroiditis;
   intracranial calcifications
ID T-CELLS; ANTIGENS; INFLAMMATION; PROTECTION; ANTIBODIES; MICE
AB Background: The aim of this study was to evaluate the association between clinical signs of congenital toxoplasmosis and IgG subclasses found in newborns participating in the Minas Gerais State Neonatal Screening Program.
   Methods: Neonates with confirmed congenital toxoplasmosis underwent standardized ophthalmologic evaluation, neuroimaging studies and hearing assessment, as well as enzyme-linked immunosorbent assay testing for total IgG and its subclasses (IgG1, IgG2, IgG3 and IgG4) against soluble (STAg) and recombinant (rSAG1 and rMIC3) antigens of Toxoplasma gondii.
   Results: Newborns with congenital toxoplasmosis but without ocular lesions were more likely to present anti-rMIC3 total IgG when compared with those newborns with active or cicatricial retinochoroidal lesions. Detection of anti-rMIC3 IgG2 and IgG4 was associated with presence of retinochoroidal lesions and intracranial calcifications, with higher mean reactivity index values than unaffected newborns with congenital toxoplasmosis. Anti-STAg IgG3 was associated with newborns without neurologic damage.
   Conclusions: Specific subclasses of IgG antibodies reacting with recombinant antigens of T. gondii may serve as biomarkers of neurologic and ocular changes in newborns with congenital toxoplasmosis.
C1 [de Souza-e-Silva, Carlos Henryque; Carneiro, Mariangela; de Aguiar Vasconcelos Carneiro, Ana Carolina; de Almeida Vitor, Ricardo Wagner] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Vasconcelos-Santos, Daniel Vitor; de Andrade, Glaucia Queiroz; Machado Carellos, Ericka Viana; de Castro Romanelli, Roberta Maia; de Resende, Luciana Macedo; Januario, Jose Nelio] Univ Fed Minas Gerais, Fac Med, BR-31270901 Belo Horizonte, MG, Brazil.
RP Vitor, RWD (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM ricardovitor@icb.ufmg.br
RI Januario, Jose Nelio/Y-7825-2019; Vasconcelos-Santos, Daniel
   V/D-3576-2013; Romanelli, Roberta M/H-4124-2018; de Resende, Luciana
   Macedo/O-6988-2018; Vitor, Ricardo/B-8924-2013
OI Vasconcelos-Santos, Daniel V/0000-0002-6747-2024; Romanelli, Roberta
   M/0000-0002-1660-0751; de Resende, Luciana Macedo/0000-0002-2004-2692; 
FU Secretaria do Estado de Saude de Minas Gerais (SES-MG); Fundacao de
   Amparo a Pesquisa de Minas Gerais (FAPEMIG), BrazilMinas Gerais State
   Research Foundation (FAPEMIG); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), BrazilNational Council for Scientific
   and Technological Development (CNPq)
FX Supported by grants from Secretaria do Estado de Saude de Minas Gerais
   (SES-MG); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Brazil. The authors have no other funding or conflicts of interest to
   disclose.
CR Andrade Glaucia Manzan Queiroz de, 2008, Braz J Otorhinolaryngol, V74, P21
   Beghetto E, 2006, J CLIN MICROBIOL, V44, P2133, DOI 10.1128/JCM.00237-06
   Buffolano W, 2005, J CLIN MICROBIOL, V43, P5916, DOI 10.1128/JCM.43.12.5916-5924.2005
   Canedo-Solares I, 2008, PEDIATR INFECT DIS J, V27, P469, DOI 10.1097/INF.0b013e31816591df
   Correa D, 2007, PARASITE IMMUNOL, V29, P651, DOI 10.1111/j.1365-3024.2007.00982.x
   de Resende LM, 2010, SCI MED, V20, P13
   Silva CHDE, 2012, MEM I OSWALDO CRUZ, V107, P342, DOI 10.1590/S0074-02762012000300008
   Elsaid MMA, 2001, MEM I OSWALDO CRUZ, V96, P99, DOI 10.1590/S0074-02762001000100011
   Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009
   Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48
   HUSKINSON J, 1989, J CLIN MICROBIOL, V27, P2031, DOI 10.1128/JCM.27.9.2031-2038.1989
   Ismael AB, 2009, VACCINE, V27, P2959, DOI 10.1016/j.vaccine.2009.02.107
   Johnson LL, 2002, INFECT IMMUN, V70, P185, DOI 10.1128/IAI.70.1.185-191.2002
   Kahi S, 1999, CLIN EXP IMMUNOL, V117, P524
   Kawano Y, 1996, IMMUNOLOGY, V88, P40, DOI 10.1046/j.1365-2567.1996.d01-634.x
   Lu FL, 2004, INFECT IMMUN, V72, P4966, DOI 10.1128/IAI.72.9.4966-4972.2004
   Mekhaiel DNA, 2011, TRENDS PARASITOL, V27, P523, DOI 10.1016/j.pt.2011.08.003
   Nguyen TD, 1998, INFECT IMMUN, V66, P2991, DOI 10.1128/IAI.66.6.2991-2995.1998
   Rorman E, 2006, REPROD TOXICOL, V21, P458, DOI 10.1016/j.reprotox.2005.10.006
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Suzuki Y, 1997, INFECT IMMUN, V65, P2339, DOI 10.1128/IAI.65.6.2339-2345.1997
   VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415
   Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199
   Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018
NR 24
TC 9
Z9 9
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD JAN
PY 2013
VL 32
IS 1
BP 13
EP 16
DI 10.1097/INF.0b013e3182703460
PG 4
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA 062FC
UT WOS:000312903600010
PM 22935868
DA 2020-12-08
ER

PT J
AU Marques, LHD
   Gomes, LI
   da Rocha, ICM
   da Silva, TAM
   Oliveira, E
   Morais, MHF
   Rabello, A
   Carneiro, M
AF dos Santos Marques, Leticia Helena
   Gomes, Luciana Inacia
   Marques da Rocha, Iara Caixeta
   Marques da Silva, Thais Almeida
   Oliveira, Edward
   Franco Morais, Maria Helena
   Rabello, Ana
   Carneiro, Mariangela
TI Low Parasite Load Estimated by qPCR in a Cohort of Children Living in
   Urban Area Endemic for Visceral Leishmaniasis in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; LINKED-IMMUNOSORBENT-ASSAY; REAL-TIME PCR;
   DIAGNOSTIC METHODS; MINAS-GERAIS; INFANTUM; INFECTION; DNA; CHAGASI;
   QUANTIFICATION
AB Background: An important issue associated with the control of visceral leishmaniasis is the need to identify and understand the relevance of asymptomatic infection caused by Leishmania infantum. The aim of this study was to follow the course of asymptomatic L. infantum infection in children in an area of Brazil where it is endemic. The children were assessed twice during a 12-month period.
   Methodology: In this population study, 1875 children, ranging from 6 months to 7 years of age, were assessed. Blood samples were collected on filter papers via finger prick and tested by ELISA (L. infantum soluble antigen and rk39). Seropositives samples (n = 317) and a number of seronegatives samples (n = 242) were subjected to qPCR. After 12 months, blood samples were collected from a subgroup of 199 children and tested for Leishmania spp. to follow the course of infection.
   Principal Findings: At baseline qPCR testing identified 82 positive samples. The prevalence rate, as estimated for 1875 children based on the qPCR results, was 13.9%. The qPCR testing of whole blood samples collected from a cohort of children after 12 months (n = 199) yielded the following results: of the 44 (22.1%) children with positive qPCR results at baseline, only 10 (5.0%) remained positive, and 34 (17.1%) became negative; and of the 155 (77.9%) children with negative qPCR results, 131 (65.8%) remained negative, and 24 (12.1%) became positive at the follow-up measurement. The samples with positive findings at baseline (n = 82) had a mean of 56.5 parasites/mL of blood; and at follow-up the mean positive result was 7.8 parasites/mL.
   Conclusions: The peripheral blood of asymptomatic children had a low and fluctuating quantity of Leishmania DNA and a significant decrease in parasitemia at 1-year follow-up. Quantitative PCR enables adequate monitoring of Leishmania infection.
C1 [dos Santos Marques, Leticia Helena; Marques da Rocha, Iara Caixeta; Marques da Silva, Thais Almeida; Franco Morais, Maria Helena; Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [Gomes, Luciana Inacia; Oliveira, Edward; Rabello, Ana] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Pesquisas Clin, Belo Horizonte, MG, Brazil.
   [Marques da Rocha, Iara Caixeta; Franco Morais, Maria Helena] Prefeitura Belo Horizonte, Secretaria Municipal Saude, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
RP Marques, LHD (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
FU DECIT/MS/CNPq/BR/grant [576062/2008-1];
   PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant [CDS-APQ-00343-10]; MCT/CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [477430/2010]; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX The authors thank the Pro-Reitoria de Pesquisa of Universidade Federal
   de Minas Gerais for supporting this publication.; This work was
   partially supported by DECIT/MS/CNPq/BR/grant: 576062/2008-1,
   PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant: CDS-APQ-00343-10 and MCT/CNPq:
   477430/2010. AR and MC are grateful to the CNPq for fellowships
   researcher. The CNPq sponsored LHSM scholarships (Master Degree -
   Programa de Pos-Graduacao em Parasitologia, Universidade Federal de
   Minas Gerais). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Biglino A, 2010, J CLIN MICROBIOL, V48, P131, DOI 10.1128/JCM.00416-09
   Bonne N, 2008, J VET DIAGN INVEST, V20, P60, DOI 10.1177/104063870802000111
   Brazil MoHo, 2011, CAS CONF LEISHM VISC
   Carneiro M, 2011, DRUG DEVELOP RES, V72, P442, DOI 10.1002/ddr.20451
   Carvalho GML, 2010, J MED ENTOMOL, V47, P972, DOI 10.1603/ME09127
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   de Souza CM, 2004, MEM I OSWALDO CRUZ, V99, P795, DOI 10.1590/S0074-02762004000800003
   Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509
   Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001
   HO M, 1983, AM J TROP MED HYG, V32, P943, DOI 10.4269/ajtmh.1983.32.943
   Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010
   le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999
   Martin-Sanchez J, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-20
   Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004
   de Souza VMM, 2008, EPIDEMIOL SERV SAUDE, V17, P97
   Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002
   Moreno EC, 2006, REV SOC BRAS MED TRO, V39, P421, DOI 10.1590/S0037-86822006000500001
   Moreno EC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000536
   Musso O, 1996, J VIROL METHODS, V56, P125, DOI 10.1016/0166-0934(95)01892-1
   Orsini M, 2012, T ROY SOC TROP MED H, V106, P283, DOI 10.1016/j.trstmh.2012.01.008
   Pedras MJ, 2008, T ROY SOC TROP MED H, V102, P172, DOI 10.1016/j.trstmh.2007.11.004
   PIARROUX R, 1993, AM J TROP MED HYG, V49, P364, DOI 10.4269/ajtmh.1993.49.364
   Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005
   Riera C, 2004, T ROY SOC TROP MED H, V98, P102, DOI 10.1016/S0035-9203(03)00015-4
   Rolao N, 2004, J PARASITOL, V90, P1150, DOI 10.1645/GE-264R1
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Romero HD, 2009, AM J TROP MED HYG, V81, P27
   Srivastava P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019304
   VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   World Health Organization, 2008, GLOB BURD DIS 2004 U
   Wortmann G, 2001, AM J TROP MED HYG, V65, P583, DOI 10.4269/ajtmh.2001.65.583
NR 32
TC 20
Z9 20
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2012
VL 6
IS 12
AR e1955
DI 10.1371/journal.pntd.0001955
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 062HN
UT WOS:000312910200027
PM 23272263
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, CV
   Heller, L
   Carneiro, M
AF da Silva, Carolina Ventura
   Heller, Leo
   Carneiro, Mariangela
TI Rainwater cisterns and its effect in children diarrhoea: a study in semi
   arid rural area at Minas Gerais
SO ENGENHARIA SANITARIA E AMBIENTAL
LA Portuguese
DT Article
DE cistern; diarrhoea; rain water; rural sanitation; water supply
ID CONTAMINATION; SANITATION; WATER
AB The present text evaluated the diarrhea prevalence in children under 60 months, according to water supply. An epidemic study was conducted with quasi-experimental design with 664 children, 332 who lived in residence that had cistern and 332 that use water from another source. Diarrhoea occurrence in the last 72 hours was the dependent variable, the others informations were obtained by structured questionnaires. Total diarrhoea prevalence was of 5%, however with no significant difference among the groups. The variables that explained the disease were child's age; if it was taking vitamin and where the dirty diapers with the child's feces were displaced. There were no significant difference among the groups in water microbiological analyses; in other words, the use of rainwater had might not provided improvements in the access of a better quality water supply when compared with the other alternative sources. However, it has to be considered faults in handling and water treatment. It stands out the need of sanitary practices improvement of rural area population, so that personal and home hygiene and in relation to consumed water could be incorporated as routine habits.
C1 [da Silva, Carolina Ventura] Univ Fed Vicosa, Vicosa, MG, Brazil.
   [Heller, Leo] Univ Fed Minas Gerais, Dept Engn Sanit & Ambiental, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RP da Silva, CV (corresponding author), Ave Coronel Aristides Bittencourt 02,Apto 10, BR-36570000 Vicosa, MG, Brazil.
EM carolventurasilva@yahoo.com.br
CR *AM PUBL HLTH ASS, 2005, STANDARD METHODS FOR
   AMARAL L. A., 2003, REV SAUDE PUBL, V37, P10
   AMORIM M.C.C., 2001, SIMPOSIO BRASILEIRO, V3
   [Anonymous], 1988, B WORLD HEALTH ORGAN, V66, P709
   AZEVEDO Elciene, 2003, THESIS
   BRASIL, 2004, SISTEMA NACIONAL DE
   BRASIL. Ministerio das Cidades, 2011, PLANO NACIONAL DE SA
   Brito L.T., 2005, SIMPOSIO BRASILEIRO, V5
   Clasen T, 2007, BMJ-BRIT MED J, P334
   CORREIA L.L., 1999, EPIDEMIOLOGIA SAUDE, P375
   Costa Silvano Silvério da, 2005, Eng. Sanit. Ambient., V10, P118, DOI 10.1590/S1413-41522005000200005
   Dias A, 2004, THESIS
   ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757
   ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609
   Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8
   Heller L., 1997, SANEAMENTO E SAUDE
   Joventino ES, 2010, TEXTO CONTEXTO ENFER, V19, P691, DOI 10.1590/S0104-07072010000400012
   LUNA C. F., 2011, THESIS
   Malheiros Patricia da Silva, 2009, Revista do Instituto Adolfo Lutz, V68, P305
   MARCYNUK P., 2009, SIMPOSIO BRASILEIRO, V7
   MORAES LRS, 1997, SANEAMENTO SAUDE PAI, P281
   ROCHA C.M.B.M., 2006, CAD SAUDE PUBLICA, V22, P1967
   RODRIGO S., 2003, PROCEEDINGS OF THE 1
   Silva C. C., 2006, THESIS
   Simmon G, 2001, WATER RES, V35, P1518, DOI 10.1016/S0043-1354(00)00420-6
   Teixeira JC, 2003, THESIS
   WORLD HEALTH ORGANIZATION, 2009, DIARRHEA WHY CHILDRE
NR 27
TC 6
Z9 6
U1 0
U2 19
PU ASSOC BRASILEIRA ENGENHARIA SANITARIA AMBIENTAL
PI RIO DE JANEIRO
PA AV BEIRA MAR, 216-13 ANDAR-CASTELO, RIO DE JANEIRO, RJ 20021-060, BRAZIL
SN 1413-4152
EI 1809-4457
J9 ENG SANIT AMBIENT
JI Eng. Sanit. Ambient.
PD OCT-DEC
PY 2012
VL 17
IS 4
BP 393
EP 400
DI 10.1590/S1413-41522012000400006
PG 8
WC Water Resources
SC Water Resources
GA 117OF
UT WOS:000316962100006
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Silva, CHDE
   de Andrade, GQ
   Januario, JN
   Carneiro, ACDV
   Carneiro, M
   Vasconcelos-Santos, DV
   Vitor, RWD
AF de Souza e Silva, Carlos Henryque
   de Andrade, Glaucia Queiroz
   Januario, Jose Nelio
   de Aguiar Vasconcelos Carneiro, Ana Carolina
   Carneiro, Mariangela
   Vasconcelos-Santos, Daniel Vitor
   de Almeida Vitor, Ricardo Wagner
TI Early diagnosis of congenital toxoplasmosis in newborn infants using IgG
   subclasses against two Toxoplasma gondii recombinant proteins
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE congenital toxoplasmosis; ELISA; recombinant proteins; IgG subclasses
ID ANTIGENS; COMBINATION; INFECTION
AB The aim of this work was to evaluate the utility of ELISA-based testing of total IgG (IgGt) antibodies and its subclasses (IgG1, IgG2, IgG3 and IgG4) against soluble (STAg) and recombinant (rSAG1 and rMIC3) antigens of Toxoplasma gondii for diagnosing congenital toxoplasmosis. Sera from 217 newborns initially testing positive for specific IgM in filter paper dried blood spots were tested for specific IgM and IgG by ELFA-VIDAS (R). Congenital toxoplasmosis was confirmed in 175 and ruled out in 42 infants. The validity of the ELISA tests was determined using the persistence of IgG antibodies (ELFA-VIDAS (R) kit) at the end of 12 months, which is considered the reference test for the diagnosis of congenital toxoplasmosis. The frequency of positivity with IgGt against STAg, rSAG1 and rMIC3 was found in 97.2%, 96.3% and 80.2%, respectively, of the newborns with confirmed congenital toxoplasmosis. IgG1 reacted with all three antigens, while IgG3 and IgG4 reacted preferentially with rMIC3. Higher mean values of reactivity (sample optical density/cut-off) were found for all subclasses when using rMIC3. All of the antigens showed high sensitivity and low specificity in detecting anti-T. gondii IgGt and IgG1 and low sensitivity and high specificity in detecting IgG3 and IgG4. In conclusion, the combined detection of IgG antibody subclasses against recombinant toxoplasmic antigens may be useful for the early diagnosis of congenital toxoplasmosis.
C1 [de Souza e Silva, Carlos Henryque; de Aguiar Vasconcelos Carneiro, Ana Carolina; Carneiro, Mariangela; de Almeida Vitor, Ricardo Wagner] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Andrade, Glaucia Queiroz; Januario, Jose Nelio; Vasconcelos-Santos, Daniel Vitor] Univ Fed Minas Gerais, Fac Med, BR-31270901 Belo Horizonte, MG, Brazil.
RP Vitor, RWD (corresponding author), CNPq, Campinas, SP, Brazil.
EM ricardovitor@icb.ufmg.br
RI Vasconcelos-Santos, Daniel V/D-3576-2013; Vitor, Ricardo/B-8924-2013;
   Januario, Jose Nelio/Y-7825-2019
OI Vasconcelos-Santos, Daniel V/0000-0002-6747-2024; 
FU SES/MG; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CBB-APQ-00129-09]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [301110/2009-3]
FX Financial support: SES/MG, FAPEMIG (CBB-APQ-00129-09), CNPq
   (301110/2009-3)
CR Altcheh J, 2006, DIAGN MICR INFEC DIS, V56, P161, DOI 10.1016/j.diagmicrobio.2006.03.012
   Beghetto E, 2005, J INFECT DIS, V191, P637, DOI 10.1086/427660
   Buffolano W, 2005, J CLIN MICROBIOL, V43, P5916, DOI 10.1128/JCM.43.12.5916-5924.2005
   Canedo-Solares I, 2008, PEDIATR INFECT DIS J, V27, P469, DOI 10.1097/INF.0b013e31816591df
   Correa D, 2007, PARASITE IMMUNOL, V29, P651, DOI 10.1111/j.1365-3024.2007.00982.x
   Elsaid MMA, 2001, MEM I OSWALDO CRUZ, V96, P99, DOI 10.1590/S0074-02762001000100011
   Gilbert RE, 2007, J MED SCREEN, V14, P8, DOI 10.1258/096914107780154440
   Gross U, 2000, J CLIN MICROBIOL, V38, P3619, DOI 10.1128/JCM.38.10.3619-3622.2000
   HUSKINSON J, 1989, J CLIN MICROBIOL, V27, P2031, DOI 10.1128/JCM.27.9.2031-2038.1989
   Li SL, 2000, CLIN DIAGN LAB IMMUN, V7, P781, DOI 10.1128/CDLI.7.5.781-787.2000
   Petersen E, 2007, SEMIN FETAL NEONAT M, V12, P214, DOI 10.1016/j.siny.2007.01.011
   Rorman E, 2006, REPROD TOXICOL, V21, P458, DOI 10.1016/j.reprotox.2005.10.006
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042
NR 14
TC 5
Z9 5
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2012
VL 107
IS 3
BP 342
EP 347
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 927TM
UT WOS:000302933000008
PM 22510829
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Araujo, VEM
   Morais, MHF
   Reis, IA
   Rabello, A
   Carneiro, M
AF Miranda de Araujo, Valdelaine Etelvina
   Franco Morais, Maria Helena
   Reis, Ilka Afonso
   Rabello, Ana
   Carneiro, Mariangela
TI Early Clinical Manifestations Associated with Death from Visceral
   Leishmaniasis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RISK-FACTORS; INFLAMMATORY RESPONSE; PROGNOSTIC-FACTORS; SOUTHERN SUDAN;
   KALA-AZAR; BRAZIL; INFECTION; DISEASE; IMPACT
AB Background: In Brazil, lethality from visceral leishmaniasis (VL) is high and few studies have addressed prognostic factors. This historical cohort study was designed to investigate the prognostic factors for death from VL in Belo Horizonte (Brazil).
   Methodology: The analysis was based on data of the Reportable Disease Information System-SINAN (Brazilian Ministry of Health) relating to the clinical manifestations of the disease. During the study period (2002-2009), the SINAN changed platform from a Windows to a Net-version that differed with respect to some of the parameters collected. Multivariate logistic regression models were performed to identify variables associated with death from VL, and these were included in prognostic score.
   Principal Findings: Model 1 (period 2002-2009; 111 deaths from VL and 777 cured patients) included the variables present in both SINAN versions, whereas Model 2 (period 2007-2009; 49 deaths from VL and 327 cured patients) included variables common to both SINAN versions plus the additional variables included in the Net version. In Model 1, the variables significantly associated with a greater risk of death from VL were weakness (OR 2.9; 95%CI 1.3-6.4), Leishmania-HIV co-infection (OR 2.4; 95%CI 1.2-4.8) and age >= 60 years (OR 2.5; 95%CI 1.5-4.3). In Model 2, the variables were bleeding (OR 3.5; 95%CI 1.2-10.3), other associated infections (OR 3.2; 95%CI 1.3-7.8), jaundice (OR 10.1; 95%CI 3.7-27.2) and age >= 60 years (OR 3.1; 95%CI 1.4-7.1). The prognosis score was developed using the variables associated with death from VL of the latest version of the SINAN (Model 2). The predictive performance of which was evaluated by sensitivity (71.4%), specificity (73.7%), positive and negative predictive values (28.9% and 94.5%) and area under the receiver operating characteristic curve (75.6%).
   Conclusions: Knowledge regarding the factors associated with death from VL may improve clinical management of patients and contribute to lower mortality.
C1 [Miranda de Araujo, Valdelaine Etelvina; Franco Morais, Maria Helena; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Miranda de Araujo, Valdelaine Etelvina; Franco Morais, Maria Helena] Secretaria Municipal Saude, Belo Horizonte, MG, Brazil.
   [Reis, Ilka Afonso] Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil.
   [Rabello, Ana] Fundacao Oswaldo Cruz, Lab Pesquisas Clin, Ctr Pesquisas Rene, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
RP de Araujo, VEM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Reis, Ilka Afonso/AAG-8007-2019
OI Reis, Ilka Afonso/0000-0001-7199-8590
FU DECIT/MS/CNPq/BRNational Council for Scientific and Technological
   Development (CNPq) [576062/2008-1]; PPSUS/MS/CNPq/FAPEMIG/SES-MGNational
   Council for Scientific and Technological Development (CNPq)Minas Gerais
   State Research Foundation (FAPEMIG) [CDS-APQ-00343-10]; FAPEMIG/PPM
FX This work was partially supported by
   DECIT/MS/CNPq/BR/grant:576062/2008-1,
   PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant: CDS-APQ-00343-10 and FAPEMIG/PPM.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abdelmoula Mohamed Slim, 2003, Tunis Med, V81, P535
   Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298
   Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07
   Sampaio MJAD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000877
   ANDRADE TM, 1990, J INFECT DIS, V162, P1354, DOI 10.1093/infdis/162.6.1354
   Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213
   Barquet N, 1997, JAMA-J AM MED ASSOC, V278, P491, DOI 10.1001/jama.278.6.491
   Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313
   Brasil, 2000, CENS DEM 2010
   Brasil, 2006, LEISHM VISC GRAV NOR
   Brasil, 2006, MAN VIG CONTR LEISHM
   Chaisson RE, 1998, AIDS, V12, P29, DOI 10.1097/00002030-199801000-00004
   Choi CM, 2001, J INVEST DERM SYMP P, V6, P175, DOI 10.1046/j.0022-202x.2001.00038.x
   Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203
   Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153
   Cruz I, 2006, INDIAN J MED RES, V123, P357
   de Oliveira JM, 2010, REV SOC BRAS MED TRO, V43, P188, DOI 10.1590/S0037-86822010000200016
   de Oliveira JF, 2006, REV SOC BRAS MED TRO, V39, P146, DOI 10.1590/S0037-86822006000500005
   Desjeux P, 2001, MED MICROBIOL IMMUN, V190, P77, DOI 10.1007/s004300100085
   DUARTE MIS, 1987, REV INST MED TROP SP, V29, P131, DOI 10.1590/S0036-46651987000300003
   Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125
   Esmon CT, 2004, THROMB RES, V114, P321, DOI 10.1016/j.thromres.2004.06.028
   Harway MO, 2011, TRENDS PARASITOLOGY
   HERVAS JA, 1991, PEDIATR INFECT DIS J, V10, P409
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Kajaia M, 2011, TROP MED INT HEALTH, V16, P186, DOI 10.1111/j.1365-3156.2010.02694.x
   Lomtadze M L, 2005, Georgian Med News, P47
   Ministry of Health of Brazil, 2009, GUIA VIG EP
   Ministry of Health of Brazil, 2010, LET LEISHM VISC BRAS
   Ministry of Health of Brazil, 2010, CAS CONF LEISHM VISC
   Mueller Y, 2009, TROP MED INT HEALTH, V14, P910, DOI 10.1111/j.1365-3156.2009.02305.x
   Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010
   Profeta da Luz Z M, 2001, Rev Soc Bras Med Trop, V34, P249, DOI 10.1590/S0037-86822001000300004
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Seaman J, 1996, ANN INTERN MED, V124, P664, DOI 10.7326/0003-4819-124-7-199604010-00007
   Silva Fábia Gama, 2007, Rev. bras. educ. med., V31, P113, DOI 10.1590/S0100-55022007000200002
   Maia-Elkhoury ANS, 2007, REV SAUDE PUBL, V41, P929
   Szklo M, 2007, EPIDEMIOLOGY BASIS
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9
   WHO, 2010, 1 WHO
   Wolday D, 1998, SCAND J INFECT DIS, V30, P29, DOI 10.1080/003655498750002268
   World Health Organization, 2008, GLOB BURD DIS 2004 U
   Zerpa Olga, 2003, Rev Panam Salud Publica, V13, P239, DOI 10.1590/S1020-49892003000300006
NR 43
TC 44
Z9 46
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2012
VL 6
IS 2
AR e1511
DI 10.1371/journal.pntd.0001511
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 901FX
UT WOS:000300949200023
PM 22347514
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Macedo, MD
   Teixeira, RA
   Bonomo, E
   da Silva, CAM
   da Silva, ME
   Sakurai, E
   Carneiro, M
   Lamounier, JA
AF Macedo, Mariana de Souza
   Teixeira, Romero Alves
   Bonomo, Elido
   Mariano da Silva, Camilo Adalton
   da Silva, Marcelo Eustaquio
   Sakurai, Emilia
   Carneiro, Mariangela
   Lamounier, Joel Alves
TI Iodine deficiency and associated factors in infants and preschool
   children in an urban community in the semiarid region of Minas Gerais
   State, Brazil, 2008
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Iodine; Iodine Deficiency; Preschool Child
ID URINARY IODINE
AB The aim of this study was to evaluate the prevalence of iodine deficiency in children aged 6 to 71 months in Novo Cruzeiro, Minas Gerais State, Brazil. A total of 475 children, allocated by stratified probability sampling, were analyzed with respect to the iodine concentrations in the salt consumed by the family and urinary iodine. Iodine deficiency was verified in 34.4% of the children, of which 23.5% showed slight deficiency, 5.9% moderate and 5% serious deficiency. A difference in the distribution of iodine deficiency was observed between the urban and the rural environments (p < 0.001) where average urinary iodine concentrations of 150.8 and 114.3 mu g/L respectively were found. A greater proportion of iodine deficiency was observed among children where the proportion of iodine in the salt consumed was below the recommended level. Although expressive, iodine deficiency in Novo Cruzeiro is not a public health problem according to World Health Organization (WHO), The limitrophe distribution of the urinary iodine associated with low iodine levels in salt suggests that efforts to control this deficiency are not yet complete.
C1 [Macedo, Mariana de Souza] Univ Fed Vales Jequitinhonha & Mucuri, Fac Ciencias Biol & Saude, Dept Nutr, BR-39100000 Diamantina, MG, Brazil.
   [Bonomo, Elido; Mariano da Silva, Camilo Adalton; da Silva, Marcelo Eustaquio] Univ Fed Ouro Preto, Escola Nutr, Ouro Preto, Brazil.
   [Sakurai, Emilia] Univ Fed Minas Gerais, Inst Ciencias Exatas, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Lamounier, Joel Alves] Univ Fed Sao Joao Del Rei, Dept Pediat, Sao Joao Del Rei, Brazil.
RP Macedo, MD (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Fac Ciencias Biol & Saude, Dept Nutr, Rodovia BR 367, BR-39100000 Diamantina, MG, Brazil.
EM marysmacedo@yahoo.com.br
RI Teixeira, Romero A/B-1582-2017
OI Teixeira, Romero A/0000-0001-6623-8239; Silva, Camilo Adalton
   Mariano/0000-0002-5683-9556
CR Andrade Carla Lourenço Tavares de, 2004, Cad. Saúde Pública, V20, pS44, DOI 10.1590/S0102-311X2004000700005
   Arruda Sampaio A, 1941, PEDIAT PRAT, V12, P15
   Battalha BHL, 1977, CONTROLE QUALIDADE A
   BOYAGES SC, 1993, J CLIN ENDOCR METAB, V77, P587, DOI 10.1210/jc.77.3.587
   CAM Silva, 2007, THESIS U FEDERAL MIN
   Centro Brasileiro de Analise e Planejamento Ministerio da Saude., 2009, PESQ NAC DEM SAUD CR
   Corrêa Filho Heleno Rodrigues, 2002, Rev Panam Salud Publica, V12, P317, DOI 10.1590/S1020-49892002001100005
   Correa Filho HR, 2002, BIBLIO DEFICIENCIA M, P3
   Dantas LM, 1986, ERADICATION ENDEMIC, P271
   Delange F, 2002, B WORLD HEALTH ORGAN, V80, P633
   Duarte Glaucia C., 2004, Arq Bras Endocrinol Metab, V48, P842, DOI 10.1590/S0004-27302004000600010
   DUNN JT, 1993, THYROID, V3, P119, DOI 10.1089/thy.1993.3.119
   Esteves RZ, 2007, ARQ BRAS ENDOCRINOL, V51, P1477, DOI 10.1590/S0004-27302007000900010
   Horowistz E, 1980, OFFICIAL METHODS ANA, P637
   International Council for the Control of iodine Deficiency Disorders, ASS IOD STAT
   MEDEIROSNETO G, 1975, HIST BOCIO ENDEMICO
   Ministerio da Saude, 2007, CAD AT BAS
   Nimer M, 2002, REV SAUDE PUBL, V36, P500, DOI 10.1590/s0034-89102002000400017
   Pessoa DGC, ANALISE DADOS AMOSTR
   Pretell EA, 2000, THYROMOBIL PROJECT L
   Sandell EB, 1937, MIKROCHIM ACTA, V1, P9, DOI [10.1007/BF01476194, DOI 10.1007/BF01476194]
   World Health Organization United Nations Children's Fund and International Council for the Control of Iodine Deficiency Disorders, 2007, ASS IOD DEF DIS MON
   World Health Organization/United Nations Children's Fund/International Council for the Control of Iodine Deficiency Disorders, 2001, ASS IDD MON THEIR EL
NR 23
TC 2
Z9 2
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD FEB
PY 2012
VL 28
IS 2
BP 346
EP 356
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 891AE
UT WOS:000300187700013
PM 22331160
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Carneiro, M
   Moreno, EC
   Goncalves, AV
   Lambertucci, JR
   Antunes, CMF
AF Carneiro, Mariangela
   Moreno, Elizabeth Castro
   Goncalves, Andrea Vieira
   Lambertucci, Jose Roberto
   Antunes, Carlos M. F.
TI Visceral Leishmaniasis: Challenges in Identifying Subclinical Leishmania
   Infection
SO DRUG DEVELOPMENT RESEARCH
LA English
DT Article
DE asymptomatic visceral leishmaniasis; kala-azar; cohort studies;
   serological and molecular diagnostic techniques
ID ASYMPTOMATIC HUMAN CARRIERS; LINKED-IMMUNOSORBENT-ASSAY;
   POLYMERASE-CHAIN-REACTION; CHAGASI INFECTION; DIAGNOSTIC METHODS;
   MINAS-GERAIS; ENDEMIC AREA; DIRECT AGGLUTINATION; DONOVANI INFECTION;
   URBAN AREA
AB The major constraint in conducting visceral leishmaniasis (VL) population studies is the difficulty of diagnosing asymptomatic infection. The aims of the present study, conducted in an urban area in the southeast of Brazil, were to appraise the performance of serological techniques in identifying VL asymptomatic cases and to follow up a cohort of Leishmania infantum-exposed individuals living in an active transmission area, in an effort to understand infection dynamics and disease natural history. After an initial population-based survey, three evaluations were carried out, covering a 7-year follow-up period. In addition to diagnostic tests, with polymerase chain reaction (PCR)-hybridization as the reference test, the study population was interviewed and clinically examined; the last evaluation included abdominal ultrasonography. Our results showed that serological tests are not adequate in diagnosing asymptomatic VL; they also did not permit conclusions concerning parasite transmission and infection dynamics. Diagnostic techniques using molecular biology methods were more promising in identifying asymptomatic infection, but the meaning of a positive PCR-hybridization test was unclear. In the present study, with one exception, after the follow-up period, all participants had at least one positive molecular test, but none developed clinical disease. The meaning of a positive PCR in areas with active parasite transmission needs to be better evaluated. Drug Dev Res 72: 442-450, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Antunes, Carlos M. F.] Santa Casa Belo Horizonte, Programa Posgrad, IEP, BR-30150240 Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela; Moreno, Elizabeth Castro; Goncalves, Andrea Vieira] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lambertucci, Jose Roberto] Univ Fed Minas Gerais, Dept Clin Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela; Lambertucci, Jose Roberto; Antunes, Carlos M. F.] Univ Fed Minas Gerais, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil.
RP Antunes, CMF (corresponding author), Santa Casa Belo Horizonte, Programa Posgrad, IEP, Rua Domingos Vieira 590, BR-30150240 Belo Horizonte, MG, Brazil.
EM antunesc@santacasabh.org.br
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [CNPq-474709/2003-5]; Fundacao de Amparo a Pesquisa de Minas GeraisMinas
   Gerais State Research Foundation (FAPEMIG) [FAPEMIG-CDS-400/03]; PPM;
   UNDP/World Bank/WHOWorld Health Organization [TDR A30406]
FX Grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico; Grant number: CNPq-474709/2003-5; Grant sponsor: Fundacao
   de Amparo a Pesquisa de Minas Gerais; Grant number: FAPEMIG-CDS-400/03
   and PPM; Grant sponsor: UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases; Grant number: TDR A30406.
CR Anam K, 1999, INFECT IMMUN, V67, P6663
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Bern C, 2007, AM J TROP MED HYG, V76, P909
   Bhattarai NR, 2009, TROP MED INT HEALTH, V14, P404, DOI 10.1111/j.1365-3156.2009.02242.x
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   CUNHA S, 1995, T ROY SOC TROP MED H, V89, P155, DOI 10.1016/0035-9203(95)90474-3
   de Andrade ASR, 2001, ACTA TROP, V78, P261, DOI 10.1016/S0001-706X(01)00081-X
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Fakhar M, 2008, ANN TROP MED PARASIT, V102, P577, DOI 10.1179/136485908X337526
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Khanal B, 2010, TROP MED INT HEALTH, V15, P1390, DOI 10.1111/j.1365-3156.2010.02631.x
   Martin-Sanchez J, 2004, AM J TROP MED HYG, V70, P545, DOI 10.4269/ajtmh.2004.70.545
   Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002
   Moreno EC, 2006, REV SOC BRAS MED TRO, V39, P421, DOI 10.1590/S0037-86822006000500001
   Moreno EC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000536
   PIARROUX R, 1993, AM J TROP MED HYG, V49, P364, DOI 10.4269/ajtmh.1993.49.364
   Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005
   Riera C, 2004, T ROY SOC TROP MED H, V98, P102, DOI 10.1016/S0035-9203(03)00015-4
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Romero HD, 2009, AM J TROP MED HYG, V81, P27
   SHAW J. J., 1964, TRANS ROY SOC TROP MED HYG, V58, P349, DOI 10.1016/0035-9203(64)90203-2
   Silveira FT, 2009, PARASITOL RES, V104, P559, DOI 10.1007/s00436-008-1230-y
   *SVS MS, 2010, COEF INC LEISHM VISC
   Tavares CAP, 2003, EXPERT REV MOL DIAGN, V3, P657, DOI 10.1586/14737159.3.5.657
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   Werneck GL, 2002, ACTA TROP, V83, P13, DOI 10.1016/S0001-706X(02)00058-X
   World Health Organization, 2010, 1 WHO, P91
   Zijlstra EE, 1998, CLIN DIAGN LAB IMMUN, V5, P717, DOI 10.1128/CDLI.5.5.717-720.1998
NR 33
TC 5
Z9 5
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4391
EI 1098-2299
J9 DRUG DEVELOP RES
JI Drug Dev. Res.
PD SEP
PY 2011
VL 72
IS 6
SI SI
BP 442
EP 450
DI 10.1002/ddr.20451
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 824CU
UT WOS:000295180100004
DA 2020-12-08
ER

PT J
AU Coura-Vital, W
   Marques, MJ
   Veloso, VM
   Reis, LE
   Braga, SL
   Morais, MH
   Reis, A
   Carneiro, M
AF Coura-Vital, W.
   Marques, M. J.
   Veloso, V. M.
   Reis, L. E.
   Braga, S. L.
   Morais, M. H.
   Reis, A.
   Carneiro, M.
TI PREVALENCE AND RISK FACTORS ASSOCIATED WITH INFECTION BY LEISHMANIA
   INFANTUM IN DOGS FROM AN URBAN AREA OF BRAZIL IDENTIFIED BY MOLECULAR
   METHODS
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Meeting Abstract
C1 [Coura-Vital, W.; Marques, M. J.; Veloso, V. M.; Reis, L. E.; Braga, S. L.; Morais, M. H.; Reis, A.; Carneiro, M.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Marques, M. J.] Univ Fed Alfenas, Alfenas, Brazil.
   [Veloso, V. M.; Reis, L. E.; Braga, S. L.; Reis, A.] Univ Fed Ouro Preto, Ouro Preto, Brazil.
RI Marques, Marcos Jose/G-8384-2012
NR 0
TC 0
Z9 0
U1 0
U2 3
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD AUG
PY 2011
VL 65
SU 1
BP A360
EP A360
DI 10.1136/jech.2011.142976m.32
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 807MG
UT WOS:000293901801592
OA Bronze
DA 2020-12-08
ER

PT J
AU Coura-Vital, W
   Marques, MJ
   Veloso, VM
   Roatt, BM
   Aguiar-Soares, RDD
   Reis, LES
   Braga, SL
   Morais, MHF
   Reis, AB
   Carneiro, M
AF Coura-Vital, Wendel
   Marques, Marcos Jose
   Veloso, Vanja Maria
   Roatt, Bruno Mendes
   de Oliveira Aguiar-Soares, Rodrigo Dian
   Soares Reis, Levi Eduardo
   Braga, Samuel Leoncio
   Franco Morais, Maria Helena
   Reis, Alexandre Barbosa
   Carneiro, Mariangela
TI Prevalence and Factors Associated with Leishmania infantum Infection of
   Dogs from an Urban Area of Brazil as Identified by Molecular Methods
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CANINE VISCERAL LEISHMANIASIS; MINAS-GERAIS STATE; PHLEBOTOMINE SAND
   FLIES; BELO-HORIZONTE; RISK-FACTORS; MONTES-CLAROS; PCR-RFLP;
   TRANSMISSION; EPIDEMIOLOGY; MUNICIPALITY
AB Background: Various factors contribute to the urbanization of the visceral leishmaniasis (VL), including the difficulties of implementing control measures relating to the domestic reservoir. The aim of this study was to determine the prevalence of canine visceral leishmaniasis in an urban endemic area in Brazil and the factors associated with Leishmania infantum infection among seronegative and PCR-positive dogs.
   Methodology: A cross-sectional study was conducted in Belo Horizonte, Minas Gerais, Brazil. Blood samples were collected from 1,443 dogs. Serology was carried out by using two enzyme-linked immunosorbent assays (Biomanguinhos/FIOCRUZ/RJ and "in house"), and molecular methods were developed, including PCR-RFLP. To identify the factors associated with early stages of infection, only seronegative (n = 1,213) animals were evaluated. These animals were divided into two groups: PCR-positive (n = 296) and PCR-negative (n = 917) for L. infantum DNA. A comparison of these two groups of dogs taking into consideration the characteristics of the animals and their owners was performed. A mixed logistic regression model was used to identify factors associated with L. infantum infection.
   Principal Findings: Of the 1,443 dogs examined, 230 (15.9%) were seropositive in at least one ELISA, whereas PCR-RFLP revealed that 356 animals (24.7%) were positive for L. infantum DNA. Results indicated that the associated factors with infection were family income < twice the Brazilian minimum salary (OR 2.3; 95% CI 1.4-3.8), knowledge of the owner regarding the vector (OR 1.9; 95% CI 1.1-3.4), the dog staying predominantly in the backyard (OR 2.2; 95% CI 1.1-4.1), and a lack of previous serological examination for VL (OR 1.5; 95% CI 1.1-2.3).
   Conclusions: PCR detected a high prevalence of L. infantum infection in dogs in an area under the Control Program of VL intervention. Socioeconomic variables, dog behavior and the knowledge of the owner regarding the vector were factors associated with canine visceral leishmaniasis (CVL). The absence of previous serological examination conducted by the control program was also associated with L. infantum infection. It is necessary to identify the risk factors associated with CVL to understand the expansion and urbanization of VL.
C1 [Coura-Vital, Wendel; Franco Morais, Maria Helena; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel; Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Soares Reis, Levi Eduardo; Braga, Samuel Leoncio; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.
   [Marques, Marcos Jose] Univ Fed Alfenas, Dept Ciencias Biol, Alfenas, MG, Brazil.
   [Veloso, Vanja Maria] Univ Fed Ouro Preto, Escola Farm, Dept Farm, Ouro Preto, MG, Brazil.
   [Franco Morais, Maria Helena] Secretaria Municipal Saude, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
RP Coura-Vital, W (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI de Oliveira Aguiar-Soares, Rodrigo Dian/ABB-7973-2020; Roatt, Bruno
   M/R-5502-2016; Marques, Marcos Jose/G-8384-2012
OI de Oliveira Aguiar-Soares, Rodrigo Dian/0000-0001-8705-7357; Roatt,
   Bruno M/0000-0001-5281-3263; de Oliveira Aguiar Soares, Rodrigo
   Dian/0000-0002-3390-7990; /0000-0002-1434-7676
FU DECIT/MS/CNPq/BRNational Council for Scientific and Technological
   Development (CNPq) [576062/2008-1]; FAPEMIG/BRMinas Gerais State
   Research Foundation (FAPEMIG) [CBB - APQ-3073-4.01/07]; CNPq/BRNational
   Council for Scientific and Technological Development (CNPq)
   [472554/2007-7]; PPSUS/MS/CNPq/FAPEMIG/SES-MGNational Council for
   Scientific and Technological Development (CNPq)Minas Gerais State
   Research Foundation (FAPEMIG) [CBB-APQ-00356-10]; CNPqNational Council
   for Scientific and Technological Development (CNPq); FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG)
FX This study was supported by the DECIT/MS/CNPq/BR/grant 576062/2008-1,
   FAPEMIG/BR/grant CBB - APQ-3073-4.01/07, CNPq/BR/grant 472554/2007-7 and
   PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10. ABR and MC are
   grateful to the CNPq for fellowships. The FAPEMIG sponsored WCV
   scholarships (Doctor Degree - Programa de Pos-Graduacao em
   Parasitologia, Universidade Federal de Minas Gerais). The funders had no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x
   [Anonymous], 2006, MAN VIG CONTR LEISHM
   Borges BKA, 2008, CAD SAUDE PUBLICA, V24, P777, DOI 10.1590/S0102-311X2008000400007
   Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53
   Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001
   Borges BKA, 2009, ARQ BRAS MED VET ZOO, V61, P1035, DOI 10.1590/S0102-09352009000500004
   Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001
   Cabrera Maria Alice A., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P79, DOI 10.1590/S0036-46652003000200005
   Costa CHN, 2005, ANN TROP MED PARASIT, V99, P229, DOI 10.1179/136485905X28018
   Malaquias LCC, 2007, PARASITOL RES, V100, P233, DOI 10.1007/s00436-006-0259-z
   COURAVITAL W, 2011, VET J IN PRESS
   D'Andrea LAZ, 2009, J VENOM ANIM TOXINS, V15, P305, DOI 10.1590/S1678-91992009000200012
   de Andrade HM, 2006, VET PARASITOL, V140, P231, DOI 10.1016/j.vetpar.2006.03.031
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015
   Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5
   Galvez R, 2010, VET PARASITOL, V169, P327, DOI 10.1016/j.vetpar.2009.11.025
   HARHAY MO, 2011, TRENDS PARASITOL
   *IBGE, 2000, CENS DEM 2000 AGR SE
   Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2
   Lachaud L, 2002, PARASITOLOGY, V125, P197, DOI 10.1017/S0031182002002081
   Lopes EGP, 2010, ARQ BRAS MED VET ZOO, V62, P1062, DOI 10.1590/S0102-09352010000500007
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Margonari C, 2006, MEM I OSWALDO CRUZ, V101, P31, DOI 10.1590/S0074-02762006000100007
   Sanchez JM, 2009, EMERG INFECT DIS, V15, P795, DOI 10.3201/eid1505.080969
   Mohebali M, 2005, VET PARASITOL, V129, P243, DOI 10.1016/j.vetpar.2005.01.010
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   Monteiro EM, 2005, REV SOC BRAS MED TRO, V38, P147, DOI 10.1590/S0037-86822005000200004
   Moreira ED, 2004, VET PARASITOL, V122, P245, DOI 10.1016/j.vetpar.2004.05.019
   Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393
   Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002
   Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4
   Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006
   Oliveira CD, 2006, REV PANAM SALUD PUBL, V20, P369, DOI 10.1590/S1020-49892006001100002
   Oliveira CDL, 2008, CAD SAUDE PUBLICA, V24, P2953, DOI 10.1590/S0102-311X2008001200026
   OLIVEIRA GGS, 1993, MEM I OSWALDO CRUZ, V88, P243, DOI 10.1590/S0074-02761993000200011
   PBH, 2010, PERC POS LEISHM VISC
   Quaresma PF, 2009, ACTA TROP, V111, P289, DOI 10.1016/j.actatropica.2009.05.008
   Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363
   Rabe-Hesketh S., 2005, MULTILEVEL LONGITUDI
   Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Rondon FCM, 2008, VET PARASITOL, V155, P24, DOI 10.1016/j.vetpar.2008.04.014
   Sideris V, 1996, PARASITE, V3, P125
   Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001
   Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022
   Strauss-Ayali D, 2004, J INFECT DIS, V189, P1729, DOI 10.1086/383281
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008
   Werneck Guilherme L., 2002, Cad. Saúde Pública, V18, P633, DOI [10.1590/S0102-311X2002000300012, 10.1590/S0102-311X2002000300007]
NR 51
TC 82
Z9 82
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2011
VL 5
IS 8
AR e1291
DI 10.1371/journal.pntd.0001291
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 814TJ
UT WOS:000294479800039
PM 21858243
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Fausto, MA
   Carneiro, M
   Antunes, CMF
   Colosimo, EA
   Pinto, JA
AF Fausto, Maria Arlene
   Carneiro, Mariangela
   Antunes, Carlos Mauricio F.
   Colosimo, Enrico Antonio
   Pinto, Jorge Andrade
TI Longitudinal anthropometric assessment of infants born to HIV-1-infected
   mothers, Belo Horizonte, Southeastern Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Infant; Body Weights and Measures; Growth and Development; HIV
   Infections; Infectious Disease Transmission; Vertical; Cohort Studies
ID HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; IN-UTERO EXPOSURE;
   SAO-PAULO STATE; GROWTH VELOCITY; HIV; ZIDOVUDINE; INFECTION; FAILURE;
   PREVENTION
AB OBJECTIVE: To evaluate the growth parameters in infants who were born to HIV-1-infected mothers.
   METHODS: The study was a longitudinal evaluation of the z-scores for the weight-for-age (WAZ), weight-for-length (WLZ) and length-for-age (LAZ) data collected from a cohort. A total of 97 non-infected and 33 HIV-infected infants born to HIV-1-infected mothers in Belo Horizonte, Southeastern Brazil, between 1995 and 2003 was studied. The average follow-up period for the infected and non-infected children was 15.8 months (variation: 6.8 to 18.0 months) and 14.3 months (variation: 6.3 to 18.6 months), respectively. A mixed-effects linear regression model was used and was fitted using a restricted maximum likelihood.
   RESULTS: There was an observed decrease over time in the WAZ, LAZ and WLZ among the infected infants. At six months of age, the mean differences in the WAZ, LAZ and WLZ between the HIV-infected and non-infected infants were 1.02, 0.59, and 0.63 standard deviations, respectively. At 12 months, the mean differences in the WAZ, LAZ and WLZ between the HIV-infected and non-infected infants were 1.15, 1.01, and 0.87 standard deviations, respectively.
   CONCLUSIONS: The precocious and increasing deterioration of the HIV-infected infants' anthropometric indicators demonstrates the importance of the early identification of HIV-infected infants who are at nutritional risk and the importance of the continuous assessment of nutritional interventions for these infants.
C1 [Fausto, Maria Arlene] Univ Fed Ouro Preto, Dept Alimentos, Escola Nutr, Ouro Preto, MG, Brazil.
   [Carneiro, Mariangela; Antunes, Carlos Mauricio F.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30130100 Belo Horizonte, MG, Brazil.
   [Colosimo, Enrico Antonio] Univ Fed Minas Gerais, Dept Estat, Inst Ciencias Exatas, Belo Horizonte, MG, Brazil.
   [Pinto, Jorge Andrade] Univ Fed Minas Gerais, Dept Pediat, Fac Med, Belo Horizonte, MG, Brazil.
RP Pinto, JA (corresponding author), Univ Fed Minas Gerais, Dept Pediat, Fac Med, Av Alfredo Balena 190,Sala 161 St Efigneia, BR-30130100 Belo Horizonte, MG, Brazil.
EM jpinto@medicina.ufmg.br
RI Pinto, Jorge A/D-1743-2014
OI Pinto, Jorge A/0000-0003-2987-3238
CR [Anonymous], 1994, MMWR Recomm Rep, V43, P1
   ARMITAGE P, 1995, STAT METHODS MED RES
   Arpadi SM, 2000, J NUTR, V130, P2498
   Berhane R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e7
   Briand N, 2006, PEDIATR INFECT DIS J, V25, P325, DOI 10.1097/01.inf.0000207398.10466.0d
   Carey VJ, 2004, STAT MED, V23, P509, DOI 10.1002/sim.1578
   Chotpitayasunondh T, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e5
   Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151
   Succi RCD, 2007, CAD SAUDE PUBLICA, V23, pS379, DOI 10.1590/S0102-311X2007001500006
   Fausto MA, 2009, PUBLIC HEALTH NUTR, V12, P783, DOI 10.1017/S136898000800267X
   Ibieta MF, 2009, AN PEDIATR, V71, P299, DOI 10.1016/j.anpedi.2009.06.019
   HENDERSON RA, 1997, NUTRITION, V13, P269, DOI DOI 10.1016/S0899-9007(97)82626-3
   Joao EC, 2003, AIDS, V17, P1853, DOI [10.1097/01.aids.0000076326.42412.7a, 10.1097/00002030-200308150-00016]
   Kakehasi FM, 2008, MEM I OSWALDO CRUZ, V103, P351, DOI 10.1590/S0074-02762008000400007
   Matida LH, 2005, AIDS, V19, pS37, DOI 10.1097/01.aids.0000191489.59112.13
   Miller TL, 2001, PEDIATRICS, V108, P1287, DOI 10.1542/peds.108.6.1287
   Moye J, 1996, J PEDIATR-US, V128, P58, DOI 10.1016/S0022-3476(96)70428-6
   Newell ML, 2003, PEDIATRICS, V111
   Tess BH, 1998, J ACQ IMMUN DEF SYND, V19, P189, DOI 10.1097/00042560-199810010-00014
   Verbeke G, 2000, SPRINGER SERIES STAT
   Verweel G, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e25
   World Health Organisation, 1995, WHO TECHN REP SER, V854
NR 22
TC 2
Z9 2
U1 0
U2 4
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 2011
VL 45
IS 4
BP 652
EP 660
DI 10.1590/S0034-89102011005000040
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 794XM
UT WOS:000292934600003
PM 21670861
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Ercole, FF
   Chianca, TCM
   Duarte, D
   Starling, CEF
   Carneiro, M
AF Ercole, Flavia Falci
   Machado Chianca, Tania Couto
   Duarte, Denise
   Ferreira Starling, Carlos Ernesto
   Carneiro, Mariangela
TI Surgical Site Infection in Patients Submitted to Orthopedic Surgery: The
   NNIS Risk Index and Risk Prediction
SO REVISTA LATINO-AMERICANA DE ENFERMAGEM
LA English
DT Article
DE Nursing; Epidemiology; Orthopedic Procedures; Surgical Wound Infection;
   Risk Index
ID CENTERS
AB The applicability of the risk index for surgical site infection of the National Nosocomial Infection Surveillance (NNIS) has been evaluated for its performance in different surgeries. In some procedures, it is necessary to include other variables to predict. Objective: to evaluate the applicability of the NNIS index for prediction of surgical site infection in orthopedic surgeries and to propose an alternative index. The study involved a historical cohort of 8236 patients who had been submitted to orthopaedic surgery. Statistical analysis was performed using multivariate logistic regression to fit the model. The incidence of infection was 1.41%. Prediction models were evaluated and compared to the NNIS index. The proposed model was not considered a good predictor of infection, despite moderately stratified orthopedic surgical patients in at least three of the four scores. The alternative model scored higher than the NNIS models in the prediction of infection.
C1 [Ercole, Flavia Falci; Machado Chianca, Tania Couto] Univ Fed Minas Gerais, Escola Enfermagem, Belo Horizonte, MG, Brazil.
   [Duarte, Denise] Univ Fed Minas Gerais, Inst Ciencias Exatas, Belo Horizonte, MG, Brazil.
   [Ferreira Starling, Carlos Ernesto] Hosp Vera Cruz Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
RP Ercole, FF (corresponding author), Rua Bernardino de Campos 50-702, BR-30430350 Belo Horizonte, MG, Brazil.
EM flavia.ercole@gmail.com; tchianca@hotmail.com; denisedsma@gmail.com;
   cstarling@task.com.br; mcarneir@icb.ufmg.br
OI Ercole, Flavia/0000-0002-1356-0854
CR Agencia Nacional de Vigilancia Sanitaria (BR), 2009, CRIT NAC INF REL ASS
   Centers for Diseases Control and Prevention, 2009, NAT HEALTHC SAF NETW
   Conway William A Jr, 2003, Mich Health Hosp, V39, P40
   De Oliveira AC, 2006, AM J INFECT CONTROL, V34, P201, DOI 10.1016/j.ajic.2005.12.011
   Dolinger EJOV, 2008, THESIS U FEDERAL UBE
   Ercole Flávia Falci, 2002, Rev. Latino-Am. Enfermagem, V10, P157, DOI 10.1590/S0104-11692002000200006
   Freitas P F, 2000, Rev Assoc Med Bras (1992), V46, P359, DOI 10.1590/S0104-42302000000400037
   Friedman DN, 2005, AM J INFECT CONTROL, V33, P180
   Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860
   GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536
   HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   HOSMER J, 1989, APPL LOGISTIC REGRES
   Knobben BAS, 2006, J HOSP INFECT, V62, P174, DOI 10.1016/j.jhin.2005.08.007
   Maksimovic J, 2008, CROAT MED J, V49, P58, DOI 10.3325/cmj.2008.1.58
   Maksimovic Jadranka, 2006, Vojnosanit Pregl, V63, P725, DOI 10.2298/VSP0608725M
   Nichols Ronald Lee, 2004, Clin Med Res, V2, P115
   Roy MC, 2000, INFECT CONT HOSP EP, V21, P186, DOI 10.1086/501741
   Starling CEF, 1997, AM J INFECT CONTROL, V25, P303, DOI 10.1016/S0196-6553(97)90022-5
   Starling CEF, 1996, REV CIR INFANTIL, V6, P181
   *STAT, 2003, STAT STAT SOFTW REL
   Vernet E, 2004, MED CLIN-BARCELONA, V122, P92, DOI 10.1157/13056822
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   Zumiotti AV, 2004, ACTA ORTOP BRAS, V12, P23
NR 24
TC 13
Z9 16
U1 0
U2 12
PU UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO
PI RIBEIRAO PRETO
PA AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL
SN 1518-8345
J9 REV LAT-AM ENFERM
JI Rev. Latino-Am. Enfermagem
PD MAR-APR
PY 2011
VL 19
IS 2
BP 269
EP 276
DI 10.1590/S0104-11692011000200007
PG 8
WC Nursing
SC Nursing
GA 764LO
UT WOS:000290631200007
PM 21584372
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Machado, AS
   Andrade, GMQ
   Januario, JN
   Fernandes, MD
   Carneiro, ACAV
   Carneiro, M
   Carellos, EVM
   Romanelli, RMC
   Vasconcelos-Santos, DV
   Vitor, RWA
AF Machado, Anderson S.
   Andrade, Glaucia M. Q.
   Januario, Jose N.
   Fernandes, Matheus D.
   Carneiro, Ana Carolina A. V.
   Carneiro, Mariangela
   Carellos, Ericka V. M.
   Romanelli, Roberta M. C.
   Vasconcelos-Santos, Daniel V.
   Vitor, Ricardo W. A.
TI IgG and IgM western blot assay for diagnosis of congenital toxoplasmosis
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE congenital toxoplasmosis; western blot; macular toxoplasmosis
ID EARLY POSTNATAL DIAGNOSIS; IMMUNOGLOBULIN-M; GONDII
AB The aim of this study was to evaluate the utility of western blot (WB) analysis as a diagnostic tool for congenital toxoplasmosis in 215 newborn infants. The children were submitted to clinical examinations to assess macular, neurological and hearing signals. The WB results obtained were compared to the persistence of IgG antibodies at the end of 12 months, which is regarded as the "gold standard" diagnosis of congenital toxoplasmosis. Association between the WB results and the clinical signs presented by the infants was also assessed. Of the 215 children, 177 had a confirmed congenital toxoplasmosis diagnosis and 38 were uninfected. IgG-WB showed a sensitivity of 73.5% and a specificity of 97.4%. IgM-WB showed a sensitivity of 54.8% and a specificity of 94.7%. The IgG-WB and IgM-WB combination increased the sensitivity to 86.5%. The IgM-WB-positive children had a 1.4-fold greater risk of presenting active macular lesions than did those that were IgM-WB-negative. This study showed that the WB assay is a useful tool to confirm a diagnosis of congenital toxoplasmosis and that the IgM-WB-positive results can indicate active macular lesions in newborn infants.
C1 [Machado, Anderson S.; Fernandes, Matheus D.; Carneiro, Ana Carolina A. V.; Carneiro, Mariangela; Vitor, Ricardo W. A.] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Andrade, Glaucia M. Q.; Januario, Jose N.; Carellos, Ericka V. M.; Romanelli, Roberta M. C.; Vasconcelos-Santos, Daniel V.] Univ Fed Minas Gerais, Fac Med, BR-31270901 Belo Horizonte, MG, Brazil.
RP Vitor, RWA (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM ricardovitor@icb.ufmg.br
RI Januario, Jose Nelio/Y-7825-2019; Vitor, Ricardo/B-8924-2013;
   Vasconcelos-Santos, Daniel V/D-3576-2013; Romanelli, Roberta
   M/H-4124-2018
OI Vasconcelos-Santos, Daniel V/0000-0002-6747-2024; Romanelli, Roberta
   M/0000-0002-1660-0751
FU Secretaria do Estado de Sa de de Minas Gerais; FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG) [CBB-APQ-00129-09]; CNPqNational Council
   for Scientific and Technological Development (CNPq) [301110/2009-3]
FX Financial support: Secretaria do Estado de Sa de de Minas Gerais,
   FAPEMIG (CBB-APQ-00129-09), CNPq (301110/2009-3)
CR Andrushchenko ZN, 2008, J PLASMA PHYS, V74, P21, DOI 10.1017/S0022377807006484
   CHUMPITAZI BFF, 1995, J CLIN MICROBIOL, V33, P1479, DOI 10.1128/JCM.33.6.1479-1485.1995
   DESMONTS G, 1990, LANCET, V336, P1017, DOI 10.1016/0140-6736(90)92485-Z
   Ferreira AD, 2006, INFECT GENET EVOL, V6, P22, DOI 10.1016/j.meegid.2004.12.004
   Gilbert RE, 2002, J MED SCREEN, V9, P135, DOI 10.1136/jms.9.3.135
   Jones J, 2003, AM FAM PHYSICIAN, V67, P2131
   McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029
   Pinon JM, 1996, J CLIN MICROBIOL, V34, P579, DOI 10.1128/JCM.34.3.579-583.1996
   Pinon JM, 2001, J CLIN MICROBIOL, V39, P2267, DOI 10.1128/JCM.39.6.2267-2271.2001
   Press C, 2005, J CLIN MICROBIOL, V43, P3481, DOI 10.1128/JCM.43.7.3481-3483.2005
   Remington JS, 2004, J CLIN MICROBIOL, V42, P941, DOI 10.1128/JCM.42.3.941-945.2004
   Rilling V, 2003, EUR J CLIN MICROBIOL, V22, P174, DOI 10.1007/s10096-003-0906-6
   Robert-Gangneux F, 1999, J CLIN MICROBIOL, V37, P2893, DOI 10.1128/JCM.37.9.2893-2898.1999
   Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042
   Vitor RWA, 1999, VET PARASITOL, V81, P259, DOI 10.1016/S0304-4017(98)00251-9
NR 15
TC 9
Z9 9
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2010
VL 105
IS 6
BP 757
EP 761
DI 10.1590/S0074-02762010000600005
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 663JS
UT WOS:000282883300005
PM 20944989
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Carneiro, ACAV
   Carneiro, M
   Gouveia, AMG
   Vilas-Boas, LS
   Vitor, RWA
AF Carneiro, A. C. A. V.
   Carneiro, M.
   Gouveia, A. M. G.
   Vilas-Boas, L. S.
   Vitor, R. W. A.
TI Seroprevalence and risk factors of sheep toxoplasmosis in Minas Gerais,
   Brazil
SO REVUE DE MEDECINE VETERINAIRE
LA English
DT Article
DE Toxoplasma gondii; sheep; seroprevalence; indirect immunofluorescence
   test; ELISA; IgG avidity; risk factors; age
ID GONDII INFECTION; IGG AVIDITY; PREVALENCE; FREQUENCY
AB Serum samples from 711 sheep from 109 farms in Minas Gerais State, Brazil, were investigated for determining the Toxoplasma gondii seroprevalence using ELISA (enzyme-linked immunosorbent assay) and IFAT (indirect fluorescence antibody test). The T gondii seroprevalence was 31.1% and 43.2% by ELISA and IFAT, respectively. Among the positive ELISA sheep sera, 19% of samples contained low avidity IgG, suggesting the occurrence of the recent phase of toxoplasmosis in Minas Gerais. Animals' age, sex, breed, geographic origin and others variables associated with T gondii infection were analyzed as risk factors for toxoplasmosis but only the age was significantly associated with the parasite disease, the older animals (age over 36 months) being more frequently infected than young ones (OR = 1.45, 95% CI: 1.20 - 1.74).
C1 [Carneiro, A. C. A. V.; Carneiro, M.; Vilas-Boas, L. S.; Vitor, R. W. A.] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gouveia, A. M. G.] Univ Fed Minas Gerais, Dept Vet Prevent Med, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
RP Vitor, RWA (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
EM ricardovitor@icb.ufmg.br
RI Vitor, Ricardo/B-8924-2013
FU Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Instituto Mineiro
   de Agropecuaria (IMA)
FX This work was supported by Conselho Nacional de Desenvolvimento e
   Pesquisa (CNPq) and Instituto Mineiro de Agropecuaria (IMA). We thank
   Rosalida Estevan Nazar Lopes for technical assistance. RWAV is Research
   Fellow from the CNPq.
CR Buxton D, 2007, VET PARASITOL, V149, P25, DOI 10.1016/j.vetpar.2007.07.003
   Caballero-Ortega H, 2008, PARASITOLOGY, V135, P1385, DOI 10.1017/S0031182008004873
   Caballero-Ortega H, 2008, PARASITOLOGY, V135, P897, DOI 10.1017/S0031182008004460
   Clementino MM, 2007, VET PARASITOL, V146, P199, DOI 10.1016/j.vetpar.2007.02.036
   Dubey JP, 2008, INT J PARASITOL, V38, P999, DOI 10.1016/j.ijpara.2007.11.012
   Figliuolo LPC, 2004, VET PARASITOL, V123, P161, DOI 10.1016/j.vetpar.2004.06.006
   Garcia J. L., 1999, Ciencia Rural, V29, P91, DOI 10.1590/S0103-84781999000100017
   Gondim LFP, 1999, VET PARASITOL, V82, P273, DOI 10.1016/S0304-4017(99)00033-3
   Ueno TEH, 2009, TROP ANIM HEALTH PRO, V41, P547, DOI 10.1007/s11250-008-9220-8
   Klun I, 2006, VET PARASITOL, V135, P121, DOI 10.1016/j.vetpar.2005.08.010
   Morley EK, 2008, PARASITOLOGY, V135, P169, DOI 10.1017/S0031182007003721
   Natale A., 2007, Parassitologia (Rome), V49, P235
   Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001
   Sager H, 2003, PARASITOL RES, V91, P171, DOI 10.1007/s00436-003-0964-9
   Seyffert N, 2010, RES VET SCI, V88, P50, DOI 10.1016/j.rvsc.2009.07.002
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   van der Puije WNA, 2000, ACTA TROP, V76, P21, DOI 10.1016/S0001-706X(00)00084-X
   Vitor RWA, 1999, VET PARASITOL, V81, P259, DOI 10.1016/S0304-4017(98)00251-9
NR 18
TC 7
Z9 8
U1 0
U2 1
PU ECOLE NATIONALE VETERINAIRE TOULOUSE
PI TOULOUSE CEDEX 3
PA 23 CHEMIN DES CAPELLES, 31076 TOULOUSE CEDEX 3, FRANCE
SN 0035-1555
EI 2258-0646
J9 REV MED VET-TOULOUSE
JI Rev. Med. Vet.
PD NOV
PY 2009
VL 160
IS 11
BP 527
EP 531
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 534OK
UT WOS:000272906800006
DA 2020-12-08
ER

PT J
AU Maia, MMM
   Fausto, MA
   Vieira, ELM
   Benetton, MLFN
   Carneiro, M
AF Maia, M. M. M.
   Fausto, M. A.
   Vieira, E. L. M.
   Benetton, M. L. F. N.
   Carneiro, M.
TI Intestinal parasitic infection and associated risk factors, among
   children presenting at outpatient clinics in Manaus, Amazonas state,
   Brazil
SO ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
LA English
DT Article
ID SOCIOECONOMIC-FACTORS; ASCARIS-LUMBRICOIDES; NUTRITIONAL-STATUS;
   PREVALENCE; CITY; DISPAR
AB In a cross-sectional study, the prevalences of intestinal parasitic infection and the associated risk factors were explored among children aged 0-10 years attending outpatient clinics in Manaus, the capital city of the north Brazilian state of Amazonas. Data indicating socio-economic level and demographic factors were collected in interviews with the accompanying parent or guardian of each child. Parasitic infections were detected by the microscopical examination of faecal samples, while nutritional status was categorized by reference to the growth curves published by the U. S. National Center for Health Statistics. The data collected were analysed in a mixed, logistic-regression model.
   Of the 451 children tested, 58.7% were found to have intestinal parasitic infection, the most prevalent parasites being Giardia lamblia (21.5%), Endolimax nana (17.9%), Entamoeba histolytica/Entamoeba dispar (13.7%), Ascaris lumbricoides (13.5%) and Trichuris trichiura (4.9%). The prevalences of stunting, underweight and wasting among the children were 17.5%, 14.7% and 9.8%, respectively. There was no association between intestinal parasite infection and any of these indicators of malnutrition. Children whose accompanying parent/guardian was poorly educated and the elder children investigated were found to be at relatively high risk of intestinal parasitic infection (P<0.05 for each). Intestinal parasitic infections still clearly represent an important public-health problem in the northern region of Brazil.
C1 [Maia, M. M. M.; Vieira, E. L. M.; Carneiro, M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Programa Pos Grad Parasitol, BR-31279901 Belo Horizonte, MG, Brazil.
   [Fausto, M. A.; Benetton, M. L. F. N.] Univ Fed Ouro Preto, Escola Nutr, BR-3540000 Ouro Preto, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Programa Pos Grad Parasitol, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31279901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Vieira, Erica/A-1976-2013
OI Vieira, Erica/0000-0002-4147-5614
FU Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)Minas Gerais
   State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX This study received partial financial support from the Fundacao de
   Amparo a Pesquisa de Minas Gerais (FAPEMIG). The Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) sponsored the research
   of one of the authors (M. M. M. M.) within the Programa de PosGraduacao
   em Parasitologia at the Universidade Federal de Minas Gerais. Another
   author (M. C.) is a CNPq Research Fellow.
CR Araujo CF, 2005, REV SOC BRAS MED TRO, V38, P69, DOI 10.1590/S0037-86822005000100016
   ARAUJO CF, 2005, REV MED AERONAUTICA, V55, P40
   Benetton MLFN, 2005, T ROY SOC TROP MED H, V99, P532, DOI 10.1016/j.trstmh.2004.11.015
   Boia M N, 1999, Cad Saude Publica, V15, P497, DOI 10.1590/S0102-311X1999000300006
   Braga LL, 1998, J CLIN MICROBIOL, V36, P3044, DOI 10.1128/JCM.36.10.3044-3045.1998
   Carneiro FF, 2002, B WORLD HEALTH ORGAN, V80, P40
   FERRARONI MJR, 1991, J PEDIAT, V67, P14
   GUPTA MC, 1990, J TROP PEDIATRICS, V36, P189, DOI 10.1093/tropej/36.4.189
   Hosmer DW, 1989, APPL LOGISTIC REGRES
   Hurtado-Guerrero Ana Felisa, 2005, Acta Amaz., V35, P487, DOI 10.1590/S0044-59672005000400013
   JUNQUEIRA MIM, 2002, REV SOC BRASILEIRA M, V35, P133
   Lauritsen J, 2008, EPIDATA DATA ENTRY D
   Maia MMA, 2008, ARCH LATINOAM NUTR, V58, P234
   Nematian J, 2004, ACTA TROP, V92, P179, DOI 10.1016/j.actatropica.2004.06.010
   Neumann CG, 2004, PEDIATR ANN, V33, P658, DOI 10.3928/0090-4481-20041001-09
   Newman RD, 2001, TROP MED INT HEALTH, V6, P624, DOI 10.1046/j.1365-3156.2001.00757.x
   Okyay P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-64
   Ortiz D, 2000, Rev Panam Salud Publica, V8, P156, DOI 10.1590/S1020-49892000000800002
   Rabe-Hesketh S., 2005, MULTILEVEL LONGITUDI
   Silva RR, 2009, T ROY SOC TROP MED H, V103, P512, DOI 10.1016/j.trstmh.2008.10.019
   Smith HM, 2001, MEM I OSWALDO CRUZ, V96, P303, DOI 10.1590/S0074-02762001000300004
   Szklo M., 2000, EPIDEMIOLOGY BASICS
   Teixeira JC, 2006, EPIDEMIOL INFECT, V134, P694, DOI 10.1017/S0950268805005443
   VALLADA EP, 1993, MANUAL EXAMES FEZES
   *WHO, 1995, TECHN REP SER WHO, V854
   2007, SITUACAO MUNDIAL INF
   1992, PERFIL ESTATISTICO C
   1977, NATL CTR HLTH STAT G
NR 28
TC 15
Z9 17
U1 0
U2 0
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0003-4983
EI 1364-8594
J9 ANN TROP MED PARASIT
JI Ann. Trop. Med. Parasitol.
PD OCT
PY 2009
VL 103
IS 7
BP 583
EP 591
DI 10.1179/000349809X12459740922417
PG 9
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA 517NY
UT WOS:000271623200003
PM 19825280
DA 2020-12-08
ER

PT J
AU Moreno, EC
   Goncalves, AV
   Chaves, AV
   Melo, MN
   Lambertucci, JR
   Andrade, ASR
   Negrao-Correa, D
   Antunes, CMD
   Carneiro, M
AF Moreno, Elizabeth Castro
   Goncalves, Andrea Vieira
   Chaves, Anderson Vieira
   Melo, Maria Norma
   Lambertucci, Jose Roberto
   Ribeiro Andrade, Antero Silva
   Negrao-Correa, Deborah
   de Figueiredo Antunes, Carlos Mauricio
   Carneiro, Mariangela
TI Inaccuracy of Enzyme-Linked Immunosorbent Assay Using Soluble and
   Recombinant Antigens to Detect Asymptomatic Infection by Leishmania
   infantum
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AMERICAN VISCERAL LEISHMANIASIS; POLYMERASE-CHAIN-REACTION; DIAGNOSTIC
   METHODS; CHAGASI INFECTION; HUMAN CARRIERS; MINAS-GERAIS; URBAN AREA;
   PCR; DNA; BURDEN
AB Background: One of the most important drawbacks in visceral leishmaniasis (VL) population studies is the difficulty of diagnosing asymptomatic carriers. The aim of this study, conducted in an urban area in the Southeast of Brazil, was to evaluate the performance of serology to identify asymptomatic VL infection in participants selected from a cohort with a two-year follow-up period.
   Methodology: Blood samples were collected in 2001 from 136 cohort participants (97 positive and 39 negatives, PCR/hybridization carried out in 1999). They were clinically evaluated and none had progressed to disease from their asymptomatic state. As controls, blood samples from 22 control individuals and 8 patients with kala-azar were collected. Two molecular biology techniques (reference tests) were performed: PCR with Leishmania-generic primer followed by hybridization using L. infantum probe, and PCR with specific primer to L. donovani complex. Plasma samples were tested by ELISA using three different antigens: L. infantum and L. amazonensis crude antigens, and rK39 recombinant protein. Accuracy of the serological tests was evaluated using sensitivity, specificity, likelihood ratio and ROC curve.
   Findings: The presence of Leishmania was confirmed, by molecular techniques, in all kala-azar patients and in 117 (86%) of the 136 cohort participants. Kala-azar patients showed high reactivity in ELISAs, whereas asymptomatic individuals presented low reactivity against the antigens tested. When compared to molecular techniques, the L. amazonensis and L. infantum antigens showed higher sensitivity (49.6% and 41.0%, respectively) than rK39 (26.5%); however, the specificity of rK39 was higher (73.7%) than L. amazonensis (52.6%) and L. infantum antigens (36.8%). Moreover, there was low agreement among the different antigens used (kappa<0.10).
   Conclusions: Serological tests were inaccurate for diagnosing asymptomatic infections compared to molecular methods; this could lead to misclassification bias in population studies. Therefore, studies which have used serological assays to estimate prevalence, to evaluate intervention programs or to identify risk factors for Leishmania infection, may have had their results compromised.
C1 [Moreno, Elizabeth Castro; Goncalves, Andrea Vieira; Chaves, Anderson Vieira; Melo, Maria Norma; Negrao-Correa, Deborah; de Figueiredo Antunes, Carlos Mauricio; Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Programa Posgrad Parasitol, Belo Horizonte, MG, Brazil.
   [Moreno, Elizabeth Castro] Fundacao Nacl Saude, Belo Horizonte, MG, Brazil.
   [Lambertucci, Jose Roberto; de Figueiredo Antunes, Carlos Mauricio; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
   [Ribeiro Andrade, Antero Silva] Comissao Nacl Energia Nucl, Ctr Desenvolvimento Tecnol Nucl, Belo Horizonte, MG, Brazil.
RP Moreno, EC (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Programa Posgrad Parasitol, Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Moreno, Elizabeth/X-5554-2018; Chaves, Anderson Vieira/AAB-2717-2019
OI Moreno, Elizabeth/0000-0002-8434-2483; Chaves, Anderson
   Vieira/0000-0002-0934-1763
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [CNPq-474709/2003-5]; Fundacao de Amparo a Pesquisa de Minas GeraisMinas
   Gerais State Research Foundation (FAPEMIG) [FAPEMIG-CDS-400/03];
   UNDP/World Bank/WHO Special Programme for Research and Training in
   Tropical Diseases [A30406]
FX Partially supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq-474709/2003-5), Fundacao de Amparo a Pesquisa de Minas
   Gerais (FAPEMIG-CDS-400/03), and UNDP/World Bank/WHO Special Programme
   for Research and Training in Tropical Diseases (TDR-No. A30406). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anam K, 1999, INFECT IMMUN, V67, P6663
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313
   Bern C, 2007, AM J TROP MED HYG, V76, P909
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Caldas A J, 2001, Rev Soc Bras Med Trop, V34, P445, DOI 10.1590/S0037-86822001000500007
   Chappuis F, 2006, BMJ-BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C
   Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   Costa JM, 1996, J CLIN MICROBIOL, V34, P1831, DOI 10.1128/JCM.34.7.1831-1833.1996
   CUNHA S, 1995, T ROY SOC TROP MED H, V89, P155, DOI 10.1016/0035-9203(95)90474-3
   de Andrade ASR, 2001, ACTA TROP, V78, P261, DOI 10.1016/S0001-706X(01)00081-X
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015
   Fakhar M, 2008, ANN TROP MED PARASIT, V102, P577, DOI 10.1179/136485908X337526
   Gama MEA, 2004, MEM I OSWALDO CRUZ, V99, P889, DOI 10.1590/S0074-02762004000800018
   Knottnerus JA, 2002, EVIDENCE BASE CLIN D
   Martin-Sanchez J, 2004, AM J TROP MED HYG, V70, P545, DOI 10.4269/ajtmh.2004.70.545
   *MIN SAUD, 2006, LEISHM VISC AM DISTR
   Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002
   Moreno EC, 2006, REV SOC BRAS MED TRO, V39, P421, DOI 10.1590/S0037-86822006000500001
   PAMPIGLIONE S, 1974, T ROY SOC TROP MED H, V68, P447, DOI 10.1016/0035-9203(74)90067-4
   PIARROUX R, 1994, J CLIN MICROBIOL, V32, P746, DOI 10.1128/JCM.32.3.746-749.1994
   PIARROUX R, 1993, AM J TROP MED HYG, V49, P364, DOI 10.4269/ajtmh.1993.49.364
   Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005
   Riera C, 2004, T ROY SOC TROP MED H, V98, P102, DOI 10.1016/S0035-9203(03)00015-4
   Tavares C.A., 2003, EXPERT REV MOL DIAGN, V35, P89
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   Werneck GL, 2002, ACTA TROP, V83, P13, DOI 10.1016/S0001-706X(02)00058-X
NR 31
TC 32
Z9 32
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2009
VL 3
IS 10
AR e536
DI 10.1371/journal.pntd.0000536
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 522XF
UT WOS:000272032800013
PM 19841736
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Fausto, MA
   Carneiro, M
   Antunes, CMF
   Colosimo, EA
   Pinto, JA
AF Fausto, Maria Arlene
   Carneiro, Mariangela
   Antunes, Carlos Mauricio F.
   Colosimo, Enrico Antonio
   Pinto, Jorge A.
TI Longitudinal growth of infants born to HIV-1-infected mothers in Belo
   Horizonte, Brazil
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Cohort study; HIV/AIDS; Weight and length growth; Mixed-effects linear
   regression
ID VELOCITY; WEIGHT; HEIGHT
AB Objective:. To prospectively evaluate growth parameters assessed by weight and length in infected and uninfected infants born to HIV-1-infected mothers and followed from birth to 18 months.
   Methods: A cohort consisting of ninety-seven uninfected and forty-two infected infants born to HIV-infected mothers enrolled from 1995 to 2004, and admitted during their first 3 months of life at a referral Pediatric AIDS Clinic in Belo Horizonte, Brazil. infants were followed until 18 months of age. Data were analysed using mixed-effects linear regression models for weight and length fitted by restricted maximum likelihood.
   Results: Infected infants contributed to 466 weight and 411 recumbent length measurements. Uninfected infants provided 924 weight and 907 length measurements. Mean birth weight and length were similar in both groups, 3.1 (SD 0.4) Infected and and 3.0 (SD 0.5) kg, and 48.7 (SD 1.4) and 48.8 (SD 2.9) cm for uninfected infants, respectively. However, HIV-1 infection had an early impact in growth impairment: at 6 months of age, HINT-infected children were 1 kg lighter and 2 cm shorter than the Uninfected.
   Conclusions: Growth faltering in weight, but not length, in HIV-infected children in Brazil is more marked than that reported in a European cohort, probably reflecting background nutritional deficiencies and concomitant infections. In these settings, early and aggressive nutritional management in HIV-1-infected infants should be a priority intervention associated with the antiretroviral therapy.
C1 [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, BR-35400000 Ouro Preto, MG, Brazil.
   [Carneiro, Mariangela; Antunes, Carlos Mauricio F.] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Epidemiol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Colosimo, Enrico Antonio] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estatist, Belo Horizonte, MG, Brazil.
   [Pinto, Jorge A.] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil.
RP Fausto, MA (corresponding author), Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, BR-35400000 Ouro Preto, MG, Brazil.
EM mariaarlenefausto@hotmail.com
RI Pinto, Jorge A/D-1743-2014
OI Pinto, Jorge A/0000-0003-2987-3238
CR Armitage P, 2002, STAT METHODS MED RES
   Arpadi SM, 2000, J NUTR, V130, P2498
   Berhane R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e7
   Carey VJ, 2004, STAT MED, V23, P509, DOI 10.1002/sim.1578
   Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P1
   Chearskul S, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e25
   Diggle P, 1994, ANAL LONGITUDINAL DA, Vxi
   Guillen S, 2007, PEDIATR INFECT DIS J, V26, P334, DOI 10.1097/01.inf.0000257427.19764.ff
   HENDERSON RA, 1997, NUTRITION, V13, P269, DOI DOI 10.1016/S0899-9007(97)82626-3
   *MATHSOFT INC, 1999, S PLUS 2000 PROF ED
   *MIN SAUD, 2004, SER MAN MIN SAUD, V18
   *MIN SAUD, 2005, B EP AIDS DST, V1
   Moye J, 1996, J PEDIATR-US, V128, P58, DOI 10.1016/S0022-3476(96)70428-6
   Nachman SA, 2005, PEDIATR INFECT DIS J, V24, P352, DOI 10.1097/01.inf.0000157095.75081.43
   Newell ML, 2003, PEDIATRICS, V111
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   *STAT CORP, 1999, STAT STAT SOFTW REL
   *UNAIDS, 2004, 4 UNAIDS
   VERVEEL G, 2002, PEDIATRICS, V109, pE25
   World Health Organisation, 1995, WHO TECHN REP SER, V854
NR 20
TC 7
Z9 7
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JUN
PY 2009
VL 12
IS 6
BP 783
EP 788
DI 10.1017/S136898000800267X
PG 6
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 459FU
UT WOS:000267087400006
PM 18503725
OA Green Accepted, Bronze
DA 2020-12-08
ER

PT J
AU Luz, ZMP
   Carneiro, M
   Schall, V
   Rabello, A
AF Luz, Zelia M. P.
   Carneiro, Mariangela
   Schall, Virginia
   Rabello, Ana
TI The organization of health services and visceral leishmaniasis: an
   integrated intervention to improve diagnosis and treatment
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Visceral Leishmaniasis; Health Services; Lethality
ID URBAN OUTBREAK
AB The objective of this study, carried out in municipalities located in a metropolitan region of Brazil, was to promote the early diagnosis and prompt treatment of visceral leishmaniasis. In the intervention model a health professional underwent training that covered all procedures involved in assisting patients with suspected visceral leishmaniasis. The professionals then returned to their municipalities where they implemented a workplan with the following aims: (a) at least one physician able to diagnose and treat patients; (b) training of professionals for the laboratorial diagnosis of visceral leishmaniasis; (c) delivery of information on visceral leishmaniasis to the health workers. The implementation process was evaluated by follow-up meetings. Attendance of health professionals at the meetings, implementation of the workplan, and the visceral leishmaniasis case fatality rate before (1998-1999) and after (2001-2002) implementation of the model were used in the analysis. Among the 36 municipalities in the region, 22 were enrolled. Eight (36.3%) guaranteed at least 50% attendance in the meetings, and 14 (63.6%) had less than 50% attendance with no activities implemented. The fatality rate decreased in the municipalities that implemented the activities.
C1 [Luz, Zelia M. P.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Ctr Referencia Leishmaniose, Lab Pesquisa Clin, BR-30190002 Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
RP Luz, ZMP (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Ctr Referencia Leishmaniose, Lab Pesquisa Clin, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM profeta@cpqrr.fiocruz.br
CR [Anonymous], 2006, MAN VIG CONTR LEISHM
   CONTANDRIOPOULOS A-P., 2000, AVALIACAO SAUDE MODE, P29
   Costa C H, 2001, Rev Soc Bras Med Trop, V34, P223
   Costa CHN, 2005, ANN TROP MED PARASIT, V99, P229, DOI 10.1179/136485905X28018
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8
   FERREIRA CSV, 2005, AVALIACAO SAUDE MODE, P103
   Gyorkos TW, 2003, ACTA TROP, V86, P275, DOI 10.1016/S0001-706X(03)00048-2
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Luz Z. M. P., 2005, CAD SAUDE PUBLICA, V21, P608
   Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510
   Profeta da Luz Z M, 2001, Rev Soc Bras Med Trop, V34, P249, DOI 10.1590/S0037-86822001000300004
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104
   *SPEC PROGR RES TR, STRAT DIR LEISHM RES
   Werneck GL, 2002, ACTA TROP, V83, P13, DOI 10.1016/S0001-706X(02)00058-X
   *WHO, 1990, TECHN REP SER, V793
NR 16
TC 6
Z9 6
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2009
VL 25
IS 5
BP 1176
EP 1183
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 455RW
UT WOS:000266783300024
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Silva, RR
   da Silva, CAM
   Pereira, CAD
   Nicolato, RLD
   Negrao-Correa, D
   Lamounier, JA
   Carneiro, M
AF Silva, Roberta Ribeiro
   Mariano da Silva, Camilo Adalton
   de Jesus Pereira, Cintia Aparecida
   de Carvalho Nicolato, Roney Luiz
   Negrao-Correa, Deborah
   Lamounier, Joel Alves
   Carneiro, Mariangela
TI Association between nutritional status, environmental and socio-economic
   factors and Giardia lamblia infections among children aged 6-71 months
   in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Giardia lamblia; Nutritional status; Children; Risk factors;
   Cross-sectional study; Brazil
ID INTESTINAL PARASITIC INFECTIONS; PRESCHOOL-CHILDREN; RISK-FACTORS; CITY;
   DUODENALIS
AB A cross-sectional study was conducted on a randomised sample of 405 children aged 6-71 months in Brazil to investigate the association between nutritional status, environmental and socio-economic factors and Giardia lamblia infection. Data collection entailed an interview, anthropometric measurements and the collection of faeces and venous blood samples. The analysis was performed using multivariate logistic regression. The prevalence rate for G. lamblia was 26.3%. Nutritional status evaluation showed that 7.9% of the children had chronic malnutrition and 11.1% had acute malnutrition. The risk factors associated with infection by G. lamblia were an age of 2 years or older [odds ratio (OR) = 2.4], living in a two-bedroom house or smaller (OR = 2.3), living among a family of five or more people (OR = 2.4) and living in a house without access to a sewerage system (OR = 2.1). Non-participation in the social service programme was associated with a tower risk of infection (OR = 0.2). The model adjusted for age, including only biochemical and nutritional variables, showed weak associations with G. lamblia infection for two variables: inadequate animal protein intake according to the Dietary Reference Intake recommendation and low haemoglobin concentration. The sociodemographic and environmental risk factors classically described were associated with G. lamblia infection, but nutritional variables were only weakly associated with it. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [Silva, Roberta Ribeiro; de Jesus Pereira, Cintia Aparecida; Negrao-Correa, Deborah; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva, Roberta Ribeiro] Univ Fed Alfenas, Dept Nutr, BR-37130000 Alfenas, MG, Brazil.
   [Mariano da Silva, Camilo Adalton] Univ Fed Ouro Preto, Escola Nutr, Dept Nutr Clin & Social, BR-35400000 Ouro Preto, MG, Brazil.
   [de Carvalho Nicolato, Roney Luiz] Univ Fed Ouro Preto, Escola Farm, BR-35400000 Ouro Preto, MG, Brazil.
   [Lamounier, Joel Alves] Univ Fed Minas Gerais, Escola Med, Dept Pediat, BR-30130100 Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Ave Antonio Carlos 6627,Campus Pampulha,Caixa Pos, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
OI Silva, Camilo Adalton Mariano/0000-0002-5683-9556
FU Fundacao de Amparo a Pesquisas do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This study was partially funded by Fundacao de Amparo a Pesquisas do
   Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq). Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) granted a
   scholarship to RRS (Doctor Degree, Programa de Pos Graduacao em
   Parasitologia - Epidemiologia das Doencas Infecciosas e Parasitarias,
   Universidade Federal de Minas Gerais): MC, DNC and JAL are CNPq
   Researches Fellows.
CR Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   *CDC, 2000, WHAT IS EPI INF
   Costamagna S. R., 2002, Parasitologia Latinoamericana, V57, P103
   *FOOD NUTR BOARD I, 2000, DIET REF INT APPL DI
   *FUND JOAO PINH, 2008, HUM DEV IND
   Hadler Maria Claret C.M., 2002, J. Pediatr. (Rio J.), V78, P321, DOI 10.1590/S0021-75572002000400012
   Heller L, 2004, EPIDEMIOL SERV SAUDE, V13, P79
   Hoffman W. A., 1934, Puerto Rico Journal of Public Health & Tropical Medicine, V9, P283
   Hosmer DW, 1989, APPL LOGISTIC REGRES
   Katz DE, 2001, GASTROENTEROL CLIN N, V30, P797, DOI 10.1016/S0889-8553(05)70211-9
   Lebwohl B, 2003, GASTROINTEST ENDOSC, V57, P906, DOI 10.1016/S0016-5107(03)70028-5
   Marcos L., 2003, Parasitologia Latinoamericana, V58, P35
   Muniz-Junqueira Maria Imaculada, 2002, Rev. Soc. Bras. Med. Trop., V35, P133, DOI 10.1590/S0037-86822002000200002
   Neumann CG, 2004, PEDIATR ANN, V33, P658, DOI 10.3928/0090-4481-20041001-09
   Newman RD, 2001, TROP MED INT HEALTH, V6, P624, DOI 10.1046/j.1365-3156.2001.00757.x
   Northrop-Clewes CA, 2001, AM J CLIN NUTR, V73, P53
   Okyay P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-64
   *OMS, 1968, SER INF TECN OMS, V405
   Prado MS, 2003, EPIDEMIOL INFECT, V131, P899, DOI 10.1017/S0950268803001018
   Sackey ME, 2003, J TROP PEDIATRICS, V49, P17, DOI 10.1093/tropej/49.1.17
   Sadjjadi SM, 2005, IRAN J PUBLIC HEALTH, V34, P51
   Santos Margarete Aparecida, 2005, Rev. Nutr., V18, P331, DOI 10.1590/S1415-52732005000300005
   SAWAYA AL, 1990, J TROP PEDIATRICS, V36, P184, DOI 10.1093/tropej/36.4.184
   Teixeira JU, 2007, CAD SAUDE PUBLICA, V23, P1489, DOI 10.1590/S0102-311X2007000600024
   Thompson RCA, 2000, INT J PARASITOL, V30, P1259, DOI 10.1016/S0020-7519(00)00127-2
   *UNICEF, 2006, SIT MUND INF
   WHO, 1998, CONTR TROP DIS
   World Health Organization, 2001, IR DEF AN ASS PREV C, P115
   ZABOTTO CB, 1996, REGISTRO FOTOGRAFICO
   CENSO DEMOGRAFICO 20
NR 30
TC 30
Z9 32
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY
PY 2009
VL 103
IS 5
BP 512
EP 519
DI 10.1016/j.trstmh.2008.10.019
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 442EI
UT WOS:000265822400015
PM 19054535
DA 2020-12-08
ER

PT J
AU Carneiro, ACAV
   Carneiro, M
   Gouveia, AMG
   Guimaraes, AS
   Marques, APR
   Vilas-Boas, LS
   Vitor, RWA
AF Carneiro, A. C. A. V.
   Carneiro, M.
   Gouveia, A. M. G.
   Guimaraes, A. S.
   Marques, A. P. R.
   Vilas-Boas, L. S.
   Vitor, R. W. A.
TI Seroprevalence and risk factors of caprine toxoplasmosis in Minas
   Gerais, Brazil
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Toxoplasma gondii; Goats; ELISA; IgG avidity; Epidemiology;
   Seroprevalence; Risk factors
ID GONDII INFECTION; DOMESTIC GOATS; IGG AVIDITY; PREVALENCE; ANTIBODIES;
   SHEEP; PROVINCE
AB The objective of this work was to carry out a study on caprine toxoplasmosis in the state of Minas Gerais, Brazil. To determine the prevalence of toxoplasmosis in goats in Minas Gerais, 767 sera from goats were tested by ELISA (enzyme-linked immunosorbent assay) and IFAT (indirect fluorescence antibody test). The prevalence of antibodies to Toxoplasma gondii was 43.0% and 46.0% by ELISA and IFAT, respectively. It was observed that 26.8% of the goats show low-avidity IgG to T. gondii. These results suggest the presence of animals in recent phase of toxoplasmosis in Minas Gerais. The risk factors for toxoplasmosis in goats were: age over 36 months (OR = 1.21; IC 95% 1.02-1.44), use of pen (OR = 1.83; IC 95%1.01-3.31) and pure breed animals (OR = 2.49; IC 95% 1.11-5.59). (C) 2008 Elsevier B.V. All rights reserved.
C1 [Carneiro, A. C. A. V.; Carneiro, M.; Vilas-Boas, L. S.; Vitor, R. W. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gouveia, A. M. G.; Guimaraes, A. S.; Marques, A. P. R.] Univ Fed Minas Gerais, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
RP Vitor, RWA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
EM ricardovitor@icb.ufmg.br
RI Guimaraes, Alessandro/H-3454-2013; Vitor, Ricardo/B-8924-2013
FU Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq)
FX This work was supported by Conselho Nacional de Desenvolvimento e
   Pesquisa (CNPq). We thank Rosalida Estevan Nazar Lopes for technical
   assistance. RWAV is Research Fellow from the CNPq.
CR AMARAL V, 1978, BIOLOGICO, V45, P331
   Bahia M. T., 1995, Brazilian Journal of Veterinary Research and Animal Science, V32, P11
   Bisson A, 2000, ACTA TROP, V76, P33, DOI 10.1016/S0001-706X(00)00086-3
   Borde G, 2006, J VET MED B, V53, P188, DOI 10.1111/j.1439-0450.2006.00931.x
   Cavalcante ACR, 2008, ARQ BRAS MED VET ZOO, V60, P36, DOI 10.1590/S0102-09352008000100006
   CHIARI C D A, 1987, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V39, P587
   Clementino MM, 2007, VET PARASITOL, V146, P199, DOI 10.1016/j.vetpar.2007.02.036
   Dubey J.P., 1988, P1
   DUBEY JP, 1990, J AM VET MED ASSOC, V196, P259
   Figliuolo LPC, 2004, SMALL RUMINANT RES, V55, P29, DOI 10.1016/j.smallrumres.2003.12.013
   Figueiredo JF, 2001, MEM I OSWALDO CRUZ, V96, P687, DOI 10.1590/S0074-02762001000500019
   Gondim LFP, 1999, VET PARASITOL, V82, P273, DOI 10.1016/S0304-4017(99)00033-3
   Iqbal J, 2007, J MED MICROBIOL, V56, P1495, DOI 10.1099/jmm.0.47260-0
   Jittapalapong S, 2005, VET PARASITOL, V127, P17, DOI 10.1016/j.vetpar.2004.08.019
   Mainardi Rodrigo Soares, 2003, Rev. Soc. Bras. Med. Trop., V36, P759, DOI 10.1590/S0037-86822003000600021
   Masala G, 2003, VET PARASITOL, V117, P15, DOI 10.1016/j.vetpar.2003.07.012
   Neto JOA, 2008, VET PARASITOL, V156, P329, DOI 10.1016/j.vetpar.2008.05.013
   OPEL U, 1991, VET PARASITOL, V40, P181, DOI 10.1016/0304-4017(91)90098-G
   Sharif M, 2007, VET J, V174, P422, DOI 10.1016/j.tvjl.2006.07.004
   SILVA AV, 2003, BRASIL CIENC RURAL, V33, P115
   Suarez-Aranda F, 2000, VET PARASITOL, V91, P23, DOI 10.1016/S0304-4017(00)00249-1
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   Teshale S, 2007, PARASITE, V14, P155, DOI 10.1051/parasite/2007142155
   van der Puije WNA, 2000, ACTA TROP, V76, P21, DOI 10.1016/S0001-706X(00)00084-X
   Vitor RWA, 1999, VET PARASITOL, V81, P259, DOI 10.1016/S0304-4017(98)00251-9
NR 25
TC 18
Z9 19
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD MAR 23
PY 2009
VL 160
IS 3-4
BP 225
EP 229
DI 10.1016/j.vetpar.2008.10.092
PG 5
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA 426GT
UT WOS:000264696700008
PM 19091475
DA 2020-12-08
ER

PT J
AU Maia, MMA
   Fausto, MA
   Vieira, ELM
   Benetton, MLFN
   Carneiro, M
AF Maia, Marcelle M. A.
   Fausto, Maria A.
   Vieira, Erica L. M.
   Benetton, Maria L. F. N.
   Carneiro, Mariangela
TI The prevalence of malnutrition and its risk factors in children
   attending outpatient clinics in the city of Manaus, Amazonas, Brazil
SO ARCHIVOS LATINOAMERICANOS DE NUTRICION
LA English
DT Article
DE Malnutrition; risk factors; children; Brazil
ID ASCARIS-LUMBRICOIDES; HEALTH; INFECTION; REGION
AB The objective of this study was to determine the prevalence of malnutrition and its risk factors in children aged 0-10 years attending outpatient clinics in Manaus, Amazonas, Brazil. A cross-sectional epidemiological study of a population of 347 children was conducted. Data concerning socio-economic levels and food consumption were obtained by interviewing the accompanying guardian of each child. Dietetic evaluation was conducted using a semi-quantitative food frequency questionnaire, and faecal samples were examined by optical microscopy. Anthropometric measurements were transformed into percentiles and z-scores, and nutritional status was evaluated by reference to National Center for Health Statistics (NCHS) and Centers for Disease Control (CDC) indicators. Factors associated with Undernutrition were analysed using a random-effects logistic regression model. The overall prevalences Of underweight. Stunting and wasting were 18.1, 15.5 and 10.7%. respectively, with reference to CDC growth Curves, and 14.3, 17.3 and 4.4%. respectively, with reference to NCHS growth Curves. The overall prevalence of wasting was statistical higher according to the CDC reference than that estimated using the NCHS reference (P = 0.02). The prevalence rate of intestinal parasites was 58.8%. Risk factors associated with malnutrition were: low educational level of guardian respondent (OR = 4.55), energy intake <54.5 kcal/kg (OR = 4.55), children in age group 6-10 years (OR = 3.54). and attendance at outpatient clinic for paediatric visit (OR = 2.71). In the Studied population, malnutrition (stunting, underweight and wasting) and parasite infection still represent serious public health problems. The risk factors identified in the present study confirm the influence of socio-economic factors on the nutritional status of children.
C1 [Maia, Marcelle M. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Maia, MMA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RI Vieira, Erica/A-1976-2013
OI Vieira, Erica/0000-0002-4147-5614
CR Benetton MLFN, 2005, T ROY SOC TROP MED H, V99, P532, DOI 10.1016/j.trstmh.2004.11.015
   Carneiro FF, 2002, B WORLD HEALTH ORGAN, V80, P40
   *CDCP NAT CTR HLTH, 2000, 2000 CDC GROWTH CHAR
   DEAN AG, 1991, AM J PREV MED, V7, P178
   Engstrom E M, 1999, Cad Saude Publica, V15, P559, DOI 10.1590/S0102-311X1999000300013
   Falcão-Gomes Renata Couto, 2006, Rev. Nutr., V19, P713, DOI 10.1590/S1415-52732006000600008
   FERRARI AA, 1998, SAO PAULO MED J, V116, P1654
   Fisberg M., 2002, DOIS FEIJAO COM ARRO
   Guimaraes L V, 1999, Cad Saude Publica, V15, P605, DOI 10.1590/S0102-311X1999000300018
   Hoffman W. A., 1934, Puerto Rico Journal of Public Health & Tropical Medicine, V9, P283
   [IBGE UNICEF], 1992, PERF EST CRIANC MAES
   [IBGE UNICEF], 1982, PERF EST CRIANC MAES
   LAURITSEN JM, 2001, EPIDATA VERSION 2 1
   MARTINS MHS, 1982, VALOR NUTR ALIMENTOS
   *NAT CTR HLTH STAT, 1997, 78 US DHEW NAT CTR H
   National Academy of Sciences Institute of Medicine Food and Nutrition Board, 2005, DIET REF INT EN CARB
   PHILIPPI SI, 1996, VIRTUAL NUTR PROGRAM
   Pinheiro A.B.V., 2000, TABELA AVALIACAO CON
   *PROGR NAC UN DES, 2003, ATL DES HUM BRAS VER
   Rabe-Hesketh S., 2005, MULTILEVEL LONGITUDI
   Ribas DLB, 1999, REV SAUDE PUBL, V33, P358, DOI 10.1590/S0034-89101999000400006
   Romani Sylvia de Azevedo Mello, 2004, Rev. Bras. Saude Mater. Infant., V4, P15, DOI 10.1590/S1519-38292004000100002
   Smith HM, 2001, MEM I OSWALDO CRUZ, V96, P303, DOI 10.1590/S0074-02762001000300004
   *SOC CIV BEM EST F, 1996, PESQ NAC DEM SAUD PN
   StataCorp, 2005, STAT STAT SOFTW REL
   Szklo M., 2000, EPIDEMIOLOGY BASICS
   WHO, 2000, TURN TID MALN RESP C
   World Health Organisation, 1995, WHO TECHN REP SER, V854
NR 28
TC 4
Z9 6
U1 0
U2 5
PU ARCHIVOS LATINOAMERICANOS NUTRICION
PI CARACAS
PA APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060,
   VENEZUELA
SN 0004-0622
J9 ARCH LATINOAM NUTR
JI Arch. Latinoam. Nutr.
PD SEP
PY 2008
VL 58
IS 3
BP 234
EP 240
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 384HJ
UT WOS:000261735600004
PM 19137985
DA 2020-12-08
ER

PT J
AU Kakehasi, FM
   Pinto, JA
   Romanelli, RMD
   Carneiro, M
   Cardoso, CS
   Tavares, MDT
   Melo, VH
   de Aguiar, RALP
AF Kakehasi, Fabiana Maria
   Pinto, Jorge A.
   de Castro Romanelli, Roberta Maia
   Carneiro, Mariangela
   Cardoso, Carolina Silva
   Teatini Tavares, Maria do Carmo
   Melo, Victor Hugo
   Lopes Pessoa de Aguiar, Regina Amelia
TI Determinants and trends in perinatal human immunodeficiency virus type 1
   (HIV-1) transmission in the metropolitan area of Belo Horizonte, Brazil:
   1998-2005
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE HIV-1; vertical transmission; pregnant women; antiretroviral therapy
ID TO-CHILD TRANSMISSION; SAO-PAULO STATE; INTRAPARTUM TRANSMISSION;
   ANTIRETROVIRAL THERAPY; VERTICAL TRANSMISSION; HIV-1-INFECTED WOMEN;
   ORAL ZIDOVUDINE; PREGNANT-WOMEN; COTE-DIVOIRE; RISK
AB Significant decrease in human immunodeficiency virus type 1 (HIV-1) vertical transmission has been observed worldwide in centers where interventions such as antiretroviral therapy ( ART), elective cesarean section, and avoidance of breastfeeding have been implemented. This prospective cohort study aimed to assess the determinants of and the temporal trends in HIV-1 vertical transmission in the metropolitan area of Belo Horizonte, Brazil from January 1998 to December 2005. The rate of HIV-1 vertical transmission decreased from 20% in 1998 to 3% in 2005. This decline was associated with increased use of more complex ART regimens during pregnancy. Multivariate analysis restricted to clinical variables demonstrated that non ART, neonatal respiratory distress/sepsis and breastfeeding were independently associated with HIV-1 vertical transmission. When laboratory parameters were included in the model, high maternal viral load and non maternal ART were associated with HIV-1 vertical transmission. The results from this study confirm the impact of ART in the reduction of HIV-1 vertical transmission and indicate the need for improvement in the care and monitoring of mother and infant pairs affected by HIV-1.
C1 [Pinto, Jorge A.] Univ Fed Minas Gerais, Dept Pediat, BR-30130100 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Grp Aids Maternoinfantil, BR-30130100 Belo Horizonte, MG, Brazil.
   [Melo, Victor Hugo; Lopes Pessoa de Aguiar, Regina Amelia] Univ Fed Minas Gerais, Dept Obstet & Ginecol, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30130100 Belo Horizonte, MG, Brazil.
   [Teatini Tavares, Maria do Carmo] Ctr Treinamento & Referencia Doencas Infecciosas, Secretaria Saude Prefeitura Municipal Belo Horizo, Belo Horizonte, MG, Brazil.
RP Pinto, JA (corresponding author), Univ Fed Minas Gerais, Dept Pediat, Av Alfredo Balena 190,S-161, BR-30130100 Belo Horizonte, MG, Brazil.
EM jpinto@medicina.ufmg.br
RI Romanelli, Roberta M/H-4124-2018; Pinto, Jorge A/D-1743-2014
OI Romanelli, Roberta M/0000-0002-1660-0751; Pinto, Jorge
   A/0000-0003-2987-3238
CR BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   *CDCP, 1992, MMWR-MORBID MORTAL W, V41
   Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P1
   CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801
   Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009
   Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2
   Succi RCD, 2007, CAD SAUDE PUBLICA, V23, pS379, DOI 10.1590/S0102-311X2007001500006
   Dominguez KL, 2003, JAIDS-J ACQ IMM DEF, V33, P232, DOI 10.1097/00126334-200306010-00019
   Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189
   *EMDC, 1999, LANCET, V353, P1035
   Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602
   Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287
   Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7
   Hosmer DW, 2002, STAT MED, V21, P2723, DOI 10.1002/sim.1200
   *IPHIVG, 1999, NEW ENGL J MED, V340, P977
   Joao EC, 2003, AIDS, V17, P1853, DOI [10.1097/01.aids.0000076326.42412.7a, 10.1097/00002030-200308150-00016]
   Kalish LA, 1997, J INFECT DIS, V175, P712, DOI 10.1093/infdis/175.3.712
   Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500
   Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016
   Matida LH, 2005, AIDS, V19, pS37, DOI 10.1097/01.aids.0000191489.59112.13
   Mayaux MJ, 1997, J INFECT DIS, V175, P172, DOI 10.1093/infdis/175.1.172
   *MS, 2007, PROGR NAC DST AIDS M, V4
   Nduati R, 2001, LANCET, V357, P1651, DOI 10.1016/S0140-6736(00)04820-0
   Newell ML, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-60
   Nogueira S A, 2001, Braz J Infect Dis, V5, P78
   Read JS, 2007, OBSTET GYNECOL, V109, P1358, DOI 10.1097/01.AOG.0000265211.76196.ac
   Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076
   Saba J, 2002, LANCET, V359, P1178
   Semba RD, 1997, ACTA PAEDIATR, V86, P107
   Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7
   Szyld EG, 2006, AIDS, V20, P2345, DOI 10.1097/01.aids.0000253362.01696.9d
   Taha TE, 2004, JAMA-J AM MED ASSOC, V292, P202, DOI 10.1001/jama.292.2.202
   Taha TE, 1997, BRIT MED J, V315, P216, DOI 10.1136/bmj.315.7102.216
   Tess BH, 1998, J ACQ IMMUN DEF SYND, V19, P189, DOI 10.1097/00042560-199810010-00014
   Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159
   *UNAIDS JOINT UN P, 2007, AIDS EP UPD
   Wade NA, 2004, JAIDS-J ACQ IMM DEF, V36, P1075, DOI 10.1097/00126334-200408150-00011
   *WGMTCT, 1995, J ACQ IMMUN DEF SYND, V8, P506
   Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9
NR 40
TC 19
Z9 22
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2008
VL 103
IS 4
BP 351
EP 357
DI 10.1590/S0074-02762008000400007
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 331AE
UT WOS:000257984300007
PM 18660989
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Fausto, MA
   Carneiro, M
   Antunes, CMD
   Pinto, JA
   Colosimo, EA
AF Fausto, Maria Arlene
   Carneiro, Mariangela
   de Figueiredo Antunes, Carlos Mauricio
   Pinto, Jorge Andrade
   Colosimo, Enrico A.
TI Mixed linear regression model for longitudinal data: application to an
   unbalanced anthropometric data set
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE linear models; likelihood functions; anthropometry; growth
AB A longitudinal data set is characterized by a time sequence of two or more observations from each individual. In cohort studies, these data are usually not balanced. A data set related to longitudinal height measurements in children of HIV-infected mothers was recorded at the university hospital of the Federal University in Minas Gerais, Brazil. The objective was to assess the application of the mixed effect model to this unbalanced data set. At six months of age, on average boys were 1.8cm taller than girls, and seroreverter infants were 2.9cm taller than their HIV+ peers. At 12 months of age, on average boys were 2.4cm taller than girls and seroreverter children were 3.5cm taller than HIV+ ones. In addition to describing longitudinal height behavior, this model also includes the growth rate estimation for this infant population by gender and group.
C1 [Colosimo, Enrico A.] Univ Fed Minas Gerais, Inst Ciencias Exata, Dept Estat, BR-31270901 Belo Horizonte, MG, Brazil.
   [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Ouro Preto, Brazil.
   [Carneiro, Mariangela; de Figueiredo Antunes, Carlos Mauricio] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pinto, Jorge Andrade] Univ Fed Minas Gerais, Fac Med, BR-31270901 Belo Horizonte, MG, Brazil.
RP Colosimo, EA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Exata, Dept Estat, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM enricoc@est.ufmg.br
RI Pinto, Jorge A/D-1743-2014
OI Pinto, Jorge A/0000-0003-2987-3238
CR BELLOCO R, 2001, ANAL LONGITUDINAL DA
   Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P1
   Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E
   Diggle P, 1994, ANAL LONGITUDINAL DA, Vxi
   Draper NR, 1998, APPL REGRESSION ANAL
   EKUMA O, 2004, RANDOM EFFECTS MODEL
   Goldstein H, 2002, STAT MED, V21, P3291, DOI 10.1002/sim.1264
   KER HW, APPL LINEAR MIXED EF
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267
   MOLENBERGHS G, REV LINEAR MIXED MOD
   Pinheiro J.C., 1995, LME NLME MIXED EFFEC
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   Royston P, 1991, STATA TECH B, V3, P7
   SKRONDAL A, 2003, NORWEGIAN J EPIDEMIO, V265, P78
   Verbeke G., 2000, LINEAR MIXED MODELS
   World Health Organisation, 1995, WHO TECHN REP SER, V854
NR 17
TC 15
Z9 19
U1 0
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAR
PY 2008
VL 24
IS 3
BP 513
EP 524
DI 10.1590/S0102-311X2008000300005
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 275UE
UT WOS:000254096400005
PM 18327439
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Cavalcante, ACR
   Carneiro, M
   Gouveia, AMG
   Pinheiro, RR
   Vitor, RWA
AF Cavalcante, A. C. R.
   Carneiro, M.
   Gouveia, A. M. G.
   Pinheiro, R. R.
   Vitor, R. W. A.
TI Risk factors for infection by Toxoplasma gondii in herds of goats in
   Ceara, Brazil
SO ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA
LA English
DT Article
DE goat; prevalence; Toxoplasma gondii; risk factor; Ceara
ID STATE; ABORTION
AB In order to identify possible risk factors for T gondii infection in goat herds in Ceara, Brazil, 2362 serum samples were tested by ELISA. The serological prevalence was 25.1%. The risk factors identified for Toxoplasma gondii infection in goat herds were age, number of cats., use of wooden feeding troughs and absence of feeding troughs. Goats older than 37 months had 2.01 (CI 95%; 1.55 - 2.61) higher risk of infection than younger animals. Greater risk of infection was observed in farms with more than 10 cats (OR = 1.73; CI 95%; 1.01 - 3.33). The use of wooden feeding troughs represented a high probability of infection (OR = 7.81; CI 95%; 1.66 - 36.67). The lack of feeding troughs also represented a high probability of infection (OR = 5.50; CI 95%; 1.24 - 24.39).
C1 [Carneiro, M.; Vitor, R. W. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Cavalcante, A. C. R.; Pinheiro, R. R.] Embrapa Caprinos, Sobral, CE, Brazil.
   [Gouveia, A. M. G.] Univ Fed Minas Gerais, EV, Belo Horizonte, MG, Brazil.
RP Vitor, RWA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Caxia Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM ricardovitor@icb.ufmg.br
RI Vitor, Ricardo/B-8924-2013
OI Pinheiro, Raymundo Rizaldo/0000-0003-3590-6948
CR Alves C. J., 1997, Revista brasileira de Ciencia Veterinaria, V4, P75
   ASTUDILLO VM, 1979, ENCUESTAS MUESTRO ES
   Bandeira DA, 2007, ARQ BRAS MED VET ZOO, V59, P1597, DOI 10.1590/S0102-09352007000600040
   Chanton-Greutmann H, 2002, SCHWEIZ ARCH TIERH, V144, P483, DOI 10.1024/0036-7281.144.9.483
   CHIARI C D A, 1987, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V39, P587
   DEAN AG, 1992, EPIINFO WORD PROCESS
   Diggle P, 1994, ANAL LONGITUDINAL DA, Vxi
   Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005
   DUBEY JP, 1982, J AM VET MED ASSOC, V180, P1220
   DUBEY JP, 1986, J AM VET MED ASSOC, V188, P159
   Figliuolo LPC, 2004, SMALL RUMINANT RES, V55, P29, DOI 10.1016/j.smallrumres.2003.12.013
   Figueiredo JF, 2001, MEM I OSWALDO CRUZ, V96, P687, DOI 10.1590/S0074-02762001000500019
   Jittapalapong S, 2005, VET PARASITOL, V127, P17, DOI 10.1016/j.vetpar.2004.08.019
   MACHADO T M M, 1987, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V39, P255
   Pinheiro RR, 2000, ARQ BRAS MED VET ZOO, V52, P534, DOI 10.1590/S0102-09352000000500021
   SELLA MZ, 1994, REV BRAS PARASITOL V, V3, P13
   Silva Aristeu Vieira da, 2003, Cienc. Rural, V33, P115, DOI 10.1590/S0103-84782003000100018
   Silva JS, 2005, ARQ BRAS MED VET ZOO, V57, P726
   StataCorp, 2005, STAT STAT SOFTW REL
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   Vitor RWA, 1999, VET PARASITOL, V81, P259, DOI 10.1016/S0304-4017(98)00251-9
   Weigel RM, 1999, AM J TROP MED HYG, V60, P793, DOI 10.4269/ajtmh.1999.60.793
NR 22
TC 24
Z9 27
U1 0
U2 3
PU ARQUIVO BRASILEIRO MEDICINA VETERINARIA ZOOTECNIA
PI MINAS GERAIS
PA FEDERAL MINAS GERAIS CAIXA POSTAL 567-BELO HORIZ, MINAS GERAIS, BRAZIL
SN 0102-0935
EI 1678-4162
J9 ARQ BRAS MED VET ZOO
JI Arq. Bras. Med. Vet. Zootec.
PD FEB
PY 2008
VL 60
IS 1
BP 36
EP 41
DI 10.1590/S0102-09352008000100006
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA 305NX
UT WOS:000256186200006
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ferreira, ED
   de Lana, M
   Carneiro, M
   Reis, AB
   Paes, DV
   da Silva, ES
   Schallig, H
   Gontijo, CMF
AF Ferreira, Eduardo de Castro
   de Lana, Marta
   Carneiro, Mariangela
   Reis, Alexandre Barbosa
   Paes, Daniela Vieira
   da Silva, Eduardo Sergio
   Schallig, Henk
   Ferreira Gontijo, Celia Maria
TI Comparison of serological assays for the diagnosis of canine visceral
   leishmaniasis in animals presenting different clinical manifestations
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE visceral leishmaniasis; serological assays; dogs; diagnosis
ID LINKED-IMMUNOSORBENT-ASSAY; DIRECT AGGLUTINATION-TEST; INDIRECT
   IMMUNOFLUORESCENCE; SERODIAGNOSIS; BRAZIL; ELISA; ANTIBODIES; INFECTION;
   ANTIGEN; STATE
AB Three serological methods, indirect fluorescent immunoassay (IFI), enzyme-linked immunosorbent assay (ELISA) and direct agglutination test (DAT) that are commonly employed in the diagnosis of canine visceral leishmaniasis (CVL), have been assessed. A total of 234 domestic dogs, drawn from an area in the municipality of Belo Horizonte, Minas Gerais, Brazil, endemic for visceral leishmaniasis, were submitted to clinical and parasitological examinations and serological assay. Sera collected from confirmed non-infected dogs (n = 20), and from dogs with other parasitic diseases including Trypanosoma cruzi (n = 7), Leishmania braziliensis (n = 5), Toxoplasma gondii (n = 5) and Ehrlichia canis (n = 3), were also included in the study. IFI presented a lower sensitivity (72%) than ELISA (95%), although the specificities of these assays were low (52 and 64%, respectively) and both exhibited cross-reactivity with sera from dogs infected with T. cruzi, L. braziliensis and E. canis. In contrast, DAT exhibited a high sensitivity (93%) and a high specificity (95%) and cross-reacted with only one serum sample derived from an E. canis-infected dog. The reproducibilities of the ELISA and DAT assays were excellent, whilst that of IFI was considered to be acceptable. The results produced by ELISA and DAT were in complete agreement, those between ELISA and IFI were at an acceptable level of agreement, whilst the concurrence between the IFI and DAT results were either acceptable or poor depending on the clinical conditions of the group of dogs examined. Since there is no readily accessible method for the diagnosis of CVL that offers 100% specificity and sensitivity, the choice of technique employed must depend on the aim of the investigation. (C) 2007 Elsevier B.V. All rights reserved.
C1 Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   Univ Fed Ouru Preto, Ouru Preto, MG, Brazil.
   Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   Univ Fed Sao Joao Del Rei, Sao Joao Del Rei, MG, Brazil.
   Royal Trop Inst, KIT, NL-1105 AZ Amsterdam, Netherlands.
RP Gontijo, CMF (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Ave Augusto Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM gontijo@cpqrr.fiocruz.br
RI Gontijo, Celia MF/AAU-7736-2020; Silva, Eduardo/N-7254-2019
OI Silva, Eduardo/0000-0001-7409-9216; Lana, Marta/0000-0002-1565-4707;
   Ferreira, Eduardo/0000-0002-4073-6704
CR ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159
   Adler S, 1932, P R SOC LOND B-CONTA, V110, P402, DOI 10.1098/rspb.1932.0035
   ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879
   Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X
   ANDRADE CR, 1987, ANN INST PASTEUR IMM, V138, P457, DOI 10.1016/S0769-2625(87)80056-9
   BADARO R, 1986, AM J TROP MED HYG, V35, P72, DOI 10.4269/ajtmh.1986.35.72
   Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72
   Boelaert M, 1999, AM J TROP MED HYG, V60, P129, DOI 10.4269/ajtmh.1999.60.129
   Cortada VMCL, 2004, VET RES COMMUN, V28, P365, DOI 10.1023/B:VERC.0000035014.80785.b7
   Cortes S, 2004, T ROY SOC TROP MED H, V98, P12, DOI 10.1016/S0035-9203(03)00002-6
   da Costa C.A., 1991, Revista da Sociedade Brasileira de Medicina Tropical, V24, P21, DOI 10.1590/S0037-86821991000100004
   do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015
   DYE C, 1993, EPIDEMIOL INFECT, V110, P647, DOI 10.1017/S0950268800051074
   ELSAFI SH, 1989, T ROY SOC TROP MED H, V83, P334, DOI 10.1016/0035-9203(89)90493-8
   Ertabaklar H, 2005, ACTA TROP, V93, P239, DOI 10.1016/j.actatropica.2005.01.002
   EVANS TG, 1990, AM J TROP MED HYG, V42, P118, DOI 10.4269/ajtmh.1990.42.118
   Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338
   HARITH AE, 1987, T ROY SOC TROP MED H, V81, P603, DOI 10.1016/0035-9203(87)90423-8
   Lachaud L, 2002, PARASITOLOGY, V125, P197, DOI 10.1017/S0031182002002081
   MANCIANTI F, 1988, AM J VET RES, V49, P1409
   Mancianti F, 1996, VET PARASITOL, V65, P1, DOI 10.1016/0304-4017(96)00946-6
   Marzochi MC, 1997, REV SOCIEDADE BRASIL, V30, P162
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   Oskam L, 1996, FEMS IMMUNOL MED MIC, V16, P235, DOI 10.1111/j.1574-695X.1996.tb00141.x
   Rami M, 2003, PARASITE, V10, P79, DOI 10.1051/parasite/2003101p77
   Reed SG, 1996, CLIN DERMATOL, V14, P471, DOI 10.1016/0738-081X(96)00038-7
   ROFFI J, 1980, AM J TROP MED HYG, V29, P183, DOI 10.4269/ajtmh.1980.29.183
   Schallig HDFH, 2002, VET PARASITOL, V109, P1, DOI 10.1016/S0304-4017(02)00268-6
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   SILVA ES, 2006, VET RES COMMUN, V30, P637
   Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002
NR 31
TC 79
Z9 84
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD MAY 31
PY 2007
VL 146
IS 3-4
BP 235
EP 241
DI 10.1016/j.vetpar.2007.02.015
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA 171EI
UT WOS:000246717300007
PM 17403582
DA 2020-12-08
ER

PT J
AU Ercole, FF
   Starling, CEF
   Chianca, TCM
   Carneiro, M
AF Ercole, Flavia Falci
   Ferreira Starling, Carlos Ernesto
   Machado Chianca, Tania Couto
   Carneiro, Mariangela
TI Applicability of the national nosocomial infections surveillance system
   risk index for the prediction of surgical site infections: A review
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE SSI/NNIS Index; quality indicators; hospital infections; surgical
   procedures; orthopaedic operations
ID POSTOPERATIVE WOUND-INFECTION; MULTIVARIATE-ANALYSIS; GLOBAL ASPECTS;
   RATES; NNIS; HOSPITALS; EFFICACY; SURGERY; SEPSIS; ROOM
AB This review outlines the evolution of risk rates of surgical site infection adopted by the Study on the Efficacy of Nosocomial Infection Control (SENIC) and the National Nosocomial Infections Surveillance (NNIS) system, and evaluates their advantages and limitations. The types of surgical procedures for which the NNIS index has proven to be an efficient system for the classification of patients are presented. The necessity of adapting the NNIS index to take into account specific characteristics associated with hospitals and practices in various regions and countries is stressed. The requirement for further testing and development of the rate concerning specific procedures, particularly those involving orthopaedic surgery, is discussed.
C1 [Ercole, Flavia Falci; Machado Chianca, Tania Couto] Univ Fed Minas Gerais, Nurse Dept, Belo Horizonte, MG, Brazil.
   [Ferreira Starling, Carlos Ernesto] Vera Cruz Hosp, Life Ctr, Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, ICB, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Ercole, FF (corresponding author), Av Prof Afredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
EM fercole@enf.ufmg.br
OI Ercole, Flavia/0000-0002-1356-0854
CR ABRUTYN E, 1987, INFECT CONT HOSP EP, V8, P459, DOI 10.1017/S0195941700069782
   ALMEIDA FF, 2001, THESIS U FEDERAL MIN
   [Anonymous], 1996, Am J Infect Control, V24, P380
   BERARD F, 1964, Ann Surg, V160, P1
   Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991
   Brandt C, 2004, INFECT CONT HOSP EP, V25, P313, DOI 10.1086/502398
   Brewer GE, 1915, J AMER MED ASSOC, V64, P1369
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001
   CHRISTOU NV, 1987, ARCH SURG-CHICAGO, V122, P165
   Coello R, 2001, INFECT CONT HOSP EP, V22, P393, DOI 10.1086/501923
   CRUSE PJE, 1973, ARCH SURG-CHICAGO, V107, P206, DOI 10.1001/archsurg.1973.01350200078018
   CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z
   CULVER DH, 1997, INFECT CONT HOSP EP, V18, P55
   DAVIDSON AI, 1971, BRIT J SURG, V58, P333, DOI 10.1002/bjs.1800580504
   DECKER MD, 1991, INFECT CONT HOSP EP, V12, P490
   DelgadoRodriguez M, 1997, INFECT CONT HOSP EP, V18, P19
   DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743
   EHRENKRANZ NJ, 1981, AM J MED, V70, P909, DOI 10.1016/0002-9343(81)90554-4
   EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8
   Farinas-Alvarez C, 2000, INFECT CONT HOSP EP, V21, P633, DOI 10.1086/501705
   Ferraz EM, 2001, REV COL BRAS CIR, V28, P17
   FREEMAN J, 1987, INFECT CONT HOSP EP, V8, P465, DOI 10.1017/S0195941700069794
   Freitas P F, 2000, Rev Assoc Med Bras (1992), V46, P359, DOI 10.1590/S0104-42302000000400037
   Gaynes RP, 2001, INFECT CONT HOSP EP, V22, P266, DOI 10.1086/501897
   Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860
   Gaynes RP, 2000, INFECT CONT HOSP EP, V21, P184, DOI 10.1086/501740
   GOFF BH, 1925, SURG GYNECOL OBSTET, V41, P728
   GRINBAUM ES, 1994, THESIS U SAO PAULO
   GRINBAUM RS, 1999, THESIS U FEDERAL SAO
   Gulacsi L, 2000, J HOSP INFECT, V44, P43, DOI 10.1053/jhin.1999.0655
   HALEY RW, 1991, AM J MED, V91, pS145, DOI 10.1016/0002-9343(91)90360-A
   HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991
   HOOTON TM, 1981, AM J MED, V70, P960, DOI 10.1016/0002-9343(81)90562-3
   HORAN TC, 1994, INFECT CONT HOSP EP, V15, P46
   HUGHES JM, 1988, CHEMOTHERAPY, V34, P553, DOI 10.1159/000238624
   KEATS AS, 1978, ANESTHESIOLOGY, V49, P233, DOI 10.1097/00000542-197810000-00001
   KeitaPerse O, 1996, AM J INFECT CONTROL, V24, P429, DOI 10.1016/S0196-6553(96)90036-X
   LIDWELL OM, 1961, J HYG-CAMBRIDGE, V59, P259, DOI 10.1017/S0022172400038900
   LizanGarcia M, 1997, INFECT CONT HOSP EP, V18, P310
   Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620
   MARTINS MA, 2001, MANUAL INFECCAO HOSP
   Martone WJ, 1995, AM J INFECT CONTROL, V23, P377
   NETO GPB, 1992, REV COLEGIO BRASILER, V21, P216
   NETO GPB, 1986, ARS CVRANDI, V19, P48
   NICHOLS RL, 1984, NEW ENGL J MED, V311, P1065, DOI 10.1056/NEJM198410253111701
   Oliveira AC, 2002, REV SAUDE PUBL, V36, P717, DOI 10.1590/S0034-89102002000700009
   OLIVEIRA AC, 2003, THESIS U SAO PAULO
   PANNUTI CS, 1995, INFECT CONT HOSP EP, V16, P170
   Poveda Vanessa de Brito, 2003, Rev. esc. enferm. USP, V37, P81, DOI 10.1590/S0080-62342003000100010
   Ronveaux O, 1996, ACTA CHIR BELG, V96, P3
   ROY MC, 2000, INFECT CONTROL EPIDE, V3, P189
   Russo PL, 2002, INFECT CONT HOSP EP, V23, P372, DOI 10.1086/502068
   Salemi C, 1997, INFECT CONT HOSP EP, V18, P246
   Sands K, 1996, J INFECT DIS, V173, P963, DOI 10.1093/infdis/173.4.963
   SIMCHEN E, 1981, REV INFECT DIS, V3, P678
   Smyth STM, 2000, J HOSP INFECT, V45, P173, DOI 10.1053/jhin.2000.0736
   Soleto L, 2003, INFECT CONT HOSP EP, V24, P26, DOI 10.1086/502111
   Starling CEF, 1997, AM J INFECT CONTROL, V25, P303, DOI 10.1016/S0196-6553(97)90022-5
   STARLING CEF, 2005, PROGR ABSTR 12 ANN M
   STARLING CEF, 1993, VIGILANCIA EPIDEMIOL
   Starling CEF, 1996, REV CIR INFANTIL, V6, P181
   STARLING CEF, 2005, RISK FACTORS NOSOCOM
   Valls V, 1999, INFECT CONT HOSP EP, V20, P196, DOI 10.1086/501611
   VEGAS AA, 1993, MED CLIN-BARCELONA, V100, P251
   Vernet E, 2004, MED CLIN-BARCELONA, V122, P92, DOI 10.1157/13056822
   VILLAR JIB, 1999, MED CLIN-BARCELONA, V107, P767
   WENZEL RP, 1985, AM J MED, V78, P3, DOI 10.1016/0002-9343(85)90356-0
   WEY SB, 1995, INFECT CONT HOSP EP, V16, P175
   WILSON APR, 1992, SURG INFECT, V4, P6
NR 69
TC 19
Z9 20
U1 0
U2 7
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD FEB
PY 2007
VL 11
IS 1
BP 134
EP 141
DI 10.1590/S1413-86702007000100028
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA 274JM
UT WOS:000253997600028
PM 17625742
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Candiani, TMS
   Pinto, J
   Cardoso, CAA
   Carvalho, IR
   Dias, ACM
   Carneiro, M
   Goulart, EA
AF Candiani, Talitah M. S.
   Pinto, Jorge
   Araujo Cardoso, Claudete A.
   Carvalho, Inacio R.
   Dias, Arlete C. M.
   Carneiro, Mariangela
   Goulart, Eugenio A.
TI Impact of highly active antiretroviral therapy (HAART) on the incidence
   of opportunistic infections, hospitalizations and mortality among
   children and adolescents living with HIV/AIDS in Belo Horizonte, Minas
   Gerais State, Brazil
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE highly active antiretroviral therapy; oppurtunist infections; HIV
ID HUMAN-IMMUNODEFICIENCY-VIRUS; COMBINATION THERAPY; TYPE-1 INFECTION;
   HIV-INFECTION; SURVIVAL; INITIATION; ILLNESSES; DISEASE; COHORT
AB The impact of highly active antiretroviral therapy (HAART) can be evaluated using indicators, such as rates of opportunistic infections, hospitalizations by cause of infection, and associated death. This study aimed to estimate the impact of HAART on the incidence of these indicators, in children and adolescents with HIV/AIDS. It was a hybrid cohort study; 371 patients were followed from 1989 to 2003. In December 2003, 76% of the patients were still being followed, while 12.1% had died, 9.5% had dropped out, and 2.4% had been transferred. The overall rate of opportunistic infections was 18.32 infections/100 persons-year and 2.63 in the pre- and post-HAART periods, respectively. In the multivariate analysis, the risk of developing an opportunistic infection was 5.4 times greater and 3.3 times greater for hospitalization risk before HAART Respiratory causes represented 65% of the hospitalizations and they were reduced by 44.6% with therapeutic intervention. The average hospital stay of 15 days was reduced to 9. There was a post-HAART decline in deaths of 38%. This study demonstrates the effectiveness of HAART in significantly reducing opportunistic infections, hospitalizations, and deaths in this Brazilian cohort.
C1 [Pinto, Jorge; Goulart, Eugenio A.] Univ Fed Minas Gerais, Dept Pediat, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [Candiani, Talitah M. S.; Pinto, Jorge; Araujo Cardoso, Claudete A.; Carvalho, Inacio R.; Dias, Arlete C. M.; Carneiro, Mariangela] Univ Fed Minas Gerais, Hosp Clin, BR-30130100 Belo Horizonte, MG, Brazil.
   [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-30130100 Belo Horizonte, MG, Brazil.
RP Pinto, J (corresponding author), Univ Fed Minas Gerais, Dept Pediat, Fac Med, Av Alferdo Balena 190,4 Andar, BR-30130100 Belo Horizonte, MG, Brazil.
EM jpinto@rnedicina.ufmg.br
RI Pinto, Jorge A/D-1743-2014
OI Pinto, Jorge A/0000-0003-2987-3238
CR [Anonymous], 1994, MMWR Recomm Rep, V43, P1
   Bernard P-M, 1987, MESURES STAT EPIDEMI
   Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010
   Canani RB, 1999, AIDS, V13, P1005, DOI 10.1097/00002030-199905280-00026
   Chaisson RE, 1998, AIDS, V12, P29, DOI 10.1097/00002030-199801000-00004
   Chakraborty Rana, 2004, Paediatr Respir Rev, V5, P132, DOI 10.1016/j.prrv.2004.01.005
   Chantry CJ, 2003, PEDIATR INFECT DIS J, V22, P1033, DOI 10.1097/01.inf.0000100575.64298.bc
   Cohen J, 2001, GASTROENTEROL CLIN N, V30, P637, DOI 10.1016/S0889-8553(05)70203-X
   *COORD NAC DST AID, B EPIDEMIOLOGICO AID
   Dankner WM, 2001, PEDIATR INFECT DIS J, V20, P40, DOI 10.1097/00006454-200101000-00008
   Detels R, 2001, AIDS, V15, P347, DOI 10.1097/00002030-200102160-00008
   Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024
   Dufour V, 2004, LUNG, V182, P331, DOI 10.1007/s00408-004-2513-4
   Fallo Aurelia A., 2002, International Journal of Infectious Diseases, V6, P9, DOI 10.1016/S1201-9712(02)90129-3
   Finkelstein DM, 1996, J ACQ IMMUN DEF SYND, V12, P38, DOI 10.1097/00042560-199605010-00006
   Granados JMS, 2003, PEDIATR INFECT DIS J, V22, P863, DOI 10.1097/01.inf.0000091282.70253.5f
   Holmes CB, 2003, CLIN INFECT DIS, V36, P652, DOI 10.1086/367655
   Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220
   Lederman MM, 2000, JAMA-J AM MED ASSOC, V284, P223, DOI 10.1001/jama.284.2.223
   Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012
   MATIDA LH, B EPIDEMIOLOGICO AID, P49
   *MIN SAUD, 2004, CRIT DEF CAS AIDS AD
   Mocroft A, 2004, HIV MED, V5, P437, DOI 10.1111/j.1468-1293.2004.00250.x
   Nachman S, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1847
   Powderly WG, 1999, AIDS, V13, P1603, DOI 10.1097/00002030-199909100-00001
   Powderly WG, 1998, JAMA-J AM MED ASSOC, V280, P72, DOI 10.1001/jama.280.1.72
   Schmidt-Westhausen AM, 2000, J ORAL PATHOL MED, V29, P336, DOI 10.1034/j.1600-0714.2000.290708.x
   Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56
   Sterling TR, 2003, J INFECT DIS, V188, P1659, DOI 10.1086/379741
   SZKLO M, 2000, EP BAS
   Viani RM, 2004, CLIN INFECT DIS, V39, P725, DOI 10.1086/423178
NR 31
TC 36
Z9 40
U1 0
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2007
VL 23
SU 3
BP S414
EP S423
DI 10.1590/S0102-311X2007001500009
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 271RV
UT WOS:000253807300009
PM 17992347
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Moreno, EC
   Melo, MN
   Lambertucci, JR
   Serufo, JC
   Andrade, ASR
   Antunes, CMF
   Genaro, O
   Carneiro, M
AF Moreno, Elizabeth Castro
   Melo, Maria Norma
   Lambertucci, Jose Roberto
   Serufo, Jose Carlos
   Andrade, Antero S. R.
   Antunes, Carlos Mauricio F.
   Genaro, Odair
   Carneiro, Mariangela
TI Diagnosing human asymptomatic visceral leishmaniasis in an urban area of
   the State of Minas Gerais, using serological and molecular biology
   techniques
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE asymptomatic visceral leishmaniasis; Leishmania chagasi; prevalence
   rate; diagnostic; hybridization
ID POLYMERASE-CHAIN-REACTION; BLOOD-DONORS; CHAGASI INFECTION; SUBCLINICAL
   FORM; ENDEMIC AREA; BRAZIL; PCR; DNA; RISK; ANTIGEN
AB A population-based cross-sectional study was set up in Sabara country, Southeastern Brazil, to identify asymptomatic human visceral leishmaniasis in an urban area of low disease prevalence. Blood was collected on filter paper (n=1,604 inhabitants) and examined by indirect immunofluorescent test, enzyme-linked immunosorbent assay and immunochromatographic strip test. The prevalence rates of infection ranged from 2.4 to 5.6% depending on the test used One year later, venous blood was collected in a subset of 226 participants (102 seropositive and 124 seronegative). The tests performed were IFAT, ELISA, rk39-ELISA, polymerase chain reaction and hybridization with Leishmania donovani complex probe. No clinical signs or symptoms of leishmaniasis were observed Using hybridization as a reference test, the sensitivity and specificity of serology were respectively: 24.8 and 71% (ELISA); 26.3 and 76.3% (rk-39); 30.1 and 63.4% (IFAT). Due to disagreements, different criteria were tested to define the infection and hybridization should be considered in epidemiological studies.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31279901 Belo Horizonte, MG, Brazil.
   Fdn Nacl Saude, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Fac Med, Dept Clin Med, BR-31279901 Belo Horizonte, MG, Brazil.
   Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31279901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
CR BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Caldas A J, 2001, Rev Soc Bras Med Trop, V34, P445, DOI 10.1590/S0037-86822001000500007
   CAMARGO ME, 1969, AM J TROP MED HYG, V18, P500, DOI 10.4269/ajtmh.1969.18.500
   CANCADO JR, 2002, REV INST MED TROP SP, V1, P29
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   Costa JM, 1996, J CLIN MICROBIOL, V34, P1831, DOI 10.1128/JCM.34.7.1831-1833.1996
   CUNHA S, 1995, T ROY SOC TROP MED H, V89, P155, DOI 10.1016/0035-9203(95)90474-3
   de Andrade ASR, 2001, ACTA TROP, V78, P261, DOI 10.1016/S0001-706X(01)00081-X
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Gama MEA, 2004, MEM I OSWALDO CRUZ, V99, P889, DOI 10.1590/S0074-02762004000800018
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Junior AD, 1997, MEM I OSWALDO CRUZ, V92, P15, DOI 10.1590/S0074-02761997000100003
   KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0
   le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999
   Martin-Sanchez J, 2004, AM J TROP MED HYG, V70, P545, DOI 10.4269/ajtmh.2004.70.545
   Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002
   NUZUM E, 1995, J INFECT DIS, V171, P751, DOI 10.1093/infdis/171.3.751
   Otero ACS, 2000, AM J TROP MED HYG, V62, P128, DOI 10.4269/ajtmh.2000.62.128
   PAMPIGLIONE S, 1974, T ROY SOC TROP MED H, V68, P447, DOI 10.1016/0035-9203(74)90067-4
   PIARROUX R, 1994, J CLIN MICROBIOL, V32, P746, DOI 10.1128/JCM.32.3.746-749.1994
   Riera C, 2004, T ROY SOC TROP MED H, V98, P102, DOI 10.1016/S0035-9203(03)00015-4
   Sackett DL, 1991, CLIN EPIDEMIOLOGY BA
   SANTOS FR, 1993, HUM GENET, V90, P655
   SHAW J. J., 1964, TRANS ROY SOC TROP MED HYG, V58, P349, DOI 10.1016/0035-9203(64)90203-2
   Silva ES, 2001, AM J TROP MED HYG, V65, P896, DOI 10.4269/ajtmh.2001.65.896
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X
   Vieira J B, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P85
   VOLLER A, 1976, T ROY SOC TROP MED H, V70, P98, DOI 10.1016/0035-9203(76)90163-2
NR 35
TC 34
Z9 35
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2006
VL 39
IS 5
BP 421
EP 427
DI 10.1590/S0037-86822006000500001
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 106RH
UT WOS:000242117900001
PM 17160317
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Moreno, EC
   Melo, MN
   Genaro, O
   Lambertucci, JR
   Serufo, JC
   Andrade, ASR
   Antunes, CMF
   Carneiro, M
AF Moreno, EC
   Melo, MN
   Genaro, O
   Lambertucci, JR
   Serufo, JC
   Andrade, ASR
   Antunes, CMF
   Carneiro, M
TI Risk factors for Leishmania chagasi infection in an urban area of Minas
   Gerais State
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE visceral leishmaniasis; Kala-Azar; Leishmania chagasi; asymptomatic
   infection; risk factors
ID VISCERAL LEISHMANIASIS
AB In order to understand the determinants of human infection by Leishmania chagasi in an urban area, a cross-sectional population based study was conducted using molecular and serologic methods to identify infection. Participants were interviewed using a pre-coded questionnaire. Two criteria were tested to identify risk factors: Model 1- including all participants positive in hybridization by Leishmania donovani complex probe; Model 2- including all participants positive for hybridization and at least one serologic test. in Model 1, the variables associated with infection were: ownership of birds, time spent outside house between 6:00-10:00 PM and garbage not collected. In Model 2, the variables associated with infection were: family with knowledge of the vector, garbage not collected, garbage not removed or buried, ownership of birds and eroded areas in the neighborhood. The risk factors identified were associated with household conditions, presence of animals and the likelihood of contact with phlebotomine sandflies.
C1 Univ Fed Minas Gerais, ICB, Dept Parasitol, BR-31279901 Belo Horizonte, MG, Brazil.
   Fdn Nacl Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Clin Med, Fac Med, Belo Horizonte, MG, Brazil.
   Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, ICB, Dept Parasitol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31279901 Belo Horizonte, MG, Brazil.
EM mcarneir@mono.icb.ufmg.br
CR Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485
   Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   Caldas A J, 2001, Rev Soc Bras Med Trop, V34, P445, DOI 10.1590/S0037-86822001000500007
   CALDAS AJM, 2001, T R SOC TROP MED HYG, V95, P1
   CALLADO ES, 2001, REV SOCIEDADE BRA S3, V34, P151
   Costa C H, 2001, Rev Soc Bras Med Trop, V34, P223
   de Andrade ASR, 2001, ACTA TROP, V78, P261, DOI 10.1016/S0001-706X(01)00081-X
   DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198
   DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032
   HOSMER DW, 1999, APPL LOGISTIC REGRES
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Junior AD, 1997, MEM I OSWALDO CRUZ, V92, P15, DOI 10.1590/S0074-02761997000100003
   Kelsey J, 1996, METHODS OBSERVATIONA
   KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0
   LAINSON R, 1983, T ROY SOC TROP MED H, V77, P569, DOI 10.1016/0035-9203(83)90185-2
   MORENO EC, 2002, THESIS U FEDERAL MIN
   Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023
   PAMPIGLIONE S, 1974, T ROY SOC TROP MED H, V68, P447, DOI 10.1016/0035-9203(74)90067-4
   Profeta da Luz Z M, 2001, Rev Soc Bras Med Trop, V34, P249, DOI 10.1590/S0037-86822001000300004
   SANTOS FR, 1993, HUM GENET, V90, P655
   Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X
   TESH RB, 1995, AM J TROP MED HYG, V52, P287, DOI 10.4269/ajtmh.1995.52.287
   Vieira J B, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P85
   Werneck GL, 2002, ACTA TROP, V83, P13, DOI 10.1016/S0001-706X(02)00058-X
   *WHO EXP COMM, 1990, WHO TECHN REP SER, V793
   WIJEYARATNE PM, 1994, ACTA TROP, V56, P349, DOI 10.1016/0001-706X(94)90106-6
NR 29
TC 44
Z9 46
U1 0
U2 3
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2005
VL 38
IS 6
BP 456
EP 463
DI 10.1590/S0037-86822005000600002
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 000KU
UT WOS:000234461500002
PM 16410918
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Benetton, MLFN
   Goncalves, AV
   Meneghini, MEF
   Silva, EF
   Carneiro, M
AF Benetton, MLFN
   Goncalves, AV
   Meneghini, MEF
   Silva, EF
   Carneiro, M
TI Risk factors for infection by the Entamoeba histolytica/E. dispar
   complex: An epidemiological study conducted in outpatient clinics in the
   city of Manaus, Amazon Region, Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE amoebiasis; Entamoeba histolytica; Entamoeba dispar; risk factors;
   Brazil
ID AMEBIASIS
AB An epidemiological study was conducted on a population attending outpatient clinics in Manaus, Amazon, Brazil to determine the prevalences of infection by the Entamoeba histolytica/E. dispar complex and by E. histolytica alone, as well as to identify the risk factors involved in transmission. The study was conducted in two phases: survey and case-control. Face-to-face interviews were carried out and faecal samples collected from 1578 individuals. Faeces were examined by optical microscopy and tested for the pathogenic E. histolytica specific antigen. Positivity to E. histolytica/E. dispar was 21.5% (340 cases). Cases were compared with 340 control samples, negative for the E. histotytica/E. dispar complex based on examination by optical microscopy. The analysis was conducted by logistic regression. The risk factors identified were: place of residence, age, ingestion of raw vegetables, quality of water consumed, number of rooms and bedrooms per house, and having other protozoan infections. Specific antigen detection tests identified 22 participants infected by E. histolytica (6.8%) among those positive for E. histolytica/E. dispar. There was a higher proportion of mates among participants infected by E. histolytica than among those with E. dispar infections. The study population was asymptomatic or presented non-specific symptoms that could be attributed to amoebiasis. (c) 2005 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Amazonas, Dept Parasitol, Manaus, Amazonas, Brazil.
   Univ Fed Amazonas, Dept Anal Clin & Toxocol, Manaus, Amazonas, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Avenida Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
CR Acuna-Soto R, 2000, AM J GASTROENTEROL, V95, P1277, DOI 10.1111/j.1572-0241.2000.01525.x
   Blessmann J, 2002, AM J TROP MED HYG, V66, P578, DOI 10.4269/ajtmh.2002.66.578
   Braga L L, 2001, Rev Soc Bras Med Trop, V34, P467, DOI 10.1590/S0037-86822001000500010
   Braga LL, 1996, AM J TROP MED HYG, V55, P693, DOI 10.4269/ajtmh.1996.55.693
   Braga LL, 1998, J CLIN MICROBIOL, V36, P3044, DOI 10.1128/JCM.36.10.3044-3045.1998
   Clark CG, 1998, T ROY SOC TROP MED H, V92, P361, DOI 10.1016/S0035-9203(98)91049-5
   CUNHA AS, 1991, AMEBIASES, P287
   DIAMOND LS, 1993, J EUKARYOT MICROBIOL, V40, P340, DOI 10.1111/j.1550-7408.1993.tb04926.x
   Espinosa-Cantellano M, 2000, CLIN MICROBIOL REV, V13, P318, DOI 10.1128/CMR.13.2.318-331.2000
   HAQUE R, 1998, J CLIN MICROBIOL, V41, P237
   Hosmer DW, 1989, APPL LOGISTIC REGRES
   Kobayashi Jun, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P13, DOI 10.1590/S0036-46651995000100003
   MARTINS SJ, 1994, REV SOC BRASIL ME S1, V27, P322
   Miranda R dos A, 1999, Rev Soc Bras Med Trop, V32, P389
   OYERINDE JPO, 1979, INT J EPIDEMIOL, V8, P55, DOI 10.1093/ije/8.1.55
   Pinheiro SMB, 2004, AM J TROP MED HYG, V70, P221, DOI 10.4269/ajtmh.2004.70.221
   RAVDIN JI, 1995, CLIN INFECT DIS, V20, P1453, DOI 10.1093/clinids/20.6.1453
   SCHLESSELMAN JJ, 1982, DESIGN CONDUCT ANAL
   SILVA EF, 2001, PARASITOLOGIA HUMANA, P114
   SODRE FC, 2002, REV SOC BRAS MED S1, V35, P247
   VALLADA EP, 1993, MANUAL EXAMES FEZES
   WANKE C, 1988, AM J TROP MED HYG, V38, P335, DOI 10.4269/ajtmh.1988.38.335
   WARHUST DC, 1999, PROTOZOAL DIS, P548
   *WHO, 1997, WHO PAHO UNESCO REP
NR 24
TC 33
Z9 35
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JUL
PY 2005
VL 99
IS 7
BP 532
EP 540
DI 10.1016/j.trstmh.2004.11.015
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 934NB
UT WOS:000229714400010
PM 15869773
DA 2020-12-08
ER

PT J
AU do Rosario, EY
   Genaro, O
   Franca-Silva, JC
   da Costa, RT
   Mayrink, W
   Reis, AB
   Carneiro, M
AF do Rosario, EY
   Genaro, O
   Franca-Silva, JC
   da Costa, RT
   Mayrink, W
   Reis, AB
   Carneiro, M
TI Evaluation of enzyme-linked immunosorbent assay using crude Leishmania
   and recombinant antigens as a diagnostic marker for canine visceral
   leishmaniasis
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE canine visceral leishmaniasis; Leishmania (Leishmania) chagasi;
   diagnosis; recombinant antigens
ID K-39 ANTIGEN; INDIRECT IMMUNOFLUORESCENCE; SCREENING-TEST; CHAGASI;
   ELISA; SERODIAGNOSIS; INFANTUM; VALIDATION; INFECTION; BRAZIL
AB The performances of ELISA assays with different antigen preparations, such as Leishmania amazonensis or L. chagasi lysates and the recombinant antigens rK-39 and rK-26, were compared using sera or eluates from dried blood collected on filter paper to detect anti-Leishmania antibodies in dogs from a visceral leishmaniasis-endemic area in Brazil. Of 115 IFAT-reactive dogs at 1:40 titre, 106 (92.2%) were positive in parasitological exams (skin and/or spleen). These animals were compared to healthy animals (n = 25), negative for IFAT at a titre of 1:40 and parasitological exams. The sensitivities of crude and recombinant antigens were similar and remarkably high for both sera and eluates (97-100%). Specificity was higher than 96% for sera and eluates for different antigens, except for L. chagasi antigen using eluates (88%). Concordance values among the tests were higher either for sera or eluates (J = 0.95-1.00). High concordances were observed between sera and eluates tested with different antigens (kappa = 0.93-0.97). Crude and recombinant antigens identified different clinical phases of canine leishmaniasis. These results show that eluates could be used in canine surveys to identify L. chagasi infection. Recombinant antigens added little when compared to crude antigen in identifying positive dogs. Cross-reactivity with other diseases whose distribution often overlaps VL-endemic areas is a limitation of crude antigen use however.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Ouro Preto, Nucl Pesquisas Ciencias Biol, Lab Parasitol & Histopatol, Ouro Preto, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
CR Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213
   ASHFORD DA, 1993, AM J TROP MED HYG, V48, P1
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   Bhatia A, 1999, MOL BIOCHEM PARASIT, V102, P249, DOI 10.1016/S0166-6851(99)00098-5
   Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Carvalho SFG, 2003, AM J TROP MED HYG, V68, P321
   CHIARI CA, 1987, REV BRAS MED VET ZOO, V39, P471
   Costa C H, 2001, Rev Soc Bras Med Trop, V34, P223
   Coutinho S G, 1985, Mem Inst Oswaldo Cruz, V80, P17, DOI 10.1590/S0074-02761985000100003
   Deane LM, 1962, REV INST MED TROP SP, V4, P149
   EVANS TG, 1990, AM J TROP MED HYG, V42, P118, DOI 10.4269/ajtmh.1990.42.118
   FRANCASILVA JC, 2002, VET PARASITOL, V2474, P1
   GART JJ, 1966, AM J EPIDEMIOL, V83, P593, DOI 10.1093/oxfordjournals.aje.a120610
   GOMES HR, 2001, REV SOC BRAS MED S1, V34, P197
   Guimaraes M C, 1983, Rev Inst Med Trop Sao Paulo, V25, P93
   HOMMEL M, 1978, ANN TROP MED PARASIT, V72, P213, DOI 10.1080/00034983.1978.11719308
   LANOTTE G, 1979, ANN PARASIT HUM COMP, V54, P277, DOI 10.1051/parasite/1979543277
   MACHADOCOELHO GLL, 1995, MEM I OSWALDO CRUZ, V90, P59, DOI 10.1590/S0074-02761995000100013
   MANCIANTI F, 1995, VET PARASITOL, V59, P13, DOI 10.1016/0304-4017(94)00738-X
   Mancianti F, 1996, VET PARASITOL, V65, P1, DOI 10.1016/0304-4017(96)00946-6
   MANCIANTI F, 1988, T ROY SOC TROP MED H, V82, P566, DOI 10.1016/0035-9203(88)90510-X
   MARZOCHI M C A, 1985, Memorias do Instituto Oswaldo Cruz, V80, P349, DOI 10.1590/S0074-02761985000300012
   MOHAMMED EAE, 1986, T ROY SOC TROP MED H, V80, P271, DOI 10.1016/0035-9203(86)90033-7
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   NUNES MP, 1991, MEM I OSWALDO CRUZ, V86, P411, DOI 10.1590/S0074-02761991000400006
   ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39
   POZIO E, 1981, ACTA TROP, V38, P383
   Rhalem A, 1999, VET PARASITOL, V81, P173, DOI 10.1016/S0304-4017(98)00240-4
   ROFFI J, 1980, AM J TROP MED HYG, V29, P183, DOI 10.4269/ajtmh.1980.29.183
   Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4
   Singh S, 2003, J Postgrad Med, V49, P55
   Szklo M, 2000, EPIDEMIOLOGY BASIS
   Vieira J B, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P85
NR 35
TC 55
Z9 56
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2005
VL 100
IS 2
BP 197
EP 203
DI 10.1590/S0074-02762005000200015
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 920WP
UT WOS:000228726500015
PM 16021309
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Carneiro, M
   Cardoso, FA
   Greco, M
   Oliveira, E
   Andrade, J
   Greco, DB
   Antunes, CMD
AF Carneiro, M
   Cardoso, FA
   Greco, M
   Oliveira, E
   Andrade, J
   Greco, DB
   Antunes, CMD
CA Project Horizonte Team
TI Determinants of human immunodeficiency virus (HIV) prevalence in
   homosexual and bisexual men screened for admission to a cohort study of
   HIV negatives in Belo Horizonte, Brazil: Project Horizonte
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE human immunodeficiency virus prevalence; risk factors; homosexual and
   bisexual men; open cohort; Minas Gerais; Brazil
ID MULTICENTER AIDS COHORT; RISK-FACTORS; TYPE-1 SEROCONVERSION;
   SEXUAL-BEHAVIOR; INFECTION; RESISTANCE; POPULATIONS; ANTIBODIES;
   MUTATION; ORIGIN
AB Project Horizonte, an open cohort of homosexual and bisexual human immunodeficiency virus (HIV-1) negative men, is a component of the AIDS Vaccine Program, in Belo Horizonte, Minas Gerais, Brazil. The objective of this study was to compare volunteers testing HIV positive at cohort entry with a sample of those who tested HIV negative in order to identify risk factors for prevalent HIV infection, in a population being screened for enrollment at Project Horizonte. A nested case-control study was conducted. HIV positive volunteers at entry (cases) were matched by age and admission date to three HIV negative controls each. Selected variables used for the current analysis, included demographic factors, sexual behavior and other risk factors for HIV infection. During the study period (1994-2001), among the 621 volunteers screened, 61 tested positive for HIV Cases were matched to 183 HIV negative control subjects. After adjustments, the main risk factors associated with HIV infection were unprotected sex with an occasional partners, OR = 3.7 (CI 95% 1.3-10.6), receptive anal intercourse with an occasional partner OR 2.8(95% CI 0.9-8.9) and belonging to the negro racial group, OR = 3.4 (Cl 95% 1.1-11.9). These variables were associated with an increase in the risk of HIV infection among men who have sex with men at the screening for admission to an open HIV negative cohort.
C1 Univ Fed Minas Gerais, Fac Med, Serv Doencas Infecciosas & Parasitarias, Dept Clin Med,Inst Ciencias Biol,Dept Parasitol E, BR-31270901 Belo Horizonte, MG, Brazil.
   Santa Casa Misericordia Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Fac Med, Serv Doencas Infecciosas & Parasitarias, Dept Clin Med,Inst Ciencias Biol,Dept Parasitol E, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RI Greco, Dirceu/AAR-4714-2020
OI Greco, Dirceu/0000-0002-4419-5634
CR BURCHAM JL, 1989, MED J AUSTRALIA, V150, P634, DOI 10.5694/j.1326-5377.1989.tb136727.x
   CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004
   Carneiro M, 2000, J ACQ IMMUN DEF SYND, V25, P182, DOI 10.1097/00126334-200010010-00013
   Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907
   CHMIEL JS, 1987, AM J EPIDEMIOL, V126, P568, DOI 10.1093/oxfordjournals.aje.a114696
   Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856
   GRIECO E, 2001, OVERWIEW RACE HISPAN
   Heckman TG, 1999, J NATL MED ASSOC, V91, P92
   Hosmer DW, 1989, APPL LOGISTIC REGRES
   KINGSLEY LA, 1987, LANCET, V1, P345
   KINGSLEY LA, 1991, AM J EPIDEMIOL, V134, P331, DOI 10.1093/oxfordjournals.aje.a116094
   KLOBIN BA, 1990, AM J EPIDEMIOL, V132, P837
   KUIKEN CL, 1990, AM J EPIDEMIOL, V132, P523, DOI 10.1093/oxfordjournals.aje.a115688
   LEIGH BC, 1993, AM PSYCHOL, V48, P1035, DOI 10.1037/0003-066X.48.10.1035
   Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399
   Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
   MOSS AR, 1987, AM J EPIDEMIOL, V125, P1035, DOI 10.1093/oxfordjournals.aje.a114619
   Ostrow D G, 1993, J Subst Abuse, V5, P311, DOI 10.1016/0899-3289(93)90001-R
   OSTROW DG, 1995, AM J EPIDEMIOL, V142, P875, DOI 10.1093/oxfordjournals.aje.a117727
   PageShafer K, 1997, AM J EPIDEMIOL, V146, P531, DOI 10.1093/oxfordjournals.aje.a009311
   SAMSON M, 1996, NATURE, V382, P668
   SEAGE GR, 1992, AM J EPIDEMIOL, V135, P1
   *STAT CORP, 2001, STAT STAT SOFTW REL
   Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867
   Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198
   VANGRIENSVEN GJP, 1987, AM J EPIDEMIOL, V125, P1048, DOI 10.1093/oxfordjournals.aje.a114620
   WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321
   Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665
NR 28
TC 6
Z9 7
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2003
VL 98
IS 3
BP 325
EP 329
DI 10.1590/S0074-02762003000300006
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 691QV
UT WOS:000183617700006
PM 12886410
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Lignani, L
   Greco, DB
   Carneiro, M
AF Lignani, L
   Greco, DB
   Carneiro, M
TI Assessment of the compliance to antiretroviral drugs among HIV/AIDS
   patients
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE acquired immunodeficiency syndrome, drug therapy; HIV infections, drug
   therapy; anti-HIV agents, therapeutic use; patient compliance;
   antiretroviral therapy, highly active; CD4 lymphocyte count; adherence;
   antiretrovirals
ID ADHERENCE; THERAPY
AB Objectives To assess the compliance to antiretroviral drugs, and identify the main predictive factors and causes for treatment failure and poor compliance.
   Methods Twenty HIV/AIDS were randomly selected for the study. The assessment was carried out using self-reporting and complemented with diary and pharmacy checks. Univariate analysis was performed using Student test and Qui-square. Odds ratio was calculated as an inclusion measure.
   Results One hundred and twenty patients were assessed, ofuhich 87(72.5%) were males and 33(27.5%) were females, with a mean age of 35.5 years old.. Most of them were light dark skin, had completed only elementary school, and were employed, with an income of up to two minimum wages. The mean time of the antiretroviral use was 12 months. The main reason to initiate treatment was a decrease in CD4 lymphcyte counts to less than 350 cells mm(2). Most were taking three or more antiretrovirals. Eighty-nine patients (74%) were considered compliant. The main cause of treatment failure was the medication side effects. The educational level, ago and time of antiretroviral use wore the most important predictors of compliance to antiretrovirals.
   Conclusions To improve treatment compliance there is a need to have treatment regimens with less side effects and treatment all the aspects should be constantly reviewed.
C1 Univ Fed Minas Gerais, Fac Med, Setor Imunodeficiencias, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
RP Lignani, L (corresponding author), Rua Prof Estevao Pinto 685-102, BR-30220060 Belo Horizonte, MG, Brazil.
RI Greco, Dirceu/AAR-4714-2020
OI Greco, Dirceu/0000-0002-4419-5634
CR Altice FL, 1998, ANN INTERN MED, V129, P503, DOI 10.7326/0003-4819-129-6-199809150-00015
   *CDCP, 1992, MMWR-MORBID MORTAL W, V41
   CHAISSON RE, 1999, TAKE DIRECTED ADHERE
   ELDRED L, 1998, UPDATE ADHERENCE HIV
   GORDIS L, 1996, EPIDEMIOLOGY
   Kastrissios H, 1998, AIDS, V12, P2295, DOI 10.1097/00002030-199817000-00011
   LEMES C, 1998, TREGUA AMEACADA
   METHA S, 1997, AIDS, V11, P1665
   *MIN SAUD, 1995, B EP, V8
   *MIN SAUD, 1999, B EP, V12
   NEMES MIB, 1999, AVALIACAO ADERENCIA
   Vitoria MAA, 1998, CONCEITOS RECOMENDAC
   Williams AB, 1999, NURS CLIN N AM, V34, P113
NR 13
TC 25
Z9 31
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD DEC
PY 2001
VL 35
IS 6
BP 495
EP 501
DI 10.1590/S0034-89102001000600001
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 511VX
UT WOS:000173287200001
PM 11799461
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Carneiro, M
   Moreno, EC
   Antunes, CMF
AF Carneiro, M
   Moreno, EC
   Antunes, CMF
TI Nested case-control study in a serological survey to evaluate the
   effectiveness of a Chagas disease control programme in Brazil
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
DE chagas disease/prevention and control; child; program
   evaluation/methods; risk factors; logistic models; seroepidemiologic
   studies; case-control studies; Brazil
ID EFFICACY
AB Objective To identify risk factors associated with Trypanosoma cruzi infections in areas under surveillance in the State of Minas Gerais, Brazil.
   Methods A model using a nested case-control design incorporated within a serological survey of schoolchildren which was employed to evaluate the effectiveness of the Chagas disease control programme.
   Findings In a sample of 40 374 schoolchildren (aged 7-14 years) surveyed, 16 children tested positive for T. cruzi antibody (by indirect immunofluorescence and indirect haemagglutination). In the case-control study, each case was randomly matched to three seronegative controls (classroom and age +/- 1 year). Compared to controls, T: cruzi-seropositive children were more likely to have a seropositive mother (odds ratio (OR) = 6.8; 95% confidence interval (CI) = 0.71-63.9) or a seropositive family member (OR = 8.6; 95% CI = 1.0-75.5).
   Conclusion Use of the nested case-control model in a sero-epidemiological survey to evaluate risk factors for T cruzi transmission was adequate for assessing the effectiveness of a Chagas disease control programme.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
   Fdn Nacl Saude, Coordenacao Reg Minas Gerais, Belo Horizonte, MG, Brazil.
   Santa Casa Misericordia Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM mcarneir@icb.ufmg.br
RI Oliveira, Claudia DL/G-8618-2011
CR Andrade Ana Lucia S. Sgambatti De, 1995, American Journal of Tropical Medicine and Hygiene, V52, P183
   ARMENIAN HK, 1994, EPIDEMIOL REV, V16, P163, DOI 10.1093/oxfordjournals.epirev.a036141
   BITTENCOURT AL, 1992, REV I MED TROP, V34, P403, DOI 10.1590/S0036-46651992000500006
   CAMARGO ME, 1984, REV I MED TROP, V26, P192, DOI 10.1590/S0036-46651984000400003
   Carneiro M, 1994, Cad Saude Publica, V10 Suppl 2, P261, DOI 10.1590/S0102-311X1994000800004
   CARNEIRO M, 1994, B WORLD HEALTH ORGAN, V72, P721
   Costa FC, 1998, B WORLD HEALTH ORGAN, V76, P385
   de Andrade A L, 1994, Cad Saude Publica, V10 Suppl 2, P345, DOI 10.1590/S0102-311X1994000800012
   DIAS JCP, 1987, PARASITOL TODAY, V3, P336, DOI 10.1016/0169-4758(87)90117-7
   DIAS JCP, 1992, CHAGAS DIS AM TRYPAN, P49
   Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10
   Holland W., 1983, EVALUATION HLTH CARE
   Ibrahim M A, 1983, J Health Adm Educ, V1, P37
   Kelsey J, 1996, METHODS OBSERVATIONA
   KLEINBAUM DG, 1982, EPIDEMIOLOGICAL RES
   Moncayo Alvaro, 1997, World Health Statistics Quarterly, V50, P195
   Moreb JS, 1996, CANCER RES THER CONT, V5, P49
   *NAT HLTH FDN, 1994, EP ENQ EV CHAG DIS C
   Omran A R, 1990, World Health Forum, V11, P286
   RMENIA HK, 1998, EPIDEMIOLOGY HLTH SE, P135
   SCHMUNIS GA, 1991, TRANSFUSION, V31, P547, DOI 10.1046/j.1537-2995.1991.31691306255.x
   SELBY JV, EPIDEMIOLOGICAL REV, V16, P90
   SHAPIRO S, 1998, EPIDEMIOLOGY HLTH SE, P157
   Silveira A. C., 1994, Revista da Sociedade Brasileira de Medicina Tropical, V27, P11, DOI 10.1590/S0037-86821994000100003
   Silveira Antonio Carlos, 1998, Revista da Sociedade Brasileira de Medicina Tropical, V31, P15
   SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87
   *WHO, 1997, WEEKLY EPIDEMIOLOGIC, V72, P1
   1999, TDR NEWS         JUN, P10
NR 28
TC 3
Z9 5
U1 0
U2 0
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PY 2001
VL 79
IS 5
BP 409
EP 414
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 435DW
UT WOS:000168863000006
PM 11417036
DA 2020-12-08
ER

PT J
AU Carneiro, M
   Antunes, CMD
   Greco, M
   Oliveira, E
   Andrade, J
   Lignani, L
   Greco, DB
AF Carneiro, M
   Antunes, CMD
   Greco, M
   Oliveira, E
   Andrade, J
   Lignani, L
   Greco, DB
CA Project Horizonte
TI Design, implementation, and evaluation at entry of a prospective cohort
   study of homosexual and bisexual HIV-1-negative men in Belo Horizonte,
   Brazil: Project Horizonte
SO JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE HIV; HIV incidence; homosexual and bisexual; open cohort; vaccines
ID MULTICENTER AIDS COHORT; VACCINE TRIALS; HIV-INFECTION; UNITED-STATES;
   WILLINGNESS; EPIDEMIC; TRENDS; RISK
AB Background and Objectives: Project Horizonte, an open cohort of homosexual and bisexual HIV-l-negative men, is a component of the Minas Gerais AIDS Vaccine Program of the Federal University of Minas Gerais, Belo Horizonte, Brazil. Its objectives included the evaluation of seroincidence of HIV, to ascertain the role of counseling on behavior modification and to assess their willingness to participate in future HIV vaccine trials.
   Methods: Various means of recruitment were used, including pamphlets, notices in community newspapers, radio, and television, at anonymous testing centers;, and by word of mouth.
   Results: From October 1994 to May 1999, 470 volunteers were enrolled, Their mean age was 26 years and over 70% of them had high school or college education. During the follow-up, they were seen every 6 months, when they received counseling and condoms, and when HIV testing was done. Eighteen seroconversions were observed, and the incidence rates estimates were 1.75 per 100 and 1.99 per 100 person years, for 36 and 48 months of follow-up, respectively. During the entire period, 139 volunteers were lost to follow-up. Among them, 59 (42.4%) never returned after the initial visit and 51 (36.7) came only once after their initial visit. No losses were observed for those observed during follow-up for more than 3 years. At enrollment, 50% of participants said they would participate in a vaccine trial, and 30% said they might participate.
   Conclusions: The results obtained up to this moment confirm the feasibility of following this type of cohort for an extended period, estimating HIV incidence rate, and evaluating counseling for safe sexual practices in preparation for clinical trials with candidate HIV vaccines in Brazil.
C1 Univ Fed Minas Gerais, DIP, Fac Med,Dept Clin Med, Serv Doencas Infecciosas & Parasitarias, BR-30130100 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Fac Med, Programa Posgrad Med Trop, BR-30130100 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30130100 Belo Horizonte, MG, Brazil.
   Santa Casa Misericordia Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Greco, DB (corresponding author), Univ Fed Minas Gerais, DIP, Fac Med,Dept Clin Med, Serv Doencas Infecciosas & Parasitarias, Ave Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
EM greco@medicina.ufmg.br
RI Oliveira, Edward/AAA-4949-2020; Greco, Dirceu/AAR-4714-2020
OI Greco, Dirceu/0000-0002-4419-5634
CR ANDRADE J, 1996, 11 INT C AIDS VANC B
   Bartholow BN, 1997, J ACQ IMMUN DEF SYND, V16, P108, DOI 10.1097/00042560-199710010-00006
   BRETA MBA, 1996, 11 INT C AIDS VANC B
   BRUNDAGE JF, 1990, J ACQ IMMUN DEF SYND, V3, P1168
   Buchbinder SP, 1996, J INFECT DIS, V174, P954, DOI 10.1093/infdis/174.5.954
   CARNEIRO M, 1996, 11 INT C AIDS VANC B
   DUDLEY J, 1995, AM J EPIDEMIOL, V142, P323, DOI 10.1093/oxfordjournals.aje.a117638
   FONSECA JJ, 1996, 11 INT C AIDS VANC B
   GRECO DB, 1998, 12 INT C AIDS GEN SW
   GRECO M, 1998, 12 INT C AIDS GEN SW
   Harrison LH, 1999, J ACQ IMMUN DEF SYND, V21, P408
   KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310
   KINGSLEY LA, 1991, AM J EPIDEMIOL, V134, P331, DOI 10.1093/oxfordjournals.aje.a116094
   Lignani L, 2000, MEM I OSWALDO CRUZ, V95, P783, DOI 10.1590/S0074-02762000000600006
   *MIN SAUD, 1998, B EP AIDS 11 YEAR, V3
   OLIVEIRA EL, 1996, 11 INT C AIDS VANC B
   ROSENBERG PS, 1992, JAMA-J AM MED ASSOC, V268, P495
   Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299
   *STATC, 1999, STAT STAT SOFTW REL
   VIANA L, 1996, 11 INT C AIDS VANC B
   VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406
NR 21
TC 16
Z9 18
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
J9 J ACQ IMMUN DEF SYND
JI J. Acquir. Immune Defic. Syndr.
PD OCT 1
PY 2000
VL 25
IS 2
BP 182
EP 187
DI 10.1097/00126334-200010010-00013
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 376AA
UT WOS:000165434600012
PM 11103049
DA 2020-12-08
ER

EF